histology,behavior,preferred,description
8000,0,1,"Neoplasm, benign"
8000,0,0,"Tumor, benign"
8000,0,0,"Tumor, benign, unclassified"
8000,0,0,"Tumor, unclassified, benign"
8000,0,0,"Unclassified tumor, benign"
8000,1,1,"Neoplasm, uncertain whether benign or malignant"
8000,1,0,"Neoplasm, NOS"
8000,1,0,"Tumor, NOS"
8000,1,0,"Tumor, unclassified, borderline malignancy"
8000,1,0,"Tumor, unclassified, uncertain whether benign or malignant"
8000,1,0,"Unclassified tumor, borderline malignancy"
8000,1,0,"Unclassified tumor, uncertain whether benign or malignant"
8000,3,1,"Neoplasm, malignant"
8000,3,0,"Blastoma, NOS"
8000,3,0,"Cancer [see coding guidelines, page 27 of ICD-O-3 manual]"
8000,3,0,Malignancy
8000,3,0,"Tumor, malignant, NOS"
8000,3,0,"Tumor, malignant, unclassified"
8000,3,0,"Tumor, unclassified, malignant"
8000,3,0,"Unclassified tumor, malignant"
8000,6,1,"Neoplasm, metastatic"
8000,6,0,"Embolus, tumor"
8000,6,0,Metastatic neoplasm
8000,6,0,Metastatic tumor
8000,6,0,"Neoplasm, secondary"
8000,6,0,Secondary neoplasm
8000,6,0,Secondary tumor
8000,6,0,Tumor embolus
8000,6,0,"Tumor, metastatic"
8000,6,0,"Tumor, secondary"
8000,9,1,"Neoplasm, malignant, uncertain whether primary or metastatic"
8000,9,0,"Tumor, malignant, unclassified, uncertain whether primary or metastatic"
8000,9,0,"Tumor, unclassified, malignant, uncertain whether primary or metastatic"
8000,9,0,"Unclassified tumor, malignant, uncertain whether primary or metastatic"
8001,0,1,"Tumor cells, benign"
8001,1,1,"Tumor cells, uncertain whether benign or malignant"
8001,1,0,"Tumor cells, NOS"
8001,3,1,"Tumor cells, malignant"
8002,3,1,"Malignant tumor, small cell type"
8002,3,0,"Small cell type, malignant tumor"
8002,3,0,"Tumor, malignant, small cell type"
8002,3,0,"Tumor, small cell type, malignant"
8003,3,1,"Malignant tumor, giant cell type"
8003,3,0,"Giant cell type, malignant tumor"
8003,3,0,"Tumor, giant cell type, malignant"
8003,3,0,"Tumor, malignant, giant cell type"
8004,3,1,"Malignant tumor, spindle cell type"
8004,3,0,"Fusiform cell type, malignant tumor"
8004,3,0,"Malignant tumor, fusiform cell type"
8004,3,0,"Spindle cell type, malignant tumor"
8004,3,0,"Tumor, fusiform cell type, malignant"
8004,3,0,"Tumor, malignant, fusiform cell type"
8004,3,0,"Tumor, malignant, spindle cell type"
8004,3,0,"Tumor, spindle cell type, malignant"
8005,0,1,"Clear cell tumor, NOS"
8005,0,0,"Tumor, clear cell, NOS"
8005,3,1,"Malignant tumor, clear cell type"
8005,3,0,Clear cell type malignant tumor
8005,3,0,"Tumor, clear cell type, malignant"
8005,3,0,"Tumor, malignant, clear cell type"
8010,0,1,"Epithelial tumor, benign"
8010,0,0,"Tumor, epithelial, benign"
8010,2,1,"Carcinoma in situ, NOS"
8010,2,0,"Carcinoma, intraepithelial, NOS"
8010,2,0,"In situ carcinoma, NOS"
8010,2,0,"Intraepithelial carcinoma, NOS"
8010,3,1,"Carcinoma, NOS"
8010,3,0,"Carcinoma, urachal (C65.9, C66.9, C67._, C68._) [2018+]"
8010,3,0,"Epithelial tumor, malignant"
8010,3,0,"Tumor, epithelial, malignant"
8010,3,0,"Urachal carcinoma (C65.9, C66.9, C67._, C68._) [2018+]"
8010,6,1,"Carcinoma, metastatic, NOS"
8010,6,0,"Carcinoma, NOS, metastatic"
8010,6,0,"Carcinoma, secondary"
8010,6,0,"Metastatic carcinoma, NOS"
8010,6,0,Secondary carcinoma
8010,9,1,Carcinomatosis
8011,0,1,"Epithelioma, benign"
8011,3,1,"Epithelioma, malignant"
8011,3,0,"Epithelioma, NOS"
8012,3,1,"Large cell carcinoma, NOS"
8012,3,0,"Carcinoma, large cell, NOS"
8013,3,1,Large cell neuroendocrine carcinoma
8013,3,0,"Carcinoma, combined large cell neuroendocrine (C34._, C37.9) [2018+]"
8013,3,0,"Carcinoma, large cell neuroendocrine combined (C34._, C37.9) [2018+]"
8013,3,0,"Carcinoma, large cell, neuroendocrine"
8013,3,0,"Carcinoma, neuroendocrine, large cell"
8013,3,0,"Carcinoma, neuroendocrine, large cell combined (C34._, C37.9) [2018+]"
8013,3,0,"Combined large cell neuroendocrine carcinoma (C34._, C37.9) [2018+]"
8013,3,0,"Large cell carcinoma, neuroendocrine"
8013,3,0,"Large cell carcinoma, neuroendocrine combined (C34._, C37.9) [2018+]"
8013,3,0,"Neuroendocrine carcinoma, combined large cell (C34._, C37.9) [2018+]"
8013,3,0,"Neuroendocrine carcinoma, large cell"
8014,3,1,Large cell carcinoma with rhabdoid phenotype
8014,3,0,"Carcinoma, large cell, with rhabdoid phenotype"
8014,3,0,"Phenotype, large cell carcinoma with rhabdoid"
8014,3,0,"Rhabdoid phenotype, large cell carcinoma with"
8015,3,1,Glassy cell carcinoma
8015,3,0,"Carcinoma, glassy cell"
8020,3,1,"Carcinoma, undifferentiated, NOS"
8020,3,0,Anaplastic undifferentiated carcinoma (C73.9) [2021+]
8020,3,0,"Carcinoma, anaplastic undifferentiated (C73.9) [2021+]"
8020,3,0,"Carcinoma, dedifferentiated [2021+]"
8020,3,0,"Carcinoma, poorly differentiated, NOS [2021+]"
8020,3,0,Dedifferentiated carcinoma [2021+]
8020,3,0,"Poorly differentiated carcinoma, NOS [2021+]"
8020,3,0,"Undifferentiated carcinoma, NOS"
8021,3,1,"Carcinoma, anaplastic, NOS"
8021,3,0,"Anaplastic carcinoma, NOS"
8022,3,1,Pleomorphic carcinoma
8022,3,0,"Carcinoma, pleomorphic"
8023,3,1,Nuclear protein in testis (NUT)-associated carcinoma 
8023,3,0,"Carcinoma, midline, of children and young adults with NUT rearrangement (C30.0, C31.9, C34._) [2018+]"
8023,3,0,"Carcinoma, NUT (C30.0, C31.9, C34._) [2018+]"
8023,3,0,"Carcinoma, NUT midline (C30.0, C31.9, C34._) [2018+]"
8023,3,0,"Midline carcinoma of children and young adults with NUT rearrangement (C30.0, C31.9, C34._) [2018+]"
8023,3,0,"NUT carcinoma (C30.0, C31.9, C34._) [2018+]"
8023,3,0,"NUT midline (C30.0, C31.9, C34._) [2018+]"
8030,3,1,Giant cell and spindle cell carcinoma
8030,3,0,"Carcinoma, giant cell and spindle cell"
8030,3,0,"Carcinoma, spindle cell and giant cell"
8030,3,0,Spindle cell carcinoma and giant cell carcinoma
8031,3,1,Giant cell carcinoma
8031,3,0,"Carcinoma, giant cell"
8032,3,1,"Spindle cell carcinoma, NOS"
8032,3,0,"Carcinoma, spindle cell, NOS"
8033,3,1,Pseudosarcomatous carcinoma
8033,3,0,Carcinoma with sarcomatoid component [2022+]
8033,3,0,"Carcinoma, pseudosarcomatous"
8033,3,0,"Carcinoma, sarcomatoid"
8033,3,0,Sarcomatoid carcinoma
8033,3,0,"Sarcomatoid component, carcinoma with [2022+]"
8034,3,1,Polygonal cell carcinoma
8034,3,0,"Carcinoma, polygonal cell"
8035,3,1,Carcinoma with osteoclast-like giant cells
8035,3,0,"Giant cells, carcinoma with osteoclast-like"
8035,3,0,"Osteoclast-like giant cells, carcinoma with"
8040,0,1,"Tumorlet, benign"
8040,1,1,"Tumorlet, NOS"
8041,3,1,"Small cell carcinoma, NOS"
8041,3,0,"Carcinoma, neuroendocrine, high grade (C54._, C55.9) [2018+]"
8041,3,0,"Carcinoma, neuroendocrine, poorly differentiated [OF BREAST] (C50._) [2018+]"
8041,3,0,"Carcinoma, reserve cell"
8041,3,0,"Carcinoma, round cell"
8041,3,0,"Carcinoma, small cell, neuroendocrine"
8041,3,0,"Carcinoma, small cell, NOS"
8041,3,0,"Carcinoma, small cell, pulmonary type (C56.9) [2018+]"
8041,3,0,"High-grade neuroendocrine carcinoma (C54._, C55.9) [2018+]"
8041,3,0,"Neuroendocrine carcinoma, high grade  (C54._, C55.9) [2018+]"
8041,3,0,"Neuroendocrine carcinoma, poorly differentiated [OF BREAST] (C50._) [2018+]"
8041,3,0,"Neuroendocrine carcinoma, small cell"
8041,3,0,Reserve cell carcinoma
8041,3,0,Round cell carcinoma
8041,3,0,Small cell carcinoma pulmonary type (C56.9) [2018+]
8041,3,0,"Small cell carcinoma, neuroendocrine"
8041,3,0,Small cell neuroendocrine carcinoma
8042,3,1,Oat cell carcinoma (C34._)
8042,3,0,"Carcinoma, oat cell (C34._)"
8043,3,1,"Small cell carcinoma, fusiform cell"
8043,3,0,"Carcinoma, small cell, fusiform cell"
8043,3,0,"Fusiform cell, small cell carcinoma"
8044,3,1,"Small cell carcinoma, intermediate cell"
8044,3,0,"Carcinoma, small cell, hypercalcemic type (C56.9) [2018+]"
8044,3,0,"Carcinoma, small cell, intermediate cell"
8044,3,0,"Carcinoma, small cell, large cell variant (C56.9) [2022+]"
8044,3,0,"Intermediate cell, small cell carcinoma"
8044,3,0,"Large cell variant, small cell carcinoma (C56.9) [2022+]"
8044,3,0,"Small cell carcinoma, hypercalcemic type (C56.9) [2018+]"
8044,3,0,"Small cell carcinoma, large cell variant (C56.9) [2022+]"
8045,3,1,Combined small cell carcinoma
8045,3,0,"Adenocarcinoma, combined small cell-adenocarcinoma"
8045,3,0,"Carcinoma, combined small cell"
8045,3,0,"Carcinoma, combined small cell-large cell"
8045,3,0,"Carcinoma, combined small cell-squamous cell"
8045,3,0,"Carcinoma, large cell-small cell, combined"
8045,3,0,"Carcinoma, mixed small cell"
8045,3,0,"Carcinoma, small cell-large cell, combined"
8045,3,0,Combined small cell-adenocarcinoma
8045,3,0,Combined small cell-large cell carcinoma
8045,3,0,Combined small cell-squamous cell carcinoma
8045,3,0,"Large cell-small cell carcinoma, combined"
8045,3,0,Mixed small cell carcinoma
8045,3,0,"Small cell carcinoma, combined"
8045,3,0,"Small cell carcinoma, mixed"
8045,3,0,"Small cell-adenocarcinoma, combined"
8045,3,0,"Small cell-large cell carcinoma, combined"
8045,3,0,"Small cell-squamous cell carcinoma, combined"
8045,3,0,"Squamous cell-small cell carcinoma, combined"
8046,3,1,Non-small cell carcinoma (C34._)
8046,3,0,"Carcinoma, non-small cell (C34._)"
8050,0,1,"Papilloma, NOS (except papilloma of bladder M-8120/1)"
8050,2,1,Papillary carcinoma in situ
8050,2,0,"Carcinoma in situ, papillary"
8050,2,0,"Carcinoma, papillary, in situ"
8050,2,0,"In situ carcinoma, papillary"
8050,2,0,In situ papillary carcinoma
8050,3,1,"Papillary carcinoma, NOS"
8050,3,0,"Carcinoma, papillary, NOS"
8051,0,1,Verrucous papilloma
8051,0,0,"Papilloma, verrucous"
8051,3,1,"Warty carcinoma [2018+ CASES FOR C60._, USE 8054/3. ALL OTHER SITES USE 8051/3 FOR ALL YEARS]"
8051,3,0,"Carcinoma, condylomatous [2018+ CASES FOR C60._, USE 8054/3. ALL OTHER SITES USE 8051/3 FOR ALL YEARS]"
8051,3,0,"Carcinoma, epidermoid, verrucous"
8051,3,0,"Carcinoma, squamous cell, verrucous"
8051,3,0,"Carcinoma, verrucous, epidermoid"
8051,3,0,"Carcinoma, verrucous, NOS"
8051,3,0,"Carcinoma, verrucous, squamous cell"
8051,3,0,"Carcinoma, warty [2018+ CASES FOR C60._, USE 8054/3. ALL OTHER SITES USE 8051/3 FOR ALL YEARS]"
8051,3,0,"Condylomatous carcinoma [2018+ CASES FOR C60._, USE 8054/3. ALL OTHER SITES USE 8051/3 FOR ALL YEARS]"
8051,3,0,"Epidermoid carcinoma, verrucous"
8051,3,0,"Squamous cell carcinoma, verrucous"
8051,3,0,"Verrucous carcinoma, epidermoid"
8051,3,0,"Verrucous carcinoma, NOS"
8051,3,0,"Verrucous carcinoma, squamous cell"
8051,3,0,Verrucous epidermoid carcinoma
8051,3,0,Verrucous squamous cell carcinoma
8052,0,1,"Squamous cell papilloma, NOS"
8052,0,0,Keratotic papilloma
8052,0,0,"Papilloma, keratotic"
8052,0,0,"Papilloma, squamous"
8052,0,0,"Papilloma, squamous cell, NOS"
8052,0,0,Squamous papilloma
8052,2,1,"Papillary squamous cell carcinoma, non-invasive"
8052,2,0,"Carcinoma, papillary squamous cell, in situ"
8052,2,0,"Carcinoma, papillary squamous cell, non-invasive"
8052,2,0,"Carcinoma, squamous cell papillary, non-invasive"
8052,2,0,In situ papillary squamous cell carcinoma
8052,2,0,"In situ squamous cell carcinoma, papillary"
8052,2,0,"Non-invasive carcinoma, papillary squamous cell"
8052,2,0,"Papillary carcinoma in situ, squamous cell"
8052,2,0,"Papillary carcinoma, squamous cell, non-invasive"
8052,2,0,Papillary squamous cell carcinoma in situ
8052,2,0,"Squamous cell carcinoma, papillary, in situ"
8052,2,0,"Squamous cell carcinoma, papillary, non-invasive"
8052,3,1,Papillary squamous cell carcinoma
8052,3,0,"Carcinoma, epidermoid, papillary"
8052,3,0,"Carcinoma, papillary epidermoid"
8052,3,0,"Carcinoma, papillary squamous cell"
8052,3,0,"Carcinoma, papillary, epidermoid"
8052,3,0,"Carcinoma, squamous cell, papillary"
8052,3,0,"Epidermoid carcinoma, papillary"
8052,3,0,"Papillary carcinoma, epidermoid"
8052,3,0,"Papillary carcinoma, squamous cell"
8052,3,0,Papillary epidermoid carcinoma
8052,3,0,"Squamous cell carcinoma, papillary"
8053,0,1,"Squamous cell papilloma, inverted"
8053,0,0,"Inverted papilloma, squamous cell"
8053,0,0,"Papilloma, inverted squamous cell"
8053,0,0,"Papilloma, squamous cell, inverted"
8054,3,1,"Warty carcinoma (C60.0-C60.2, C60.9) [2018+. PRE-2018 CASES FOR C60, USE 8051/3.  ALL OTHER SITES USE 8051/3 FOR ALL YEARS]"
8054,3,0,"Carcinoma, condylomatous (C60.0-C60.2, C60.9) [2018+. PRE-2018 CASES FOR C60, USE 8051/3. ALL OTHER SITES USE 8051/3 FOR ALL YEARS]"
8054,3,0,"Carcinoma, warty (C60.0-C60.2, C60.9) [2018+. PRE-2018 CASES FOR C60, USE 8051/3.  ALL OTHER SITES USE 8051/3 FOR ALL YEARS]"
8054,3,0,"Carcinoma, warty-basaloid [2021+]"
8054,3,0,"Condylomatous carcinoma (C60.0-C60.2, C60.9) [2018+. PRE-2018 CASES FOR C60, USE 8051/3. ALL OTHER SITES USE 8051/3 FOR ALL YEARS]"
8054,3,0,Warty-basaloid carcinoma [2021+]
8060,0,1,Squamous papillomatosis
8060,0,0,"Papillomatosis, NOS"
8060,0,0,"Papillomatosis, squamous"
8070,2,1,"Squamous cell carcinoma in situ, NOS"
8070,2,0,"Carcinoma in situ, epidermoid, NOS"
8070,2,0,"Carcinoma in situ, squamous cell, NOS"
8070,2,0,"Carcinoma, epidermoid, in situ, NOS"
8070,2,0,"Carcinoma, intraepidermal, NOS"
8070,2,0,"Carcinoma, intraepithelial, squamous cell"
8070,2,0,"Carcinoma, squamous cell, in situ, NOS"
8070,2,0,"Carcinoma, squamous cell, intraepithelial"
8070,2,0,"Epidermoid carcinoma in situ, NOS"
8070,2,0,"In situ carcinoma, epidermoid, NOS"
8070,2,0,"In situ carcinoma, squamous cell, NOS"
8070,2,0,"In situ epidermoid carcinoma, NOS"
8070,2,0,"In situ squamous cell carcinoma, NOS"
8070,2,0,"Intraepidermal carcinoma, NOS"
8070,2,0,Intraepithelial squamous cell carcinoma
8070,2,0,"Squamous cell carcinoma, intraepithelial"
8070,3,1,"Squamous cell carcinoma, NOS"
8070,3,0,"Carcinoma, epidermoid, NOS"
8070,3,0,"Carcinoma, squamous"
8070,3,0,"Carcinoma, squamous cell, NOS"
8070,3,0,"Epidermoid carcinoma, NOS"
8070,3,0,"Epithelioma, squamous cell"
8070,3,0,Squamous carcinoma
8070,3,0,Squamous cell epithelioma
8070,6,1,"Squamous cell carcinoma, metastatic, NOS"
8070,6,0,"Carcinoma, squamous cell, metastatic, NOS"
8070,6,0,"Carcinoma, squamous cell, NOS, metastatic"
8070,6,0,"Metastatic squamous cell carcinoma, NOS"
8071,2,1,Differentiated penile [or vulvar] intraepithelial neoplasia (C60._  [or C51._]) [2018+ CASES ONLY]
8071,2,0,Differentiated penile intraepithelial neoplasia (C60._) [2018+ CASES ONLY]
8071,2,0,Differentiated-type vulvar intraepithelial neoplasia (C51._) [2018+ CASES ONLY]
8071,2,0,"Intraepithelial neoplasia, penile differentiated (C60._) [2018+ CASES ONLY]"
8071,2,0,"Intraepithelial neoplasia, vulvar differentiated-type (C51._) [2018+ CASES ONLY]"
8071,3,1,"Squamous cell carcinoma, keratinizing, NOS"
8071,3,0,"Carcinoma, epidermoid, keratinizing"
8071,3,0,"Carcinoma, large cell, squamous cell, keratinizing"
8071,3,0,"Carcinoma, squamous cell, keratinizing, NOS"
8071,3,0,"Carcinoma, squamous cell, large cell, keratinizing"
8071,3,0,"Epidermoid carcinoma, keratinizing"
8071,3,0,Keratinizing epidermoid carcinoma
8071,3,0,"Keratinizing squamous cell carcinoma, large cell"
8071,3,0,"Keratinizing squamous cell carcinoma, NOS"
8071,3,0,Keratoacanthoma [2021+]
8071,3,0,"Large cell carcinoma, squamous cell, keratinizing"
8071,3,0,"Squamous cell carcinoma, large cell, keratinizing"
8072,3,1,"Squamous cell carcinoma, large cell, nonkeratinizing, NOS"
8072,3,0,"Carcinoma, epidermoid, large cell, nonkeratinizing"
8072,3,0,"Carcinoma, large cell epidermoid, nonkeratinizing"
8072,3,0,"Carcinoma, large cell, squamous cell, nonkeratinizing, NOS"
8072,3,0,"Carcinoma, squamous cell, large cell, nonkeratinizing, NOS"
8072,3,0,"Carcinoma, squamous cell, nonkeratinizing, NOS"
8072,3,0,"Epidermoid carcinoma, large cell, nonkeratinizing"
8072,3,0,"Large cell carcinoma, epidermoid, nonkeratinizing"
8072,3,0,"Large cell carcinoma, squamous cell, nonkeratinizing, NOS"
8072,3,0,"Nonkeratinizing epidermoid carcinoma, large cell"
8072,3,0,"Nonkeratinizing squamous cell carcinoma, large cell, NOS"
8072,3,0,"Nonkeratinizing squamous cell carcinoma, NOS"
8072,3,0,"Squamous cell carcinoma, nonkeratinizing, NOS"
8073,3,1,"Squamous cell carcinoma, small cell, nonkeratinizing"
8073,3,0,"Carcinoma, epidermoid, small cell, nonkeratinizing"
8073,3,0,"Carcinoma, small cell, squamous cell, nonkeratinizing"
8073,3,0,"Carcinoma, squamous cell, small cell, nonkeratinizing"
8073,3,0,"Epidermoid carcinoma, small cell, nonkeratinizing"
8073,3,0,"Nonkeratinizing epidermoid carcinoma, small cell"
8073,3,0,"Nonkeratinizing squamous cell carcinoma, small cell"
8073,3,0,"Small cell carcinoma, epidermoid, nonkeratinizing"
8073,3,0,"Small cell carcinoma, squamous cell, nonkeratinizing"
8074,3,1,"Squamous cell carcinoma, spindle cell"
8074,3,0,"Carcinoma, epidermoid, spindle cell"
8074,3,0,"Carcinoma, squamous cell, pseudovascular [2021+]"
8074,3,0,"Carcinoma, squamous cell, sarcomatoid"
8074,3,0,"Carcinoma, squamous cell, spindle cell"
8074,3,0,"Epidermoid carcinoma, spindle cell"
8074,3,0,Pseudovascular squamous cell carcinoma [2021+]
8074,3,0,"Sarcomatoid carcinoma, squamous cell"
8074,3,0,Sarcomatoid squamous cell carcinoma
8074,3,0,Spindle cell epidermoid carcinoma
8074,3,0,Spindle cell squamous cell carcinoma
8074,3,0,"Squamous cell carcinoma, pseudovascular [2021+]"
8074,3,0,"Squamous cell carcinoma, sarcomatoid"
8075,3,1,"Squamous cell carcinoma, adenoid"
8075,3,0,Acantholytic squamous cell carcinoma
8075,3,0,Adenoid squamous cell carcinoma
8075,3,0,"Carcinoma, acantholytic squamous cell"
8075,3,0,"Carcinoma, adenoid squamous cell"
8075,3,0,"Carcinoma, pseudoglandular, squamous cell"
8075,3,0,"Carcinoma, squamous cell, acantholytic"
8075,3,0,"Carcinoma, squamous cell, adenoid"
8075,3,0,"Carcinoma, squamous cell, pseudoglandular"
8075,3,0,Pseudoglandular squamous cell carcinoma
8075,3,0,"Squamous cell carcinoma, acantholytic"
8075,3,0,"Squamous cell carcinoma, pseudoglandular"
8076,2,1,Squamous cell carcinoma in situ with questionable stromal invasion
8076,2,0,"Carcinoma in situ, epidermoid with questionable stromal invasion"
8076,2,0,"Carcinoma in situ, squamous cell with questionable stromal invasion"
8076,2,0,"Carcinoma, epidermoid in situ with questionable stromal invasion"
8076,2,0,"Carcinoma, squamous cell, in situ, with questionable stromal invasion"
8076,2,0,Epidermoid carcinoma in situ with questionable stromal invasion
8076,2,0,"In situ carcinoma, epidermoid with questionable stromal invasion"
8076,2,0,"In situ carcinoma, squamous cell with questionable stromal invasion"
8076,2,0,In situ epidermoid carcinoma with questionable stromal invasion
8076,2,0,In situ squamous cell carcinoma with questionable stromal invasion
8076,2,0,"Questionable stromal invasion, epidermoid carcinoma in situ with"
8076,2,0,"Questionable stromal invasion, squamous cell carcinoma in situ with"
8076,3,1,"Squamous cell carcinoma, microinvasive"
8076,3,0,"Carcinoma, microinvasive squamous cell"
8076,3,0,"Carcinoma, squamous cell, microinvasive"
8076,3,0,Microinvasive squamous cell carcinoma
8077,2,1,"Squamous intraepithelial neoplasia, grade III [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,AIN III (C21.1) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]
8077,2,0,"Anal intraepithelial neoplasia, grade III (C21.1) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,"Cervical intraepithelial neoplasia, grade III (C53._) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,CIN III with severe dysplasia (C53._) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]
8077,2,0,"CIN III, NOS (C53._) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,"Dysplasia, CIN III with severe (C53._) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,"Dysplasia, squamous, high grade [REPORTABLE 2021+, EXCLUDING C53._; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,Grade III anal intraepithelial neoplasia (C21.1) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]
8077,2,0,Grade III cervical intraepithelial neoplasia (C53._) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]
8077,2,0,Grade III squamous intraepithelial neoplasia [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]
8077,2,0,Grade III vaginal intraepithelial neoplasia (C52._) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]
8077,2,0,Grade III vulvar intraepithelial neoplasia (C51._) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]
8077,2,0,"High grade squamous dysplasia [REPORTABLE 2021+, EXCLUDING C53._; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,"High grade squamous intraepithelial lesion [REPORTABLE 2021+, EXCLUDING C53._; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,"Intraepithelial neoplasia, grade II, squamous [REPORTABLE 2021+, EXCLUDING C53._; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,"Intraepithelial neoplasia, grade III, anal (C21.1) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,"Intraepithelial neoplasia, grade III, cervical (C53._) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,"Intraepithelial neoplasia, grade III, squamous [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,"Intraepithelial neoplasia, grade III, vaginal (C52._) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,"Intraepithelial neoplasia, grade III, vulvar (C51._) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,"Neoplasia, anal intraepithelial, grade III (C21.1) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,"Neoplasia, cervical intraepithelial, grade III (C53._) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,"Neoplasia, squamous intraepithelial, grade II [REPORTABLE 2021+, EXCLUDING C53._; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,"Neoplasia, squamous intraepithelial, grade III [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,"Neoplasia, vaginal intraepithelial, grade III (C52._) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,"Neoplasia, vulvar intraepithelial, grade III (C51._) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,"Severe dysplasia, CIN III with (C53._) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,"Squamous dysplasia, high grade [REPORTABLE 2021+, EXCLUDING C53._; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,"Squamous intraepithelial lesion, high grade [REPORTABLE 2021+, EXCLUDING C53._; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,"Squamous intraepithelial neoplasia, grade II [REPORTABLE 2021+, EXCLUDING C53._; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,"Vaginal intraepithelial neoplasia, grade III (C52._) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8077,2,0,VAIN III (C52._) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]
8077,2,0,VIN III (C51._) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]
8077,2,0,"Vulvar intraepithelial neoplasia, grade III (C51._) [SEE STANDARD SETTER REQUIREMENTS FOR REPORTABLE SITES]"
8078,3,1,Squamous cell carcinoma with horn formation
8078,3,0,"Carcinoma, squamous cell, with horn formation"
8078,3,0,"Horn formation, squamous cell carcinoma with"
8078,3,0,"Squamous cell carcinoma, with horn formation"
8080,2,1,Queyrat erythroplasia (C60._)
8080,2,0,"Erythroplasia, Queyrat (C60._)"
8081,2,1,Bowen disease (C44._)
8081,2,0,Bowen type intraepidermal squamous cell carcinoma (C44._)
8081,2,0,"Carcinoma, Bowen type, intraepidermal squamous cell (C44._)"
8081,2,0,"Carcinoma, intraepidermal, squamous cell, Bowen type (C44._)"
8081,2,0,"Carcinoma, squamous cell, intradermal, Bowen type (C44._)"
8081,2,0,"Disease, Bowen (C44._)"
8081,2,0,"Intraepidermal squamous cell carcinoma, Bowen type (C44._)"
8081,2,0,"Squamous cell carcinoma, Bowen type, intraepidermal (C44._)"
8081,2,0,"Squamous cell carcinoma, intraepidermal, Bowen type (C44._)"
8082,3,1,Lymphoepithelial carcinoma
8082,3,0,"Carcinoma, lymphoepithelial"
8082,3,0,"Carcinoma, lymphoepithelioma-like"
8082,3,0,Lymphoepithelioma
8082,3,0,Lymphoepithelioma-like carcinoma
8082,3,0,Schmincke tumor (C11._)
8082,3,0,"Tumor, Schmincke (C11._)"
8083,3,1,Basaloid squamous cell carcinoma
8083,3,0,"Carcinoma, basaloid squamous cell"
8083,3,0,"Carcinoma, papillary-basaloid [2021+]"
8083,3,0,"Carcinoma, squamous cell, basaloid"
8083,3,0,Papillary-basaloid carcinoma [2021+]
8083,3,0,"Squamous cell carcinoma, basaloid"
8084,3,1,"Squamous cell carcinoma, clear cell type"
8084,3,0,"Carcinoma, squamous cell, clear cell type"
8084,3,0,Clear cell type squamous cell carcinoma
8085,3,1,"Squamous cell carcinoma, HPV-positive (C01.9, C09.9, C10.2, C10.3, C10.8, C10.9, C31.0–C31.3, C31.9) [2018+]"
8085,3,0,"Carcinoma, squamous cell, HPV-associated (C53._) [2022+]"
8085,3,0,"Carcinoma, squamous cell, HPV-positive (C01.9, C09.9, C10.2, C10.3, C10.8, C10.9, C31.0–C31.3, C31.9) [2018+]"
8085,3,0,HPV-associated squamous cell carcinoma (C53._) [2022+]
8085,3,0,"HPV-positive squamous cell carcinoma (C01.9, C09.9, C10.2, C10.3, C10.8, C10.9, C31.0–C31.3, C31.9) [2018+]"
8085,3,0,"Squamous cell carcinoma, HPV-associated (C53._) [2022+]"
8086,3,1,"Squamous cell carcinoma, HPV-negative (C01.9, C09.9, C10.2, C10.3, C10.8, C10.9, C31.0–C31.3, C31.9) [2018+]"
8086,3,0,"Carcinoma, squamous cell, HPV-independent (C53._) [2022+]"
8086,3,0,"Carcinoma, squamous cell, HPV-negative (C01.9, C09.9, C10.2, C10.3, C10.8, C10.9, C31.0–C31.3, C31.9) [2018+]"
8086,3,0,HPV-independent squamous cell carcinoma (C53._) [2022+]
8086,3,0,"HPV-negative squamous cell carcinoma (C01.9, C09.9, C10.2, C10.3, C10.8, C10.9, C31.0–C31.3, C31.9) [2018+]"
8086,3,0,"Squamous cell carcinoma, HPV-independent (C53._) [2022+]"
8090,1,1,Basal cell tumor (C44._)
8090,1,0,"Tumor, basal cell (C44._)"
8090,3,1,"Basal cell carcinoma, NOS (C44._)"
8090,3,0,Basal cell carcinoma with adnexal differentiation (C44._)
8090,3,0,"Basal cell carcinoma, pigmented (C44._)"
8090,3,0,Basal cell epithelioma (C44._)
8090,3,0,"Carcinoma, basal cell with adnexal differentiation (C44._)"
8090,3,0,"Carcinoma, basal cell, NOS (C44._)"
8090,3,0,"Carcinoma, basal cell, pigmented (C44._)"
8090,3,0,"Carcinoma, pigmented basal cell (C44._)"
8090,3,0,"Epithelioma, basal cell (C44._)"
8090,3,0,Pigmented basal cell carcinoma (C44._)
8090,3,0,Rodent ulcer (C44._)
8090,3,0,"Ulcer, rodent (C44._)"
8091,3,1,Superficial basal cell carcinoma (C44._)
8091,3,0,"Basal cell carcinoma, multicentric (C44._)"
8091,3,0,"Basal cell carcinoma, multifocal superficial (C44._)"
8091,3,0,"Basal cell carcinoma, superficial (C44._)"
8091,3,0,"Carcinoma, basal cell, multicentric (C44._)"
8091,3,0,"Carcinoma, basal cell, multifocal superficial (C44._)"
8091,3,0,"Carcinoma, basal cell, superficial (C44._)"
8091,3,0,"Carcinoma, basal cell, superficial, multifocal (C44._)"
8091,3,0,"Carcinoma, multicentric basal cell (C44._)"
8091,3,0,"Carcinoma, multifocal superficial basal cell (C44._)"
8091,3,0,Multicentric basal cell carcinoma (C44._)
8091,3,0,Multifocal superficial basal cell carcinoma (C44._)
8091,3,0,"Superficial basal cell carcinoma, multifocal (C44._)"
8092,3,1,"Infiltrating basal cell carcinoma, NOS (C44._)"
8092,3,0,"Basal cell carcinoma, desmoplastic type (C44._)"
8092,3,0,"Basal cell carcinoma, infiltrating, non-sclerosing (C44._)"
8092,3,0,"Basal cell carcinoma, infiltrating, NOS (C44._)"
8092,3,0,"Basal cell carcinoma, infiltrating, sclerosing (C44._)"
8092,3,0,"Basal cell carcinoma, morpheic (C44._)"
8092,3,0,"Carcinoma, basal cell, desmoplastic type (C44._)"
8092,3,0,"Carcinoma, basal cell, morpheic (C44._)"
8092,3,0,"Carcinoma, basal cell, non-sclerosing, infiltrating (C44._)"
8092,3,0,"Carcinoma, basal cell, sclerosing, infiltrating (C44._)"
8092,3,0,"Desmoplastic type, basal cell carcinoma (C44._)"
8092,3,0,"Infiltrating basal cell carcinoma, non-sclerosing (C44._)"
8092,3,0,"Infiltrating basal cell carcinoma, sclerosing (C44._)"
8092,3,0,Morpheic basal cell carcinoma (C44._)
8092,3,0,Non-sclerosing infiltrating basal cell carcinoma (C44._)
8092,3,0,"Sclerosing basal cell carcinoma, infiltrating (C44._)"
8093,3,1,"Basal cell carcinoma, fibroepithelial (C44._)"
8093,3,0,"Basal cell carcinoma, fibroepithelial, Pinkus type"
8093,3,0,"Carcinoma, basal cell, fibroepithelial (C44._)"
8093,3,0,"Carcinoma, basal cell, fibroepithelial, Pinkus type"
8093,3,0,Fibroepithelial basal cell carcinoma (C44._)
8093,3,0,"Fibroepithelial basal cell carcinoma, Pinkus type"
8093,3,0,Fibroepithelioma of Pinkus type
8093,3,0,"Fibroepithelioma, NOS"
8093,3,0,Pinkus tumor
8093,3,0,"Pinkus type, fibroepithelial basal cell carcinoma"
8093,3,0,"Pinkus type, fibroepithelioma"
8093,3,0,"Tumor, Pinkus"
8094,3,1,Basosquamous carcinoma (C44._)
8094,3,0,"Basal-squamous cell carcinoma, mixed (C44._)"
8094,3,0,"Carcinoma, basal-squamous cell, mixed (C44._)"
8094,3,0,"Carcinoma, basosquamous (C44._)"
8094,3,0,"Carcinoma, mixed basal-squamous cell (C44._)"
8094,3,0,Mixed basal-squamous cell carcinoma (C44._)
8094,3,0,Mixed squamous-basal cell carcinoma (C44._)
8094,3,0,"Squamous-basal cell carcinoma, mixed (C44._)"
8095,3,1,Metatypical carcinoma (C44._)
8095,3,0,"Carcinoma, metatypical (C44._)"
8096,0,1,Intraepidermal epithelioma of Jadassohn (C44._)
8096,0,0,"Epithelioma, intraepidermal, Jadassohn (C44._)"
8096,0,0,"Intraepidermal epithelioma, Jadassohn (C44._)"
8096,0,0,Jadassohn intraepidermal epithelioma (C44._)
8097,3,1,"Basal cell carcinoma, nodular (C44._)"
8097,3,0,"Basal cell carcinoma, micronodular (C44._)"
8097,3,0,"Carcinoma, basal cell, micronodular (C44._)"
8097,3,0,"Carcinoma, basal cell, nodular (C44._)"
8097,3,0,Micronodular basal cell carcinoma (C44._)
8097,3,0,Nodular basal cell carcinoma (C44._)
8098,3,1,Adenoid basal carcinoma (C53._)
8098,3,0,"Basal carcinoma, adenoid (C53._)"
8098,3,0,"Carcinoma, adenoid basal (C53._)"
8098,3,0,"Carcinoma, basal, adenoid (C53._)"
8100,0,1,Trichoepithelioma (C44._)
8100,0,0,"Adenoideos cysticum, epithelioma (C44._)"
8100,0,0,Brooke tumor (C44._)
8100,0,0,"Cysticum, epithelioma adenoideos (C44._)"
8100,0,0,Epithelioma adenoideos cysticum (C44._)
8100,0,0,"Tumor, Brooke (C44._)"
8100,3,1,Trichoblastic carcinoma (C44._) [2022+]
8100,3,0,"Carcinoma, trichoblastic (C44._) [2022+]"
8100,3,0,"Carcinosarcoma, trichoblastic (C44._) [2022+]"
8100,3,0,Trichoblastic carcinosarcoma (C44._) [2022+]
8101,0,1,Trichofolliculoma (C44._)
8102,0,1,Trichilemmoma (C44._)
8102,3,1,Trichilemmocarcinoma (C44._)
8102,3,0,"Carcinoma, trichilemmal (C44._)"
8102,3,0,Trichilemmal carcinoma (C44._)
8103,0,1,Pilar tumor (C44._)
8103,0,0,"Cyst, proliferating trichilemmal (C44._)"
8103,0,0,"Cyst, trichilemmal, proliferating (C44._)"
8103,0,0,Proliferating trichilemmal cyst (C44._)
8103,0,0,Proliferating trichilemmal tumor (C44._)
8103,0,0,"Trichilemmal cyst, proliferating (C44._)"
8103,0,0,"Trichilemmal tumor, proliferating (C44._)"
8103,0,0,"Tumor, pilar (C44._)"
8103,0,0,"Tumor, proliferating trichilemmal (C44._)"
8103,0,0,"Tumor, trichilemmal, proliferating (C44._)"
8104,0,1,Pilar sheath acanthoma (C44._) [2021+]
8104,0,0,"Acanthoma, pilar sheath (C44._) [2021+]"
8104,0,0,Tumor of the follicular infundibulum (C44._) [2021+]
8110,0,1,"Pilomatrixoma, NOS (C44._)"
8110,0,0,Calcifying epithelioma of Malherbe (C44._)
8110,0,0,"Epithelioma, calcifying, Malherbe (C44._)"
8110,0,0,Malherbe calcifying epithelioma (C44._)
8110,0,0,"Pilomatricoma, NOS"
8110,3,1,Pilomatrical carcinoma (C44._)
8110,3,0,"Carcinoma, matrical (C44._)"
8110,3,0,"Carcinoma, pilomatrical (C44._)"
8110,3,0,"Carcinoma, pilomatrix (C44._)"
8110,3,0,Matrical carcinoma (C44._)
8110,3,0,"Pilomatricoma, malignant (C44._)"
8110,3,0,Pilomatrix carcinoma (C44._)
8110,3,0,"Pilomatrixoma, malignant (C44._)"
8120,0,1,"Transitional cell papilloma, benign"
8120,0,0,"Papilloma, transitional"
8120,0,0,"Papilloma, transitional cell, benign"
8120,0,0,"Papilloma, transitional, NOS"
8120,0,0,Transitional papilloma
8120,1,1,"Urothelial papilloma, NOS"
8120,1,0,"Bladder, papilloma of (C67._)"
8120,1,0,Papilloma of bladder (C67._)
8120,1,0,"Papilloma, bladder (C67._)"
8120,1,0,"Papilloma, NOS of bladder (C67._)"
8120,1,0,"Papilloma, transitional cell, NOS"
8120,1,0,"Papilloma, urothelial, NOS"
8120,1,0,"Transitional cell papilloma, NOS"
8120,2,1,Transitional cell carcinoma in situ
8120,2,0,"Carcinoma in situ, transitional cell"
8120,2,0,"Carcinoma in situ, urothelial"
8120,2,0,"Carcinoma, transitional cell in situ"
8120,2,0,"Carcinoma, urothelial, in situ"
8120,2,0,"In situ carcinoma, transitional cell"
8120,2,0,In situ transitional cell carcinoma
8120,2,0,Urothelial carcinoma in situ
8120,3,1,"Transitional cell carcinoma, NOS"
8120,3,0,"Carcinoma, squamotransitional [2018+]"
8120,3,0,"Carcinoma, squamotransitional cell (C53._) [2018+]"
8120,3,0,"Carcinoma, transitional"
8120,3,0,"Carcinoma, transitional cell, NOS"
8120,3,0,"Carcinoma, urothelial with divergent differentiation  (C65.9, C66.9, C67._, C68._) [2018+]"
8120,3,0,"Carcinoma, urothelial with squamous differentiation (C65.9, C66.9, C67._, C68._) [2018+]"
8120,3,0,"Carcinoma, urothelial with trophoblastic differentiation  (C65.9, C66.9, C67._, C68._) [2018+]"
8120,3,0,"Carcinoma, urothelial, clear cell (glycogen-rich) (C65.9, C66.9, C67._, C68._) [2018+]"
8120,3,0,"Carcinoma, urothelial, lipid-rich (C65.9, C66.9, C67._, C68._) [2018+]"
8120,3,0,"Carcinoma, urothelial, microcystic (C65.9, C66.9, C67._, C68._) [2018+]"
8120,3,0,"Carcinoma, urothelial, nested (C65.9, C66.9, C67._, C68._) [2018+]"
8120,3,0,"Carcinoma, urothelial, NOS"
8120,3,0,"Clear cell (glycogen-rich) urothelial carcinoma (C65.9, C66.9, C67._, C68._) [2018+]"
8120,3,0,"Lipid-rich urothelial carcinoma (C65.9, C66.9, C67._, C68._) [2018+]"
8120,3,0,"Microcystic urothelial carcinoma (C65.9, C66.9, C67._, C68._) [2018+]"
8120,3,0,"Nested urothelial carcinoma (C65.9, C66.9, C67._, C68._) [2018+]"
8120,3,0,Squamotransitional carcinoma [2018+]
8120,3,0,Squamotransitional cell carcinoma (C53._) [2018+]
8120,3,0,Transitional carcinoma
8120,3,0,"Urothelial carcinoma with divergent differentiation  (C65.9, C66.9, C67._, C68._)"
8120,3,0,"Urothelial carcinoma with squamous differentiation (C65.9, C66.9, C67._, C68._)"
8120,3,0,"Urothelial carcinoma with trophoblastic differentiation (C65.9, C66.9, C67._, C68._) "
8120,3,0,"Urothelial carcinoma, clear cell (glycogen-rich) (C65.9, C66.9, C67._, C68._) [2018+]"
8120,3,0,"Urothelial carcinoma, lipid-rich (C65.9, C66.9, C67._, C68._) [2018+]"
8120,3,0,"Urothelial carcinoma, microcystic (C65.9, C66.9, C67._, C68._) [2018+]"
8120,3,0,"Urothelial carcinoma, nested (C65.9, C66.9, C67._, C68._) [2018+]"
8120,3,0,"Urothelial carcinoma, NOS"
8121,0,1,"Schneiderian papilloma, NOS (C30.0, C31._)"
8121,0,0,"Exophytic sinonasal papilloma (C30.0, C31._)"
8121,0,0,"Fungiform sinonasal papilloma (C30.0, C31._)"
8121,0,0,"Papilloma, Schneiderian, NOS (C30.0, C31._)"
8121,0,0,"Papilloma, sinonasal, exophytic (C30.0, C31._)"
8121,0,0,"Papilloma, sinonasal, fungiform (C30.0, C31._)"
8121,0,0,"Papilloma, sinonasal, NOS (C30.0, C31._)"
8121,0,0,"Papilloma, transitional cell, inverted, benign"
8121,0,0,"Papilloma, transitional, inverted, benign"
8121,0,0,"Sinonasal papilloma, exophytic (C30.0, C31._)"
8121,0,0,"Sinonasal papilloma, fungiform (C30.0, C31._)"
8121,0,0,"Sinonasal papilloma, NOS (C30.0, C31._)"
8121,0,0,"Transitional cell papilloma, inverted, benign"
8121,0,0,"Transitional papilloma, inverted, benign"
8121,1,1,"Transitional cell papilloma, inverted, NOS"
8121,1,0,Columnar cell papilloma
8121,1,0,"Cylindrical cell papilloma (C30.0, C31._)"
8121,1,0,"Inverted Schneiderian papilloma (C30.0, C31._)"
8121,1,0,"Inverted transitional cell papilloma, NOS"
8121,1,0,"Oncocytic Schneiderian papilloma (C30.0, C31._)"
8121,1,0,"Papilloma, columnar cell"
8121,1,0,"Papilloma, cylindrical cell (C30.0, C31._)"
8121,1,0,"Papilloma, Schneiderian, inverted (C30.0, C31._)"
8121,1,0,"Papilloma, Schneiderian, oncocytic (C30.0, C31._)"
8121,1,0,"Papilloma, transitional cell, inverted, NOS"
8121,1,0,"Papilloma, transitional, inverted, NOS"
8121,1,0,"Schneiderian papilloma, inverted (C30.0, C31._)"
8121,1,0,"Schneiderian papilloma, oncocytic (C30.0, C31._)"
8121,1,0,"Transitional papilloma, inverted, NOS"
8121,3,1,"Schneiderian carcinoma (C30.0, C31._)"
8121,3,0,"Carcinoma, cylindrical cell (C30.0, C31._)"
8121,3,0,"Carcinoma, Schneiderian (C30.0, C31._)"
8121,3,0,"Cylindrical cell carcinoma (C30.0, C31._)"
8122,3,1,"Urothelial carcinoma, sarcomatoid"
8122,3,0,"Carcinoma, transitional cell, sarcomatoid"
8122,3,0,"Carcinoma, transitional cell, spindle cell"
8122,3,0,"Carcinoma, urothelial, sarcomatoid"
8122,3,0,"Carcinoma, urothelial, spindle cell"
8122,3,0,Sarcomatoid transitional cell carcinoma
8122,3,0,Sarcomatoid urothelial carcinoma
8122,3,0,Spindle cell transitional cell carcinoma
8122,3,0,Spindle cell urothelial cell carcinoma
8122,3,0,"Transitional cell carcinoma, sarcomatoid"
8122,3,0,"Transitional cell carcinoma, spindle cell"
8122,3,0,"Urothelial carcinoma, spindle cell"
8123,3,1,Basaloid carcinoma
8123,3,0,"Carcinoma, basaloid"
8124,3,1,Cloacogenic carcinoma (C21.2)
8124,3,0,"Carcinoma, cloacogenic (C21.2)"
8130,1,1,Papillary urothelial neoplasm of low malignant potential (C67._)
8130,1,0,"Low malignant potential, papillary transitional cell neoplasm (C67._)"
8130,1,0,"Low malignant potential, papillary urothelial neoplasm (C67._)"
8130,1,0,"Neoplasm, papillary transitional cell, low malignant potential (C67._)"
8130,1,0,"Neoplasm, papillary urothelial, low malignant potential (C67._)"
8130,1,0,Papillary transitional cell neoplasm of low malignant potential (C67._)
8130,1,0,"Transitional cell neoplasm, papillary, low malignant potential (C67._)"
8130,1,0,"Urothelial neoplasm, papillary, of low malignant potential (C67._)"
8130,2,1,"Papillary transitional cell carcinoma, non-invasive (C67._)"
8130,2,0,"Carcinoma, non-invasive, papillary transitional cell (C67._)"
8130,2,0,"Carcinoma, non-invasive, papillary urothelial (C67._)"
8130,2,0,"Carcinoma, papillary transitional cell, non-invasive (C67._)"
8130,2,0,"Carcinoma, papillary urothelial, non-invasive (C67._)"
8130,2,0,"Carcinoma, transitional cell, papillary, non-invasive (C67._)"
8130,2,0,"Carcinoma, urothelial, non-invasive, papillary (C67._)"
8130,2,0,"Carcinoma, urothelial, papillary, non-invasive (C67._)"
8130,2,0,"Non-invasive carcinoma, papillary transitional cell (C67._)"
8130,2,0,"Non-invasive carcinoma, papillary urothelial (C67._)"
8130,2,0,"Papillary carcinoma, urothelial, non-invasive (C67._)"
8130,2,0,"Papillary urothelial carcinoma, non-invasive (C67._)"
8130,2,0,"Transitional cell carcinoma, papillary, non-invasive (C67._)"
8130,2,0,"Urothelial carcinoma, papillary, non-invasive (C67._)"
8130,3,1,Papillary transitional cell carcinoma (C67._)
8130,3,0,"Carcinoma, papillary transitional cell (C67._)"
8130,3,0,"Carcinoma, papillary urothelial (C67._)"
8130,3,0,"Carcinoma, transitional cell, papillary (C67._)"
8130,3,0,"Papillary carcinoma, transitional cell (C67._)"
8130,3,0,"Papillary carcinoma, urothelial (C67._)"
8130,3,0,Papillary urothelial carcinoma (C67._)
8130,3,0,"Transitional cell carcinoma, papillary (C67._)"
8130,3,0,"Urothelial carcinoma, papillary (C67._)"
8131,3,1,"Urothelial carcinoma, micropapillary (C67._)"
8131,3,0,"Carcinoma, micropapillary transitional cell (C67._)"
8131,3,0,"Carcinoma, transitional cell, micropapillary (C67._)"
8131,3,0,"Carcinoma, urothelial, micropapillary (C67._)"
8131,3,0,Micropapillary transitional cell carcinoma (C67._)
8131,3,0,Micropapillary urothelial carcinoma (C67._)
8131,3,0,"Transitional cell carcinoma, micropapillary (C67._)"
8140,0,1,"Adenoma, NOS"
8140,1,1,Atypical adenoma
8140,1,0,"Adenoma, atypical"
8140,1,0,"Adenoma, bronchial, NOS (C34._)"
8140,1,0,"Bronchial adenoma, NOS (C34._)"
8140,2,1,"Adenocarcinoma in situ, NOS"
8140,2,0,"In situ adenocarcinoma, NOS"
8140,3,1,"Adenocarcinoma, NOS"
8140,3,0,Acinar adenocarcinoma (C61.9 ONLY) [DO NOT USE 8550/3 OR 8551/3 FOR PROSTATE] [2018+]
8140,3,0,"Adenocarcinoma, acinar (C61.9 ONLY) [DO NOT USE 8550/3 OR 8551/3 FOR PROSTATE] [2018+]"
8140,3,0,"Adenocarcinoma, endocervical, usual type (C53._) [2018+]"
8140,3,0,"Adenocarcinoma, minimally invasive, NOS (C34._) [2018+]"
8140,3,0,"Adenocarcinoma, usual type"
8140,3,0,"Carcinoma of Skene, Cowper and Littre Glands [REPORTABLE 2021+]"
8140,3,0,Endocervical adenocarcinoma usual type (C53._) [2018+]
8140,3,0,Endolymphatic sac tumor [REPORTABLE 2021+]
8140,3,0,"Minimally invasive adenocarcinoma, NOS (C34._) [2018+]"
8140,3,0,Parathyroid tumor (C75.0) [REPORTABLE 2021+]
8140,3,0,"Tumor, endolymphatic sac [REPORTABLE 2021+]"
8140,3,0,"Tumor, parathyroid (C75.0) [REPORTABLE 2021+]"
8140,3,0,Usual type adenocarcinoma
8140,6,1,"Adenocarcinoma, metastatic, NOS"
8140,6,0,"Adenocarcinoma, NOS, metastatic"
8140,6,0,"Metastatic adenocarcinoma, NOS"
8141,3,1,Scirrhous adenocarcinoma
8141,3,0,"Adenocarcinoma, scirrhous"
8141,3,0,Carcinoma with productive fibrosis
8141,3,0,"Carcinoma, scirrhous"
8141,3,0,"Fibrosis, carcinoma with productive"
8141,3,0,"Productive fibrosis, carcinoma with"
8141,3,0,Scirrhous carcinoma
8142,3,1,Linitis plastica (C16._)
8142,3,0,"Plastica, linitis (C16._)"
8143,3,1,Superficial spreading adenocarcinoma
8143,3,0,"Adenocarcinoma, superficial spreading"
8144,2,1,"Intestinal-type adenoma, high grade (C16._, C17._) [REPORTABLE 2022+ FOR STOMACH AND SMALL INTESTINE ONLY; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY.]"
8144,2,0,"Adenoma, intestinal-type, high grade (C16._, C17._) [REPORTABLE 2022+ FOR STOMACH AND SMALL INTESTINE ONLY; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY.]"
8144,2,0,"High grade intestinal-type adenoma (C16._, C17._) [REPORTABLE 2022+ FOR STOMACH AND SMALL INTESTINE ONLY; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY.]"
8144,3,1,"Adenocarcinoma, intestinal type (C16._)"
8144,3,0,"Adenocarcinoma, enteric (C34. _, C65.9, C66.9, C67._, C68._) [2018+]"
8144,3,0,"Adenocarcinoma, intestinal type (C30.0, C53._) [2018+]"
8144,3,0,"Carcinoma, intestinal type (C16._)"
8144,3,0,"Carcinoma, mucinous, intestinal type (C53._) [2018+]"
8144,3,0,"Enteric adenocarcinoma (C34. _, C65.9, C66.9, C67._, C68._) [2018+]"
8144,3,0,Intestinal type adenocarcinoma (C16._)
8144,3,0,"Intestinal type adenocarcinoma (C30.0, C53._) [2018+]"
8144,3,0,Intestinal type carcinoma (C16._)
8144,3,0,Intestinal type mucinous carcinoma (C53._) [2018+]
8144,3,0,"Mucinous carcinoma, intestinal type (C53._) [2018+]"
8145,3,1,"Carcinoma, diffuse type (C16._)"
8145,3,0,"Adenocarcinoma, diffuse type (C16._)"
8145,3,0,"Diffuse type, adenocarcinoma (C16._)"
8145,3,0,"Diffuse type, carcinoma (C16._)"
8146,0,1,Monomorphic adenoma
8146,0,0,"Adenoma, monomorphic"
8147,0,1,Basal cell adenoma
8147,0,0,"Adenoma, basal cell"
8147,3,1,Basal cell adenocarcinoma
8147,3,0,"Adenocarcinoma, basal cell"
8148,2,1,"Glandular intraepithelial neoplasia, grade III"
8148,2,0,Grade III glandular intraepithelial neoplasia
8148,2,0,"Intraepithelial neoplasia, grade III, glandular"
8148,2,0,"Intraepithelial neoplasia, grade III, prostatic (C61.9)"
8148,2,0,PIN III (C61.9)
8148,2,0,"Prostatic intraepithelial neoplasia, grade III (C61.9)"
8149,0,1,Canalicular adenoma
8149,0,0,"Adenoma, canalicular"
8150,0,1,Pancreatic neuroendocrine microadenoma (C25._)
8150,0,0,"Adenoma, islet cell (C25._) [PRE-2021 ONLY. FOR 2021+ USE CODE 8150/3.]"
8150,0,0,"Adenomatosis, islet cell (C25._) [PRE-2021 ONLY. FOR 2021+ USE CODE 8150/3.]"
8150,0,0,Islet cell adenoma (C25._) [PRE-2021 ONLY. FOR 2021+ USE CODE 8150/3.]
8150,0,0,Islet cell adenomatosis (C25._) [PRE-2021 ONLY. FOR 2021+ USE CODE 8150/3.]
8150,0,0,"Islet cell tumor, benign (C25._)"
8150,0,0,Nesidioblastoma (C25._) [PRE-2021 ONLY. FOR 2021+ USE CODE 8150/3.]
8150,0,0,"Pancreatic endocrine tumor, benign (C25._)"
8150,0,0,Pancreatic microadenoma (C25._)
8150,0,0,"Tumor, islet cell, benign (C25._)"
8150,1,1,"Pancreatic endocrine tumor, NOS (C25._) [PRE-2021 ONLY. FOR 2021+ USE CODE 8150/3.]"
8150,1,0,"Islet cell tumor, NOS (C25._) [PRE-2021 ONLY. FOR 2021+ USE CODE 8150/3.]"
8150,1,0,"Tumor, islet cell, NOS (C25._) [PRE-2021 ONLY. FOR 2021+ USE CODE 8150/3.]"
8150,3,1,"Pancreatic neuroendocrine tumor, nonfunctioning (C25._) [REPORTABLE 2021+.]"
8150,3,0,"Adenocarcinoma, islet cell (C25._)"
8150,3,0,"Adenoma, islet cell (C25._) [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8150/0]"
8150,3,0,"Adenomatosis, islet cell (C25._) [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8150/0]"
8150,3,0,"Carcinoma, islet cell (C25._)"
8150,3,0,"Clear cell neuroendocrine tumor, non-functioning pancreatic (C25._) [2022+]"
8150,3,0,"Cystic neuroendocrine tumor, non-functioning pancreatic (C25._) [2022+]"
8150,3,0,Islet cell adenocarcinoma (C25._)
8150,3,0,"Islet cell adenoma (C25._) [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8150/0]"
8150,3,0,"Islet cell adenomatosis (C25._) [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8150/0]"
8150,3,0,Islet cell carcinoma (C25._)
8150,3,0,"Islet cell tumor, NOS (C25._) [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8150/1]"
8150,3,0,"Nesidioblastoma (C25._) [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8150/0]"
8150,3,0,"Neuroendocrine tumor, clear cell, non-functioning pancreatic (C25._) [2022+]"
8150,3,0,"Neuroendocrine tumor, cystic, non-functioning pancreatic (C25._) [2022+]"
8150,3,0,"Neuroendocrine tumor, oncocytic, non-functioning pancreatic (C25._) [2022+]"
8150,3,0,"Neuroendocrine tumor, pleomorphic, non-functioning pancreatic (C25._) [2022+]"
8150,3,0,"Non-functioning pancreatic, clear cell neuroendocrine tumor (C25._) [2022+]"
8150,3,0,"Non-functioning pancreatic, cystic neuroendocrine tumor (C25._) [2022+]"
8150,3,0,"Non-functioning pancreatic, oncocytic neuroendocrine tumor (C25._) [2022+]"
8150,3,0,"Non-functioning pancreatic, pleomorphic neuroendocrine tumor (C25._) [2022+]"
8150,3,0,"Oncocytic neuroendocrine tumor, non-functioning pancreatic (C25._) [2022+]"
8150,3,0,"Pancreatic endocrine tumor, malignant (C25._)"
8150,3,0,"Pancreatic endocrine tumor, nonfunctioning (C25._) [REPORTABLE 2021+]"
8150,3,0,"Pancreatic endocrine tumor, NOS (C25._) [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8150/1]"
8150,3,0,"Pleomorphic neuroendocrine tumor, non-functioning pancreatic (C25._) [2022+]"
8150,3,0,"Tumor, clear cell neuroendocrine, non-functioning pancreatic (C25._) [2022+]"
8150,3,0,"Tumor, cystic neuroendocrine, non-functioning pancreatic (C25._) [2022+]"
8150,3,0,"Tumor, islet cell, NOS (C25._) [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8150/1]"
8150,3,0,"Tumor, oncocytic neuroendocrine, non-functioning pancreatic (C25._) [2022+]"
8150,3,0,"Tumor, pancreatic endocrine, nonfunctioning (C25._) [REPORTABLE 2021+]"
8150,3,0,"Tumor, pancreatic neuroendocrine, nonfunctioning (C25._) [REPORTABLE 2021+]"
8150,3,0,"Tumor, pleomorphic neuroendocrine, non-functioning pancreatic (C25._) [2022+]"
8151,0,1,"Insulinoma, NOS (C25._) [PRE-2021 ONLY. FOR 2021+ USE CODE 8151/3.]"
8151,0,0,"Adenoma, beta cell (C25._) [PRE-2021 ONLY. FOR 2021+ USE CODE 8151/3.]"
8151,0,0,Beta cell adenoma (C25._) [PRE-2021 ONLY. FOR 2021+ USE CODE 8151/3.]
8151,3,1,"Insulinoma, NOS (C25._) [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8151/0]"
8151,3,0,"Adenoma, beta cell (C25._) [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8151/0]"
8151,3,0,"Beta cell adenoma (C25._) [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8151/0]"
8151,3,0,"Beta cell tumor, malignant (C25._)"
8151,3,0,"Insulinoma, malignant (C25._)"
8151,3,0,"Tumor, beta cell, malignant (C25._)"
8152,1,1,"Glucagonoma, NOS (C25._) [PRE-2021 ONLY. FOR 2021+ USE CODE 8152/3.]"
8152,1,0,"Alpha cell tumor, NOS (C25._) [PRE-2021 ONLY. FOR 2021+ USE CODE 8152/3.]"
8152,1,0,Enteroglucagonoma [PRE-2021 ONLY. FOR 2021+ USE CODE 8152/3.]
8152,1,0,Glucagon-like peptide-producing tumor (C25._) [PRE-2021 ONLY. FOR 2021+ USE CODE 8152/3.]
8152,1,0,L-cell tumor [PRE-2021 ONLY. FOR 2021+ USE CODE 8152/3.]
8152,1,0,Pancreatic peptide and pancreatic peptide-like peptide within terminal tyrosine amide producing tumor [PRE-2021 ONLY. FOR 2021+ USE CODE 8152/3.]
8152,1,0,PP/PYY producing tumor [PRE-2021 ONLY. FOR 2021+ USE CODE 8152/3.]
8152,1,0,"Tumor, alpha cell, NOS (C25._) [PRE-2021 ONLY. FOR 2021+ USE CODE 8152/3.]"
8152,3,1,"Glucagonoma, NOS (C25._) [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8152/1]"
8152,3,0,"Alpha cell tumor, malignant (C25._)"
8152,3,0,"Alpha cell tumor, NOS (C25._) [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8152/1]"
8152,3,0,"Enteroglucagonoma, malignant"
8152,3,0,"Enteroglucagonoma, NOS [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8152/1]"
8152,3,0,"Glucagon-like peptide-producing tumor (C25._) [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8152/1]"
8152,3,0,"Glucagonoma, malignant (C25._)"
8152,3,0,"L-cell tumor [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8152/1]"
8152,3,0,"Pancreatic peptide and pancreatic peptide-like peptide within terminal tyrosine amide producing tumor (C25.4) [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8152/1]"
8152,3,0,"PP/PYY producing tumor [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8152/1]"
8152,3,0,"Tumor, alpha cell, malignant (C25._)"
8153,1,1,"Gastrinoma, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8153/3.]"
8153,1,0,"G cell tumor, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8153/3.]"
8153,1,0,Gastrin cell tumor [PRE-2021 ONLY. FOR 2021+ USE CODE 8153/3.]
8153,1,0,"Tumor, G cell, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8153/3.]"
8153,1,0,"Tumor, gastrin cell [PRE-2021 ONLY. FOR 2021+ USE CODE 8153/3.]"
8153,3,1,"Gastrinoma, NOS [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8153/1]"
8153,3,0,"G cell tumor, malignant"
8153,3,0,"G cell tumor, NOS [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8153/1]"
8153,3,0,"Gastrin cell tumor [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8153/1]"
8153,3,0,"Gastrin cell tumor, malignant"
8153,3,0,"Gastrinoma, malignant"
8153,3,0,"Tumor, G cell, malignant"
8153,3,0,"Tumor, G cell, NOS [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8153/1]"
8153,3,0,"Tumor, gastrin cell [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8153/1]"
8153,3,0,"Tumor, gastrin cell, malignant"
8154,3,1,"Mixed pancreatic endocrine and exocrine tumor, malignant (C25._)"
8154,3,0,"Acinar-endocrine carcinoma, mixed (C25._)"
8154,3,0,"Adenocarcinoma, exocrine and islet cell, mixed (C25._)"
8154,3,0,"Adenocarcinoma, islet cell and exocrine, mixed (C25._)"
8154,3,0,"Adenocarcinoma, mixed islet cell and exocrine (C25._)"
8154,3,0,"Carcinoma, mixed acinar-endocrine (C25._)"
8154,3,0,"Carcinoma, mixed ductal-endocrine (C25._)"
8154,3,0,"Ductal, mixed ductal-endocrine carcinoma (C25._)"
8154,3,0,"Endocrine-acinar carcinoma, mixed (C25._)"
8154,3,0,"Endocrine-ductal carcinoma, mixed (C25._)"
8154,3,0,"Exocrine and islet cell adenocarcinoma, mixed (C25._)"
8154,3,0,"Islet cell and exocrine adenocarcinoma, mixed (C25._)"
8154,3,0,Mixed acinar-endocrine carcinoma (C25._)
8154,3,0,Mixed acinar-endocrine-ductal carcinoma
8154,3,0,Mixed ductal-endocrine carcinoma (C25._)
8154,3,0,Mixed endocrine and exocrine adenocarcinoma (C25._)
8154,3,0,Mixed endocrine-acinar carcinoma (C25._)
8154,3,0,Mixed endocrine-ductal carcinoma (C25._)
8154,3,0,Mixed exocrine and islet cell adenocarcinoma (C25._)
8154,3,0,Mixed islet cell and exocrine adenocarcinoma (C25._)
8155,1,1,"Vipoma, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8155/3.]"
8155,3,1,"Vipoma, NOS [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8155/1.]"
8155,3,0,"Vipoma, malignant"
8156,1,1,"Somatostatinoma, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8156/3.]"
8156,1,0,"Somatostatin cell tumor, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8156/3.]"
8156,1,0,"Tumor, somatostatin cell, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8156/3.]"
8156,3,1,"Somatostatinoma, NOS [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8156/1.]"
8156,3,0,"Somatostatin cell tumor, malignant"
8156,3,0,"Somatostatin cell tumor, NOS [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8156/1.]"
8156,3,0,"Somatostatinoma, malignant"
8156,3,0,"Tumor, somatostatin cell, malignant"
8156,3,0,"Tumor, somatostatin cell, NOS [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8156/1.]"
8157,1,1,"Enteroglucagonoma, NOS [obs] [FOR 2014-2020, USE CODE 8152/1; FOR 2021+, USE CODE 8152/3.] "
8157,3,1,"Enteroglucagonoma, malignant [obs] [FOR 2014+, USE CODE 8152/3.]  "
8157,3,0,"Malignant enteroglucagonoma [obs] [FOR 2014+, USE CODE 8152/3.] "
8158,1,1,ACTH-producing tumor [2018-2020 ONLY. FOR 2021+ USE CODE 8158/3.]
8158,1,0,"Endocrine tumor, functioning, NOS [2018-2020 ONLY. FOR 2021+ USE CODE 8158/3.]"
8158,1,0,"Tumor, ACTH-producing [2018-2020 ONLY. FOR 2021+ USE CODE 8158/3.]"
8158,1,0,"Tumor, endocrine functioning, NOS [2018-2020 ONLY. FOR 2021+ USE CODE 8158/3.]"
8158,3,1,"ACTH-producing tumor [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8158/1.]"
8158,3,0,"Endocrine tumor, functioning, NOS [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8158/1.]"
8158,3,0,"Tumor, ACTH-producing [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8158/1.]"
8158,3,0,"Tumor, endocrine functioning, NOS [REPORTABLE 2021+. FOR PRE-2021, USE CODE 8158/1.]"
8160,0,1,"Bile duct adenoma (C22.1, C24.0)"
8160,0,0,"Adenoma, bile duct (C22.1, C24.0)"
8160,0,0,"Cholangioma (C22.1, C24.0)"
8160,3,1,"Cholangiocarcinoma (C22.1, C24.0)"
8160,3,0,"Adenocarcinoma, bile duct (C22.1, C24.0)"
8160,3,0,"Bile duct adenocarcinoma (C22.1, C24.0)"
8160,3,0,"Bile duct carcinoma (C22.1, C24.0)"
8160,3,0,"Carcinoma, bile duct (C22.1, C24.0)"
8161,0,1,"Bile duct cystadenoma (C22.1, C24.0)"
8161,0,0,"Cystadenoma, bile duct (C22.1, C24.0)"
8161,3,1,"Bile duct cystadenocarcinoma (C22.1, C24.0)"
8161,3,0,"Cystadenocarcinoma, bile duct (C22.1, C24.0)"
8162,3,1,"Klatskin tumor (C22.1, C24.0)"
8162,3,0,"Tumor, Klatskin (C22.1, C24.0)"
8163,2,1,"Papillary neoplasm, pancreatobiliary type, with high grade intraepithelial neoplasia (C24.1) [2022+]"
8163,2,0,Non-invasive pancreatobiliary papillary neoplasm with high grade dysplasia (C24.1) [2022+]
8163,2,0,Non-invasive pancreatobiliary papillary neoplasm with high grade intraepithelial neoplasia (C24.1) [2022+]
8163,2,0,"Pancreatobiliary type papillary neoplasm, with high grade intraepithelial neoplasia (C24.1) [2022+]"
8163,2,0,"Papillary neoplasm, non-invasive pancreatobiliary, with high grade dysplasia (C24.1) [2022+]"
8163,2,0,"Papillary neoplasm, non-invasive pancreatobiliary, with high grade intraepithelial neoplasia (C24.1) [2022+]"
8163,3,1,"Pancreatobiliary-type carcinoma (C24.1) [2018+. FOR 2015-2017, USE 8255/3]"
8163,3,0,"Adenocarcinoma, pancreatobiliary-type (C24.1) [2018+. FOR 2015-2017, USE 8255/3]"
8163,3,0,"Carcinoma, pancreatobiliary-type carcinoma (C24.1) [2018+. FOR 2015-2017, USE 8255/3]"
8163,3,0,"Pancreatobiliary-type adenocarcinoma (C24.1) [2018+. FOR 2015-2017, USE 8255/3]"
8170,0,1,Liver cell adenoma (C22.0)
8170,0,0,"Adenoma, hepatocellular (C22.0)"
8170,0,0,"Adenoma, liver cell (C22.0)"
8170,0,0,Hepatocellular adenoma (C22.0)
8170,0,0,"Hepatoma, benign (C22.0)"
8170,3,1,"Hepatocellular carcinoma, NOS (C22.0)"
8170,3,0,"Carcinoma, hepatocellular, NOS (C22.0)"
8170,3,0,"Carcinoma, liver cell (C22.0)"
8170,3,0,Hepatocarcinoma (C22.0)
8170,3,0,"Hepatoma, malignant (C22.0)"
8170,3,0,"Hepatoma, NOS (C22.0)"
8170,3,0,Liver cell carcinoma (C22.0)
8171,3,1,"Hepatocellular carcinoma, fibrolamellar (C22.0)"
8171,3,0,"Carcinoma, fibrolamellar, hepatocellular (C22.0)"
8171,3,0,"Carcinoma, hepatocellular, fibrolamellar (C22.0)"
8171,3,0,"Fibrolamellar, hepatocellular carcinoma (C22.0)"
8172,3,1,"Hepatocellular carcinoma, scirrhous (C22.0)"
8172,3,0,"Carcinoma, hepatic, sclerosing (C22.0)"
8172,3,0,"Carcinoma, hepatocellular, scirrhous (C22.0)"
8172,3,0,"Hepatic carcinoma, sclerosing (C22.0)"
8172,3,0,"Scirrhous carcinoma, hepatocellular (C22.0)"
8172,3,0,Sclerosing hepatic carcinoma (C22.0)
8173,3,1,"Hepatocellular carcinoma, spindle cell variant (C22.0)"
8173,3,0,"Carcinoma, hepatocellular, sarcomatoid (C22.0)"
8173,3,0,"Carcinoma, hepatocellular, spindle cell variant (C22.0)"
8173,3,0,"Hepatocellular carcinoma, sarcomatoid (C22.0)"
8173,3,0,"Sarcomatoid carcinoma, hepatocellular (C22.0)"
8173,3,0,"Spindle cell variant, hepatocellular carcinoma (C22.0)"
8174,3,1,"Hepatocellular carcinoma, clear cell type (C22.0)"
8174,3,0,"Carcinoma, hepatocellular, clear cell type (C22.0)"
8174,3,0,Chromophobe hepatocellular carcinoma (C22.0) [2022+]
8174,3,0,Clear cell type hepatocellular carcinoma (C22.0)
8174,3,0,"Hepatocellular carcinoma, chromophobe (C22.0) [2022+]"
8174,3,0,"Hepatocellular carcinoma, lymphocyte-rich (C22.0) [2022+]"
8174,3,0,"Hepatocellular carcinoma, macrotrabecular massive (C22.0) [2022+]"
8174,3,0,"Hepatocellular carcinoma, neutrophil-rich (C22.0) [2022+]"
8174,3,0,"Hepatocellular carcinoma, steatohepatic (C22.0) [2022+]"
8174,3,0,Lymphocyte-rich hepatocellular carcinoma (C22.0) [2022+]
8174,3,0,Macrotrabecular massive hepatocellular carcinoma (C22.0) [2022+]
8174,3,0,Neutrophil-rich hepatocellular carcinoma (C22.0) [2022+]
8174,3,0,Steatohepatic hepatocellular carcinoma (C22.0) [2022+]
8175,3,1,"Hepatocellular carcinoma, pleomorphic type (C22.0)"
8175,3,0,"Carcinoma, hepatocellular, pleomorphic type (C22.0)"
8175,3,0,"Pleomorphic type, hepatocellular carcinoma (C22.0)"
8180,3,1,Combined hepatocellular carcinoma and cholangiocarcinoma (C22.0)
8180,3,0,"Bile duct carcinoma and hepatocellular carcinoma, mixed (C22.0)"
8180,3,0,"Carcinoma, bile duct and hepatocellular, mixed (C22.0)"
8180,3,0,"Carcinoma, combined hepatocellular and cholangiocarcinoma (C22.0)"
8180,3,0,"Carcinoma, hepatocellular and bile duct, mixed (C22.0)"
8180,3,0,"Carcinoma, hepatocellular and cholangiocarcinoma, combined (C22.0)"
8180,3,0,"Carcinoma, mixed hepatocellular and bile duct (C22.0)"
8180,3,0,"Cholangiocarcinoma and hepatocellular carcinoma, combined (C22.0)"
8180,3,0,"Hepatocellular and bile duct carcinoma, mixed (C22.0)"
8180,3,0,"Hepatocellular carcinoma and bile duct carcinoma, mixed (C22.0)"
8180,3,0,"Hepatocellular carcinoma and cholangiocarcinoma, combined (C22.0)"
8180,3,0,Hepatocholangiocarcinoma (C22.0)
8180,3,0,Mixed bile duct and hepatocellular carcinoma (C22.0)
8180,3,0,Mixed hepatocellular and bile duct carcinoma (C22.0)
8190,0,1,Trabecular adenoma
8190,0,0,"Adenoma, trabecular"
8190,3,1,Trabecular adenocarcinoma
8190,3,0,"Adenocarcinoma, trabecular"
8190,3,0,"Carcinoma, trabecular"
8190,3,0,Trabecular carcinoma
8191,0,1,Embryonal adenoma
8191,0,0,"Adenoma, embryonal"
8200,0,1,Eccrine dermal cylindroma (C44._)
8200,0,0,Cylindroma of skin (C44._)
8200,0,0,"Cylindroma, eccrine dermal (C44._)"
8200,0,0,"Cylindroma, skin (C44._)"
8200,0,0,"Dermal cylindroma, eccrine (C44._)"
8200,0,0,Dermal eccrine cylindroma (C44._)
8200,0,0,"Tumor, turban (C44.4)"
8200,0,0,Turban tumor (C44.4)
8200,3,1,Adenoid cystic carcinoma
8200,3,0,"Adenocarcinoma, cylindroid"
8200,3,0,Adenocystic carcinoma
8200,3,0,Adenoid cystic carcinoma with high-grade transformation [2022+]
8200,3,0,"Adenoid cystic carcinoma, solid-basaloid [2022+]"
8200,3,0,"Adenoma, bronchial, cylindroid (C34._) [obs]"
8200,3,0,"Bronchial adenoma, cylindroid (C34._) [obs]"
8200,3,0,"Carcinoma, adenocystic"
8200,3,0,"Carcinoma, adenoid cystic"
8200,3,0,"Carcinoma, adenoid cystic with high-grade transformation [2022+]"
8200,3,0,"Carcinoma, adenoid cystic, solid-basaloid [2022+]"
8200,3,0,"Carcinoma, solid-basaloid adenoid cystic [2022+]"
8200,3,0,"Carcinoma, thymic with adenoid cystic carcinoma-like features (C37.9)"
8200,3,0,Cylindroid adenocarcinoma
8200,3,0,Cylindroid bronchial adenoma (C34._) [obs]
8200,3,0,"Cylindroma, NOS (except cylindroma of skin M-8200/0)"
8200,3,0,"Cystic carcinoma, adenoid"
8200,3,0,Solid-basaloid adenoid cystic carcinoma [2022+]
8200,3,0,Thymic carcinoma with adenoid cystic carcinoma-like features (C37.9)
8201,2,1,Cribriform carcinoma in situ (C50._)
8201,2,0,"Carcinoma, cribriform in situ (C50._)"
8201,2,0,"Carcinoma, ductal in situ, cribriform type (C50._)"
8201,2,0,Cribriform ductal carcinoma in situ (C50._)
8201,2,0,"Ductal carcinoma in situ, cribriform type (C50._)"
8201,2,0,"Ductal carcinoma, cribriform type, in situ (C50._)"
8201,2,0,In situ cribriform carcinoma (C50._)
8201,2,0,"In situ ductal carcinoma, cribriform type (C50._)"
8201,3,1,"Cribriform carcinoma, NOS"
8201,3,0,"Adenocarcinoma, cribriform comedo-type (C18._, C19.9, C20.9)"
8201,3,0,"Carcinoma, cribriform, NOS"
8201,3,0,"Carcinoma, ductal, cribriform type (C50._)"
8201,3,0,"Cribriform comedo-type carcinoma (C18._, C19.9, C20.9)"
8201,3,0,Cribriform ductal carcinoma (C50._)
8201,3,0,"Ductal carcinoma, cribriform type (C50._)"
8202,0,1,Microcystic adenoma (C25._)
8202,0,0,"Adenoma, microcystic, NOS (C25._)"
8204,0,1,Lactating adenoma (C50._)
8204,0,0,Adenoma. lactating (C50._)
8210,0,1,"Adenomatous polyp, NOS"
8210,0,0,"Adenoma, polypoid, NOS"
8210,0,0,"Polyp, adenomatous, NOS"
8210,0,0,Polypoid adenoma
8210,2,1,Adenocarcinoma in situ in adenomatous polyp
8210,2,0,"Adenocarcinoma in situ in a polyp, NOS"
8210,2,0,Adenocarcinoma in situ in polypoid adenoma
8210,2,0,Adenocarcinoma in situ in tubular adenoma
8210,2,0,"Adenoma, polypoid, adenocarcinoma in situ in"
8210,2,0,"Adenoma, tubular, adenocarcinoma in situ in"
8210,2,0,"Adenomatous polyp, adenocarcinoma in situ in"
8210,2,0,"Adenomatous polyp, carcinoma in situ in"
8210,2,0,"Adenomatous polyp, high grade dysplasia (C16._, C17._) [REPORTABLE 2022+ FOR STOMACH AND SMALL INTESTINE ONLY; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY.]"
8210,2,0,"Carcinoma in situ in a polyp, NOS"
8210,2,0,Carcinoma in situ in adenomatous polyp
8210,2,0,"High grade dysplasia in adenomatous polyp (C16._, C17._) [REPORTABLE 2022+ FOR STOMACH AND SMALL INTESTINE ONLY; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY.]"
8210,2,0,"In situ adenocarcinoma, in a polyp, NOS"
8210,2,0,"In situ adenocarcinoma, in adenomatous polyp"
8210,2,0,"In situ adenocarcinoma, in polypoid adenoma"
8210,2,0,"In situ adenocarcinoma, in tubular adenoma"
8210,2,0,"In situ carcinoma, in a polyp, NOS"
8210,2,0,"In situ carcinoma, in adenomatous polyp"
8210,2,0,"Polyp, adenomatous, adenocarcinoma in situ in"
8210,2,0,"Polyp, adenomatous, carcinoma in situ in"
8210,2,0,"Polyp, NOS, adenocarcinoma in situ in"
8210,2,0,"Polyp, NOS, carcinoma in situ in"
8210,2,0,"Polypoid adenoma, adenocarcinoma in situ in"
8210,2,0,"Tubular adenoma, adenocarcinoma in situ in"
8210,3,1,Adenocarcinoma in adenomatous polyp
8210,3,0,"Adenocarcinoma in a polyp, NOS"
8210,3,0,Adenocarcinoma in polypoid adenoma
8210,3,0,Adenocarcinoma in tubular adenoma
8210,3,0,"Adenoma, adenocarcinoma in polypoid"
8210,3,0,"Adenoma, polypoid, adenocarcinoma in"
8210,3,0,"Adenoma, tubular, adenocarcinoma in"
8210,3,0,"Adenomatous polyp, adenocarcinoma in"
8210,3,0,"Adenomatous polyp, carcinoma in"
8210,3,0,"Carcinoma in a polyp, NOS"
8210,3,0,Carcinoma in adenomatous polyp
8210,3,0,"Polyp, adenomatous, adenocarcinoma in"
8210,3,0,"Polyp, adenomatous, carcinoma in"
8210,3,0,"Polyp, NOS, adenocarcinoma in"
8210,3,0,"Polyp, NOS, carcinoma in"
8210,3,0,"Polypoid adenoma, adenocarcinoma in"
8210,3,0,"Tubular adenoma, adenocarcinoma in"
8211,0,1,"Tubular adenoma, NOS"
8211,0,0,"Adenoma, tubular, NOS"
8211,2,1,"Tubular adenoma, high grade [2022+; NOT REPORTABLE; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY.]"
8211,2,0,High grade tubular adenoma [2022+; NOT REPORTABLE; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY.]
8211,3,1,Tubular adenocarcinoma
8211,3,0,"Adenocarcinoma, tubular"
8211,3,0,"Carcinoma, tubular"
8211,3,0,Tubular carcinoma
8212,0,1,Flat adenoma
8212,0,0,"Adenoma, flat"
8213,0,1,Serrated adenoma (C18._)
8213,0,0,"Adenoma, serrated (C18._)"
8213,0,0,"Adenomatous and hyperplastic polyp, mixed (C18._)"
8213,0,0,"Adenomatous polyp, mixed, and hyperplastic (C18._)"
8213,0,0,"Hyperplastic and adenomatous polyp, mixed (C18._)"
8213,0,0,Mixed adenomatous and hyperplastic polyp (C18._)
8213,0,0,Mixed hyperplastic and adenomatous polyp (C18._)
8213,0,0,Sessile serrated adenoma
8213,0,0,Sessile serrated polyp
8213,0,0,Traditional serrated adenoma
8213,0,0,Traditional sessile serrated adenoma
8213,2,1,"Serrated dysplasia, high grade (C16._, C17._) [REPORTABLE 2022+ FOR STOMACH AND SMALL INTESTINE ONLY; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY.]"
8213,2,0,"High grade serrated dysplasia (C16._, C17._) [REPORTABLE 2022+ FOR STOMACH AND SMALL INTESTINE ONLY; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY.]"
8213,3,1,"Serrated adenocarcinoma (C18.0, C18.2, C18.9, C19.9, C20.9) [CODE FOR USE IN 2015+]"
8213,3,0,"Adenocarcinoma, serrated (C18.0, C18.2, C18.9, C19.9, C20.9) [CODE FOR USE IN 2015+]"
8214,3,1,Parietal cell carcinoma (C16._)
8214,3,0,"Adenocarcinoma, parietal cell (C16._)"
8214,3,0,"Carcinoma, parietal cell (C16._)"
8214,3,0,Parietal cell adenocarcinoma (C16._)
8215,3,1,Adenocarcinoma of anal glands (C21.1)
8215,3,0,Adenocarcinoma of anal ducts (C21.1)
8215,3,0,"Adenocarcinoma, anal ducts (C21.1)"
8215,3,0,"Adenocarcinoma, anal glands (C21.1)"
8215,3,0,Anal ducts adenocarcinoma (C21.1)
8215,3,0,Anal glands adenocarcinoma (C21.1)
8220,0,1,Adenomatous polyposis coli (C18._)
8220,0,0,"Adenomatosis, NOS"
8220,0,0,Familial polyposis coli (C18._)
8220,0,0,"Polyposis coli, familial (C18._)"
8220,0,0,"Polyposis, adenomatous, coli (C18._)"
8220,3,1,Adenocarcinoma in adenomatous polyposis coli (C18._)
8220,3,0,"Adenomatous polyposis coli, adenocarcinoma in (C18._)"
8220,3,0,"Polyposis, adenomatous, coli, adenocarcinoma in (C18._)"
8221,0,1,Multiple adenomatous polyps
8221,0,0,"Adenomatous polyps, multiple"
8221,0,0,"Multiple polyps, adenomatous"
8221,0,0,"Polyposis, multiple"
8221,0,0,"Polyps, adenomatous, multiple"
8221,3,1,Adenocarcinoma in multiple adenomatous polyps
8221,3,0,"Adenomatous polyps, multiple, adenocarcinoma in"
8221,3,0,"Multiple adenomatous polyps, adenocarcinoma in"
8221,3,0,"Multiple polyps, adenomatous, adenocarcinoma in"
8221,3,0,"Polyps, adenomatous, multiple, adenocarcinoma in"
8230,2,1,"Ductal carcinoma in situ, solid type (C50._)"
8230,2,0,"Carcinoma, ductal in situ, solid type (C50._)"
8230,2,0,"Carcinoma, intraductal, solid type"
8230,2,0,"In situ ductal carcinoma, solid type (C50._)"
8230,2,0,"Intraductal carcinoma, solid type"
8230,2,0,"Solid type, ductal carcinoma in situ (C50._)"
8230,2,0,"Solid type, intraductal carcinoma"
8230,3,1,"Solid carcinoma, NOS"
8230,3,0,"Adenocarcinoma, solid, NOS [2021+]"
8230,3,0,"Adenocarcinoma, solid, with mucin formation"
8230,3,0,"Carcinoma, solid, NOS"
8230,3,0,"Carcinoma, solid, with mucin formation"
8230,3,0,"Mucin formation, solid adenocarcinoma with"
8230,3,0,"Mucin formation, solid carcinoma with"
8230,3,0,Solid adenocarcinoma with mucin formation
8230,3,0,"Solid adenocarcinoma, NOS [2021+]"
8230,3,0,Solid carcinoma with mucin formation
8231,3,1,Carcinoma simplex
8231,3,0,"Simplex, carcinoma"
8240,1,1,Carcinoid tumor of uncertain malignant potential
8240,1,0,"Argentaffin carcinoid tumor, NOS"
8240,1,0,"Argentaffinoma, NOS [obs]"
8240,1,0,"Carcinoid tumor, argentaffin, NOS"
8240,1,0,"Tumor, carcinoid, argentaffin, NOS"
8240,1,0,"Uncertain malignant potential, tumor, carcinoid"
8240,3,1,"Carcinoid tumor, NOS [including of appendix]"
8240,3,0,"Adenoma, bronchial, carcinoid (C34._)"
8240,3,0,"Bronchial adenoma, carcinoid (C34._)"
8240,3,0,"Carcinoid tumor, typical"
8240,3,0,"Carcinoid, bronchial adenoma (C34._)"
8240,3,0,"Carcinoid, NOS [including of appendix]"
8240,3,0,"Neuroendocrine carcinoma, low grade"
8240,3,0,"Neuroendocrine carcinoma, well-differentiated"
8240,3,0,"Neuroendocrine tumor, grade 1"
8240,3,0,"Tumor, carcinoid, NOS [including of appendix]"
8240,3,0,Typical carcinoid
8241,3,1,Enterochromaffin cell carcinoid
8241,3,0,"Argentaffin carcinoid tumor, malignant"
8241,3,0,"Argentaffinoma, malignant [obs]"
8241,3,0,"Carcinoid tumor, argentaffin, malignant"
8241,3,0,"Carcinoid, EC cell"
8241,3,0,"Carcinoid, enterochromaffin cell"
8241,3,0,"Carcinoid, serotonin producing"
8241,3,0,EC cell carcinoid
8241,3,0,Serotonin producing carcinoid
8241,3,0,"Tumor, carcinoid, argentaffin, malignant"
8242,1,1,"Enterochromaffin-like cell carcinoid, NOS"
8242,1,0,"Carcinoid, ECL cell, NOS"
8242,1,0,"Carcinoid, enterochromaffin-like cell, NOS"
8242,1,0,"ECL cell carcinoid, NOS"
8242,3,1,"Enterochromaffin-like cell tumor, malignant"
8242,3,0,"Carcinoid, ECL cell, malignant"
8242,3,0,"ECL cell carcinoid, malignant"
8242,3,0,"Tumor, enterochromaffin-like cell, malignant"
8243,3,1,Goblet cell adenocarcinoma [2022+]
8243,3,0,"Adenocarcinoma, goblet cell [2022+]"
8243,3,0,"Carcinoid, goblet cell"
8243,3,0,"Carcinoid, mucinous"
8243,3,0,Goblet cell carcinoid
8243,3,0,Mucinous carcinoid
8243,3,0,Mucocarcinoid tumor
8243,3,0,"Tumor, mucocarcinoid"
8244,3,1,Mixed adenoneuroendocrine carcinoma
8244,3,0,"Adenocarcinoma and carcinoid, combined"
8244,3,0,"Adenocarcinoma, combined carcinoid and adenocarcinoma"
8244,3,0,"Adenocarcinoma, mixed carcinoid-adenocarcinoma"
8244,3,0,"Carcinoid and adenocarcinoma, combined"
8244,3,0,"Carcinoid, adenocarcinoma and, combined"
8244,3,0,"Carcinoid, adenocarcinoma and, mixed"
8244,3,0,"Carcinoid, combined carcinoid and adenocarcinoma"
8244,3,0,"Carcinoid, composite"
8244,3,0,"Carcinoid, mixed carcinoid-adenocarcinoma"
8244,3,0,Combined adenocarcinoma and carcinoid
8244,3,0,Combined carcinoid and adenocarcinoma
8244,3,0,Combined/mixed carcinoid and adenocarcinoma
8244,3,0,Composite carcinoid
8244,3,0,MANEC
8244,3,0,Mixed adenocarcinoma and carcinoid
8244,3,0,Mixed adenocarcinoma-carcinoid
8244,3,0,Mixed carcinoid and adenocarcinoma
8244,3,0,Mixed carcinoid-adenocarcinoma
8245,1,1,Tubular carcinoid
8245,1,0,"Carcinoid, tubular"
8245,3,1,Adenocarcinoid tumor
8245,3,0,"Tumor, adenocarcinoid"
8246,3,1,"Neuroendocrine carcinoma, NOS"
8246,3,0,"Carcinoma, neuroendocrine, NOS"
8246,3,0,"Neoplasm, neuroendocrine, poorly differentiated [2021+]"
8246,3,0,"Neuroendocrine neoplasm, poorly differentiated [2021+]"
8246,3,0,"Neuroendocrine tumor, well differentiated [OF BREAST} (C50._)"
8246,3,0,Poorly differentiated neuroendocrine neoplasm [2021+]
8246,3,0,"Tumor, neuroendocrine, well differentiated [OF BREAST} (C50._)"
8247,3,1,Merkel cell carcinoma (C44._)
8247,3,0,"Carcinoma, Merkel cell (C44._)"
8247,3,0,"Carcinoma, neuroendocrine, primary cutaneous (C44._)"
8247,3,0,"Cutaneous neuroendocrine carcinoma, primary (C44._)"
8247,3,0,Merkel cell tumor (C44._)
8247,3,0,"Neuroendocrine carcinoma, primary cutaneous (C44._)"
8247,3,0,Primary cutaneous neuroendocrine carcinoma (C44._)
8247,3,0,"Tumor, Merkel cell (C44._)"
8248,1,1,Apudoma
8249,3,1,"Neuroendocrine tumor, grade 2"
8249,3,0,Atypical carcinoid tumor
8249,3,0,"Carcinoid tumor, atypical"
8249,3,0,"Neuroendocrine carcinoma, moderately differentiated"
8249,3,0,"Neuroendocrine tumor, grade 3 [2021+]"
8249,3,0,"Tumor, atypical carcinoid"
8249,3,0,"Tumor, neuroendocrine, grade 2"
8249,3,0,"Tumor, neuroendocrine, grade 3 [2021+]"
8250,1,1,Pulmonary adenomatosis (C34._)
8250,1,0,"Adenomatosis, pulmonary (C34._)"
8250,2,1,"Adenocarcinoma in situ, non-mucinous (C34._)"
8250,2,0,Non-mucinous adenocarcinoma in situ (C34._)
8250,3,1,Lepidic adenocarcinoma (C34._) 
8250,3,0,"Adenocarcinoma, bronchiolar (C34._)"
8250,3,0,"Adenocarcinoma, bronchiolo-alveolar, NOS (C34._)"
8250,3,0,"Adenocarcinoma, lepidic (C34._)"
8250,3,0,"Adenocarcinoma, lepidic predominant (C34._)"
8250,3,0,Alveolar cell carcinoma (C34._)
8250,3,0,Bronchiolar adenocarcinoma (C34._)
8250,3,0,Bronchiolar carcinoma (C34._)
8250,3,0,"Bronchiolo-alveolar adenocarcinoma, NOS (C34._)"
8250,3,0,"Bronchiolo-alveolar carcinoma, NOS (C34._)"
8250,3,0,"Carcinoma, alveolar cell (C34._)"
8250,3,0,"Carcinoma, bronchiolar (C34._)"
8250,3,0,"Carcinoma, bronchiolo-alveolar, NOS (C34._)"
8250,3,0,Lepidic predominant adenocarcinoma (C34._) 
8251,0,1,Alveolar adenoma (C34._)
8251,0,0,"Adenoma, alveolar (C34._)"
8251,3,1,Alveolar adenocarcinoma (C34._)
8251,3,0,"Adenocarcinoma, alveolar (C34._)"
8251,3,0,Alveolar carcinoma (C34._)
8251,3,0,"Carcinoma, alveolar (C34._)"
8252,3,1,"Bronchiolo-alveolar carcinoma, non-mucinous (C34._)"
8252,3,0,"Bronchiolo-alveolar carcinoma, Clara cell (C34._)"
8252,3,0,"Bronchiolo-alveolar carcinoma, type II pneumocyte (C34._)"
8252,3,0,"Carcinoma, bronchiolo-alveolar, Clara cell (C34._)"
8252,3,0,"Carcinoma, bronchiolo-alveolar, type II pneumocyte (C34._)"
8252,3,0,"Carcinoma, bronchiolo-alveolar,  non-mucinous (C34._)"
8252,3,0,Clara cell bronchiolo-alveolar carcinoma (C34._)
8252,3,0,Non-mucinous bronchiolo-alveolar carcinoma (C34._)
8252,3,0,"Pneumocyte, type II, bronchiolo-alveolar carcinoma (C34._)"
8253,2,1,"Adenocarcinoma in situ, mucinous (C34._) [LUNG ONLY, 2018+, DO NOT USE 8480]"
8253,2,0,"Mucinous adenocarcinoma in situ (C34._) [LUNG ONLY, 2018+, DO NOT USE 8480]"
8253,3,1,"Invasive mucinous adenocarcinoma (C34._) [LUNG ONLY, 2018+, DO NOT USE 8480]"
8253,3,0,"Adenocarcinoma, invasive mucinous (C34._) [LUNG ONLY, 2018+, DO NOT USE 8480]"
8253,3,0,"Bronchiolo-alveolar carcinoma, goblet cell type (C34._)"
8253,3,0,"Bronchiolo-alveolar carcinoma, mucinous (C34._)"
8253,3,0,"Carcinoma, bronchiolo-alveolar, goblet cell type (C34._)"
8253,3,0,"Carcinoma, bronchiolo-alveolar, mucinous (C34._)"
8253,3,0,"Goblet cell type, bronchiolo-alveolar carcinoma (C34._)"
8253,3,0,Mucinous bronchiolo-alveolar carcinoma (C34._)
8254,3,1,Mixed invasive mucinous and non-mucinous adenocarcinoma (C34._) 
8254,3,0,"Adenocarcinoma, mixed invasive mucinous and non-mucinous (C34._) "
8254,3,0,"Bronchiolo-alveolar carcinoma, Clara cell and goblet cell type (C34._)"
8254,3,0,"Bronchiolo-alveolar carcinoma, indeterminate type (C34._)"
8254,3,0,"Bronchiolo-alveolar carcinoma, mixed mucinous and non-mucinous (C34._)"
8254,3,0,"Bronchiolo-alveolar carcinoma, type II pneumocyte and goblet cell type (C34._)"
8254,3,0,"Carcinoma, bronchiolo-alveolar, Clara cell and goblet cell type (C34._)"
8254,3,0,"Carcinoma, bronchiolo-alveolar, indeterminate type (C34._)"
8254,3,0,"Carcinoma, bronchiolo-alveolar, mixed mucinous and non-mucinous (C34._)"
8254,3,0,"Carcinoma, bronchiolo-alveolar, type II pneumocyte and goblet cell (C34._)"
8254,3,0,Clara cell and goblet cell type bronchiolo-alveolar carcinoma (C34._)
8254,3,0,"Goblet cell type, bronchiolo-alveolar carcinoma, Clara cell and (C34._)"
8254,3,0,"Goblet cell type, bronchiolo-alveolar carcinoma, type II pneumocyte and (C34._)"
8254,3,0,Indeterminate type bronchiolo-alveolar carcinoma (C34._)
8254,3,0,Mixed mucinous and non-mucinous bronchiolo-alveolar carcinoma (C34._)
8254,3,0,Mixed non-mucinous and mucinous bronchiolo-alveolar carcinoma (C34._)
8254,3,0,"Mucinous and non-mucinous adenocarcinoma, mixed (C34._)"
8254,3,0,"Mucinous bronchiolo-alveolar carcinoma, non-mucinous and, mixed (C34._)"
8254,3,0,"Non-mucinous and mucinous bronchiolo-alveolar carcinoma, mixed (C34._)"
8254,3,0,"Pneumocyte, type II and goblet cell type bronchiolo-alveolar carcinoma (C34._)"
8255,3,1,Adenocarcinoma with mixed subtypes
8255,3,0,Adenocarcinoma combined with other types of carcinoma
8255,3,0,"Adenocarcinoma with other types of carcinoma, combined"
8255,3,0,"Adenocarcinoma, pancreatobiliary-type (C24.1)  [2015-2017. FOR 2018+ USE 8163/3]"
8255,3,0,"Carcinoma, combined adenocarcinoma with other types of carcinoma"
8255,3,0,Pancreatobiliary-type carcinoma (C24.1) [2015-2017. FOR 2018+ USE 8163/3]
8256,3,1,"Minimally invasive adenocarcinoma, non-mucinous (C34._) [2018+]"
8256,3,0,"Adenocarcinoma, minimally invasive, non-mucinous (C34._) [2018+]"
8256,3,0,"Non-mucinous adenocarcinoma, minimally invasive (C34._) [2018+]"
8257,3,1,"Minimally invasive adenocarcinoma, mucinous (C34._) [2018+]"
8257,3,0,"Adenocarcinoma, minimally invasive, mucinous (C34._) [2018+]"
8257,3,0,"Mucinous adenocarcinoma, minimally invasive (C34._) [2018+]"
8260,0,1,"Papillary adenoma, NOS"
8260,0,0,"Adenoma, papillary, NOS"
8260,0,0,Glandular papilloma
8260,0,0,"Papilloma, glandular"
8260,3,1,"Papillary adenocarcinoma, NOS"
8260,3,0,"Adenocarcinoma, papillary, NOS"
8260,3,0,"Carcinoma, papillary renal cell (C64.9)"
8260,3,0,"Carcinoma, papillary, thyroid (C73.9)"
8260,3,0,"Carcinoma, renal cell, papillary (C64.9)"
8260,3,0,Papillary carcinoma of thyroid (C73.9)
8260,3,0,"Papillary carcinoma, thyroid (C73.9)"
8260,3,0,Papillary renal cell carcinoma (C64.9)
8261,0,1,"Villous adenoma, NOS"
8261,0,0,"Adenoma, villous, NOS"
8261,0,0,"Papilloma, villous"
8261,0,0,Villous papilloma
8261,2,1,Adenocarcinoma in situ in villous adenoma
8261,2,0,"Adenoma, villous, adenocarcinoma in situ in"
8261,2,0,High grade villous adenoma [2022+; NOT REPORTABLE; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY.]
8261,2,0,"In situ adenocarcinoma, in villous adenoma"
8261,2,0,"Villous adenoma, adenocarcinoma in situ in"
8261,2,0,"Villous adenoma, high grade [2022+; NOT REPORTABLE; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY.]"
8261,3,1,Adenocarcinoma in villous adenoma
8261,3,0,"Adenoma, villous, adenocarcinoma in"
8261,3,0,"Villous adenoma, adenocarcinoma in"
8262,3,1,Villous adenocarcinoma
8262,3,0,"Adenocarcinoma, adenoma-like [2022+]"
8262,3,0,"Adenocarcinoma, villous"
8262,3,0,Adenoma-like adenocarcinoma [2022+]
8263,0,1,"Tubulovillous adenoma, NOS"
8263,0,0,"Adenoma, papillotubular"
8263,0,0,"Adenoma, tubulovillous, NOS"
8263,0,0,"Adenoma, villoglandular"
8263,0,0,Papillotubular adenoma
8263,0,0,Tubulo-papillary adenoma
8263,0,0,Villoglandular adenoma
8263,2,1,Adenocarcinoma in situ in tubulovillous adenoma
8263,2,0,"Adenoma, tubulovillous, adenocarcinoma in situ in"
8263,2,0,High grade tubulovillous adenoma [2022+; NOT REPORTABLE; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY.]
8263,2,0,"In situ adenocarcinoma, in tubulovillous adenoma"
8263,2,0,"Tubulovillous adenoma, adenocarcinoma in situ in"
8263,2,0,"Tubulovillous adenoma, high grade [2022+; NOT REPORTABLE; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY.]"
8263,3,1,Adenocarcinoma in tubulovillous adenoma
8263,3,0,"Adenocarcinoma, papillotubular"
8263,3,0,"Adenocarcinoma, tubulopapillary"
8263,3,0,"Adenocarcinoma, villoglandular endometrioid (C54._, C55.9) "
8263,3,0,"Adenoma, tubulovillous, adenocarcinoma in"
8263,3,0,"Carcinoma, villoglandular (C53._)"
8263,3,0,"Endometrioid adenocarcinoma, villoglandular (C54._, C55.9) "
8263,3,0,Papillotubular adenocarcinoma
8263,3,0,Tubulopapillary adenocarcinoma
8263,3,0,"Tubulovillous adenoma, adenocarcinoma in"
8263,3,0,"Villoglandular adenocarcinoma, endometrioid (C54._, C55.9) "
8263,3,0,Villoglandular carcinoma (C53._)
8264,0,1,"Papillomatosis, glandular"
8264,0,0,"Biliary papillomatosis (C22.1, C24.0)"
8264,0,0,Glandular papillomatosis
8264,0,0,"Papillomatosis, biliary (C22.1, C24.0)"
8265,3,1,"Micropapillary carcinoma, NOS (C18._, C19.9, C20.9, C34._) [2018+ ONLY. FOR PRE-2018, USE 8507/3. FOR BREAST ALL YEARS, USE 8507/3.]"
8265,3,0,"Adenocarcinoma, micropapillary (C34._) [2018+ ONLY. FOR PRE-2018, USE 8507/3. FOR BREAST ALL YEARS, USE 8507/3.]"
8265,3,0,"Carcinoma, micropapillary, NOS (C18._, C19.9, C20.9, C34._) [2018+ ONLY. FOR PRE-2018, USE 8507/3. FOR BREAST ALL YEARS, USE 8507/3.]"
8265,3,0,"Micropapillary adenocarcinoma (C34._) [2018+ ONLY. FOR PRE-2018, USE 8507/3. FOR BREAST ALL YEARS, USE 8507/3.]"
8270,0,1,Chromophobe adenoma (C75.1)
8270,0,0,"Adenoma, chromophobe (C75.1)"
8270,3,1,Chromophobe carcinoma (C75.1)
8270,3,0,"Adenocarcinoma, chromophobe (C75.1)"
8270,3,0,"Carcinoma, chromophobe (C75.1)"
8270,3,0,Chromophobe adenocarcinoma (C75.1)
8271,0,1,Prolactinoma (C75.1)
8272,0,1,"Pituitary adenoma, NOS (C75.1)"
8272,0,0,"Adenoma, pituitary, NOS (C75.1)"
8272,3,1,"Pituitary carcinoma, NOS (C75.1)"
8272,3,0,"Carcinoma, pituitary, NOS (C75.1)"
8273,3,1,Pituitary blastoma (C75.1) [REPORTABLE 2021+]
8273,3,0,"Blastoma, pituitary (C75.1) [REPORTABLE 2021+]"
8273,3,0,Embryoma [REPORTABLE 2021+]
8280,0,1,Acidophil adenoma (C75.1)
8280,0,0,"Adenoma, acidophil (C75.1)"
8280,0,0,"Adenoma, eosinophil (C75.1)"
8280,0,0,Eosinophil adenoma (C75.1)
8280,3,1,Acidophil carcinoma (C75.1)
8280,3,0,Acidophil adenocarcinoma (C75.1)
8280,3,0,"Adenocarcinoma, acidophil (C75.1)"
8280,3,0,"Adenocarcinoma, eosinophil (C75.1)"
8280,3,0,"Carcinoma, acidophil (C75.1)"
8280,3,0,"Carcinoma, eosinophil (C75.1)"
8280,3,0,Eosinophil adenocarcinoma (C75.1)
8280,3,0,Eosinophil carcinoma (C75.1)
8281,0,1,Mixed acidophil-basophil adenoma (C75.1)
8281,0,0,"Acidophil-basophil adenoma, mixed (C75.1)"
8281,0,0,"Adenoma, acidophil-basophil, mixed (C75.1)"
8281,0,0,"Adenoma, basophil-acidophil, mixed (C75.1)"
8281,0,0,"Adenoma, mixed acidophil-basophil (C75.1)"
8281,0,0,"Basophil acidophil adenoma, mixed (C75.1)"
8281,0,0,"Basophil-acidophil adenoma, mixed (C75.1)"
8281,0,0,Mixed basophil-acidophil adenoma (C75.1)
8281,3,1,Mixed acidophil-basophil carcinoma (C75.1)
8281,3,0,"Acidophil-basophil carcinoma, mixed (C75.1)"
8281,3,0,"Basophil acidophil carcinoma, mixed (C75.1)"
8281,3,0,"Basophil-acidophil carcinoma, mixed (C75.1)"
8281,3,0,"Carcinoma, acidophil-basophil, mixed (C75.1)"
8281,3,0,"Carcinoma, basophil-acidophil, mixed (C75.1)"
8281,3,0,Mixed basophil-acidophil carcinoma (C75.1)
8290,0,1,Oxyphilic adenoma
8290,0,0,"Adenoma, follicular, oxyphilic cell (C73.9)"
8290,0,0,"Adenoma, Hurthle cell (C73.9)"
8290,0,0,"Adenoma, oncocytic"
8290,0,0,"Adenoma, oxyphilic"
8290,0,0,"Adenoma, oxyphilic cell follicular (C73.9)"
8290,0,0,"Follicular adenoma, oxyphilic cell (C73.9)"
8290,0,0,Hurthle cell adenoma (C73.9)
8290,0,0,Hurthle cell tumor (C73.9)
8290,0,0,Oncocytic adenoma
8290,0,0,Oncocytoma
8290,0,0,Oxyphilic cell follicular adenoma (C73.9)
8290,0,0,Spindle cell oncocytoma (C75.1)
8290,0,0,"Tumor, Hurthle cell (C73.9)"
8290,3,1,Oxyphilic adenocarcinoma
8290,3,0,"Adenocarcinoma, Hurthle cell (C73.9)"
8290,3,0,"Adenocarcinoma, oncocytic"
8290,3,0,"Adenocarcinoma, oxyphilic"
8290,3,0,"Carcinoma, follicular, oxyphilic cell (C73.9)"
8290,3,0,"Carcinoma, Hurthle cell (C73.9)"
8290,3,0,"Carcinoma, oncocytic"
8290,3,0,"Follicular carcinoma, oxyphilic cell (C73.9)"
8290,3,0,Hurthle cell adenocarcinoma (C73.9)
8290,3,0,Hurthle cell carcinoma (C73.9)
8290,3,0,Oncocytic adenocarcinoma
8290,3,0,Oncocytic carcinoma
8290,3,0,Oxyphilic cell follicular carcinoma (C73.9)
8300,0,1,Basophil adenoma (C75.1)
8300,0,0,"Adenoma, basophil (C75.1)"
8300,0,0,"Adenoma, mucoid cell (C75.1)"
8300,0,0,Mucoid cell adenoma (C75.1)
8300,3,1,Basophil carcinoma (C75.1)
8300,3,0,"Adenocarcinoma, basophil (C75.1)"
8300,3,0,"Adenocarcinoma, mucoid cell (C75.1)"
8300,3,0,Basophil adenocarcinoma (C75.1)
8300,3,0,"Carcinoma, basophil (C75.1)"
8300,3,0,Mucoid cell adenocarcinoma (C75.1)
8310,0,1,Clear cell adenoma
8310,0,0,"Adenoma, clear cell"
8310,3,1,"Clear cell adenocarcinoma, NOS"
8310,3,0,"Adenocarcinoma, clear cell, mesonephroid"
8310,3,0,"Adenocarcinoma, clear cell, NOS"
8310,3,0,"Adenocarcinoma, HPV-independent, clear cell type (C53._) [2022+]"
8310,3,0,"Adenocarcinoma, mesonephroid, clear cell"
8310,3,0,"Carcinoma, clear cell"
8310,3,0,"Clear cell adenocarcinoma, mesonephroid"
8310,3,0,Clear cell carcinoma
8310,3,0,"HPV-independent adenocarcinoma, clear cell type (C53._) [2022+]"
8310,3,0,Mesonephroid clear cell adenocarcinoma
8311,1,1,Hypernephroid tumor [obs]
8311,1,0,"Tumor, hypernephroid [obs]"
8311,3,1,Hereditary leiomyomatosis and renal cell carcinoma (RCC- associated renal cell carcinoma) (C64.9) [2018+]
8311,3,0,"Carcinoma, renal cell, and hereditary leiomyomatosis (RCC- associated renal cell carcinoma) (C64.9) [2018+]"
8311,3,0,HLRCC (Hereditary leiomyomatosis and renal cell cancer) (C64.9) [2018+]
8311,3,0,"Leiomyomatosis, hereditary, and renal cell carcinoma (C64.9) [2018+]"
8311,3,0,MiT family translocation renal cell carcinoma (C64.9) [2018+]
8311,3,0,"Renal cell carcinoma, associated with hereditary leiomyomatosis (C64.9) [2018+]"
8311,3,0,"Renal cell carcinoma, MiT family translocation (C64.9) [2018+]"
8312,3,1,"Renal cell carcinoma, NOS (C64.9)"
8312,3,0,"Adenocarcinoma, renal cell (C64.9)"
8312,3,0,"Carcinoma, renal cell unclassified (C64.9)"
8312,3,0,"Carcinoma, renal cell, NOS (C64.9)"
8312,3,0,Grawitz tumor (C64.9) [obs]
8312,3,0,Hypernephroma (C64.9) [obs]
8312,3,0,Renal cell adenocarcinoma (C64.9)
8312,3,0,"Renal cell carcinoma, unclassified (C64.9) "
8312,3,0,"Tumor, Grawitz (C64.9) [obs]"
8313,0,1,Clear cell adenofibroma (C56.9)
8313,0,0,"Adenofibroma, clear cell (C56.9)"
8313,0,0,Clear cell cystadenofibroma (C56.9)
8313,0,0,"Cystadenofibroma, clear cell (C56.9)"
8313,1,1,Clear cell borderline tumor (C56.9)
8313,1,0,"Adenofibroma, clear cell, of borderline malignancy (C56.9)"
8313,1,0,"Atypical proliferative clear cell tumor (C56.9) [2021+ ONLY. FOR PRE-2021, USE 8444/1.]"
8313,1,0,"Borderline tumor, clear cell (C56.9)"
8313,1,0,Clear cell adenofibroma of borderline malignancy (C56.9)
8313,1,0,Clear cell cystadenofibroma of borderline malignancy (C56.9)
8313,1,0,"Clear cell cystic tumor of borderline malignancy (C56.9) [2021+ ONLY. FOR PRE-2021, USE 8444/1.]"
8313,1,0,"Clear cell tumor, atypical proliferative (C56.9) [2021+ ONLY. FOR PRE-2021, USE 8444/1.]"
8313,1,0,"Cystadenofibroma, clear cell, of borderline malignancy (C56.9)"
8313,1,0,"Cystic clear cell, tumor of borderline malignancy (C56.9) [2021+ ONLY. FOR PRE-2021, USE 8444/1.]"
8313,1,0,"Cystic tumor, clear cell, borderline malignancy (C56.9) [2021+ ONLY. FOR PRE-2021, USE 8444/1.]"
8313,1,0,"Proliferative clear cell tumor, atypical (C56.9) [2021+ ONLY. FOR PRE-2021, USE 8444/1.]"
8313,1,0,"Tumor, clear cell, atypical proliferative (C56.9) [2021+ ONLY. FOR PRE-2021, USE 8444/1.]"
8313,1,0,"Tumor, clear cell, cystic, borderline malignancy (C56.9) [2021+ ONLY. FOR PRE-2021, USE 8444/1.]"
8313,1,0,"Tumor, cystic, clear cell, borderline malignancy (C56.9) [2021+ ONLY. FOR PRE-2021, USE 8444/1.]"
8313,3,1,Clear cell adenocarcinofibroma (C56.9)
8313,3,0,"Adenocarcinofibroma, clear cell (C56.9)"
8313,3,0,Clear cell cystadenocarcinofibroma (C56.9)
8313,3,0,"Cystadenocarcinofibroma, clear cell (C56.9)"
8314,3,1,Lipid-rich carcinoma (C50._)
8314,3,0,"Carcinoma, lipid-rich (C50._)"
8315,3,1,Glycogen-rich carcinoma (C50._)
8315,3,0,"Carcinoma, clear cell, glycogen-rich [2021+]"
8315,3,0,"Carcinoma, glycogen-rich (C50._)"
8315,3,0,"Carcinoma, glycogen-rich, clear cell [2021+]"
8315,3,0,Glycogen-rich clear cell carcinoma [2021+]
8316,3,1,Cyst-associated renal cell carcinoma (C64.9)
8316,3,0,Acquired cystic disease-associated renal cell carcinoma (RCC) (C64.9) 
8316,3,0,"Carcinoma, renal cell, acquired cystic disease-associated (RCC) (C64.9)"
8316,3,0,"Carcinoma, renal cell, cyst-associated (C64.9)"
8316,3,0,"Carcinoma, renal cell, tubulocystic (C64.9)"
8316,3,0,"Cystic disease-associated renal cell carcinoma, acquired (RCC) (C64.9)"
8316,3,0,"Renal cell carcinoma, acquired cystic disease-associated (RCC) (C64.9) "
8316,3,0,"Renal cell carcinoma, cyst-associated (C64.9)"
8316,3,0,"Renal cell carcinoma, tubulocystic (C64.9)"
8316,3,0,Tubulocystic renal cell carcinoma (C64.9) 
8317,3,1,"Renal cell carcinoma, chromophobe type (C64.9)"
8317,3,0,"Carcinoma, chromophobe cell renal (C64.9)"
8317,3,0,"Carcinoma, renal cell, chromophobe type (C64.9)"
8317,3,0,"Carcinoma, renal, chromophobe cell (C64.9)"
8317,3,0,Chromophobe cell renal carcinoma (C64.9)
8317,3,0,"Renal carcinoma, chromophobe cell (C64.9)"
8318,3,1,"Renal cell carcinoma, sarcomatoid (C64.9)"
8318,3,0,"Carcinoma, renal cell, sarcomatoid (C64.9)"
8318,3,0,"Carcinoma, renal cell, spindle cell (C64.9)"
8318,3,0,"Carcinoma, sarcomatoid renal cell (C64.9)"
8318,3,0,"Carcinoma, spindle cell, renal cell (C64.9)"
8318,3,0,"Renal cell carcinoma, spindle cell (C64.9)"
8318,3,0,"Sarcomatoid carcinoma, renal cell (C64.9)"
8318,3,0,Sarcomatoid renal cell carcinoma (C64.9)
8318,3,0,"Spindle cell carcinoma, renal cell (C64.9)"
8318,3,0,Spindle cell renal cell carcinoma (C64.9)
8319,3,1,Collecting duct carcinoma (C64.9)
8319,3,0,Bellini duct carcinoma (C64.9)
8319,3,0,"Carcinoma, Bellini duct (C64.9)"
8319,3,0,"Carcinoma, collecting duct (C64.9)"
8319,3,0,"Carcinoma, duct, collecting (C64.9)"
8319,3,0,"Carcinoma, renal, collecting duct type (C64.9)"
8319,3,0,Collecting duct type renal carcinoma (C64.9)
8319,3,0,"Duct carcinoma, Bellini (C64.9)"
8319,3,0,"Duct carcinoma, collecting (C64.9)"
8319,3,0,"Duct, Bellini, carcinoma (C64.9)"
8319,3,0,"Duct, renal carcinoma, collecting duct type (C64.9)"
8319,3,0,"Renal carcinoma, collecting duct type (C64.9)"
8320,3,1,Granular cell carcinoma
8320,3,0,"Adenocarcinoma, granular cell"
8320,3,0,"Carcinoma, granular cell"
8320,3,0,Granular cell adenocarcinoma
8321,0,1,Chief cell adenoma (C75.0)
8321,0,0,"Adenoma, chief cell (C75.0)"
8322,0,1,Water-clear cell adenoma (C75.0)
8322,0,0,"Adenoma, water-clear cell (C75.0)"
8322,3,1,Water-clear cell adenocarcinoma (C75.0)
8322,3,0,"Adenocarcinoma, water-clear cell (C75.0)"
8322,3,0,"Carcinoma, water-clear cell (C75.0)"
8322,3,0,Water-clear cell carcinoma (C75.0)
8323,0,1,Mixed cell adenoma
8323,0,0,"Adenoma, mixed cell"
8323,3,1,Mixed cell adenocarcinoma
8323,3,0,"Adenocarcinoma, mixed cell"
8324,0,1,Lipoadenoma
8324,0,0,Adenolipoma
8325,0,1,Metanephric adenoma (C64.9)
8325,0,0,"Adenoma, metanephric (C64.9)"
8330,0,1,"Follicular adenoma, NOS (C73.9)"
8330,0,0,"Adenoma, follicular, NOS (C73.9)"
8330,1,1,Atypical follicular adenoma (C73.9)
8330,1,0,"Adenoma, follicular, atypical (C73.9)"
8330,1,0,"Follicular adenoma, atypical (C73.9)"
8330,3,1,"Follicular carcinoma, NOS (C73.9)"
8330,3,0,"Adenocarcinoma, follicular, NOS (C73.9)"
8330,3,0,"Carcinoma, follicular, NOS (C73.9)"
8330,3,0,"Follicular adenocarcinoma, NOS (C73.9)"
8331,3,1,"Follicular adenocarcinoma, well differentiated (C73.9)"
8331,3,0,"Adenocarcinoma, follicular, well differentiated (C73.9)"
8331,3,0,"Carcinoma, follicular, well differentiated (C73.9)"
8331,3,0,"Follicular carcinoma, well differentiated (C73.9)"
8331,3,0,Well differentiated follicular adenocarcinoma (C73.9)
8331,3,0,Well differentiated follicular carcinoma (C73.9)
8332,3,1,"Follicular adenocarcinoma, trabecular (C73.9)"
8332,3,0,"Adenocarcinoma, follicular, moderately differentiated (C73.9)"
8332,3,0,"Adenocarcinoma, follicular, trabecular (C73.9)"
8332,3,0,"Carcinoma, follicular, moderately differentiated (C73.9)"
8332,3,0,"Carcinoma, follicular, trabecular (C73.9)"
8332,3,0,"Follicular adenocarcinoma, moderately differentiated (C73.9)"
8332,3,0,"Follicular carcinoma, moderately differentiated (C73.9)"
8332,3,0,"Follicular carcinoma, trabecular (C73.9)"
8332,3,0,Moderately differentiated follicular adenocarcinoma (C73.9)
8332,3,0,Moderately differentiated follicular carcinoma (C73.9)
8332,3,0,Trabecular follicular adenocarcinoma (C73.9)
8332,3,0,Trabecular follicular carcinoma (C73.9)
8333,0,1,"Microfollicular adenoma, NOS (C73.9)"
8333,0,0,"Adenoma, fetal (C73.9)"
8333,0,0,"Adenoma, microfollicular, NOS (C73.9)"
8333,0,0,Fetal adenoma (C73.9)
8333,3,1,Fetal adenocarcinoma (C73.9)
8333,3,0,"Adenocarcinoma, fetal (C73.9)"
8334,0,1,Macrofollicular adenoma (C73.9)
8334,0,0,"Adenoma, colloid (C73.9)"
8334,0,0,"Adenoma, macrofollicular (C73.9)"
8334,0,0,Colloid adenoma (C73.9)
8335,1,1,Follicular tumor of uncertain malignant potential (C73.9)
8335,1,0,"Carcinoma, follicular, encapsulated (C73.9) [2021+ NOT REPORTABLE; FOR PRE-2021, USE 8335/3]"
8335,1,0,"Encapsulated follicular carcinoma (C73.9) [2021+ NOT REPORTABLE; FOR PRE-2021, USE 8335/3]"
8335,1,0,"Follicular carcinoma, encapsulated (C73.9) [2021+ NOT REPORTABLE; FOR PRE-2021, USE 8335/3]"
8335,3,1,"Follicular carcinoma, minimally invasive (C73.9)"
8335,3,0,"Carcinoma, follicular, encapsulated (C73.9) [REPORTABLE PRE-2021 ONLY; FOR 2021+, USE 8335/1]"
8335,3,0,"Carcinoma, follicular, minimally invasive (C73.9)"
8335,3,0,"Encapsulated follicular carcinoma (C73.9) [REPORTABLE PRE-2021 ONLY; FOR 2021+, USE 8335/1]"
8335,3,0,"Follicular carcinoma, encapsulated (C73.9) [REPORTABLE PRE-2021 ONLY; FOR 2021+, USE 8335/1]"
8335,3,0,Minimally invasive follicular carcinoma (C73.9)
8336,0,1,Hyalinizing trabecular adenoma (C73.9)
8336,0,0,"Adenoma, trabecular, hyalinizing (C73.9)"
8336,0,0,"Trabecular adenoma, hyalinizing (C73.9)"
8337,3,1,Poorly differentiated thyroid carcinoma (C73.9) [2021+]
8337,3,0,"Carcinoma, insular (C73.9)"
8337,3,0,"Carcinoma, thyroid, poorly differentiated (C73.9) [2021+]"
8337,3,0,Insular carcinoma (C73.9)
8339,3,1,"Follicular thyroid carcinoma (FTC), encapsulated angioinvasive (C73.9) [2018+]"
8339,3,0,Angioinvasive encapsulated follicular thyroid carcinoma (FTC) (C73.9) [2018+]
8339,3,0,"Carcinoma, follicular thyroid (FTC), encapsulated angioinvasive (C73.9) [2018+]"
8339,3,0,Encapsulated angioinvasive follicular thyroid carcinoma (FTC) (C73.9) [2018+]
8339,3,0,"FTC (follicular thyroid carcinoma), encapsulated angioinvasive (C73.9) [2018+]"
8340,3,1,"Papillary carcinoma, follicular variant (C73.9)"
8340,3,0,"Adenocarcinoma, follicular and papillary (C73.9)"
8340,3,0,"Adenocarcinoma, papillary and follicular (C73.9)"
8340,3,0,"Adenocarcinoma, papillary, follicular variant (C73.9)"
8340,3,0,"Carcinoma, follicular and papillary (C73.9)"
8340,3,0,"Carcinoma, papillary and follicular (C73.9)"
8340,3,0,"Carcinoma, papillary, follicular variant (C73.9)"
8340,3,0,Follicular and papillary adenocarcinoma (C73.9)
8340,3,0,Follicular and papillary carcinoma (C73.9)
8340,3,0,"Follicular variant, papillary adenocarcinoma (C73.9)"
8340,3,0,"Follicular variant, papillary carcinoma (C73.9)"
8340,3,0,"Papillary adenocarcinoma, follicular variant (C73.9)"
8340,3,0,Papillary and follicular adenocarcinoma (C73.9)
8340,3,0,Papillary and follicular carcinoma (C73.9)
8340,3,0,"Papillary, follicular variant, adenocarcinoma (C73.9)"
8341,3,1,Papillary microcarcinoma (C73.9)
8341,3,0,"Microcarcinoma, papillary (C73.9)"
8342,3,1,"Papillary carcinoma, oncocytic variant (C73.9) [2021+]"
8342,3,0,"Carcinoma, papillary, oncocytic variant (C73.9) [2021+]"
8342,3,0,"Carcinoma, papillary, oxyphilic cell (C73.9)"
8342,3,0,Oncocytic variant papillary carcinoma (C73.9) [2021+]
8342,3,0,Oxyphilic cell papillary carcinoma (C73.9)
8342,3,0,"Papillary carcinoma, oxyphilic cell (C73.9)"
8343,2,1,Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) (C73.9) [REPORTABLE 2017-2020 ONLY. FOR 2021+ USE CODE 8349/1.]
8343,2,0,"Carcinoma, encapsulated follicular variant of papillary thyroid carcinoma, non-invasive (non-invasive EFVPTC) (C73.9) [REPORTABLE 2017-2020 ONLY. FOR 2021+ USE CODE 8349/1.]"
8343,2,0,"Carcinoma, papillary thyroid, follicular variant, non-invasive encapsulated (non-invasive EFVPTC) (C73.9) [REPORTABLE 2017-2020 ONLY. FOR 2021+ USE CODE 8349/1.]"
8343,2,0,"EFVPTC (Encapsulated follicular variant of papillary thyroid carcinoma), non-invasive (C73.9) [REPORTABLE 2017-2020 ONLY. FOR 2021+ USE CODE 8349/1.]"
8343,2,0,"Encapsulated follicular variant of papillary thyroid carcinoma, non-invasive (non-invasive EFVPTC) (C73.9) [REPORTABLE 2017-2020 ONLY. FOR 2021+ USE CODE 8349/1.]"
8343,2,0,"Follicular thyroid neoplasm w/papillary-like nuclear features, non-invasive (NIFTP) (C73.9) [REPORTABLE 2017-2020 ONLY. FOR 2021+ USE CODE 8349/1.]"
8343,2,0,"Follicular variant of papillary thyroid carcinoma, encapsulated non-invasive (non-invasive EFVPTC) (C73.9) [REPORTABLE 2017-2020 ONLY. FOR 2021+ USE CODE 8349/1.]"
8343,2,0,"Follicular variant of papillary thyroid carcinoma, non-invasive encapsulated (non-invasive EFVPTC) (C73.9) [REPORTABLE 2017-2020 ONLY. FOR 2021+ USE CODE 8349/1.]"
8343,2,0,"FTP, non-invasive (C73.9) [REPORTABLE 2017-2020 ONLY. FOR 2021+ USE CODE 8349/1.]"
8343,2,0,"Neoplasm, follicular thyroid w/papillary-like nuclear features, non-invasive (NIFTP) (C73.9) [REPORTABLE 2017-2020 ONLY. FOR 2021+ USE CODE 8349/1.]"
8343,2,0,NIFTP (C73.9) [REPORTABLE 2017-2020 ONLY. FOR 2021+ USE CODE 8349/1.]
8343,2,0,Non-invasive EFVPTC (encapsulated follicular variant of papillary thyroid carcinoma) (C73.9) [REPORTABLE 2017-2020 ONLY. FOR 2021+ USE CODE 8349/1.]
8343,2,0,Non-invasive encapsulated follicular variant of papillary thyroid carcinoma (non-invasive EFVPTC) (C73.9) [REPORTABLE 2017-2020 ONLY. FOR 2021+ USE CODE 8349/1.]
8343,2,0,Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) (C73.9) [REPORTABLE 2017-2020 ONLY. FOR 2021+ USE CODE 8349/1.]
8343,2,0,Non-invasive FTP (C73.9) [REPORTABLE 2017-2020 ONLY. FOR 2021+ USE CODE 8349/1.]
8343,2,0,"Papillary thyroid carcinoma, follicular variant, encapsulated non-invasive (non-invasive EFVPTC) (C73.9) [REPORTABLE 2017-2020 ONLY. FOR 2021+ USE CODE 8349/1.]"
8343,3,1,"Papillary carcinoma, encapsulated (C73.9)"
8343,3,0,"Carcinoma, papillary, encapsulated (C73.9)"
8343,3,0,"EFVPTC, invasive [or NOS] (C73.9)"
8343,3,0,"Encapsulated follicular variant of papillary thyroid carcinoma, invasive (invasive EFVPTC)"
8343,3,0,"Encapsulated follicular variant of papillary thyroid carcinoma, NOS (EFVPTC, NOS) (C73.9) (2017+)"
8343,3,0,Encapsulated papillary carcinoma (C73.9)
8343,3,0,"Follicular variant of papillary thyroid carcinoma, encapsulated invasive (invasive EFVPTC) (C73.9) (2017+)"
8343,3,0,"Follicular variant of papillary thyroid carcinoma, encapsulated, NOS (EFVPTC, NOS) (C73.9) (2017+)"
8343,3,0,"Follicular variant of papillary thyroid carcinoma, invasive encapsulated (invasive EFVPTC) (C73.9) (2017+)"
8343,3,0,Invasive encapsulated follicular variant of papillary thyroid carcinoma (invasive EFVPTC) (C73.9) (2017+)
8343,3,0,"Papillary thyroid carcinoma, follicular variant, encapsulated Invasive (invasive EFVPTC) (C73.9) (2017+)"
8343,3,0,"Papillary thyroid carcinoma, follicular variant, encapsulated, NOS (EFVPTC, NOS) (C73.9) (2017+)"
8343,3,0,"Papillary thyroid carcinoma, follicular variant, invasive encapsulated (invasive EFVPTC) (C73.9) (2017+)"
8343,3,0,"Papillary thyroid carcinoma, follicular variant, non-invasive encapsulated (non-invasive EFVPTC) (C73.9) (2017+)"
8344,3,1,"Papillary carcinoma, columnar cell (C73.9)"
8344,3,0,"Carcinoma, papillary, columnar cell (C73.9)"
8344,3,0,"Carcinoma, papillary, tall cell (C73.9)"
8344,3,0,Columnar cell papillary carcinoma (C73.9)
8344,3,0,"Papillary carcinoma, tall cell (C73.9)"
8344,3,0,Tall cell papillary carcinoma (C73.9)
8345,3,1,Medullary carcinoma (C73.9) [FOR THYROID 2018+. FOR BREAST FOR ALL YEARS USE 8510.]
8345,3,0,"Amyloid stroma, medullary carcinoma with (C73.9)"
8345,3,0,C cell carcinoma (C73.9)
8345,3,0,"Carcinoma, C cell (C73.9)"
8345,3,0,"Carcinoma, medullary with amyloid stroma (C73.9)"
8345,3,0,"Carcinoma, parafollicular cell (C73.9)"
8345,3,0,Medullary carcinoma with amyloid stroma (C73.9)
8345,3,0,Parafollicular cell carcinoma (C73.9)
8346,3,1,Mixed medullary-follicular carcinoma (C73.9)
8346,3,0,"Carcinoma, follicular-medullary, mixed (C73.9)"
8346,3,0,"Carcinoma, mixed follicular-medullary (C73.9)"
8346,3,0,"Carcinoma, mixed medullary-follicular (C73.9)"
8346,3,0,"Follicular-medullary carcinoma, mixed (C73.9)"
8346,3,0,"Medullary-follicular carcinoma, mixed (C73.9)"
8346,3,0,Mixed follicular-medullary carcinoma (C73.9)
8347,3,1,Mixed medullary-papillary carcinoma (C73.9)
8347,3,0,"Carcinoma, mixed medullary-papillary (C73.9)"
8347,3,0,"Carcinoma, mixed papillary-medullary (C73.9)"
8347,3,0,"Carcinoma, papillary-medullary, mixed (C73.9)"
8347,3,0,"Medullary-papillary carcinoma, mixed (C73.9)"
8347,3,0,Mixed papillary-medullary carcinoma (C73.9)
8347,3,0,"Papillary-medullary carcinoma, mixed (C73.9)"
8348,1,1,Well differentiated tumor of uncertain malignant potential (C73.9) [2021+]
8348,1,0,"Tumor of uncertain malignant potential, well differentiated (C73.9) [2021+]"
8349,1,1,"Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) (C73.9) [2021+ NOT REPORTABLE. FOR 2017-2020, USE CODE 8343/2]"
8349,1,0,"Carcinoma, encapsulated follicular variant of papillary thyroid carcinoma, non-invasive (non-invasive EFVPTC) (C73.9) [2021+ NOT REPORTABLE. FOR 2017-2020, USE CODE 8343/2]"
8349,1,0,"Carcinoma, papillary thyroid, follicular variant, non-invasive encapsulated (non-invasive EFVPTC) (C73.9) [2021+ NOT REPORTABLE. FOR 2017-2020, USE CODE 8343/2]"
8349,1,0,"EFVPTC (Encapsulated follicular variant of papillary thyroid carcinoma), non-invasive (C73.9) [2021+ NOT REPORTABLE. FOR 2017-2020, USE CODE 8343/2]"
8349,1,0,"Encapsulated follicular variant of papillary thyroid carcinoma, non-invasive (non-invasive EFVPTC) (C73.9) [2021+ NOT REPORTABLE. FOR 2017-2020, USE CODE 8343/2]"
8349,1,0,"Follicular thyroid neoplasm w/papillary-like nuclear features, non-invasive (NIFTP) (C73.9) [2021+ NOT REPORTABLE. FOR 2017-2020, USE CODE 8343/2]"
8349,1,0,"Follicular variant of papillary thyroid carcinoma, encapsulated non-invasive (non-invasive EFVPTC) (C73.9) [2021+ NOT REPORTABLE. FOR 2017-2020, USE CODE 8343/2]"
8349,1,0,"Follicular variant of papillary thyroid carcinoma, non-invasive encapsulated (non-invasive EFVPTC) (C73.9) [2021+ NOT REPORTABLE. FOR 2017-2020, USE CODE 8343/2]"
8349,1,0,"FTP, non-invasive (C73.9) [2021+ NOT REPORTABLE. FOR 2017-2020, USE CODE 8343/2]"
8349,1,0,"Neoplasm, follicular thyroid w/papillary-like nuclear features, non-invasive (NIFTP) (C73.9) [2021+ NOT REPORTABLE. FOR 2017-2020, USE CODE 8343/2]"
8349,1,0,"NIFTP (C73.9) [2021+ NOT REPORTABLE. FOR 2017-2020, USE CODE 8343/2]"
8349,1,0,"Non-invasive EFVPTC (encapsulated follicular variant of papillary thyroid carcinoma) (C73.9) [2021+ NOT REPORTABLE. FOR 2017-2020, USE CODE 8343/2]"
8349,1,0,"Non-invasive encapsulated follicular variant of papillary thyroid carcinoma (non-invasive EFVPTC) (C73.9) [2021+ NOT REPORTABLE. FOR 2017-2020, USE CODE 8343/2]"
8349,1,0,"Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) (C73.9) [2021+ NOT REPORTABLE. FOR 2017-2020, USE CODE 8343/2]"
8349,1,0,"Non-invasive FTP (C73.9) [2021+ NOT REPORTABLE. FOR 2017-2020, USE CODE 8343/2]"
8349,1,0,"Papillary thyroid carcinoma, follicular variant, encapsulated non-invasive (non-invasive EFVPTC) (C73.9) [2021+ NOT REPORTABLE. FOR 2017-2020, USE CODE 8343/2]"
8350,3,1,Nonencapsulated sclerosing carcinoma (C73.9)
8350,3,0,"Adenocarcinoma, nonencapsulated sclerosing (C73.9)"
8350,3,0,"Adenocarcinoma, sclerosing, nonencapsulated (C73.9)"
8350,3,0,"Carcinoma, nonencapsulated sclerosing (C73.9)"
8350,3,0,"Carcinoma, papillary, diffuse sclerosing (C73.9)"
8350,3,0,"Carcinoma, sclerosing, nonencapsulated (C73.9)"
8350,3,0,"Diffuse papillary carcinoma, sclerosing (C73.9)"
8350,3,0,Nonencapsulated sclerosing adenocarcinoma (C73.9)
8350,3,0,Nonencapsulated sclerosing tumor (C73.9)
8350,3,0,"Papillary carcinoma, diffuse sclerosing (C73.9)"
8350,3,0,"Sclerosing adenocarcinoma, nonencapsulated (C73.9)"
8350,3,0,"Sclerosing carcinoma, nonencapsulated (C73.9)"
8350,3,0,"Sclerosing carcinoma, papillary, diffuse (C73.9)"
8350,3,0,"Sclerosing papillary carcinoma, diffuse (C73.9)"
8350,3,0,"Sclerosing tumor, nonencapsulated (C73.9)"
8350,3,0,"Tumor, nonencapsulated sclerosing (C73.9)"
8350,3,0,"Tumor, sclerosing, nonencapsulated (C73.9)"
8360,1,1,Multiple endocrine adenomas
8360,1,0,"Adenomas, multiple, endocrine"
8360,1,0,"Adenomatosis, endocrine"
8360,1,0,"Endocrine adenomas, multiple"
8360,1,0,Endocrine adenomatosis
8360,1,0,"Multiple adenomas, endocrine"
8361,0,1,Juxtaglomerular tumor (C64.9)
8361,0,0,Reninoma (C64.9)
8361,0,0,"Tumor, juxtaglomerular (C64.9)"
8370,0,1,"Adrenal cortical adenoma, NOS (C74.0)"
8370,0,0,"Adenoma, adrenal cortical, NOS (C74.0)"
8370,0,0,"Adrenal cortical tumor, benign (C74.0)"
8370,0,0,"Adrenal cortical tumor, NOS (C74.0)"
8370,0,0,"Tumor, adrenal cortical, benign (C74.0)"
8370,0,0,"Tumor, adrenal cortical, NOS (C74.0)"
8370,3,1,Adrenal cortical carcinoma (C74.0)
8370,3,0,"Adenocarcinoma, adrenal cortical (C74.0)"
8370,3,0,Adrenal cortical adenocarcinoma (C74.0)
8370,3,0,"Adrenal cortical tumor, malignant (C74.0)"
8370,3,0,"Carcinoma, adrenal cortical (C74.0)"
8370,3,0,"Tumor, adrenal cortical, malignant (C74.0)"
8371,0,1,"Adrenal cortical adenoma, compact cell (C74.0)"
8371,0,0,"Adenoma, adrenal cortical, compact cell (C74.0)"
8371,0,0,Compact cell adrenal cortical adenoma (C74.0)
8372,0,1,"Adrenal cortical adenoma, pigmented (C74.0)"
8372,0,0,"Adenoma, adrenal cortical, pigmented (C74.0)"
8372,0,0,"Adenoma, black (C74.0)"
8372,0,0,"Adenoma, pigmented (C74.0)"
8372,0,0,Black adenoma (C74.0)
8372,0,0,Pigmented adenoma (C74.0)
8372,0,0,Pigmented adrenal cortical adenoma (C74.0)
8373,0,1,"Adrenal cortical adenoma, clear cell (C74.0)"
8373,0,0,"Adenoma, adrenal cortical, clear cell (C74.0)"
8373,0,0,Clear cell adrenal cortical adenoma (C74.0)
8374,0,1,"Adrenal cortical adenoma, glomerulosa cell (C74.0)"
8374,0,0,"Adenoma, adrenal cortical, glomerulosa cell (C74.0)"
8374,0,0,"Glomerulosa cell, adrenal cortical adenoma (C74.0)"
8375,0,1,"Adrenal cortical adenoma, mixed cell (C74.0)"
8375,0,0,"Adenoma, adrenal cortical, mixed cell (C74.0)"
8375,0,0,"Mixed cell, adrenal cortical adenoma (C74.0)"
8380,0,1,"Endometrioid adenoma, NOS"
8380,0,0,"Adenoma, endometrioid, NOS"
8380,0,0,"Cystadenoma, endometrioid, NOS"
8380,0,0,"Endometrioid cystadenoma, NOS"
8380,1,1,"Endometrioid adenoma, borderline malignancy"
8380,1,0,"Adenoma, endometrioid, borderline malignancy"
8380,1,0,Atypical proliferative endometrioid tumor
8380,1,0,"Cystadenoma, endometrioid, borderline malignancy"
8380,1,0,"Endometrioid cystadenoma, borderline malignancy"
8380,1,0,Endometrioid tumor of low malignant potential
8380,1,0,"Endometrioid tumor, atypical proliferative"
8380,1,0,"Low malignant potential, endometrioid tumor"
8380,1,0,"Proliferative endometrioid tumor, atypical"
8380,1,0,"Tumor, endometrioid of low malignant potential (C56.9)"
8380,1,0,"Tumor, endometrioid, atypical proliferative"
8380,2,1,Endometrioid intraepithelial neoplasia (C54._) [2018+; REPORTABLE 2021+]
8380,2,0,Atypical hyperplasia of the endometrium (C54._) [2018+; REPORTABLE 2021+]
8380,2,0,Atypical hyperplasia/Endometrioid intraepithelial neoplasm (C54._) [2018+; REPORTABLE 2021+]
8380,2,0,Endometrioid intraepithelial neoplasm/Atypical hyperplasia (C54._) [2018+; REPORTABLE 2021+]
8380,3,1,"Endometrioid adenocarcinoma, NOS"
8380,3,0,"Adenocarcinoma, endometrioid, NOS"
8380,3,0,"Carcinoma, endometrioid, NOS"
8380,3,0,"Cystadenocarcinoma, endometrioid"
8380,3,0,"Endometrioid carcinoma, NOS"
8380,3,0,Endometrioid cystadenocarcinoma
8381,0,1,"Endometrioid adenofibroma, NOS"
8381,0,0,"Adenofibroma, endometrioid, NOS"
8381,0,0,"Cystadenofibroma, endometrioid, NOS"
8381,0,0,"Endometrioid cystadenofibroma, NOS"
8381,1,1,"Endometrioid adenofibroma, borderline malignancy"
8381,1,0,"Adenofibroma, endometrioid, borderline malignancy"
8381,1,0,"Cystadenofibroma, endometrioid, borderline malignancy"
8381,1,0,"Endometrioid cystadenofibroma, borderline malignancy"
8381,3,1,"Endometrioid adenofibroma, malignant"
8381,3,0,"Adenofibroma, endometrioid, malignant"
8381,3,0,"Cystadenofibroma, endometrioid, malignant"
8381,3,0,"Endometrioid cystadenofibroma, malignant"
8382,3,1,"Endometrioid adenocarcinoma, secretory variant"
8382,3,0,"Adenocarcinoma, endometrioid, secretory variant"
8382,3,0,"secretory variant, endometrioid adenocarcinoma"
8383,3,1,"Endometrioid adenocarcinoma, ciliated cell variant"
8383,3,0,"Adenocarcinoma, endometrioid, ciliated cell variant"
8383,3,0,"Ciliated cell variant, endometrioid adenocarcinoma"
8384,3,1,"Adenocarcinoma, endocervical type"
8384,3,0,Endocervical type adenocarcinoma
8390,0,1,Skin appendage adenoma (C44._)
8390,0,0,"Adenoma, skin appendage (C44._)"
8390,0,0,"Adnexal tumor, benign (C44._)"
8390,0,0,"Skin appendage tumor, benign (C44._)"
8390,0,0,"Tumor, adnexal, benign (C44._)"
8390,0,0,"Tumor, skin appendage, benign (C44._)"
8390,3,1,Adnexal adenocarcinoma (C44. _)
8390,3,0,"Adenocarcinoma, adnexal (C44._)"
8390,3,0,Adnexal carcinoma (C44._)
8390,3,0,"Carcinoma, adnexal (C44._)"
8390,3,0,"Carcinoma, skin appendage (C44._)"
8390,3,0,Skin appendage carcinoma (C44._)
8391,0,1,Follicular fibroma (C44._)
8391,0,0,Fibrofolliculoma (C44._)
8391,0,0,"Fibroma, follicular (C44._)"
8391,0,0,"Fibroma, perifollicular (C44._)"
8391,0,0,Perifollicular fibroma (C44._)
8391,0,0,Trichodiscoma (C44._)
8392,0,1,Syringofibroadenoma (C44._)
8400,0,1,Sweat gland adenoma (C44._)
8400,0,0,"Adenoma, sweat gland (C44._)"
8400,0,0,"Hidradenoma, NOS (C44._)"
8400,0,0,"Sweat gland tumor, benign (C44._)"
8400,0,0,"Syringadenoma, NOS (C44._)"
8400,0,0,"Tumor, sweat gland, benign (C44._)"
8400,1,1,"Sweat gland tumor, NOS (C44._)"
8400,1,0,"Tumor, sweat gland, NOS (C44._)"
8400,3,1,Sweat gland adenocarcinoma (C44._)
8400,3,0,"Adenocarcinoma, sweat gland (C44._)"
8400,3,0,"Carcinoma, sweat gland (C44._)"
8400,3,0,Sweat gland carcinoma (C44._)
8400,3,0,"Sweat gland tumor, malignant (C44._)"
8400,3,0,"Tumor, sweat gland, malignant (C44._)"
8401,0,1,Apocrine adenoma
8401,0,0,"Adenoma, apocrine"
8401,0,0,Apocrine cystadenoma
8401,0,0,"Cystadenoma, apocrine"
8401,3,1,Apocrine adenocarcinoma
8401,3,0,"Adenocarcinoma, apocrine"
8402,0,1,Nodular hidradenoma (C44._)
8402,0,0,"Acrospiroma, eccrine (C44._)"
8402,0,0,Clear cell hidradenoma (C44._)
8402,0,0,Eccrine acrospiroma (C44._)
8402,0,0,"Hidradenoma, clear cell (C44._)"
8402,0,0,"Hidradenoma, nodular (C44._)"
8402,3,1,Hidradenocarcinoma (C44. _)
8402,3,0,"Hidradenoma, nodular, malignant (C44._)"
8402,3,0,"Nodular hidradenoma, malignant (C44._)"
8403,0,1,Eccrine spiradenoma (C44._)
8403,0,0,"Spiradenoma, eccrine (C44._)"
8403,0,0,"Spiradenoma, NOS (C44._)"
8403,3,1,Malignant eccrine spiradenoma (C44._)
8403,3,0,"Eccrine spiradenoma, malignant (C44._)"
8403,3,0,"Spiradenoma, eccrine, malignant (C44._)"
8404,0,1,Hidrocystoma (C44._)
8404,0,0,"Cystadenoma, eccrine (C44._)"
8404,0,0,Eccrine cystadenoma (C44._)
8405,0,1,Papillary hidradenoma
8405,0,0,Hidradenoma papilliferum
8405,0,0,"Hidradenoma, papillary"
8405,0,0,"Papilliferum, hidradenoma"
8406,0,1,Papillary syringadenoma (C44._)
8406,0,0,Papillary syringocystadenoma (C44._)
8406,0,0,"Papilliferum, syringocystadenoma"
8406,0,0,"Syringadenoma, papillary (C44._)"
8406,0,0,Syringocystadenoma papilliferum
8406,0,0,"Syringocystadenoma, papillary (C44._)"
8406,3,1,Syringocystadenocarcinoma papilliferum [2022+]
8406,3,0,"Papilliferum, syringocystadenocarcinoma [2022+]"
8407,0,1,"Syringoma, NOS (C44._)"
8407,3,1,Microcystic adnexal carcinoma (C44. _)
8407,3,0,"Adnexal carcinoma, microcystic (C44._)"
8407,3,0,"Adnexal microcystic, carcinoma (C44._)"
8407,3,0,"Carcinoma, adnexal, microcystic (C44._)"
8407,3,0,"Carcinoma, microcystic adnexal (C44._)"
8407,3,0,"Carcinoma, sclerosing sweat duct (C44._)"
8407,3,0,"Carcinoma, sweat duct, sclerosing (C44._)"
8407,3,0,"Carcinoma, syringomatous (C44._)"
8407,3,0,"Duct carcinoma, sclerosing sweat (C44._)"
8407,3,0,Sclerosing sweat duct carcinoma (C44._)
8407,3,0,"Sweat duct carcinoma, sclerosing (C44._)"
8407,3,0,Syringomatous carcinoma (C44._)
8408,0,1,Eccrine papillary adenoma (C44._)
8408,0,0,"Adenoma, eccrine papillary (C44._)"
8408,0,0,"Adenoma, papillary, eccrine (C44._)"
8408,0,0,"Eccrine adenoma, papillary (C44._)"
8408,0,0,"Papillary adenoma, eccrine (C44._)"
8408,1,1,Aggressive digital papillary adenoma (C44._) [PRE-2021 NOT REPORTABLE; FOR 2021+ USE CODE 8408/3.]
8408,1,0,"Adenoma, aggressive digital papillary (C44._) [PRE-2021 NOT REPORTABLE; FOR 2021+ USE CODE 8408/3.]"
8408,1,0,"Adenoma, digital papillary, aggressive (C44._) [PRE-2021 NOT REPORTABLE; FOR 2021+ USE CODE 8408/3.]"
8408,1,0,"Adenoma, papillary, aggressive digital (C44._) [PRE-2021 NOT REPORTABLE; FOR 2021+ USE CODE 8408/3.]"
8408,1,0,"Aggressive papillary adenoma, digital (C44._) [PRE-2021 NOT REPORTABLE; FOR 2021+ USE CODE 8408/3.]"
8408,1,0,"Digital papillary adenoma, aggressive (C44._) [PRE-2021 NOT REPORTABLE; FOR 2021+ USE CODE 8408/3.]"
8408,1,0,"Papillary adenoma, aggressive digital (C44._) [PRE-2021 NOT REPORTABLE; FOR 2021+ USE CODE 8408/3.]"
8408,3,1,Digital papillary adenocarcinoma (C44. _)
8408,3,0,"Adenocarcinoma, digital papillary (C44._)"
8408,3,0,"Adenocarcinoma, eccrine papillary (C44._)"
8408,3,0,"Adenocarcinoma, papillary digital (C44._)"
8408,3,0,"Adenocarcinoma, papillary eccrine (C44._)"
8408,3,0,"Adenoma, aggressive digital papillary (C44._) [REPORTABLE 2021+; FOR PRE-2021, USE CODE 8408/1]"
8408,3,0,"Adenoma, digital papillary, aggressive (C44._) [REPORTABLE 2021+; FOR PRE-2021, USE CODE 8408/1]"
8408,3,0,"Adenoma, papillary, aggressive digital (C44._) [REPORTABLE 2021+; FOR PRE-2021, USE CODE 8408/1]"
8408,3,0,"Aggressive digital papillary adenoma (C44._) [REPORTABLE 2021+; FOR PRE-2021, USE CODE 8408/1]"
8408,3,0,"Aggressive papillary adenoma, digital (C44._) [REPORTABLE 2021+; FOR PRE-2021, USE CODE 8408/1]"
8408,3,0,"Digital papillary adenoma, aggressive (C44._) [REPORTABLE 2021+; FOR PRE-2021, USE CODE 8408/1]"
8408,3,0,"Eccrine adenocarcinoma, papillary (C44._)"
8408,3,0,Eccrine papillary adenocarcinoma (C44._)
8408,3,0,"Papillary adenocarcinoma, digital (C44._)"
8408,3,0,"Papillary adenocarcinoma, eccrine (C44._)"
8408,3,0,"Papillary adenoma, aggressive digital (C44._) [REPORTABLE 2021+]"
8409,0,1,Eccrine poroma (C44._)
8409,0,0,"Poroma, eccrine (C44._)"
8409,2,1,Porocarcinoma in situ [2022+]
8409,2,0,In situ porocarcinoma [2022+]
8409,3,1,Porocarcinoma (C44._)
8409,3,0,"Eccrine poroma, malignant (C44._)"
8409,3,0,"Poroma, eccrine, malignant (C44._)"
8410,0,1,Sebaceous adenoma (C44._)
8410,0,0,"Adenoma, sebaceous (C44._)"
8410,0,0,"Epithelioma, sebaceous (C44._)"
8410,0,0,Sebaceous epithelioma (C44._)
8410,3,1,Sebaceous carcinoma (C44._)
8410,3,0,"Adenocarcinoma, sebaceous (C44._)"
8410,3,0,"Carcinoma, sebaceous (C44._)"
8410,3,0,Sebaceous adenocarcinoma (C44._)
8413,3,1,Eccrine adenocarcinoma (C44._)
8413,3,0,"Adenocarcinoma, eccrine, NOS (C44._)"
8420,0,1,Ceruminous adenoma (C44.2)
8420,3,1,Ceruminous adenocarcinoma (C44.2)
8420,3,0,"Adenocarcinoma, ceruminous (C44.2)"
8420,3,0,"Adenoma, ceruminous (C44.2)"
8420,3,0,"Carcinoma, ceruminous (C44.2)"
8420,3,0,Ceruminous carcinoma (C44.2)
8430,1,1,Mucoepidermoid tumor [obs]
8430,1,0,"Tumor, mucoepidermoid [obs]"
8430,3,1,Mucoepidermoid carcinoma
8430,3,0,"Carcinoma, mucoepidermoid"
8440,0,1,"Cystadenoma, NOS"
8440,0,0,"Cystoma, NOS"
8440,3,1,"Cystadenocarcinoma, NOS"
8441,0,1,"Serous cystadenoma, NOS"
8441,0,0,"Adenoma, microcystic, serous"
8441,0,0,"Adenoma, serous microcystic"
8441,0,0,"Cystadenoma, serous, NOS"
8441,0,0,"Cystoma, serous"
8441,0,0,"Microcystic adenoma, serous"
8441,0,0,"Serous adenoma, microcystic"
8441,0,0,Serous cystoma
8441,0,0,Serous microcystic adenoma
8441,2,1,"Serous endometrial [tubal] intraepithelial carcinoma (C54._, C55.9 [C57.0]) "
8441,2,0,"Carcinoma, intraepithelial, serous endometrial (C54._, C55.9) "
8441,2,0,"Carcinoma, intraepithelial, serous tubal (C57.0) "
8441,2,0,"Carcinoma, serous endometrial [tubal] intraepithelial (C54._, C55.9 [C57.0]) "
8441,2,0,"Endometrial intraepithelial carcinoma, serous (C54._, C55.9) "
8441,2,0,"Intraepithelial carcinoma, serous endometrial (C54._, C55.9) "
8441,2,0,"Intraepithelial carcinoma, serous tubal (C57.0) "
8441,2,0,"Intraepithelial serous endometrial [tubal] carcinoma (C54._, C55.9 [C57.0]) "
8441,2,0,"Serous endometrial intraepithelial carcinoma (C54._, C55.9) "
8441,2,0,Serous tubal intraepithelial carcinoma (C57.0)
8441,2,0,"Tubal intraepithelial carcinoma, serous (C57.0) "
8441,3,1,"Serous carcinoma, NOS"
8441,3,0,"Adenocarcinoma, papillary, serous (C56.9) [2021+. FOR PRE-2021, USE CODE 8460/3.]"
8441,3,0,"Adenocarcinoma, serous, NOS"
8441,3,0,"Adenocarcinoma, serous, papillary (C56.9) [2021+. FOR PRE-2021, USE CODE 8460/3.]"
8441,3,0,"Carcinoma, papillary, serous surface (C56.9) [2021+. FOR PRE-2021, USE CODE 8461/3.]"
8441,3,0,"Carcinoma, serous surface papillary (C56.9) [2021+. FOR PRE-2021, USE CODE 8461/3.]"
8441,3,0,"Carcinoma, serous, NOS"
8441,3,0,"Cystadenocarcinoma, papillary serous (C56.9) [2021+. FOR PRE-2021, USE CODE 8460/3.]"
8441,3,0,"Cystadenocarcinoma, serous, NOS (C56.9)"
8441,3,0,"Papillary adenocarcinoma, serous (C56.9) [2021+. FOR PRE-2021, USE CODE 8460/3.]"
8441,3,0,"Papillary carcinoma, serous surface (C56.9) [2021+. FOR PRE-2021, USE CODE 8461/3.]"
8441,3,0,"Papillary cystadenocarcinoma, serous (C56.9) [2021+. FOR PRE-2021, USE CODE 8460/3.]"
8441,3,0,"Papillary serous adenocarcinoma (C56.9) [2021+. FOR PRE-2021, USE CODE 8460/3.]"
8441,3,0,"Papillary serous cystadenocarcinoma (C56.9) [2021+. FOR PRE-2021, USE CODE 8460/3.]"
8441,3,0,"Serous adenocarcinoma, NOS"
8441,3,0,"Serous adenocarcinoma, papillary (C56.9) [2021+. FOR PRE-2021, USE CODE 8460/3.]"
8441,3,0,"Serous cystadenocarcinoma, NOS (C56.9)"
8441,3,0,"Serous cystadenocarcinoma, papillary (C56.9) [2021+. FOR PRE-2021, USE CODE 8460/3.]"
8441,3,0,"Serous surface carcinoma, papillary (C56.9) [2021+. FOR PRE-2021, USE CODE 8461/3.]"
8441,3,0,"Serous surface papillary carcinoma (C56.9) [2021+. FOR PRE-2021, USE CODE 8461/3.]"
8441,3,0,"Surface papillary carcinoma, serous (C56.9) [2021+. FOR PRE-2021, USE CODE 8461/3.]"
8442,1,1,"Serous cystadenoma, borderline malignancy (C56.9)"
8442,1,0,Atypical proliferating serous tumor (C56.9)
8442,1,0,"Cystadenoma, serous, borderline malignancy (C56.9)"
8442,1,0,"Low malignant potential, serous tumor, NOS (C56.9)"
8442,1,0,"Proliferating serous tumor, atypical (C56.9)"
8442,1,0,"Serous tumor, atypical proliferating (C56.9)"
8442,1,0,"Serous tumor, NOS, of low malignant potential (C56.9)"
8442,1,0,"Tumor, serous, atypical proliferating (C56.9)"
8442,1,0,"Tumor, serous, NOS, of low malignant potential (C56.9)"
8443,0,1,Clear cell cystadenoma (C56.9)
8443,0,0,"Cystadenoma, clear cell (C56.9)"
8444,1,1,Clear cell cystic tumor of borderline malignancy (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+ USE CODE 8313/1.] 
8444,1,0,Atypical proliferating clear cell tumor (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+ USE CODE 8313/1.] 
8444,1,0,"Clear cell tumor, atypical proliferating (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+ USE CODE 8313/1.] "
8444,1,0,"Cystic clear cell, tumor of borderline malignancy (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+ USE CODE 8313/1.] "
8444,1,0,"Cystic tumor, clear cell, borderline malignancy (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+ USE CODE 8313/1.] "
8444,1,0,"Proliferating clear cell tumor, atypical (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+ USE CODE 8313/1.] "
8444,1,0,"Tumor, clear cell, atypical proliferating (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+ USE CODE 8313/1.] "
8444,1,0,"Tumor, clear cell, cystic, borderline malignancy (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+ USE CODE 8313/1.] "
8444,1,0,"Tumor, cystic, clear cell, borderline malignancy (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+ USE CODE 8313/1.] "
8450,0,1,"Papillary cystadenoma, NOS (C56.9)"
8450,0,0,"Cystadenoma, papillary, NOS (C56.9)"
8450,3,1,"Papillary cystadenocarcinoma, NOS (C56.9)"
8450,3,0,"Adenocarcinoma, papillocystic"
8450,3,0,"Cystadenocarcinoma, papillary, NOS (C56.9)"
8450,3,0,Papillocystic adenocarcinoma
8451,1,1,"Papillary cystadenoma, borderline malignancy (C56.9)"
8451,1,0,"Cystadenoma, papillary, borderline malignancy (C56.9)"
8452,1,1,Solid pseudopapillary tumor of ovary (C56.9)
8452,1,0,Cystic and solid tumor (C25._)
8452,1,0,"Cystic papillary, tumor (C25._)"
8452,1,0,"Cystic tumor, papillary (C25._)"
8452,1,0,"Epithelial neoplasm, solid and papillary (C25._)"
8452,1,0,"Neoplasm, papillary and solid epithelial (C25._)"
8452,1,0,"Neoplasm, solid and papillary epithelial (C25._)"
8452,1,0,Papillary cystic tumor (C25._)
8452,1,0,"Papillary epithelial neoplasm, solid and (C25._)"
8452,1,0,Solid and cystic tumor (C25._)
8452,1,0,Solid and papillary epithelial neoplasm (C25._)
8452,1,0,Solid pseudopapillary tumor (C25._)
8452,1,0,"Tumor, cystic and solid (C25._)"
8452,1,0,"Tumor, cystic, papillary (C25._)"
8452,1,0,"Tumor, papillary cystic (C25._)"
8452,1,0,"Tumor, pseudopapillary, solid (C25._)"
8452,1,0,"Tumor, pseudopapillary, solid (C56.9)"
8452,1,0,"Tumor, solid and cystic (C25._)"
8452,3,1,Solid pseudopapillary neoplasm of the pancreas (C25._) [REPORTABLE 2021+]
8452,3,0,"Carcinoma, solid, pseudopapillary (C25._)"
8452,3,0,"Neoplasm, solid pseudopapillary (C25._) [REPORTABLE 2021+]"
8452,3,0,Solid pseudopapillary carcinoma (C25._)
8452,3,0,Solid pseudopapillary tumor (C25._) [REPORTABLE 2021+]
8452,3,0,"Tumor, pseudopapillary, solid (C25._) [REPORTABLE 2021+]"
8453,0,1,Intraductal papillary-mucinous adenoma (C25._)
8453,0,0,"Adenoma, intraductal papillary-mucinous (C25._)"
8453,0,0,"Adenoma, mucinous-papillary, intraductal (C25._)"
8453,0,0,"Adenoma, papillary-mucinous, intraductal (C25._)"
8453,0,0,"Dysplasia, intraductal papillary-mucinous tumor with moderate (C25._)"
8453,0,0,Intraductal papillary-mucinous tumor with moderate dysplasia (C25._)
8453,0,0,"Moderate dysplasia, intraductal papillary-mucinous tumor with (C25._)"
8453,0,0,"Mucinous-papillary adenoma, intraductal (C25._)"
8453,0,0,"Mucinous-papillary tumor, intraductal, with moderate dysplasia (C25._)"
8453,0,0,"Papillary-mucinous tumor, intraductal, with moderate dysplasia (C25._)"
8453,0,0,"Tumor, intraductal papillary-mucinous, with moderate dysplasia (C25._)"
8453,0,0,"Tumor, mucinous-papillary, intraductal, with moderate dysplasia (C25._)"
8453,0,0,"Tumor, papillary-mucinous, intraductal, with moderate dysplasia (C25._)"
8453,2,1,"Intraductal papillary-mucinous carcinoma, non-invasive (C25._)"
8453,2,0,"Carcinoma, papillary-mucinous, intraductal, non-invasive (C25._)"
8453,2,0,Intraductal papillary mucinous neoplasm with high-grade dysplasia (C25._)
8453,2,0,"Mucinous papillary carcinoma, intraductal, non-invasive (C25._)"
8453,2,0,"Mucinous papillary neoplasm, Intraductal with high-grade dysplasia (C25._)"
8453,2,0,"Non-invasive carcinoma, intraductal papillary-mucinous (C25._)"
8453,2,0,"Papillary mucinous carcinoma, intraductal, non-invasive (C25._)"
8453,2,0,"Papillary mucinous neoplasm, Intraductal with high-grade dysplasia (C25._)"
8453,3,1,"Intraductal papillary-mucinous carcinoma, invasive (C25._)"
8453,3,0,"Carcinoma, invasive, associated with intraductal papillary mucinous neoplasm (IPMN) (C25._)"
8453,3,0,Intraductal papillary-mucinous neoplasm (IPMN) with an associated invasive carcinoma (C25._)
8453,3,0,Invasive intraductal papillary-mucinous carcinoma (C25._)
8453,3,0,IPMN (intraductal papillary mucinous neoplasm) with an associated invasive carcinoma  (C25._)
8453,3,0,"Mucinous papillary neoplasm, Intraductal (IPMN) with an associated invasive carcinoma  (C25._)"
8453,3,0,"Mucinous-papillary carcinoma, intraductal, invasive (C25._)"
8453,3,0,"Papillary mucinous neoplasm, Intraductal (IPMN) with an associated invasive carcinoma  (C25._)"
8453,3,0,"Papillary-mucinous carcinoma, intraductal, invasive (C25._)"
8454,0,1,Cystic tumor of atrio-ventricular node (C38.0)
8454,0,0,"Tumor, cystic, atrio-ventricular node (C38.0)"
8455,2,1,"Intraductal oncocytic papillary neoplasm, NOS (C25._) [2022+]"
8455,2,0,"Neoplasm, intraductal oncocytic papillary, NOS (C25._) [2022+]"
8455,3,1,Intraductal oncocytic papillary neoplasm with associated invasive carcinoma (C25._) [2022+]
8455,3,0,"Neoplasm, intraductal oncocytic papillary, with associated invasive carcinoma (C25._) [2022+]"
8460,0,1,"Papillary serous cystadenoma, NOS (C56.9)"
8460,0,0,"Cystadenoma, papillary serous, NOS (C56.9)"
8460,0,0,"Papillary cystadenoma, serous, NOS (C56.9)"
8460,0,0,"Serous cystadenoma, papillary, NOS (C56.9)"
8460,2,1,Non-invasive low grade serous carcinoma (C56.9) 
8460,2,0,"Carcinoma, non-invasive low grade serous (C56.9) "
8460,2,0,"Micropapillary variant, serous borderline tumor (C56.9) [2018+ CASES ONLY; NOT REPORTABLE]"
8460,2,0,Serous borderline tumor-micropapillary variant (C56.9) [2018+ CASES ONLY; NOT REPORTABLE]
8460,2,0,"Serous carcinoma, non-invasive low grade (C56.9) "
8460,2,0,"Tumor, serous borderline-micropapillary variant (C56.9) [2018+ CASES ONLY; NOT REPORTABLE]"
8460,2,0,"Tumor, serous borderline-micropapillary variant (C56.9) [2018+ CASES ONLY; NOT REPORTABLE]"
8460,3,1,"Low-grade serous carcinoma (C56.9, C48._, C57.0, C57.1–C57.3)"
8460,3,0,"Adenocarcinoma, papillary, serous (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8441/3.]"
8460,3,0,"Adenocarcinoma, serous, papillary (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8441/3.]"
8460,3,0,"Carcinoma, micropapillary serous (C56.9)"
8460,3,0,"Carcinoma, serous, Low-grade (C56.9, C48._, C57.0, C57.1–C57.3)"
8460,3,0,"Cystadenocarcinoma, papillary serous (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8441/3.]"
8460,3,0,Micropapillary serous carcinoma (C56.9)
8460,3,0,"Papillary adenocarcinoma, serous (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8441/3.]"
8460,3,0,"Papillary cystadenocarcinoma, serous (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8441/3.]"
8460,3,0,Papillary serous adenocarcinoma (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8441/3.]
8460,3,0,Papillary serous cystadenocarcinoma (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8441/3.]
8460,3,0,"Serous adenocarcinoma, papillary (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8441/3.]"
8460,3,0,"Serous carcinoma, low-grade (C56.9, C48._, C57.0, C57.1–C57.3)"
8460,3,0,"Serous carcinoma, micropapillary (C56.9)"
8460,3,0,"Serous cystadenocarcinoma, papillary (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8441/3.]"
8461,0,1,Serous surface papilloma (C56.9)
8461,0,0,"Papilloma, serous surface (C56.9)"
8461,0,0,"Surface papilloma, serous (C56.9)"
8461,3,1,"High-grade serous carcinoma (C48._, C56.9, C57.0, C57.1–C57.3) "
8461,3,0,"Carcinoma, papillary serous, primary, peritoneum (C48.1)"
8461,3,0,"Carcinoma, papillary, serous surface (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8441/3.]"
8461,3,0,"Carcinoma, primary serous papillary, peritoneum (C48.1)"
8461,3,0,"Carcinoma, serous papillary, primary, peritoneum (C48.1)"
8461,3,0,"Carcinoma, serous surface papillary (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8441/3.]"
8461,3,0,"Carcinoma, serous, high-grade (C48._, C56.9, C57.0, C57.1–C57.3) "
8461,3,0,"Papillary carcinoma, primary serous, peritoneum (C48.1)"
8461,3,0,"Papillary carcinoma, serous surface (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8441/3.]"
8461,3,0,"Papillary primary serous carcinoma, peritoneum (C48.1)"
8461,3,0,Primary serous papillary carcinoma of peritoneum (C48.1)
8461,3,0,"Serous carcinoma, high-grade (C48._, C56.9, C57.0, C57.1–C57.3) "
8461,3,0,"Serous papillary carcinoma, primary, peritoneum (C48.1)"
8461,3,0,"Serous surface carcinoma, papillary (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8441/3.]"
8461,3,0,Serous surface papillary carcinoma (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8441/3.]
8461,3,0,"Surface papillary carcinoma, serous (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8441/3.]"
8462,1,1,Serous papillary cystic tumor of borderline malignancy (C56.9)
8462,1,0,Atypical proliferative papillary serous tumor (C56.9)
8462,1,0,"Cystadenoma, papillary serous, borderline malignancy (C56.9)"
8462,1,0,"Cystic serous papillary, tumor, borderline malignancy (C56.9)"
8462,1,0,"Cystic tumor, serous papillary, borderline malignancy (C56.9)"
8462,1,0,"Low malignant potential, papillary serous tumor (C56.9)"
8462,1,0,"Papillary cystadenoma, serous, borderline malignancy (C56.9)"
8462,1,0,"Papillary cystic tumor, serous, borderline malignancy (C56.9)"
8462,1,0,"Papillary serous cystadenoma, borderline malignancy (C56.9)"
8462,1,0,Papillary serous tumor of low malignant potential (C56.9)
8462,1,0,"Papillary serous tumor, atypical proliferative (C56.9)"
8462,1,0,"Proliferative papillary serous tumor, atypical (C56.9)"
8462,1,0,"Serous cystadenoma, papillary, borderline malignancy (C56.9)"
8462,1,0,"Serous tumor, papillary, atypical proliferating (C56.9)"
8462,1,0,"Serous tumor, papillary, of low malignant potential (C56.9)"
8462,1,0,"Tumor, papillary serous, of low malignant potential (C56.9)"
8462,1,0,"Tumor, papillary, serous, atypical proliferative (C56.9)"
8462,1,0,"Tumor, serous, papillary cystic, of borderline malignancy (C56.9)"
8462,1,0,"Tumor, serous, papillary, of low malignant potential (C56.9)"
8463,1,1,Serous surface papillary tumor of borderline malignancy (C56.9)
8463,1,0,"Surface papillary tumor, serous surface, borderline malignancy (C56.9)"
8463,1,0,"Tumor, serous surface papillary, of borderline malignancy (C56.9)"
8470,0,1,"Mucinous cystadenoma, NOS (C56.9)"
8470,0,0,"Cystadenoma, mucinous, NOS (C56.9)"
8470,0,0,"Cystadenoma, pseudomucinous, NOS (C56.9)"
8470,0,0,"Cystic mucinous, tumor with moderate dysplasia (C25._)"
8470,0,0,"Cystic tumor, mucinous, with moderate dysplasia (C25._)"
8470,0,0,"Cystoma, mucinous (C56.9)"
8470,0,0,"Dysplasia, mucinous cystic tumor with moderate (C25._)"
8470,0,0,"Moderate dysplasia, mucinous cystic tumor with (C25._)"
8470,0,0,Mucinous cystic tumor with moderate dysplasia (C25._)
8470,0,0,Mucinous cystoma (C56.9)
8470,0,0,"Mucinous tumor, cystic, with moderate dysplasia (C25._)"
8470,0,0,"Pseudomucinous cystadenoma, NOS (C56.9)"
8470,0,0,"Tumor, cystic, mucinous, with moderate dysplasia (C25._)"
8470,0,0,"Tumor, mucinous, cystic, with moderate dysplasia (C25._)"
8470,2,1,Mucinous cystic neoplasm with high grade dysplasia (C25. _)
8470,2,0,"Cystadenocarcinoma, mucinous, non-invasive (C25._)"
8470,2,0,"Mucinous cystadenocarcinoma, non-invasive (C25._)"
8470,2,0,"Neoplasm, mucinous cystic with high grade dysplasia (C25. _)"
8470,2,0,"Non-invasive cystadenocarcinoma, mucinous (C25._)"
8470,3,1,"Mucinous cystadenocarcinoma, NOS (C56.9)"
8470,3,0,"Adenocarcinoma, pseudomucinous (C56.9)"
8470,3,0,"Carcinoma, invasive, associated with mucinous cystic tumor (C25._)"
8470,3,0,"Cystadenocarcinoma, mucinous, NOS (C56.9)"
8470,3,0,"Cystadenocarcinoma, papillary mucinous (C56.9) [FOR 2021+. FOR PRE-2021, USE CODE 8471/3]"
8470,3,0,"Cystadenocarcinoma, papillary pseudomucinous (C56.9) [FOR 2021+. FOR PRE-2021, USE CODE 8471/3]"
8470,3,0,"Cystadenocarcinoma, pseudomucinous, NOS (C56.9)"
8470,3,0,Cystic mucinous tumor with associated invasive carcinoma (C25._)
8470,3,0,"Mucinous cystadenocarcinoma, papillary (C56.9) [FOR 2021+. FOR PRE-2021, USE CODE 8471/3]"
8470,3,0,Mucinous cystic tumor with associated invasive carcinoma (C25._)
8470,3,0,"Papillary cystadenocarcinoma, mucinous (C56.9) [FOR 2021+. FOR PRE-2021, USE CODE 8471/3]"
8470,3,0,"Papillary cystadenocarcinoma, pseudomucinous (C56.9) [FOR 2021+. FOR PRE-2021, USE CODE 8471/3]"
8470,3,0,"Papillary mucinous cystadenocarcinoma (C56.9) [FOR 2021+. FOR PRE-2021, USE CODE 8471/3]"
8470,3,0,"Papillary pseudomucinous cystadenocarcinoma (C56.9) [FOR 2021+. FOR PRE-2021, USE CODE 8471/3]"
8470,3,0,Pseudomucinous adenocarcinoma (C56.9)
8470,3,0,"Pseudomucinous cystadenocarcinoma, NOS (C56.9)"
8470,3,0,"Pseudomucinous cystadenocarcinoma, papillary (C56.9) [FOR 2021+. FOR PRE-2021, USE CODE 8471/3]"
8470,3,0,"Tumor, mucinous cystic with associated invasive carcinoma (C25._)"
8471,0,1,"Papillary mucinous cystadenoma, NOS (C56.9)"
8471,0,0,"Cystadenoma, papillary mucinous, NOS (C56.9)"
8471,0,0,"Cystadenoma, papillary pseudomucinous, NOS (C56.9)"
8471,0,0,"Mucinous cystadenoma, papillary, NOS (C56.9)"
8471,0,0,"Papillary cystadenoma, mucinous, NOS (C56.9)"
8471,0,0,"Papillary cystadenoma, pseudomucinous, NOS (C56.9)"
8471,0,0,"Papillary pseudomucinous cystadenoma, NOS (C56.9)"
8471,0,0,"Pseudomucinous cystadenoma, papillary, NOS (C56.9)"
8471,3,1,Papillary mucinous cystadenocarcinoma (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8470/3.]
8471,3,0,"Cystadenocarcinoma, papillary mucinous (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8470/3.]"
8471,3,0,"Cystadenocarcinoma, papillary pseudomucinous (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8470/3.]"
8471,3,0,"Mucinous cystadenocarcinoma, papillary (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8470/3.]"
8471,3,0,"Papillary cystadenocarcinoma, mucinous (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8470/3.]"
8471,3,0,"Papillary cystadenocarcinoma, pseudomucinous (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8470/3.]"
8471,3,0,Papillary pseudomucinous cystadenocarcinoma (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8470/3.]
8471,3,0,"Pseudomucinous cystadenocarcinoma, papillary (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8470/3.]"
8472,1,1,Mucinous cystic tumor of borderline malignancy(C56.9)
8472,1,0,Atypical proliferative mucinous tumor (C56.9)
8472,1,0,"Cystadenoma, mucinous, borderline malignancy (C56.9)"
8472,1,0,"Cystadenoma, papillary mucinous, borderline malignancy (C56.9) [2021+ ONLY. FOR PRE-2021, USE CODE 8473/1]"
8472,1,0,"Cystadenoma, papillary pseudomucinous, borderline malignancy (C56.9) [2021+ ONLY. FOR PRE-2021, USE CODE 8473/1]"
8472,1,0,"Cystadenoma, pseudomucinous, borderline malignancy(C56.9)"
8472,1,0,"Cystic mucinous, tumor of borderline malignancy(C56.9)"
8472,1,0,"Cystic tumor, mucinous, borderline malignancy(C56.9)"
8472,1,0,"Low malignant potential, mucinous tumor, NOS (C56.9)"
8472,1,0,"Mucinous cystadenoma, borderline malignancy (C56.9)"
8472,1,0,"Mucinous cystadenoma, papillary, borderline malignancy (C56.9) [2021+ ONLY. FOR PRE-2021, USE CODE 8473/1]"
8472,1,0,"Mucinous tumor, atypical proliferative (C56.9)"
8472,1,0,"Mucinous tumor, cystic, of borderline malignancy(C56.9)"
8472,1,0,"Mucinous tumor, NOS, of low malignant potential(C56.9)"
8472,1,0,"Mucinous tumor, papillary, of low malignant potential (C56.9) [2021+ ONLY. FOR PRE-2021, USE CODE 8473/1]"
8472,1,0,"Papillary cystadenoma, mucinous, borderline malignancy (C56.9) [2021+ ONLY. FOR PRE-2021, USE CODE 8473/1]"
8472,1,0,"Papillary cystadenoma, pseudomucinous, borderline malignancy (C56.9) [2021+ ONLY. FOR PRE-2021, USE CODE 8473/1]"
8472,1,0,"Papillary mucinous cystadenoma, borderline malignancy (C56.9) [2021+ ONLY. FOR PRE-2021, USE CODE 8473/1]"
8472,1,0,"Papillary mucinous tumor of low malignant potential (C56.9) [2021+ ONLY. FOR PRE-2021, USE CODE 8473/1]"
8472,1,0,"Papillary pseudomucinous cystadenoma, borderline malignancy (C56.9) [2021+ ONLY. FOR PRE-2021, USE CODE 8473/1]"
8472,1,0,"Proliferative mucinous tumor, atypical (C56.9)"
8472,1,0,"Pseudomucinous cystadenoma, borderline malignancy (C56.9)"
8472,1,0,"Pseudomucinous cystadenoma, papillary, borderline malignancy (C56.9) [2021+ ONLY. FOR PRE-2021, USE CODE 8473/1]"
8472,1,0,"Tumor, mucinous, atypical proliferative (C56.9)"
8472,1,0,"Tumor, mucinous, cystic, of borderline malignancy (C56.9)"
8472,1,0,"Tumor, mucinous, NOS, of low malignant potential (C56.9)"
8472,1,0,"Tumor, mucinous, papillary, of low malignant potential (C56.9) [2021+ ONLY. FOR PRE-2021, USE CODE 8473/1]"
8472,1,0,"Tumor, papillary mucinous, of low malignant potential (C56.9) [2021+ ONLY. FOR PRE-2021, USE CODE 8473/1]"
8473,1,1,"Papillary mucinous cystadenoma, borderline malignancy (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+, USE CODE 8472/1]"
8473,1,0,"Cystadenoma, papillary mucinous, borderline malignancy (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+, USE CODE 8472/1]"
8473,1,0,"Cystadenoma, papillary pseudomucinous, borderline malignancy (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+, USE CODE 8472/1]"
8473,1,0,"Mucinous cystadenoma, papillary, borderline malignancy (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+, USE CODE 8472/1]"
8473,1,0,"Mucinous tumor, papillary, of low malignant potential (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+, USE CODE 8472/1]"
8473,1,0,"Papillary cystadenoma, mucinous, borderline malignancy (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+, USE CODE 8472/1]"
8473,1,0,"Papillary cystadenoma, pseudomucinous, borderline malignancy (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+, USE CODE 8472/1]"
8473,1,0,"Papillary mucinous tumor of low malignant potential (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+, USE CODE 8472/1]"
8473,1,0,"Papillary pseudomucinous cystadenoma, borderline malignancy (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+, USE CODE 8472/1]"
8473,1,0,"Pseudomucinous cystadenoma, papillary, borderline malignancy (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+, USE CODE 8472/1]"
8473,1,0,"Tumor, mucinous, papillary, of low malignant potential (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+, USE CODE 8472/1]"
8473,1,0,"Tumor, papillary mucinous, of low malignant potential (C56.9) [obs] [PRE-2021 ONLY. FOR 2021+, USE CODE 8472/1]"
8474,3,1,Seromucinous carcinoma (C56.9) [2018+]
8474,3,0,"Carcinoma, seromucinous (C56.9) [2018+]"
8480,0,1,Mucinous adenoma
8480,0,0,"Adenoma, mucinous"
8480,1,1,Low grade appendiceal mucinous neoplasm (LAMN) (C18.1) [2018-2021 NOT REPORTABLE; 2022+ USE 8480/2 PER STANDARD SETTERS SINCE TERM AND CORRESPONDING CODE NOT INCLUDED IN ICD-O-3.2; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY]
8480,1,0,"Mucinous neoplasm, appendiceal, low-grade (C18.1) [2018-2021 NOT REPORTABLE; 2022+ USE 8480/2 PER STANDARD SETTERS SINCE TERM AND CORRESPONDING CODE NOT INCLUDED IN ICD-O-3.2; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY]"
8480,1,0,"Neoplasm, appendiceal mucinous, low-grade (LAMN) (C18.1) [2018-2021 NOT REPORTABLE; 2022+ USE 8480/2 PER STANDARD SETTERS SINCE TERM AND CORRESPONDING CODE NOT INCLUDED IN ICD-O-3.2; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY]"
8480,2,1,High grade appendiceal mucinous neoplasm (HAMN) (C181) [2022+]
8480,2,0,HAMN High grade appendiceal mucinous neoplasm (C181) [2022+]
8480,2,0,"Low grade appendiceal mucinous neoplasm (LAMN) (C18.1) [FOR 2018-2021, SEE 8480/1; 2022+ PER STANDARD SETTERS SINCE TERM AND CORRESPONDING CODE NOT INCLUDED IN ICD-O-3.2; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY]"
8480,2,0,"Mucinous neoplasm, appendiceal, low-grade (C18.1) [FOR 2018-2021, SEE 8480/1; 2022+ PER STANDARD SETTERS SINCE TERM AND CORRESPONDING CODE NOT INCLUDED IN ICD-O-3.2; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY]"
8480,2,0,"Neoplasm, appendiceal mucinous, high grade (HAMN) (C18.1) [2022+]"
8480,2,0,"Neoplasm, appendiceal mucinous, low grade (LAMN) (C18.1) [FOR 2018-2021, SEE 8480/1; 2022+ PER STANDARD SETTERS SINCE TERM AND CORRESPONDING CODE NOT INCLUDED IN ICD-O-3.2; SEE STANDARD SETTER REQUIREMENTS FOR REPORTABILITY]"
8480,3,1,Mucinous adenocarcinoma [2018+: USE 8253 FOR LUNG ONLY]
8480,3,0,"Adenocarcinoma, colloid"
8480,3,0,"Adenocarcinoma, gelatinous [obs]"
8480,3,0,"Adenocarcinoma, mucinous, NOS [2018+: USE 8253 FOR LUNG ONLY]"
8480,3,0,"Adenocarcinoma, mucoid"
8480,3,0,"Adenocarcinoma, mucous"
8480,3,0,"Carcinoma, colloid"
8480,3,0,"Carcinoma, gelatinous [obs]"
8480,3,0,"Carcinoma, mucinous [2018+: USE 8253 FOR LUNG ONLY]"
8480,3,0,"Carcinoma, mucinous tubular and spindle cell (C64.9) "
8480,3,0,"Carcinoma, mucoid"
8480,3,0,"Carcinoma, mucous"
8480,3,0,Colloid adenocarcinoma
8480,3,0,Colloid carcinoma
8480,3,0,Gelatinous adenocarcinoma [obs]
8480,3,0,Gelatinous carcinoma [obs]
8480,3,0,Mucinous carcinoma [2018+: USE 8253 FOR LUNG ONLY]
8480,3,0,Mucinous tubular and spindle cell carcinoma (C64.9) 
8480,3,0,Mucoid adenocarcinoma
8480,3,0,Mucoid carcinoma
8480,3,0,Mucous adenocarcinoma
8480,3,0,Mucous carcinoma
8480,3,0,"Peritonei, pseudomyxoma, with unknown primary site (C80.9)"
8480,3,0,Pseudomyxoma peritonei with unknown primary site (C80.9)
8480,3,0,Spindle cell and mucinous tubular carcinoma (C64.9) 
8480,3,0,"Unknown primary site, pseudomyxoma peritonei with (C80.9)"
8480,6,1,Pseudomyxoma peritonei
8480,6,0,"Peritonei, pseudomyxoma"
8481,3,1,Mucin-producing adenocarcinoma
8481,3,0,"Adenocarcinoma, mucin-producing"
8481,3,0,"Adenocarcinoma, mucin-secreting"
8481,3,0,"Carcinoma, mucin-producing"
8481,3,0,"Carcinoma, mucin-secreting"
8481,3,0,Mucin-producing carcinoma
8481,3,0,Mucin-secreting adenocarcinoma
8481,3,0,Mucin-secreting carcinoma
8482,3,1,"Mucinous carcinoma, gastric type"
8482,3,0,"Adenocarcinoma, HPV-independent, gastric type (C53._) [2022+]"
8482,3,0,"Adenocarcinoma, mucinous, endocervical type (C53._)"
8482,3,0,"Carcinoma, mucinous, gastric type"
8482,3,0,Endocervical type mucinous adenocarcinoma (C53._)
8482,3,0,Gastric type mucinous carcinoma
8482,3,0,"HPV-independent adenocarcinoma, gastric type (C53._) [2022+]"
8482,3,0,"Mucinous adenocarcinoma, endocervical type (C53._)"
8483,2,1,"Adenocarcinoma in situ, HPV-associated (C53._) [2022+; NOT REPORTABLE]"
8483,2,0,HPV-associated adenocarcinoma in situ (C53._) [2022+; NOT REPORTABLE]
8483,3,1,"Adenocarcinoma, HPV-associated (C53._) [2022+]"
8483,3,0,HPV-associated adenocarcinoma (C53._) [2022+]
8484,2,1,"Adenocarcinoma in situ, HPV-independent, NOS (C53._) [2022+; NOT REPORTABLE]"
8484,2,0,"HPV-independent adenocarcinoma in situ, NOS (C53._) [2022+; NOT REPORTABLE]"
8484,3,1,"Adenocarcinoma, HPV-independent, NOS (C53._) [2022+]"
8484,3,0,"HPV-independent adenocarcinoma, NOS (C53._) [2022+]"
8490,3,1,Signet ring cell carcinoma
8490,3,0,"Adenocarcinoma, signet ring cell"
8490,3,0,"Carcinoma, signet ring cell"
8490,3,0,Poorly cohesive carcinoma
8490,3,0,Signet ring cell adenocarcinoma
8490,6,1,Metastatic signet ring cell carcinoma
8490,6,0,"Carcinoma, metastatic, signet ring cell"
8490,6,0,"Carcinoma, signet ring cell, metastatic"
8490,6,0,Krukenberg tumor
8490,6,0,"Signet ring cell carcinoma, metastatic"
8490,6,0,"Tumor, Krukenberg"
8500,2,1,"Intraductal carcinoma, noninfiltrating, NOS"
8500,2,0,"Adenocarcinoma, intraductal, noninfiltrating, NOS"
8500,2,0,"Adenocarcinoma, noninfiltrating, intraductal, NOS"
8500,2,0,"Carcinoma in situ, mammary (C50._)"
8500,2,0,"Carcinoma, cystic hypersecretory (C50. _) [FOR 2021+. FOR PRE-2021, USE CODE 8508/3]"
8500,2,0,"Carcinoma, ductal in situ, NOS (C50._)"
8500,2,0,"Carcinoma, intraductal, noninfiltrating, NOS"
8500,2,0,"Carcinoma, intraductal, NOS"
8500,2,0,"Carcinoma, mammary, non-invasive (C50._)"
8500,2,0,"Carcinoma, noninfiltrating, intraductal, NOS"
8500,2,0,"Cribriform cystadenocarcinoma, low grade (LGCCC) (C06.9, C08.9) "
8500,2,0,"Cystadenocarcinoma, cribriform low grade (LGCCC) (C06.9, C08.9) "
8500,2,0,"Cystic hypersecretory carcinoma (C50. _) [FOR 2021+. FOR PRE-2021, USE CODE 8508/3]"
8500,2,0,DCIS of high nuclear grade (C50._) [2022+]
8500,2,0,DCIS of intermediate nuclear grade (C50._) [2022+]
8500,2,0,DCIS of low nuclear grade (C50._) [2022+]
8500,2,0,"DCIS, high nuclear grade (C50._) [2022+]"
8500,2,0,"DCIS, intermediate nuclear grade (C50._) [2022+]"
8500,2,0,"DCIS, low nuclear grade (C50._) [2022+]"
8500,2,0,"DCIS, NOS (C50._)"
8500,2,0,DIN 3 (C50._)
8500,2,0,"Ductal carcinoma in situ, high nuclear grade (C50._) [2022+]"
8500,2,0,"Ductal carcinoma in situ, intermediate nuclear grade (C50._) [2022+]"
8500,2,0,"Ductal carcinoma in situ, low nuclear grade (C50._) [2022+]"
8500,2,0,"Ductal carcinoma in situ, NOS (C50._)"
8500,2,0,Ductal intraepithelial neoplasia 3 (C50._)
8500,2,0,"Hypersecretory carcinoma, cystic (C50._) [FOR 2021+. FOR PRE-2021, USE CODE 8508/3]"
8500,2,0,"In situ ductal carcinoma, high nuclear grade (C50._) [2022+]"
8500,2,0,"In situ ductal carcinoma, intermediate nuclear grade (C50._) [2022+]"
8500,2,0,"In situ ductal carcinoma, low nuclear grade (C50._) [2022+]"
8500,2,0,"In situ ductal carcinoma, NOS (C50._)"
8500,2,0,"Intraductal adenocarcinoma, noninfiltrating, NOS"
8500,2,0,"Intraductal carcinoma, NOS (C50._)"
8500,2,0,"Intraepithelial neoplasia 3, ductal (C50._)"
8500,2,0,"LGCCC (Low grade cribriform cystadenocarcinoma) (C06.9, C08.9) "
8500,2,0,"Low grade cribriform cystadenocarcinoma (LGCCC) (C06.9, C08.9) "
8500,2,0,"Mammary carcinoma, in situ  (C50._)"
8500,2,0,"Neoplasia, ductal intraepithelial 3 (C50._)"
8500,2,0,"Noninfiltrating adenocarcinoma, intraductal, NOS"
8500,2,0,"Noninfiltrating carcinoma, intraductal, NOS"
8500,2,0,Non-invasive mammary carcinoma (C50._)
8500,3,1,Invasive carcinoma of no special type (C50._) [BREAST ONLY]
8500,3,0,"Adenocarcinoma, duct, infiltrating (C50._)"
8500,3,0,"Adenocarcinoma, duct, NOS"
8500,3,0,"Adenocarcinoma, infiltrating duct (C50._)"
8500,3,0,"Carcinoma of no special type, invasive [of breast] (C50._)"
8500,3,0,"Carcinoma, duct cell"
8500,3,0,"Carcinoma, duct, infiltrating, NOS (C50._)"
8500,3,0,"Carcinoma, duct, NOS"
8500,3,0,"Carcinoma, ductal, NOS"
8500,3,0,"Carcinoma, infiltrating duct, NOS (C50._)"
8500,3,0,"Carcinoma, invasive, mammary (C50._)"
8500,3,0,"Carcinoma, invasive, of no special type (C50._) [BREAST ONLY]"
8500,3,0,"Carcinoma, mammary, invasive (C50._)"
8500,3,0,"Carcinoma, NST, invasive [of breast] (C50._)"
8500,3,0,"Carcinoma, salivary duct (C06.9, C08.9) "
8500,3,0,"Duct adenocarcinoma, infiltrating (C50._)"
8500,3,0,"Duct adenocarcinoma, NOS"
8500,3,0,"Duct carcinoma, infiltrating, NOS (C50._)"
8500,3,0,"Duct carcinoma, NOS"
8500,3,0,Duct cell carcinoma
8500,3,0,"Duct, infiltrating, adenocarcinoma (C50._)"
8500,3,0,"Duct, infiltrating, carcinoma, NOS (C50._)"
8500,3,0,"Ductal carcinoma, NOS"
8500,3,0,Infiltrating duct adenocarcinoma (C50._)
8500,3,0,"Infiltrating duct carcinoma, NOS (C50._)"
8500,3,0,"Invasive carcinoma, NST [of breast] (C50._)"
8500,3,0,Invasive mammary carcinoma (C50._)
8500,3,0,"Mammary carcinoma, invasive (C50._)"
8500,3,0,"Salivary duct carcinoma (C06.9, C08.9) "
8501,2,1,"Comedocarcinoma, noninfiltrating (C50._)"
8501,2,0,"Carcinoma, ductal in situ, comedo type (C50._)"
8501,2,0,Comedo type DCIS (C50._)
8501,2,0,Comedo type ductal carcinoma in situ (C50._)
8501,2,0,"DCIS, comedo type (C50._)"
8501,2,0,"Ductal carcinoma in situ, comedo type (C50._)"
8501,2,0,"In situ ductal carcinoma, comedo type (C50._)"
8501,2,0,"Noninfiltrating comedocarcinoma (C50,_)"
8501,3,1,"Comedocarcinoma, NOS (C50._)"
8502,3,1,Secretory carcinoma of breast (C50._)
8502,3,0,"Carcinoma, juvenile, breast (C50._)"
8502,3,0,"Carcinoma, secretory, breast (C50._)"
8502,3,0,Juvenile carcinoma of breast (C50._)
8502,3,0,"Juvenile carcinoma, breast (C50._)"
8503,0,1,Intraductal papilloma
8503,0,0,"Adenoma, duct, NOS"
8503,0,0,"Duct adenoma, NOS"
8503,0,0,Ductal papilloma
8503,0,0,"Papilloma, ductal"
8503,0,0,"Papilloma, intraductal"
8503,2,1,"Ductal carcinoma in situ, papillary (C50._)"
8503,2,0,"Adenocarcinoma, intraductal papillary, NOS (C50._)"
8503,2,0,"Adenocarcinoma, intraductal, noninfiltrating, papillary (C50._)"
8503,2,0,"Adenocarcinoma, noninfiltrating, intraductal, papillary (C50._)"
8503,2,0,"Adenocarcinoma, papillary, intraductal, noninfiltrating (C50._)"
8503,2,0,"Adenocarcinoma, papillary, intraductal, NOS (C50._)"
8503,2,0,"Carcinoma in situ, ductal, with intraductal papilloma (C50._) "
8503,2,0,"Carcinoma, ductal in situ, papillary (C50._)"
8503,2,0,"Carcinoma, intraductal, noninfiltrating, papillary (C50._)"
8503,2,0,"Carcinoma, intraductal, papillary, noninfiltrating (C50._)"
8503,2,0,"Carcinoma, intraductal, papillary, NOS (C50._)"
8503,2,0,"Carcinoma, noninfiltrating, intraductal papillary (C50._)"
8503,2,0,"Carcinoma, papillary intraductal, NOS (C50._)"
8503,2,0,"Carcinoma, papillary, intraductal, noninfiltrating (C50._)"
8503,2,0,"DCIS, papillary (C50._)"
8503,2,0,Ductal carcinoma in situ with intraductal papilloma (C50._) 
8503,2,0,"In situ ductal carcinoma, papillary (C50._)"
8503,2,0,"Intraductal adenocarcinoma, noninfiltrating papillary (C50._)"
8503,2,0,"Intraductal adenocarcinoma, papillary, noninfiltrating (C50._)"
8503,2,0,"Intraductal adenocarcinoma, papillary, NOS (C50._)"
8503,2,0,"Intraductal carcinoma, noninfiltrating, papillary (C50._)"
8503,2,0,"Intraductal carcinoma, papillary, noninfiltrating (C50._)"
8503,2,0,"Intraductal carcinoma, papillary, NOS (C50._)"
8503,2,0,"Intraductal papillary adenocarcinoma, noninfiltrating (C50._)"
8503,2,0,"Intraductal papillary adenocarcinoma, NOS (C50._)"
8503,2,0,"Intraductal papillary carcinoma, noninfiltrating (C50._)"
8503,2,0,"Intraductal papillary carcinoma, NOS (C50._)"
8503,2,0,Intraductal papilloma with ductal carcinoma in situ (C50._) 
8503,2,0,Intraductal tubulopapillary neoplasm (C25._)
8503,2,0,"Neoplasm, Intraductal tubulopapillary (C25._)"
8503,2,0,"Noninfiltrating adenocarcinoma, intraductal, papillary (C50._)"
8503,2,0,"Noninfiltrating carcinoma, intraductal, papillary (C50._)"
8503,2,0,Noninfiltrating intraductal papillary adenocarcinoma (C50._)
8503,2,0,Noninfiltrating intraductal papillary carcinoma (C50._)
8503,2,0,"Papillary adenocarcinoma, intraductal, NOS (C50._)"
8503,2,0,"Papillary adenocarcinoma, noninfiltrating, intraductal (C50._)"
8503,2,0,"Papillary carcinoma in situ, ductal (C50._)"
8503,2,0,"Papillary carcinoma, intraductal, NOS (C50._)"
8503,2,0,"Papillary carcinoma, noninfiltrating, intraductal (C50._)"
8503,2,0,Papillary DCIS (C50._)
8503,2,0,Papillary ductal carcinoma in situ (C50._)
8503,2,0,"Papilloma, intraductal with ductal carcinoma in situ (C50._) "
8503,2,0,"Tubulopapillary neoplasm, intraductal (C25._)"
8503,3,1,Intraductal papillary adenocarcinoma with invasion (C50._)
8503,3,0,"Adenocarcinoma, infiltrating and papillary"
8503,3,0,"Adenocarcinoma, intraductal papillary, with invasion (C50._)"
8503,3,0,"Adenocarcinoma, papillary and infiltrating"
8503,3,0,"Adenocarcinoma, papillary, infiltrating"
8503,3,0,"Adenocarcinoma, papillary, intraductal, with invasion (C50._)"
8503,3,0,"Carcinoma, invasive, associated with intracystic papillary neoplasm"
8503,3,0,"Carcinoma, invasive, associated with intracystic papillary neoplasm"
8503,3,0,Infiltrating and papillary adenocarcinoma
8503,3,0,Infiltrating papillary adenocarcinoma
8503,3,0,Intracystic papillary neoplasm with associated invasive carcinoma
8503,3,0,"Intraductal adenocarcinoma, papillary, with invasion (C50._)"
8503,3,0,"Invasion, intraductal papillary adenocarcinoma with (C50._)"
8503,3,0,Invasive carcinoma associated with intracystic papillary neoplasm
8503,3,0,"Neoplasm, Intracystic papillary with associated invasive carcinoma"
8503,3,0,"Neoplasm, papillary Intracystic with associated invasive carcinoma"
8503,3,0,"Papillary adenocarcinoma, infiltrating and (C50._)"
8503,3,0,"Papillary adenocarcinoma, intraductal with invasion (C50._)"
8503,3,0,Papillary intracystic neoplasm with associated invasive carcinoma
8504,0,1,Intracystic papillary adenoma
8504,0,0,"Adenoma, intracystic, papillary"
8504,0,0,"Adenoma, papillary, intracystic"
8504,0,0,"Intracystic adenoma, papillary"
8504,0,0,Intracystic papilloma
8504,0,0,"Papillary adenoma, intracystic"
8504,0,0,"Papilloma, intracystic"
8504,2,1,Encapsulated papillary carcinoma C50._) 
8504,2,0,"Adenocarcinoma, intracystic papillary [2021+. FOR PRE-2021, USE CODE 8504/3]"
8504,2,0,"Adenocarcinoma, papillary, intracystic [2021+. FOR PRE-2021, USE CODE 8504/3]"
8504,2,0,"Carcinoma, encapsulated papillary (C50._) "
8504,2,0,"Carcinoma, intracystic, noninfiltrating"
8504,2,0,"Carcinoma, intracystic, NOS [2021+. FOR PRE-2021, USE CODE 8504/3]"
8504,2,0,"Carcinoma, intracystic, papillary [2021+. FOR PRE-2021, USE CODE 8504/3]"
8504,2,0,"Carcinoma, noninfiltrating, intracystic"
8504,2,0,"Carcinoma, papillary, intracystic [2021+. FOR PRE-2021, USE CODE 8504/3]"
8504,2,0,"Intracystic adenocarcinoma, papillary [2021+. FOR PRE-2021, USE CODE 8504/3]"
8504,2,0,"Intracystic carcinoma, noninfiltrating"
8504,2,0,"Intracystic carcinoma, NOS [2021+. FOR PRE-2021, USE CODE 8504/3]"
8504,2,0,"Intracystic carcinoma, papillary [2021+. FOR PRE-2021, USE CODE 8504/3]"
8504,2,0,Intracystic noninfiltrating carcinoma
8504,2,0,"Intracystic papillary adenocarcinoma [2021+. FOR PRE-2021, USE CODE 8504/3]"
8504,2,0,"Intracystic papillary carcinoma [2021+. FOR PRE-2021, USE CODE 8504/3]"
8504,2,0,"Noninfiltrating carcinoma, intracystic"
8504,2,0,Noninfiltrating intracystic carcinoma
8504,2,0,"Papillary adenocarcinoma, intracystic [2021+. FOR PRE-2021, USE CODE 8504/3]"
8504,2,0,"Papillary carcinoma, encapsulated (C50._) "
8504,2,0,"Papillary carcinoma, intracystic [2021+. FOR PRE-2021, USE CODE 8504/3]"
8504,2,0,"Papillary intracystic adenocarcinoma [2021+. FOR PRE-2021, USE CODE 8504/3]"
8504,2,0,"Papillary intracystic carcinoma [2021+. FOR PRE-2021, USE CODE 8504/3]"
8504,3,1,Encapsulated papillary carcinoma with invasion (C50._) 
8504,3,0,"Adenocarcinoma, intracystic papillary [PRE-2021 ONLY. FOR 2021+ USE CODE 8504/2.]"
8504,3,0,"Adenocarcinoma, papillary, intracystic [PRE-2021 ONLY. FOR 2021+ USE CODE 8504/2.]"
8504,3,0,"Carcinoma, encapsulated papillary with invasion (C50._) "
8504,3,0,"Carcinoma, intracystic, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8504/2.]"
8504,3,0,"Carcinoma, intracystic, papillary [PRE-2021 ONLY. FOR 2021+ USE CODE 8504/2.]"
8504,3,0,"Carcinoma, papillary encapsulated with invasion (C50._) "
8504,3,0,"Carcinoma, papillary, intracystic [PRE-2021 ONLY. FOR 2021+ USE CODE 8504/2.]"
8504,3,0,"Intracystic adenocarcinoma, papillary [PRE-2021 ONLY. FOR 2021+ USE CODE 8504/2.]"
8504,3,0,"Intracystic carcinoma, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8504/2.]"
8504,3,0,"Intracystic carcinoma, papillary [PRE-2021 ONLY. FOR 2021+ USE CODE 8504/2.]"
8504,3,0,Intracystic papillary adenocarcinoma [PRE-2021 ONLY. FOR 2021+ USE CODE 8504/2.]
8504,3,0,Intracystic papillary carcinoma [PRE-2021 ONLY. FOR 2021+ USE CODE 8504/2.]
8504,3,0,"Papillary adenocarcinoma, intracystic [PRE-2021 ONLY. FOR 2021+ USE CODE 8504/2.]"
8504,3,0,"Papillary carcinoma, encapsulated with invasion (C50._) "
8504,3,0,"Papillary carcinoma, intracystic [PRE-2021 ONLY. FOR 2021+ USE CODE 8504/2.]"
8504,3,0,Papillary intracystic adenocarcinoma [PRE-2021 ONLY. FOR 2021+ USE CODE 8504/2.]
8504,3,0,Papillary intracystic carcinoma [PRE-2021 ONLY. FOR 2021+ USE CODE 8504/2.]
8505,0,1,"Intraductal papillomatosis, NOS"
8505,0,0,Diffuse intraductal papillomatosis
8505,0,0,"Diffuse papillomatosis, intraductal"
8505,0,0,"Intraductal papillomatosis, diffuse"
8505,0,0,"Papillomatosis, diffuse intraductal"
8505,0,0,"Papillomatosis, intraductal, diffuse"
8505,0,0,"Papillomatosis, intraductal, NOS"
8506,0,1,Adenoma of nipple (C50.0)
8506,0,0,"Adenoma, nipple (C50.0)"
8506,0,0,"Duct papillomatosis, subareolar (C50.0)"
8506,0,0,"Papillomatosis, subareolar duct (C50.0)"
8506,0,0,Subareolar duct papillomatosis (C50.0)
8507,2,1,Intraductal micropapillary carcinoma (C50._)
8507,2,0,"Carcinoma, clinging, intraductal (C50._)"
8507,2,0,"Carcinoma, ductal in situ, micropapillary (C50._)"
8507,2,0,"Carcinoma, intraductal, clinging (C50._)"
8507,2,0,"Carcinoma, intraductal, micropapillary (C50._)"
8507,2,0,"Carcinoma, micropapillary intraductal (C50._)"
8507,2,0,Clinging intraductal carcinoma (C50._)
8507,2,0,"Ductal carcinoma in situ, micropapillary (C50._)"
8507,2,0,"In situ ductal carcinoma, micropapillary (C50._)"
8507,2,0,"Intraductal carcinoma, clinging (C50._)"
8507,2,0,"Intraductal carcinoma, micropapillary (C50._)"
8507,2,0,"Micropapillary carcinoma, intraductal (C50._)"
8507,2,0,Micropapillary ductal carcinoma in situ (C50._) [USE FOR C50._ FOR ALL YEARS. FOR ALL OTHER SITES USE 8265/3 FOR 2018+ AND USE 8507/3 FOR PRE-2018.]
8507,3,1,Invasive micropapillary carcinoma (C50._) [USE FOR C50._ FOR ALL YEARS. FOR ALL OTHER SITES USE 8265/3 FOR 2018+ AND USE 8507/3 FOR PRE-2018.]
8507,3,0,"Carcinoma, micropapillary invasive (C50._) [USE FOR C50._ FOR ALL YEARS. FOR ALL OTHER SITES USE 8265/3 FOR 2018+ AND USE 8507/3 FOR PRE-2018.]"
8507,3,0,"Micropapillary carcinoma, invasive (C50._) [USE FOR C50._ FOR ALL YEARS. FOR ALL OTHER SITES USE 8265/3 FOR 2018+ AND USE 8507/3 FOR PRE-2018.]"
8507,3,0,"Micropapillary carcinoma, NOS (C18._, C19.9, C20.9) [NAACCR CODE FOR USE IN 2015+, also see 8265/3]"
8508,3,1,Cystic hypersecretory carcinoma (C50._) [PRE-2021 ONLY. FOR 2021+ USE CODE 8500/2.]
8508,3,0,"Carcinoma, cystic hypersecretory (C50._) [PRE-2021 ONLY. FOR 2021+ USE CODE 8500/2.]"
8508,3,0,"Hypersecretory carcinoma, cystic (C50._) [PRE-2021 ONLY. FOR 2021+ USE CODE 8500/2.]"
8509,2,1,Solid papillary carcinoma in situ (C50._) [2018+]
8509,2,0,"Carcinoma in situ, solid papillary  (C50._) [2018+]"
8509,2,0,Endocrine mucin-producing sweat gland carcinoma in situ (C44. _) [2021+]
8509,2,0,"Papillary carcinoma in situ, solid (C50._) [2018+]"
8509,2,0,"Sweat gland carcinoma in situ, endocrine mucin-producing (C44. _) [2021+]"
8509,3,1,Tall cell carcinoma with reversed polarity [2022+]
8509,3,0,"Carcinoma, solid papillary with invasion (C50._) [2018+]"
8509,3,0,"Carcinoma, tall cell with reversed polarity [2022+]"
8509,3,0,Endocrine mucin-producing sweat gland carcinoma (C44. _)
8509,3,0,"Papillary carcinoma, solid, with invasion (C50._) [2018+]"
8509,3,0,Solid papillary carcinoma with invasion (C50._) [2018+]
8509,3,0,"Sweat gland carcinoma, endocrine mucin-producing (C44. _)"
8510,3,1,"Medullary carcinoma, NOS [DO NOT USE FOR THYROID 2018+, USE 8345/3.]"
8510,3,0,"Adenocarcinoma, medullary"
8510,3,0,"Carcinoma, medullary, NOS [DO NOT USE FOR THYROID 2018+, USE 8345/3.]"
8510,3,0,"Carcinoma, medullary-like"
8510,3,0,"Carcinoma, renal medullary (C64.9)"
8510,3,0,Medullary adenocarcinoma
8510,3,0,"Medullary carcinoma, renal (C64.9)"
8510,3,0,Medullary-like carcinoma
8510,3,0,Renal medullary carcinoma (C64.9) 
8512,3,1,Medullary carcinoma with lymphoid stroma
8512,3,0,"Carcinoma, medullary with lymphoid stroma"
8512,3,0,"Lymphoid stroma, medullary carcinoma with"
8512,3,0,"Stroma, medullary carcinoma with lymphoid"
8513,3,1,Atypical medullary carcinoma (C50._)
8513,3,0,"Carcinoma, medullary, atypical (C50._)"
8513,3,0,"Medullary carcinoma, atypical (C50._)"
8514,3,1,"Duct carcinoma, desmoplastic type"
8514,3,0,"Carcinoma, duct, desmoplastic type"
8514,3,0,"Desmoplastic type, duct carcinoma"
8519,2,1,Pleomorphic lobular carcinoma in situ (C50._) [2018+. IF INVASIVE USE CODE 8520/3]
8519,2,0,"Carcinoma in situ, lobular, pleomorphic (C50._) [2018+. IF INVASIVE USE CODE 8520/3]"
8519,2,0,"Lobular carcinoma in situ, pleomorphic (C50._) [2018+. IF INVASIVE USE CODE 8520/3]"
8520,2,1,"Lobular carcinoma in situ, NOS (C50._)"
8520,2,0,"Carcinoma in situ, lobular with intraductal papilloma (C50._) "
8520,2,0,"Carcinoma in situ, lobular, florid (C50._) [2022+]"
8520,2,0,"Carcinoma in situ, lobular, NOS (C50._)"
8520,2,0,"Carcinoma, lobular in situ, florid (C50._) [2022+]"
8520,2,0,"Carcinoma, lobular in situ, NOS (C50._)"
8520,2,0,"Carcinoma, lobular, noninfiltrating (C50._)"
8520,2,0,"Carcinoma, noninfiltrating, lobular (C50._)"
8520,2,0,Florid lobular carcinoma in situ (C50._) [2022+]
8520,2,0,"In situ carcinoma, lobular, florid (C50._) [2022+]"
8520,2,0,"In situ carcinoma, lobular, NOS (C50._)"
8520,2,0,"In situ lobular carcinoma, florid (C50._) [2022+]"
8520,2,0,"In situ lobular carcinoma, NOS (C50._)"
8520,2,0,Intraductal papilloma with lobular carcinoma in situ (C50._) 
8520,2,0,"LCIS, florid (C50._) [2022+]"
8520,2,0,"LCIS, NOS (C50._)"
8520,2,0,Lobular carcinoma in situ with intraductal papilloma (C50._) 
8520,2,0,"Lobular carcinoma in situ, florid (C50._) [2022+]"
8520,2,0,"Lobular carcinoma, noninfiltrating (C50._)"
8520,2,0,"Noninfiltrating carcinoma, lobular (C50,_)"
8520,2,0,"Papilloma, intraductal with lobular carcinoma in situ (C50._) "
8520,3,1,"Lobular carcinoma, NOS (C50._)"
8520,3,0,"Adenocarcinoma, lobular (C50._)"
8520,3,0,"Carcinoma, infiltrating lobular, NOS (C50._)"
8520,3,0,"Carcinoma, lobular, alveolar type, invasive (C50._) "
8520,3,0,"Carcinoma, lobular, infiltrating (C50._)"
8520,3,0,"Carcinoma, lobular, invasive (C50._)"
8520,3,0,"Carcinoma, lobular, NOS (C50._)"
8520,3,0,"Carcinoma, lobular, pleomorphic (C50._) "
8520,3,0,"Carcinoma, lobular, solid type, invasive (C50._)"
8520,3,0,"Carcinoma, lobular, tubulolobular variant, invasive (C50._) "
8520,3,0,"Carcinoma, tubulolobular (C50._)"
8520,3,0,"Infiltrating lobular carcinoma, NOS (C50._)"
8520,3,0,Invasive lobular carcinoma (C50._)
8520,3,0,"Invasive lobular carcinoma, alveolar type (C50._) "
8520,3,0,"Invasive lobular carcinoma, solid type (C50._) "
8520,3,0,"Invasive lobular carcinoma, tubulolobular variant (C50._) "
8520,3,0,Lobular adenocarcinoma (C50._)
8520,3,0,"Lobular carcinoma, alveolar type, invasive (C50._) "
8520,3,0,"Lobular carcinoma, infiltrating, NOS (C50._)"
8520,3,0,"Lobular carcinoma, invasive (C50._)"
8520,3,0,"Lobular carcinoma, invasive, solid type (C50._)"
8520,3,0,"Lobular carcinoma, pleomorphic (C50._) "
8520,3,0,"Lobular carcinoma, tubulolobular variant, invasive (C50._) "
8520,3,0,Pleomorphic lobular carcinoma (C50._) 
8520,3,0,Tubulolobular carcinoma (C50._) 
8521,3,1,Infiltrating ductular carcinoma (C50._)
8521,3,0,"Carcinoma, ductular, infiltrating (C50._)"
8521,3,0,"Carcinoma, infiltrating ductular (C50._)"
8521,3,0,"Ductular carcinoma, infiltrating (C50._)"
8522,2,1,Intraductal carcinoma and lobular carcinoma in situ (C50._)
8522,2,0,"Carcinoma in situ, lobular and intraductal (C50._)"
8522,2,0,"Carcinoma, intraductal and lobular in situ (C50._)"
8522,2,0,"Carcinoma, lobular, in situ, and intraductal (C50._)"
8522,2,0,"In situ carcinoma, lobular, and intraductal carcinoma (C50._)"
8522,2,0,In situ lobular carcinoma and intraductal carcinoma (C50._)
8522,2,0,Lobular carcinoma in situ and intraductal carcinoma (C50._)
8522,3,1,Infiltrating duct and lobular carcinoma (C50._)
8522,3,0,"Carcinoma in situ, ductal and infiltrating lobular (C50._)"
8522,3,0,"Carcinoma in situ, lobular and infiltrating duct (C50._)"
8522,3,0,"Carcinoma, duct, infiltrating and lobular carcinoma (C50._)"
8522,3,0,"Carcinoma, duct, infiltrating and lobular carcinoma in situ (C50._)"
8522,3,0,"Carcinoma, ductal and lobular (C50._)"
8522,3,0,"Carcinoma, ductal in situ and infiltrating lobular (C50._)"
8522,3,0,"Carcinoma, infiltrating duct and lobular (C50._)"
8522,3,0,"Carcinoma, infiltrating duct and lobular in situ (C50._)"
8522,3,0,"Carcinoma, infiltrating lobular and ductal carcinoma in situ (C50._)"
8522,3,0,"Carcinoma, intraductal and lobular (C50._)"
8522,3,0,"Carcinoma, lobular and ductal (C50._)"
8522,3,0,"Carcinoma, lobular and infiltrating duct (C50._)"
8522,3,0,"Carcinoma, lobular and intraductal (C50._)"
8522,3,0,"Carcinoma, lobular, in situ, and infiltrating duct (C50._)"
8522,3,0,"Duct carcinoma, infiltrating and lobular carcinoma (C50._)"
8522,3,0,"Duct carcinoma, infiltrating and lobular carcinoma in situ (C50._)"
8522,3,0,"Duct, infiltrating, and lobular carcinoma (C50._)"
8522,3,0,"Duct, infiltrating, and lobular carcinoma in situ(C50._)"
8522,3,0,Ductal carcinoma and lobular carcinoma (C50._)
8522,3,0,Ductal carcinoma in situ and infiltrating lobular carcinoma (C50._)
8522,3,0,"Ductal, lobular and ductal carcinoma (C50._)"
8522,3,0,"In situ carcinoma, lobular, and infiltrating duct carcinoma (C50._)"
8522,3,0,In situ ductal carcinoma and infiltrating lobular carcinoma (C50._)
8522,3,0,Infiltrating duct and lobular carcinoma in situ(C50._)
8522,3,0,Infiltrating lobular carcinoma and ductal carcinoma in situ (C50._)
8522,3,0,Intraductal and lobular carcinoma (C50._)
8522,3,0,Intraductal carcinoma and lobular carcinoma (C50._)
8522,3,0,Lobular and ductal carcinoma (C50._)
8522,3,0,Lobular and infiltrating duct carcinoma (C50._)
8522,3,0,Lobular and intraductal carcinoma (C50._)
8522,3,0,Lobular carcinoma and ductal carcinoma (C50._)
8522,3,0,Lobular carcinoma and infiltrating duct carcinoma (C50._)
8522,3,0,Lobular carcinoma and intraductal carcinoma (C50._)
8522,3,0,Lobular carcinoma in situ and infiltrating duct carcinoma (C50._)
8522,3,0,"Lobular carcinoma, infiltrating, and ductal carcinoma in situ (C50._)"
8523,3,1,Infiltrating duct mixed with other types of carcinoma (C50._)
8523,3,0,"Carcinoma, colloid and infiltrating duct (C50._)"
8523,3,0,"Carcinoma, cribriform and infiltrating duct (C50._)"
8523,3,0,"Carcinoma, duct, infiltrating and colloid (C50._)"
8523,3,0,"Carcinoma, duct, infiltrating and cribriform (C50._)"
8523,3,0,"Carcinoma, duct, infiltrating and mucinous (C50._)"
8523,3,0,"Carcinoma, duct, infiltrating and tubular (C50._)"
8523,3,0,"Carcinoma, infiltrating duct and colloid (C50._)"
8523,3,0,"Carcinoma, infiltrating duct and cribriform (C50._)"
8523,3,0,"Carcinoma, infiltrating duct and mucinous (C50._)"
8523,3,0,"Carcinoma, infiltrating duct and tubular (C50._)"
8523,3,0,"Carcinoma, infiltrating duct mixed with other types (C50._)"
8523,3,0,"Carcinoma, mixed with other types, infiltrating duct (C50._)"
8523,3,0,"Carcinoma, mucinous and infiltrating duct (C50._)"
8523,3,0,"Carcinoma, other types, infiltrating duct mixed with (C50._)"
8523,3,0,"Carcinoma, tubular and infiltrating duct (C50._)"
8523,3,0,Colloid carcinoma and infiltrating duct (C50._)
8523,3,0,"Cribriform (type), carcinoma, infiltrating duct and (C50._)"
8523,3,0,"Duct, infiltrating, and colloid carcinoma (C50._)"
8523,3,0,"Duct, infiltrating, and cribriform carcinoma (C50._)"
8523,3,0,"Duct, infiltrating, and mucinous carcinoma (C50._)"
8523,3,0,"Duct, infiltrating, and tubular carcinoma (C50._)"
8523,3,0,"Duct, infiltrating, mixed with other types of carcinoma (C50._)"
8523,3,0,"Ductal carcinoma, acinar, mixed [FOR USE 2015-2017. FOR 2018+ USE 8552/3]"
8523,3,0,Infiltrating duct and colloid carcinoma (C50._)
8523,3,0,Infiltrating duct and cribriform carcinoma (C50._)
8523,3,0,Infiltrating duct and mucinous carcinoma (C50._)
8523,3,0,Infiltrating duct and tubular carcinoma (C50._)
8523,3,0,Mixed acinar ductal carcinoma [FOR USE 2015-2017. FOR 2018+ USE 8552/3]
8523,3,0,"Mixed duct, infiltrating, with other types of carcinoma (C50._)"
8523,3,0,"Mixed duct, infiltrating, with other types of carcinoma (C50._)"
8523,3,0,Mixed infiltrating duct with other types of carcinoma (C50._)
8523,3,0,Mucinous and infiltrating duct carcinoma (C50._)
8523,3,0,"Other types of carcinoma, infiltrating duct mixed with (C50._)"
8523,3,0,Tubular and infiltrating duct carcinoma (C50._)
8524,3,1,Infiltrating lobular mixed with other types of carcinoma (C50._)
8524,3,0,"Carcinoma, infiltrating lobular mixed with other types (C50._)"
8524,3,0,"Carcinoma, mixed with other types, infiltrating lobular (C50._)"
8524,3,0,"Carcinoma, other types, infiltrating lobular mixed with (C50._)"
8524,3,0,"Lobular infiltrating, mixed with other types of carcinoma (C50._)"
8524,3,0,Mixed infiltrating lobular with other types of carcinoma (C50._)
8524,3,0,"Mixed lobular, infiltrating, with other types of carcinoma (C50._)"
8524,3,0,"Other types of carcinoma, infiltrating lobular mixed with (C50._)"
8525,3,1,Polymorphous low grade adenocarcinoma
8525,3,0,"Adenocarcinoma, low grade, polymorphous"
8525,3,0,"Adenocarcinoma, polymorphous low grade"
8525,3,0,"Adenocarcinoma, terminal duct"
8525,3,0,"Duct, terminal, adenocarcinoma"
8525,3,0,"Low grade adenocarcinoma, polymorphous"
8525,3,0,Terminal duct adenocarcinoma
8530,3,1,Inflammatory carcinoma (C50._)
8530,3,0,"Adenocarcinoma, inflammatory (C50._)"
8530,3,0,"Carcinoma, inflammatory (C50._)"
8530,3,0,Inflammatory adenocarcinoma (C50._)
8540,3,1,"Paget disease, mammary (C50._)"
8540,3,0,Mammary Paget disease (C50._)
8540,3,0,Paget disease of breast (C50._)
8540,3,0,"Paget disease, breast (C50._)"
8541,3,1,Paget disease and infiltrating duct carcinoma of breast (C50._)
8541,3,0,"Carcinoma, duct, infiltrating and Paget disease, breast (C50._)"
8541,3,0,"Carcinoma, infiltrating duct and Paget disease, breast (C50._)"
8541,3,0,"Duct carcinoma, infiltrating and Paget disease, breast (C50._)"
8541,3,0,"Duct, infiltrating carcinoma, and Paget disease, breast (C50._)"
8541,3,0,"Infiltrating duct carcinoma and Paget disease, breast (C50._)"
8542,3,1,"Paget disease, extramammary (except Paget disease of bone)"
8542,3,0,Extramammary Paget disease (except Paget disease of bone)
8543,3,1,Paget disease and intraductal carcinoma of breast (C50._)
8543,3,0,"Carcinoma, intraductal and Paget disease, breast (C50._)"
8543,3,0,"Intraductal carcinoma and Paget disease, breast (C50._)"
8550,0,1,Acinar cell adenoma
8550,0,0,Acinar adenoma
8550,0,0,Acinic cell adenoma
8550,0,0,"Adenoma, acinar"
8550,0,0,"Adenoma, acinar cell"
8550,0,0,"Adenoma, acinic cell"
8550,1,1,Acinar cell tumor [obs]
8550,1,0,Acinic cell tumor [obs]
8550,1,0,"Tumor, acinar cell [obs]"
8550,1,0,"Tumor, acinic cell [obs]"
8550,3,1,"Acinar cell carcinoma [EXCLUDES C61.9, USE 8140/3 FOR PROSTATE]"
8550,3,0,"Acinar adenocarcinoma [USE FOR LUNG < 2018 DX. FOR LUNG 2018+ USE 8551/3. EXCLUDES C61.9, USE 8140/3 FOR PROSTATE]"
8550,3,0,"Acinar carcinoma [EXCLUDES C61.9, USE 8140/3 FOR PROSTATE]"
8550,3,0,"Acinar cell carcinoma [EXCLUDES C61.9, USE 8140/3 FOR PROSTATE]"
8550,3,0,"Acinic cell adenocarcinoma [EXCLUDES C61.9, USE 8140/3 FOR PROSTATE]"
8550,3,0,"Adenocarcinoma, acinar [EXCLUDES C61.9, USE 8140/3 FOR PROSTATE]"
8550,3,0,"Adenocarcinoma, acinic cell [EXCLUDES C61.9, USE 8140/3 FOR PROSTATE]"
8550,3,0,"Carcinoma, acinar [EXCLUDES C61.9, USE 8140/3 FOR PROSTATE]"
8550,3,0,"Carcinoma, acinar cell [EXCLUDES C61.9, USE 8140/3 FOR PROSTATE]"
8551,3,1,Acinar cell cystadenocarcinoma
8551,3,0,Acinar adenocarcinoma (C34._) [FOR LUNG 2018+. FOR LUNG < 2018 USE 8550/3. USE 8140/3 FOR PROSTATE] 
8551,3,0,"Adenocarcinoma, acinar (C34._) [ FOR LUNG 2018+. FOR LUNG < 2018 USE 8550/3. USE 8140/3 FOR PROSTATE]"
8551,3,0,"Cystadenocarcinoma, acinar cell"
8552,3,1,"Mixed acinar ductal carcinoma [2018+. FOR PRE-2018, USE CODE 8523/3]"
8552,3,0,"Acinar ductal carcinoma, mixed [2018+. FOR PRE-2018, USE CODE 8523/3]"
8552,3,0,"Acinar ductal carcinoma, mixed [2018+. FOR PRE-2018, USE CODE 8523/3]"
8552,3,0,"Carcinoma, mixed acinar ductal [2018+; FOR PRE-2018, USE CODE 8523/3]"
8552,3,0,"Ductal acinar carcinoma, mixed [2018+. FOR PRE-2018, USE CODE 8523/3]"
8560,0,1,Mixed squamous cell and glandular papilloma
8560,0,0,"Glandular papilloma, squamous cell and, mixed"
8560,0,0,Mixed glandular and squamous cell papilloma
8560,0,0,"Papilloma, mixed squamous cell and glandular"
8560,0,0,"Papilloma, squamous cell and glandular, mixed"
8560,0,0,"Squamous cell papilloma and glandular papilloma, mixed"
8560,3,1,Adenosquamous carcinoma
8560,3,0,"Adenocarcinoma and epidermoid carcinoma, mixed"
8560,3,0,"Adenocarcinoma and squamous cell carcinoma, mixed"
8560,3,0,"Adenocarcinoma, mixed adenocarcinoma and epidermoid carcinoma"
8560,3,0,"Adenocarcinoma, mixed adenocarcinoma and squamous cell carcinoma"
8560,3,0,"Carcinoma, adenosquamous"
8560,3,0,"Carcinoma, epidermoid and adenocarcinoma, mixed"
8560,3,0,"Carcinoma, mixed adenocarcinoma and epidermoid"
8560,3,0,"Carcinoma, mixed adenocarcinoma and squamous cell"
8560,3,0,"Carcinoma, mixed squamous cell and adenocarcinoma"
8560,3,0,"Carcinoma, squamous cell and adenocarcinoma, mixed"
8560,3,0,"Epidermoid carcinoma and adenocarcinoma, mixed"
8560,3,0,Mixed adenocarcinoma and epidermoid carcinoma
8560,3,0,Mixed adenocarcinoma and squamous cell carcinoma
8560,3,0,Mixed epidermoid carcinoma and adenocarcinoma
8560,3,0,Mixed squamous cell carcinoma and adenocarcinoma
8560,3,0,"Squamous cell carcinoma and adenocarcinoma, mixed"
8561,0,1,"Adenolymphoma (C07._, C08._)"
8561,0,0,"Cystadenoma lymphomatosum, papillary (C07._, C08._)"
8561,0,0,"Cystadenoma, papillary, lymphomatosum (C07._, C08._)"
8561,0,0,"Lymphomatosum, papillary cystadenoma (C07._, C08._)"
8561,0,0,"Papillary cystadenoma lymphomatosum (C07._, C08._)"
8561,0,0,"Tumor, Warthin (C07._, C08._)"
8561,0,0,"Warthin tumor (C07._, C08._)"
8562,3,1,Epithelial-myoepithelial carcinoma
8562,3,0,"Carcinoma, epithelial-myoepithelial"
8562,3,0,"Carcinoma, myoepithelial-epithelial"
8562,3,0,Myoepithelial-epithelial carcinoma
8563,0,1,Lymphadenoma [2021+]
8570,3,1,Adenocarcinoma with squamous metaplasia
8570,3,0,Adenoacanthoma
8570,3,0,"Adenosquamous carcinoma, low grade (C50._) "
8570,3,0,"Carcinoma, adenosquamous, low grade (C50._) "
8570,3,0,"Carcinoma, endometrioid with squamous differentiation (C54._, C55.9)"
8570,3,0,"Endometrioid carcinoma with squamous differentiation (C54._, C55.9)"
8570,3,0,Low grade adenosquamous carcinoma (C50._) 
8570,3,0,"Metaplasia, squamous, adenocarcinoma with"
8570,3,0,"Squamous cell metaplasia, adenocarcinoma with"
8571,3,1,Adenocarcinoma with cartilaginous and osseous metaplasia
8571,3,0,Adenocarcinoma with cartilaginous metaplasia
8571,3,0,Adenocarcinoma with osseous metaplasia
8571,3,0,Carcinoma with chondroid differentiation (C50._) 
8571,3,0,Carcinoma with osseous differentiation (C50._) 
8571,3,0,"Carcinoma, metaplastic with chondroid differentiation (C50._) "
8571,3,0,"Carcinoma, metaplastic with osseous differentiation (C50._)"
8571,3,0,"Cartilaginous and osseous metaplasia, adenocarcinoma with"
8571,3,0,"Cartilaginous metaplasia, adenocarcinoma with"
8571,3,0,"Metaplasia, cartilaginous and osseous, adenocarcinoma with"
8571,3,0,"Metaplasia, cartilaginous, adenocarcinoma with"
8571,3,0,"Metaplasia, osseous, adenocarcinoma with"
8571,3,0,Metaplastic carcinoma with chondroid differentiation (C50._) 
8571,3,0,Metaplastic carcinoma with osseous differentiation (C50._) 
8571,3,0,"Osseous metaplasia, adenocarcinoma with"
8571,3,0,"Osseous metaplasia, adenocarcinoma with cartilaginous and"
8572,3,1,Adenocarcinoma with spindle cell metaplasia
8572,3,0,"Acinar adenocarcinoma, sarcomatoid (C61.9) "
8572,3,0,"Adenocarcinoma, acinar, sarcomatoid (C61.9) "
8572,3,0,"Carcinoma, fibromatosis-like metaplastic (C50._) "
8572,3,0,"Carcinoma, metaplastic, fibromatosis-like (C50._) "
8572,3,0,Fibromatosis-like metaplastic carcinoma (C50._) 
8572,3,0,"Metaplasia, spindle cell, adenocarcinoma with"
8572,3,0,"Metaplastic carcinoma, fibromatosis-like  (C50._) "
8572,3,0,Sarcomatoid acinar adenocarcinoma (C61.9) 
8572,3,0,"Spindle cell metaplasia, adenocarcinoma with"
8573,3,1,Adenocarcinoma with apocrine metaplasia
8573,3,0,"Apocrine metaplasia, adenocarcinoma with"
8573,3,0,"Apocrine metaplasia, carcinoma with"
8573,3,0,Carcinoma with apocrine metaplasia
8573,3,0,"Metaplasia, apocrine, adenocarcinoma with"
8573,3,0,"Metaplasia, apocrine, carcinoma with"
8574,3,1,Adenocarcinoma with neuroendocrine differentiation
8574,3,0,Adenocarcinoma admixed with neuroendocrine carcinoma (C53._)
8574,3,0,Carcinoma with neuroendocrine differentiation
8574,3,0,"Carcinoma, neuroendocrine, admixed with adenocarcinoma (C53._)"
8574,3,0,"Differentiation, adenocarcinoma with neuroendocrine"
8574,3,0,"Differentiation, carcinoma with neuroendocrine"
8574,3,0,Neuroendocrine carcinoma admixed with adenocarcinoma (C53._)
8574,3,0,"Neuroendocrine differentiation, adenocarcinoma with"
8574,3,0,"Neuroendocrine differentiation, carcinoma with"
8575,3,1,"Metaplastic carcinoma, NOS"
8575,3,0,Carcinoma with other types mesenchymal differentiation (C50._) 
8575,3,0,"Carcinoma, metaplastic with other types mesenchymal differentiation (C50._) "
8575,3,0,"Carcinoma, metaplastic, NOS"
8575,3,0,"Carcinoma, metaplastic, of no special type (C50._) "
8575,3,0,Metaplastic carcinoma of no special type (C50._) 
8575,3,0,Metaplastic carcinoma with other types mesenchymal differentiation (C50._) 
8576,3,1,Hepatoid adenocarcinoma
8576,3,0,"Adenocarcinoma, hepatoid"
8576,3,0,"Carcinoma, hepatoid"
8576,3,0,"Carcinoma, paneth cell [2022+]"
8576,3,0,Hepatoid carcinoma
8576,3,0,Paneth cell carcinoma [2022+]
8580,0,1,"Thymoma, benign (C37.9)"
8580,1,1,"Thymoma, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8580/3.]"
8580,3,1,"Thymoma, NOS (C37.9) [2021+]"
8580,3,0,Intrapulmonary thymoma (C34._) [2021+]
8580,3,0,Metaplastic thymoma (C37.9) [2021+]
8580,3,0,Sclerosing thymoma (C34._) [2021+]
8580,3,0,"Thymoma, intrapulmonary (C34._) [2021+]"
8580,3,0,"Thymoma, malignant, NOS (C37.9)"
8580,3,0,"Thymoma, metaplastic (C37.9) [2021+]"
8580,3,0,"Thymoma, sclerosing (C34._) [2021+]"
8581,1,1,"Thymoma, type A, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8581/3.]"
8581,1,0,"Medullary thymoma, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8581/3.]"
8581,1,0,"Spindle cell thymoma, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8581/3.]"
8581,1,0,"Thymoma, medullary, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8581/3.]"
8581,1,0,"Thymoma, spindle cell, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8581/3.]"
8581,3,1,"Thymoma, type A, NOS (C37.9) [2021+]"
8581,3,0,"Medullary thymoma, malignant (C37.9)"
8581,3,0,"Medullary thymoma, NOS (C37.9) [2021+]"
8581,3,0,"Spindle cell thymoma, malignant (C37.9)"
8581,3,0,"Spindle cell thymoma, NOS (C37.9) [2021+]"
8581,3,0,"Thymoma, medullary, malignant (C37.9)"
8581,3,0,"Thymoma, medullary, NOS (C37.9) [2021+]"
8581,3,0,"Thymoma, spindle cell, malignant (C37.9)"
8581,3,0,"Thymoma, spindle cell, NOS (C37.9) [2021+]"
8581,3,0,"Thymoma, Type A including atypical variant (C37.9) [2021+]"
8581,3,0,"Thymoma, type A, malignant (C37.9)"
8581,3,0,Type A thymoma including atypical variant (C37.9) [2021+]
8582,1,1,"Thymoma, type AB, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8582/3.]"
8582,1,0,"Mixed type, thymoma, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8582/3.]"
8582,3,1,"Thymoma, type AB, NOS (C37.9) [2021+]"
8582,3,0,"Mixed type thymoma, malignant (C37.9)"
8582,3,0,"Mixed type, thymoma, NOS (C37.9) [2021+]"
8582,3,0,"Thymoma, mixed type, malignant (C37.9)"
8582,3,0,"Thymoma, mixed type, NOS (C37.9)"
8582,3,0,"Thymoma, type AB, malignant (C37.9)"
8582,3,0,Type AB thymoma (C37.9) [2021+]
8583,1,1,"Thymoma, type B1, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8583/3.]"
8583,1,0,"Cortical thymoma, predominantly cortical, NOS (see also adrenal cortical) (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8583/3.]"
8583,1,0,"Lymphocyte-rich thymoma, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8583/3.]"
8583,1,0,"Lymphocytic thymoma, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8583/3.]"
8583,1,0,"Organoid thymoma, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8583/3.]"
8583,1,0,"Predominantly cortical, thymoma, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8583/3.]"
8583,1,0,"Thymoma, lymphocyte-rich, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8583/3.]"
8583,1,0,"Thymoma, lymphocytic, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8583/3.]"
8583,1,0,"Thymoma, organoid, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8583/3.]"
8583,1,0,"Thymoma, predominantly cortical, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8583/3.]"
8583,3,1,"Thymoma, type B1, NOS (C37.9) [2021+]"
8583,3,0,"Cortical thymoma, predominantly cortical, malignant (C37.9)"
8583,3,0,"Cortical thymoma, predominantly cortical, NOS (see also adrenal cortical) (C37.9) [2021+]"
8583,3,0,"Lymphocyte-rich thymoma, malignant (C37.9)"
8583,3,0,"Lymphocyte-rich thymoma, NOS (C37.9) [2021+]"
8583,3,0,"Lymphocytic thymoma, malignant (C37.9)"
8583,3,0,"Lymphocytic thymoma, NOS (C37.9) [2021+]"
8583,3,0,"Organoid thymoma, malignant (C37.9)"
8583,3,0,"Organoid thymoma, NOS (C37.9) [2021+]"
8583,3,0,"Predominantly cortical, thymoma, malignant (C37.9)"
8583,3,0,"Predominantly cortical, thymoma, NOS (C37.9) [2021+]"
8583,3,0,"Thymoma, lymphocyte-rich, malignant (C37.9)"
8583,3,0,"Thymoma, lymphocyte-rich, NOS (C37.9) [2021+]"
8583,3,0,"Thymoma, lymphocytic, malignant (C37.9)"
8583,3,0,"Thymoma, lymphocytic, NOS (C37.9) [2021+]"
8583,3,0,"Thymoma, organoid, malignant (C37.9)"
8583,3,0,"Thymoma, organoid, NOS (C37.9) [2021+]"
8583,3,0,"Thymoma, predominantly cortical, malignant (C37.9)"
8583,3,0,"Thymoma, predominantly cortical, NOS (C37.9) [2021+]"
8583,3,0,"Thymoma, type B1, malignant (C37.9)"
8583,3,0,Type B1 thymoma (C37.9) [2021+]
8584,1,1,"Thymoma, type B2, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8584/3.]"
8584,1,0,"Cortical thymoma, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8584/3.]"
8584,1,0,"Thymoma, cortical, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8584/3.]"
8584,3,1,"Thymoma, type B2, NOS (C37.9) [2021+]"
8584,3,0,"Cortical thymoma, malignant (C37.9)"
8584,3,0,"Cortical thymoma, NOS (C37.9) [2021+]"
8584,3,0,"Thymoma, cortical, malignant (C37.9)"
8584,3,0,"Thymoma, cortical, NOS (C37.9) [2021+]"
8584,3,0,"Thymoma, type B2, malignant (C37.9)"
8584,3,0,Type B2 thymoma (C37.9) [2021+]
8585,1,1,"Thymoma, type B3, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8585/3.]"
8585,1,0,"Atypical thymoma, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8585/3.]"
8585,1,0,"Epithelial thymoma, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8585/3.]"
8585,1,0,"Thymoma, atypical, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8585/3.]"
8585,1,0,"Thymoma, epithelial, NOS (C37.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8585/3.]"
8585,3,1,"Thymoma, type B3, NOS (C37.9) [2021+]"
8585,3,0,"Atypical thymoma, malignant (C37.9)"
8585,3,0,"Atypical thymoma, NOS (C37.9) [2021+]"
8585,3,0,"Carcinoma, thymic, well differentiated (C37.9)"
8585,3,0,"Epithelial thymoma, NOS (C37.9) [2021+]"
8585,3,0,"Thymic carcinoma, well differentiated (C37.9)"
8585,3,0,"Thymoma, atypical, malignant (C37.9)"
8585,3,0,"Thymoma, atypical, NOS (C37.9) [2021+]"
8585,3,0,"Thymoma, epithelial, malignant (C37.9)"
8585,3,0,"Thymoma, epithelial, NOS (C37.9) [2021+]"
8585,3,0,"Thymoma, type B3, malignant (C37.9)"
8585,3,0,Type B3 thymoma (C37.9) [2021+]
8585,3,0,Well differentiated thymic carcinoma (C37.9)
8586,3,1,"Thymic carcinoma, NOS (C37.9)"
8586,3,0,"Carcinoma, thymic, NOS (C37.9)"
8586,3,0,"Thymoma, type C (C37.9)"
8587,0,1,Ectopic hamartomatous thymoma
8587,0,0,"Hamartomatous thymoma, ectopic"
8587,0,0,"Thymoma, ectopic hamartomatous"
8587,0,0,"Thymoma, hamartomatous, ectopic"
8588,3,1,Spindle epithelial tumor with thymus-like element
8588,3,0,"Differentiation, spindle epithelial tumor with thymus-like"
8588,3,0,"Element, spindle epithelial tumor with thymus-like"
8588,3,0,"Epithelial tumor, spindle, with thymus-like differentiation"
8588,3,0,"Epithelial tumor, spindle, with thymus-like element"
8588,3,0,SETTLE
8588,3,0,Spindle epithelial tumor with thymus-like differentiation
8588,3,0,"Thymus-like differentiation, spindle epithelial tumor with thymus-like"
8588,3,0,"Thymus-like element, spindle epithelial tumor with"
8588,3,0,"Tumor, spindle, epithelial, with thymus-like differentiation"
8588,3,0,"Tumor, spindle, epithelial, with thymus-like element"
8589,3,1,Intrathyroid thymic carcinoma (C73.9) [2021+]
8589,3,0,Carcinoma showing thymus-like differentiation
8589,3,0,Carcinoma showing thymus-like element
8589,3,0,"Carcinoma, intrathyroid thymic (C73.9) [2021+]"
8589,3,0,"Carcinoma, showing thymus-like differentiation"
8589,3,0,CASTLE
8589,3,0,"Differentiation, carcinoma showing thymus-like"
8589,3,0,"Thymic carcinoma, intrathyroid (C73.9) [2021+]"
8589,3,0,"Thymus-like differentiation, carcinoma showing"
8589,3,0,"Thymus-like element, carcinoma showing"
8590,1,1,"Sex cord-gonadal stromal tumor, NOS"
8590,1,0,Gonadal stromal tumor and sex cord tumor
8590,1,0,"Gonadal stromal tumor, NOS"
8590,1,0,Ovarian stromal tumor (C56.9)
8590,1,0,"Sex cord tumor, NOS"
8590,1,0,"Sex cord-gonadal stromal tumor, NOS"
8590,1,0,"Stromal tumor, gonadal, NOS"
8590,1,0,"Stromal tumor, ovarian (C56.9)"
8590,1,0,"Stromal tumor, sex cord-gonadal"
8590,1,0,"Stromal tumor, testicular (C62._)"
8590,1,0,Testicular stromal tumor (C62._)
8590,1,0,"Tumor, gonadal stromal"
8590,1,0,"Tumor, gonadal stromal-sex cord, NOS"
8590,1,0,"Tumor, ovarian stromal (C56.9)"
8590,1,0,"Tumor, sex cord, NOS"
8590,1,0,"Tumor, sex cord-gonadal stromal, NOS"
8590,1,0,"Tumor, testicular stromal (C62._)"
8590,1,0,"Tumor, testicular stromal (C62._)"
8590,1,0,"Tumor, uterine, resembling ovarian sex cord tumor [2022+; NOT REPORTABLE]"
8590,1,0,Uterine tumor resembling ovarian sex cord tumor [2022+; NOT REPORTABLE]
8591,1,1,"Sex cord-gonadal stromal tumor, incompletely differentiated"
8591,1,0,"Gonadal stromal tumor, sex cord, incompletely differentiated"
8591,1,0,Incompletely differentiated sex cord-gonadal stromal tumor
8591,1,0,"Stromal tumor, sex cord-gonadal, incompletely differentiated"
8591,1,0,"Tumor, gonadal stromal-sex cord, incompletely differentiated"
8591,1,0,"Tumor, sex cord-gonadal stromal, incompletely differentiated"
8592,1,1,"Sex cord-gonadal stromal tumor, mixed forms"
8592,1,0,"Gonadal stromal tumor, sex cord, mixed forms"
8592,1,0,"Mixed sex cord-gonadal stromal tumor, mixed forms"
8592,1,0,"Stromal tumor, sex cord-gonadal, mixed forms"
8592,1,0,"Tumor, gonadal stromal-sex cord, mixed forms"
8592,1,0,"Tumor, sex cord-gonadal stromal, mixed forms"
8593,1,1,Stromal tumor with minor sex cord elements (C56.9)
8593,1,0,"Elements, stromal tumor with minor sex cord (C56.9)"
8593,1,0,"Minor sex cord elements, stromal tumor with (C56.9)"
8593,1,0,"Sex cord elements, stromal tumor with minor (C56.9)"
8593,1,0,"Tumor, stromal, with minor sex cord elements (C56.9)"
8594,1,1,"Mixed germ cell sex cord-stromal tumor, unclassified (C48.2, C56.9, C57.9)"
8594,1,0,"Germ cell sex cord-stromal tumor, mixed, unclassified (C48.2, C56.9, C57.9)"
8594,1,0,"Sex cord-stromal germ cell tumor, mixed, unclassified (C48.2, C56.9, C57.9)"
8594,1,0,"Tumor, germ cell sex cord-stromal, mixed, unclassified (C48.2, C56.9, C57.9)"
8594,1,0,"Tumor, sex cord-stromal germ cell, mixed, unclassified (C48.2, C56.9, C57.9)"
8600,0,1,"Thecoma, NOS (C56.9)"
8600,0,0,Theca cell tumor (C56.9)
8600,0,0,"Tumor, theca cell (C56.9)"
8600,3,1,"Thecoma, malignant (C56.9)"
8601,0,1,"Thecoma, luteinized (C56.9)"
8601,0,0,Luteinized thecoma (C56.9)
8602,0,1,Sclerosing stromal tumor (C56.9)
8602,0,0,"Sclerosing tumor, stromal (C56.9)"
8602,0,0,"Stromal tumor, sclerosing (C56.9)"
8602,0,0,"Tumor, sclerosing stromal (C56.9)"
8602,0,0,"Tumor, stromal, sclerosing (C56.9)"
8610,0,1,"Luteoma, NOS (C56.9)"
8610,0,0,Luteinoma (C56.9)
8620,1,1,"Granulosa cell tumor, adult type (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8620/3.]"
8620,1,0,"Adult type, granulosa cell tumor (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8620/3.]"
8620,1,0,"Granulosa cell tumor, NOS (C56.9)"
8620,1,0,"Tumor, granulosa cell, adult type (C56.9) [PRE-2021 ONLY. FOR 2021+ USE CODE 8620/3.]"
8620,1,0,"Tumor, granulosa cell, NOS (C56.9)"
8620,3,1,Adult granulosa cell tumor (C56.9 ONLY) [2018+ CASES ONLY; NOT REPORTABLE. REPORTABLE 2021+]
8620,3,0,"Adult type, granulosa cell tumor (C56.9) [REPORTABLE 2021+]"
8620,3,0,"Carcinoma, granulosa cell (C56.9)"
8620,3,0,Granulosa cell carcinoma (C56.9)
8620,3,0,"Granulosa cell tumor, adult (C56.9 ONLY) [2018+ CASES ONLY; NOT REPORTABLE. REPORTABLE 2021+]"
8620,3,0,"Granulosa cell tumor, adult type (C56.9) [REPORTABLE 2021+]"
8620,3,0,"Granulosa cell tumor, malignant (C56.9)"
8620,3,0,"Granulosa cell tumor, sarcomatoid (C56.9)"
8620,3,0,Sarcomatoid granulosa cell tumor (C56.9)
8620,3,0,"Tumor, granulosa cell, adult (C56.9 ONLY) [2018+ CASES ONLY; NOT REPORTABLE. REPORTABLE 2021+]"
8620,3,0,"Tumor, granulosa cell, adult type (C56.9) [REPORTABLE 2021+]"
8620,3,0,"Tumor, granulosa cell, malignant (C56.9)"
8620,3,0,"Tumor, granulosa cell, sarcomatoid (C56.9)"
8621,1,1,Granulosa cell-theca cell tumor (C56.9)
8621,1,0,Theca cell-granulosa cell tumor (C56.9)
8621,1,0,"Tumor, granulosa cell-theca cell (C56.9)"
8621,1,0,"Tumor, theca cell-granulosa cell (C56.9)"
8622,1,1,"Granulosa cell tumor, juvenile (C56.9)"
8622,1,0,Juvenile granulosa cell tumor (C56.9)
8622,1,0,"Tumor, granulosa cell, juvenile (C56.9)"
8622,1,0,"Tumor, juvenile granulosa cell (C56.9)"
8623,1,1,Sex cord tumor with annular tubules (C56.9)
8623,1,0,"Annular tubules, sex cord tumor with (C56.9)"
8623,1,0,"Tubules, annular, sex cord tumor with (C56.9)"
8623,1,0,"Tumor, sex cord, with annular tubules (C56.9)"
8630,0,1,"Androblastoma, benign"
8630,0,0,"Arrhenoblastoma, benign"
8630,1,1,"Androblastoma, NOS"
8630,1,0,"Arrhenoblastoma, NOS"
8630,3,1,"Androblastoma, malignant"
8630,3,0,"Arrhenoblastoma, malignant"
8631,0,1,"Sertoli-Leydig cell tumor, well differentiated"
8631,0,0,"Leydig-Sertoli cell tumor, well differentiated"
8631,0,0,"Tumor, Leydig-Sertoli cell, well differentiated"
8631,1,1,Sertoli-Leydig cell tumor of intermediate differentiation
8631,1,0,"Leydig-Sertoli cell tumor, intermediate differentiation"
8631,1,0,"Leydig-Sertoli cell tumor, NOS"
8631,3,1,"Sertoli-Leydig cell tumor, poorly differentiated"
8631,3,0,"Leydig-Sertoli cell tumor, poorly differentiated"
8631,3,0,"Leydig-Sertoli cell tumor, sarcomatoid"
8631,3,0,Sarcomatoid Sertoli-Leydig cell tumor
8631,3,0,"Sertoli-Leydig cell tumor, sarcomatoid"
8632,1,1,Gynandroblastoma (C56.9)
8633,1,1,"Sertoli-Leydig cell tumor, retiform"
8633,1,0,"Leydig-Sertoli cell tumor, retiform"
8633,1,0,Retiform Sertoli-Leydig cell tumor
8633,1,0,"Tumor, Sertoli-Leydig cell, retiform"
8634,1,1,"Sertoli-Leydig cell tumor, intermediate differentiation, with heterologous elements"
8634,1,0,"Leydig-Sertoli cell tumor, intermediate differentiation, with heterologous elements"
8634,1,0,"Leydig-Sertoli cell tumor, retiform, with heterologous elements"
8634,1,0,"Retiform Leydig-Sertoli cell tumor, with heterologous elements"
8634,1,0,"Retiform Sertoli-Leydig cell tumor, with heterologous elements"
8634,1,0,"Sertoli-Leydig cell tumor, retiform, with heterologous elements"
8634,1,0,"Tumor, Sertoli-Leydig cell, intermediate differentiation, with heterologous elements"
8634,1,0,"Tumor, Sertoli-Leydig, retiform, with heterologous elements"
8634,3,1,"Sertoli-Leydig cell tumor, poorly differentiated, with heterologous elements"
8634,3,0,"Leydig-Sertoli cell tumor, poorly differentiated, with heterologous elements"
8634,3,0,"Tumor, Sertoli-Leydig cell, poorly differentiated, with heterologous elements"
8640,1,1,"Sertoli cell tumor, NOS"
8640,1,0,"Adenoma, Pick tubular"
8640,1,0,"Adenoma, Sertoli cell"
8640,1,0,"Adenoma, testicular"
8640,1,0,"Adenoma, tubular, Pick"
8640,1,0,"Androblastoma, tubular, NOS"
8640,1,0,Pick tubular adenoma
8640,1,0,Sertoli cell adenoma
8640,1,0,Testicular adenoma
8640,1,0,"Tubular adenoma, Pick"
8640,1,0,"Tubular androblastoma, NOS"
8640,1,0,"Tumor, Sertoli cell, NOS"
8640,3,1,Sertoli cell carcinoma (C62._)
8640,3,0,"Carcinoma, Sertoli cell (C62._)"
8641,0,1,Sertoli cell tumor with lipid storage
8641,0,0,"Androblastoma, tubular, with lipid storage (C56.9)"
8641,0,0,Folliculome lipidique (C56.9)
8641,0,0,"Lipid storage, Sertoli cell tumor with"
8641,0,0,"Lipid storage, tubular androblastoma with (C56.9)"
8641,0,0,"Lipidique, folliculome (C56.9)"
8641,0,0,Lipid-rich Sertoli cell tumor (C56.9)
8641,0,0,"Sertoli cell tumor, lipid-rich (C56.9)"
8641,0,0,"Storage, lipid, Sertoli cell tumor with"
8641,0,0,"Storage, lipid, tubular androblastoma with (C56.9)"
8641,0,0,Tubular androblastoma with lipid storage (C56.9)
8641,0,0,"Tumor, Sertoli cell with lipid storage"
8641,0,0,"Tumor, Sertoli cell, lipid-rich (C56.9)"
8642,1,1,Large cell calcifying Sertoli cell tumor
8642,1,0,"Calcifying Sertoli cell tumor, large cell"
8642,1,0,"Sertoli cell tumor, large cell calcifying"
8642,1,0,"Tumor, Sertoli cell, large cell calcifying"
8643,1,1,Intratubular large cell hyalinizing Sertoli cell neoplasia [2021+]
8643,1,0,"Neoplasia, intratubular large cell hyalinizing Sertoli cell [2021+]"
8650,0,1,"Leydig cell tumor, benign (C62._)"
8650,0,0,"Interstitial cell tumor, benign"
8650,0,0,"Tumor, interstitial cell, benign"
8650,0,0,"Tumor, Leydig cell, benign (C62._)"
8650,1,1,"Leydig cell tumor, NOS (C62._)"
8650,1,0,"Interstitial cell tumor, NOS"
8650,1,0,"Tumor, interstitial cell, NOS"
8650,1,0,"Tumor, Leydig cell, NOS (C62._)"
8650,3,1,"Leydig cell tumor, malignant (C62._)"
8650,3,0,"Interstitial cell tumor, malignant"
8650,3,0,"Tumor, interstitial cell, malignant"
8650,3,0,"Tumor, Leydig cell, malignant (C62._)"
8660,0,1,Hilus cell tumor (C56.9)
8660,0,0,Hilar cell tumor (C56.9)
8660,0,0,"Tumor, hilar cell (C56.9)"
8660,0,0,"Tumor, hilus cell (C56.9)"
8670,0,1,Lipid cell tumor of ovary (C56.9)
8670,0,0,"Lipid cell tumor, ovary (C56.9)"
8670,0,0,Lipoid cell tumor of ovary (C56.9)
8670,0,0,"Lipoid cell tumor, ovary (C56.9)"
8670,0,0,Masculinovoblastoma (C56.9)
8670,0,0,"Steroid cell tumor, NOS"
8670,0,0,"Tumor, lipid cell, ovary (C56.9)"
8670,0,0,"Tumor, lipoid cell, ovary (C56.9)"
8670,0,0,"Tumor, steroid cell, NOS"
8670,3,1,"Steroid cell tumor, malignant"
8670,3,0,"Tumor, steroid cell, malignant"
8671,0,1,Adrenal rest tumor
8671,0,0,"Rest, tumor, adrenal"
8671,0,0,"Tumor, adrenal rest"
8680,0,1,"Paraganglioma, benign"
8680,1,1,"Paraganglioma, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8680/3.]"
8680,3,1,"Paraganglioma, NOS [REPORTABLE 2021+]"
8680,3,0,"Paraganglioma, malignant"
8681,1,1,Sympathetic paraganglioma [PRE-2021 ONLY. FOR 2021+ USE CODE 8681/3.]
8681,1,0,"Paraganglioma, sympathetic [PRE-2021 ONLY. FOR 2021+ USE CODE 8681/3.]"
8681,3,1,Sympathetic paraganglioma [REPORTABLE 2021+]
8681,3,0,"Paraganglioma, sympathetic [REPORTABLE 2021+]"
8682,1,1,Parasympathetic paraganglioma [PRE-2021 ONLY. FOR 2021+ USE CODE 8682/3.]
8682,1,0,"Paraganglioma, parasympathetic [PRE-2021 ONLY. FOR 2021+ USE CODE 8682/3.]"
8682,3,1,Parasympathetic paraganglioma [REPORTABLE 2021+]
8682,3,0,"Paraganglioma, parasympathetic [REPORTABLE 2021+]"
8683,0,1,Gangliocytic paraganglioma (C17.0)
8683,0,0,"Paraganglioma, gangliocytic (C17.0)"
8690,1,1,"Glomus jugulare tumor, NOS (C75.5) [PRE-2021 ONLY. FOR 2021+ USE CODE 8690/3.]"
8690,1,0,Jugular paraganglioma (C75.5) [PRE-2021 ONLY. FOR 2021+ USE CODE 8690/3.]
8690,1,0,"Jugulare tumor, glomus, NOS (C75.5) [PRE-2021 ONLY. FOR 2021+ USE CODE 8690/3.]"
8690,1,0,Jugulotympanic paraganglioma (C75.5) [PRE-2021 ONLY. FOR 2021+ USE CODE 8690/3.]
8690,1,0,"Paraganglioma, jugular (C75.5) [PRE-2021 ONLY. FOR 2021+ USE CODE 8690/3.]"
8690,1,0,"Paraganglioma, jugulotympanic (C75.5) [PRE-2021 ONLY. FOR 2021+ USE CODE 8690/3.]"
8690,1,0,"Tumor, glomus jugulare, NOS (C75.5) [PRE-2021 ONLY. FOR 2021+ USE CODE 8690/3.]"
8690,3,1,"Middle ear paraganglioma (C30.1, C75.5) [REPORTABLE 2021+]"
8690,3,0,"Glomus jugulare tumor, NOS (C75.5) [REPORTABLE 2021+]"
8690,3,0,Jugular paraganglioma (C75.5) [REPORTABLE 2021+]
8690,3,0,"Jugulare tumor, glomus, NOS (C75.5) [REPORTABLE 2021+]"
8690,3,0,Jugulotympanic paraganglioma (C75.5) [REPORTABLE 2021+]
8690,3,0,"Paraganglioma, jugular (C75.5) [REPORTABLE 2021+]"
8690,3,0,"Paraganglioma, jugulotympanic (C75.5) [REPORTABLE 2021+]"
8690,3,0,"Paraganglioma, middle ear (C30.1, C75.5) [REPORTABLE 2021+]"
8690,3,0,"Tumor, glomus jugulare, NOS (C75.5) [REPORTABLE 2021+]"
8691,1,1,Aortic body tumor (C75.5) [PRE-2021 ONLY. FOR 2021+ USE CODE 8691/3.]
8691,1,0,Aortic body paraganglioma (C75.5) [PRE-2021 ONLY. FOR 2021+ USE CODE 8691/3.]
8691,1,0,Aorticopulmonary paraganglioma (C75.5) [PRE-2021 ONLY. FOR 2021+ USE CODE 8691/3.]
8691,1,0,"Paraganglioma, aortic body (C75.5) [PRE-2021 ONLY. FOR 2021+ USE CODE 8691/3.]"
8691,1,0,"Paraganglioma, aorticopulmonary (C75.5) [PRE-2021 ONLY. FOR 2021+ USE CODE 8691/3.]"
8691,1,0,"Tumor, aortic body (C75.5) [PRE-2021 ONLY. FOR 2021+ USE CODE 8691/3.]"
8691,3,1,Aortic body tumor (C75.5) [REPORTABLE 2021+]
8691,3,0,Aortic body paraganglioma (C75.5) [REPORTABLE 2021+]
8691,3,0,Aorticopulmonary paraganglioma (C75.5) [REPORTABLE 2021+]
8691,3,0,"Paraganglioma, aortic body (C75.5) [REPORTABLE 2021+]"
8691,3,0,"Paraganglioma, aorticopulmonary (C75.5) [REPORTABLE 2021+]"
8691,3,0,"Tumor, aortic body (C75.5) [REPORTABLE 2021+]"
8692,1,1,Carotid body tumor (C75.4) [PRE-2021 ONLY. FOR 2021+ USE CODE 8692/3.]
8692,1,0,Carotid body paraganglioma (C75.4) [PRE-2021 ONLY. FOR 2021+ USE CODE 8692/3.]
8692,1,0,"Paraganglioma, carotid body (C75.4) [PRE-2021 ONLY. FOR 2021+ USE CODE 8692/3.]"
8692,1,0,"Tumor, carotid body (C75.4) [PRE-2021 ONLY. FOR 2021+ USE CODE 8692/3.]"
8692,3,1,Carotid body paraganglioma (C75.4) [REPORTABLE 2021+]
8692,3,0,Carotid body tumor (C75.4) [REPORTABLE 2021+]
8692,3,0,"Paraganglioma, carotid body (C75.4) [REPORTABLE 2021+]"
8692,3,0,"Tumor, carotid body (C75.4) [REPORTABLE 2021+]"
8693,1,1,"Extra-adrenal paraganglioma, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8693/3.]"
8693,1,0,Chemodectoma [PRE-2021 ONLY. FOR 2021+ USE CODE 8693/3.]
8693,1,0,"Nonchromaffin paraganglioma, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8693/3.]"
8693,1,0,"Paraganglioma, extrasuprarenal, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8693/3.]"
8693,1,0,"Paraganglioma, nonchromaffin, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8693/3.]"
8693,3,1,"Extra-adrenal paraganglioma, NOS [REPORTABLE 2021+]"
8693,3,0,Chemodectoma [REPORTABLE 2021+]
8693,3,0,Composite paraganglioma [REPORTABLE 2021+]
8693,3,0,"Extra-adrenal paraganglioma, malignant"
8693,3,0,Laryngeal paraganglioma [REPORTABLE 2021+]
8693,3,0,"Nonchromaffin paraganglioma, malignant"
8693,3,0,"Nonchromaffin paraganglioma, NOS [REPORTABLE 2021+]"
8693,3,0,Paraganglioma [REPORTABLE 2021+]
8693,3,0,"Paraganglioma, composite [REPORTABLE 2021+]"
8693,3,0,"Paraganglioma, extrasuprarenal, malignant"
8693,3,0,"Paraganglioma, extrasuprarenal, NOS [REPORTABLE 2021+]"
8693,3,0,"Paraganglioma, laryngeal [REPORTABLE 2021+]"
8693,3,0,"Paraganglioma, nonchromaffin, malignant"
8693,3,0,"Paraganglioma, nonchromaffin, NOS [REPORTABLE 2021+]"
8693,3,0,"Paraganglioma, vagal [REPORTABLE 2021+]"
8693,3,0,Vagal paraganglioma [REPORTABLE 2021+]
8700,0,1,"Pheochromocytoma, NOS (C74.1) [PRE-2021 ONLY. FOR 2021+ USE CODE 8700/3.]"
8700,0,0,Adrenal medullary paraganglioma (C74.1) [PRE-2021 ONLY. FOR 2021+ USE CODE 8700/3.]
8700,0,0,Chromaffin paraganglioma [PRE-2021 ONLY. FOR 2021+ USE CODE 8700/3.]
8700,0,0,Chromaffin tumor [PRE-2021 ONLY. FOR 2021+ USE CODE 8700/3.]
8700,0,0,Chromaffinoma [PRE-2021 ONLY. FOR 2021+ USE CODE 8700/3.]
8700,0,0,"Medullary paraganglioma, adrenal (C74.1) [PRE-2021 ONLY. FOR 2021+ USE CODE 8700/3.]"
8700,0,0,"Medullary, adrenal, paraganglioma (C74.1) [PRE-2021 ONLY. FOR 2021+ USE CODE 8700/3.]"
8700,0,0,"Paraganglioma, adrenal medullary (C74.1) [PRE-2021 ONLY. FOR 2021+ USE CODE 8700/3.]"
8700,0,0,"Paraganglioma, chromaffin [PRE-2021 ONLY. FOR 2021+ USE CODE 8700/3.]"
8700,0,0,"Tumor, chromaffin [PRE-2021 ONLY. FOR 2021+ USE CODE 8700/3.]"
8700,3,1,"Pheochromocytoma, NOS (C74.1) [REPORTABLE 2021+]"
8700,3,0,Adrenal medullary paraganglioma (C74.1) [REPORTABLE 2021+]
8700,3,0,"Adrenal medullary paraganglioma, malignant (C74.1)"
8700,3,0,Chromaffin paraganglioma [REPORTABLE 2021+]
8700,3,0,Chromaffin tumor [REPORTABLE 2021+]
8700,3,0,Chromaffinoma [REPORTABLE 2021+]
8700,3,0,Composite pheochromocytoma (C74.1) [REPORTABLE 2021+]
8700,3,0,"Medullary paraganglioma, adrenal (C74.1) [REPORTABLE 2021+]"
8700,3,0,"Medullary paraganglioma, adrenal, malignant (C74.1)"
8700,3,0,"Medullary, adrenal, paraganglioma (C74.1) [REPORTABLE 2021+]"
8700,3,0,"Medullary, adrenal, paraganglioma, malignant (C74.1)"
8700,3,0,"Paraganglioma, adrenal medullary (C74.1) [REPORTABLE 2021+]"
8700,3,0,"Paraganglioma, adrenal medullary, malignant (C74.1)"
8700,3,0,"Paraganglioma, chromaffin [REPORTABLE 2021+]"
8700,3,0,Pheochromoblastoma (C74.1)
8700,3,0,"Pheochromocytoma, composite (C74.1) [REPORTABLE 2021+]"
8700,3,0,"Pheochromocytoma, malignant (C74.1)"
8700,3,0,"Tumor, chromaffin [REPORTABLE 2021+]"
8710,3,1,Glomangiosarcoma
8710,3,0,Glomoid sarcoma
8710,3,0,"Sarcoma, glomoid"
8711,0,1,"Glomus tumor, NOS"
8711,0,0,"Tumor, glomus, NOS"
8711,3,1,"Glomus tumor, malignant"
8711,3,0,"Tumor, glomus, malignant"
8712,0,1,Glomangioma
8713,0,1,Glomangiomyoma
8714,3,1,"PEComa, malignant [2018+]"
8714,3,0,"Epithelioid cell tumor, perivascular, malignant [2018+]"
8714,3,0,Malignant perivascular epithelial cell tumor [2018+]
8714,3,0,"Perivascular epithelioid cell tumor, malignant [2018+]"
8714,3,0,"Tumor, perivascular epithelioid cell, malignant  "
8720,0,1,"Pigmented nevus, NOS (C44._)"
8720,0,0,Hairy nevus (C44._)
8720,0,0,Melanocytic nevus (C44._)
8720,0,0,"Nevus, hairy (C44._)"
8720,0,0,"Nevus, melanocytic (C44._)"
8720,0,0,"Nevus, NOS (C44._)"
8720,0,0,"Nevus, pigmented, NOS (C44._)"
8720,2,1,Melanoma in situ
8720,2,0,Early/evolving melanoma in situ (C44._) [REPORTABLE 2021+]
8720,2,0,In situ melanoma
8720,2,0,"In situ melanoma, early/evolving (C44._) [REPORTABLE 2021+]"
8720,2,0,"Melanoma in situ, early/evolving (C44._) [REPORTABLE 2021+]"
8720,3,1,"Malignant melanoma, NOS (except juvenile melanoma M-8770/0)"
8720,3,0,Early/evolving invasive melanoma (C44._) [REPORTABLE 2021+]
8720,3,0,"Malignant melanoma, early/evolving (C44._) [REPORTABLE 2021+]"
8720,3,0,"Melanoma, malignant, early/evolving (C44._) [REPORTABLE 2021+]"
8720,3,0,"Melanoma, malignant, NOS (except juvenile melanoma M-8770/0)"
8720,3,0,"Melanoma, meningeal (C70._, C71._)"
8720,3,0,"Melanoma, nevoid (C44. _) [2021+]"
8720,3,0,"Melanoma, NOS"
8720,3,0,"Meningeal melanoma (C70._, C71._)"
8720,3,0,Nevoid melanoma (C44. _) [2021+]
8721,3,1,Nodular melanoma (C44._)
8721,3,0,"Melanoma, nodular (C44._)"
8722,0,1,Balloon cell nevus (C44._)
8722,0,0,"Nevus, balloon cell (C44._)"
8722,3,1,Balloon cell melanoma (C44._)
8722,3,0,"Melanoma, balloon cell (C44._)"
8723,0,1,Halo nevus (C44._)
8723,0,0,"Nevus, halo (C44._)"
8723,0,0,"Nevus, regressing (C44._)"
8723,0,0,Regressing nevus (C44._)
8723,3,1,"Malignant melanoma, regressing (C44._)"
8723,3,0,"Melanoma, malignant, regressing (C44._)"
8723,3,0,"Melanoma, regressing, malignant (C44._)"
8723,3,0,Regressing malignant melanoma (C44._)
8723,3,0,"Regressing melanoma, malignant (C44._)"
8725,0,1,Neuronevus (C44._)
8726,0,1,Magnocellular nevus (C69.4)
8726,0,0,"Melanocytoma, eyeball (C69.4)"
8726,0,0,"Melanocytoma, NOS"
8726,0,0,"Nevus, magnocellular (C69.4)"
8727,0,1,Dysplastic nevus (C44._)
8727,0,0,"Nevus, dysplastic (C44._)"
8728,0,1,Diffuse melanocytosis (C70.9)
8728,0,0,"Melanocytosis, diffuse (C70.9)"
8728,1,1,Meningeal melanocytoma (C70.9)
8728,1,0,"Melanocytoma, meningeal (C70.9)"
8728,3,1,Meningeal melanomatosis (C70.9)
8728,3,0,"Melanomatosis, meningeal (C70.9)"
8730,0,1,Nonpigmented nevus (C44._)
8730,0,0,Achromic nevus (C44._)
8730,0,0,"Nevus, achromic (C44._)"
8730,0,0,"Nevus, nonpigmented (C44._)"
8730,3,1,Amelanotic melanoma (C44._)
8730,3,0,"Melanoma, amelanotic (C44._)"
8740,0,1,"Junctional nevus, NOS (C44._)"
8740,0,0,Intraepidermal nevus (C44._)
8740,0,0,Junction nevus (C44._)
8740,0,0,"Nevus, intraepidermal (C44._)"
8740,0,0,"Nevus, junction (C44._)"
8740,0,0,"Nevus, junctional, NOS (C44._)"
8740,3,1,Malignant melanoma in junctional nevus (C44._)
8740,3,0,"Junctional nevus, malignant melanoma in (C44._)"
8740,3,0,"Melanoma, malignant, in junctional nevus (C44._)"
8740,3,0,"Nevus, junctional, malignant melanoma in (C44._)"
8741,2,1,"Precancerous melanosis, NOS (C44._)"
8741,2,0,"Melanosis, precancerous, NOS (C44._)"
8741,3,1,Malignant melanoma in precancerous melanosis (C44._)
8741,3,0,"Melanoma, malignant, in precancerous melanosis (C44._)"
8741,3,0,"Melanosis, precancerous, malignant melanoma in (C44._)"
8741,3,0,"Precancerous melanosis, malignant melanoma in (C44._)"
8742,0,1,Lentiginous melanocytic nevus (C44._) [2021+]
8742,0,0,Lentigo simplex (C44._) [2021+]
8742,0,0,"Melanocytic nevus, lentiginous (C44._) [2021+]"
8742,0,0,"Nevus, lentiginous melanocytic (C44._) [2021+]"
8742,0,0,Simple lentigo (C44._) [2021+]
8742,2,1,Lentigo maligna (C44._)
8742,2,0,"Freckle, Hutchinson melanotic, NOS (C44._)"
8742,2,0,"Hutchinson melanotic freckle, NOS (C44._)"
8742,2,0,"Maligna, lentigo (C44._)"
8742,2,0,"Melanotic freckle, Hutchinson, NOS (C44._)"
8742,3,1,Lentigo maligna melanoma (C44._)
8742,3,0,"Freckle, malignant melanoma in Hutchinson"
8742,3,0,"Hutchinson melanotic freckle, malignant melanoma in (C44._)"
8742,3,0,"Maligna melanoma, lentigo (C44._)"
8742,3,0,Malignant melanoma in Hutchinson melanotic freckle (C44._)
8742,3,0,"Melanoma, lentigo maligna (C44._)"
8742,3,0,"Melanoma, malignant, in Hutchinson melanotic freckle (C44._)"
8742,3,0,"Melanotic freckle, Hutchinson, malignant melanoma in (C44._)"
8743,3,1,Low cumulative sun damaged melanoma (C44. _) [2021+]
8743,3,0,"Melanoma, low cumulative sun damaged (C44. _) [2021+]"
8743,3,0,"Melanoma, superficial spreading (C44._)"
8743,3,0,Sun damaged low cumulative melanoma (C44. _) [2021+]
8743,3,0,Superficial spreading melanoma (C44._)
8744,3,1,Acral melanoma (C44. _)
8744,3,0,"Acral lentiginous melanoma, malignant (C44._)"
8744,3,0,"Lentiginous melanoma, acral, malignant (C44._)"
8744,3,0,"Melanoma, acral (C44. _)"
8744,3,0,"Melanoma, acral lentiginous, malignant (C44._)"
8744,3,0,"Melanoma, lentiginous, acral, malignant (C44._)"
8744,3,0,"Melanoma, malignant, acral lentiginous (C44._)"
8745,3,1,"Desmoplastic melanoma, malignant (C44._)"
8745,3,0,Amelanotic desmoplastic melanoma (C44._)
8745,3,0,"Desmoplastic melanoma, amelanotic (C44._)"
8745,3,0,"Melanoma, amelanotic, desmoplastic (C44._)"
8745,3,0,"Melanoma, desmoplastic, amelanotic (C44._)"
8745,3,0,"Melanoma, desmoplastic, malignant (C44._)"
8745,3,0,"Melanoma, malignant, desmoplastic (C44._)"
8745,3,0,"Melanoma, malignant, neurotropic (C44._)"
8745,3,0,"Melanoma, neurotropic, malignant (C44._)"
8745,3,0,"Neurotropic melanoma, malignant (C44._)"
8746,3,1,Mucosal lentiginous melanoma
8746,3,0,"Lentiginous melanoma, mucosal"
8750,0,1,Intradermal nevus (C44._)
8750,0,0,Dermal nevus (C44._)
8750,0,0,"Nevus, dermal (C44._)"
8750,0,0,"Nevus, intradermal (C44._)"
8760,0,1,Compound nevus (C44._)
8760,0,0,Dermal and epidermal nevus (C44._)
8760,0,0,Epidermal and dermal nevus (C44._)
8760,0,0,"Nevus, compound (C44._)"
8760,0,0,"Nevus, dermal and epidermal (C44._)"
8761,0,1,Small congenital nevus (C44._)
8761,0,0,"Congenital nevus, small (C44._)"
8761,0,0,"Nevus, congenital, small (C44._)"
8761,0,0,"Nevus, small congenital (C44._)"
8761,1,1,"Giant pigmented nevus, NOS (C44._)"
8761,1,0,"Congenital nevus, intermediate and giant (C44._)"
8761,1,0,"Giant congenital nevus, intermediate and (C44._)"
8761,1,0,Intermediate and giant congenital nevus (C44._)
8761,1,0,"Nevus, congenital, intermediate and giant (C44._)"
8761,1,0,"Nevus, giant and intermediate, congenital (C44._)"
8761,1,0,"Nevus, giant pigmented, NOS (C44._)"
8761,1,0,"Nevus, intermediate and giant congenital (C44._)"
8761,1,0,"Nevus, pigmented giant, NOS (C44._)"
8761,1,0,"Pigmented nevus, giant, NOS (C44._)"
8761,3,1,Malignant melanoma arising in giant congenital nevus (C44. _) [2021+]
8761,3,0,"Congenital melanocytic nevus, malignant melanoma in (C44._)"
8761,3,0,"Giant congenital nevus, malignant melanoma arising in (C44. _) [2021+]"
8761,3,0,"Giant pigmented nevus, malignant melanoma in (C44._)"
8761,3,0,Malignant melanoma in congenital melanocytic nevus (C44._)
8761,3,0,Malignant melanoma in giant pigmented nevus (C44._)
8761,3,0,"Melanocytic nevus, congenital, malignant melanoma in (C44._)"
8761,3,0,"Melanoma, malignant, arising in giant congenital nevus (C44. _) [2021+]"
8761,3,0,"Melanoma, malignant, in congenital melanocytic nevus (C44._)"
8761,3,0,"Melanoma, malignant, in giant pigmented nevus (C44._)"
8761,3,0,"Nevus, congenital giant, malignant melanoma arising in (C44. _) [2021+]"
8761,3,0,"Nevus, congenital melanocytic, malignant melanoma in (C44._)"
8761,3,0,"Nevus, giant congenital, malignant melanoma arising in (C44. _) [2021+]"
8761,3,0,"Nevus, giant pigmented, malignant melanoma in (C44._)"
8761,3,0,"Nevus, melanocytic, congenital, malignant melanoma (C44._)"
8761,3,0,"Pigmented nevus, giant, malignant melanoma in (C44._)"
8762,1,1,Proliferative dermal lesion in congenital nevus (C44._)
8762,1,0,"Congenital nevus, proliferative dermal lesion in (C44._)"
8762,1,0,"Dermal lesion, proliferative in congenital nevus (C44._)"
8762,1,0,"Dermal proliferative, lesion in congenital nevus (C44._)"
8762,1,0,"Lesion, proliferative dermal, in congenital nevus (C44._)"
8762,1,0,"Nevus, congenital, proliferative dermal lesion in (C44._)"
8770,0,1,Epithelioid and spindle cell nevus (C44._)
8770,0,0,Juvenile melanoma (C44._)
8770,0,0,Juvenile nevus (C44._)
8770,0,0,"Melanoma, juvenile (C44._)"
8770,0,0,"Nevus, epithelioid and spindle cell (C44._)"
8770,0,0,"Nevus, juvenile (C44._)"
8770,0,0,"Nevus, pigmented, spindle cell, Reed"
8770,0,0,"Nevus, Reed pigmented spindle cell"
8770,0,0,"Nevus, spindle cell and epithelioid cell (C44._)"
8770,0,0,"Nevus, spindle cell, pigmented, Reed"
8770,0,0,"Nevus, Spitz (C44._)"
8770,0,0,Pigmented spindle cell nevus of Reed (C44._)
8770,0,0,Reed pigmented spindle cell nevus (C44._)
8770,0,0,Spindle cell and epithelioid nevus (C44._)
8770,0,0,"Spindle cell nevus of Reed, pigmented (C44._)"
8770,0,0,Spitz nevus (C44._)
8770,3,1,Malignant Spitz tumor (C44. _) [2021+]
8770,3,0,"Epithelioid and spindle cell melanoma, mixed"
8770,3,0,"Melanoma, epithelioid and spindle cell, mixed"
8770,3,0,"Melanoma, spindle cell and epithelioid cell, mixed"
8770,3,0,Mixed epithelioid and spindle cell melanoma
8770,3,0,Mixed spindle cell and epithelioid cell melanoma
8770,3,0,"Spindle cell and epithelioid melanoma, mixed"
8770,3,0,"Spindle cell melanoma and epithelioid melanoma, mixed"
8770,3,0,"Spitz tumor, malignant (C44. _) [2021+]"
8770,3,0,"Tumor, malignant Spitz (C44. _) [2021+]"
8771,0,1,Epithelioid cell nevus (C44._)
8771,0,0,"Nevus, epithelioid cell (C44._)"
8771,3,1,Epithelioid cell melanoma
8771,3,0,"Melanoma, epithelioid cell"
8772,0,1,"Spindle cell nevus, NOS (C44._)"
8772,0,0,"Nevus, spindle cell, NOS (C44._)"
8772,3,1,"Spindle cell melanoma, NOS"
8772,3,0,"Melanoma, spindle cell, NOS"
8773,3,1,"Spindle cell melanoma, type A (C69._)"
8773,3,0,"Melanoma, spindle cell, type A (C69._)"
8774,3,1,"Spindle cell melanoma, type B (C69._)"
8774,3,0,"Melanoma, spindle cell, type B (C69._)"
8780,0,1,"Blue nevus, NOS (C44._)"
8780,0,0,"Blue nevus, Jadassohn (C44._)"
8780,0,0,Jadassohn blue nevus (C44._)
8780,0,0,"Nevus, blue, Jadassohn (C44._)"
8780,0,0,"Nevus, blue, NOS (C44._)"
8780,0,0,"Nevus, Jadassohn blue (C44._)"
8780,3,1,"Blue nevus, malignant (C44._)"
8780,3,0,"Blue nevus, melanoma arising in (C44. _) [2021+]"
8780,3,0,Melanoma arising in a blue nevus (C44. _) [2021+]
8780,3,0,"Nevus, blue, malignant (C44._)"
8780,3,0,"Nevus, blue, melanoma arising in (C44. _) [2021+]"
8790,0,1,Cellular blue nevus (C44._)
8790,0,0,"Blue nevus, cellular (C44._)"
8790,0,0,"Nevus, blue, cellular (C44._)"
8800,0,1,"Soft tissue tumor, benign"
8800,0,0,"Tumor, soft tissue, benign"
8800,3,1,"Sarcoma, NOS"
8800,3,0,"Mesenchymal tumor, malignant"
8800,3,0,"Sarcoma, soft tissue"
8800,3,0,Soft tissue sarcoma
8800,3,0,"Soft tissue tumor, malignant"
8800,3,0,"Tumor, malignant, mesenchymal"
8800,3,0,"Tumor, mesenchymal, malignant"
8800,3,0,"Tumor, soft tissue, malignant"
8800,9,0,"Sarcomatosis, NOS"
8801,3,1,Spindle cell sarcoma
8801,3,0,"Sarcoma, spindle cell"
8801,3,0,"Sarcoma, spindle cell, undifferentiated "
8801,3,0,"Spindle cell sarcoma, undifferentiated"
8801,3,0,Undifferentiated spindle cell sarcoma 
8802,3,1,Giant cell sarcoma (except of bone M-9250/3)
8802,3,0,"Dermal sarcoma, pleomorphic (C44. _) [2021+]"
8802,3,0,Pleomorphic cell sarcoma
8802,3,0,Pleomorphic dermal sarcoma (C44. _) [2021+]
8802,3,0,Pleomorphic sarcoma [2021+]
8802,3,0,"Pleomorphic sarcoma, undifferentiated"
8802,3,0,"Sarcoma, dermal, pleomorphic (C44. _) [2021+]"
8802,3,0,"Sarcoma, giant cell (except of bone M-9250/3)"
8802,3,0,"Sarcoma, pleomorphic [2021+]"
8802,3,0,"Sarcoma, pleomorphic cell"
8802,3,0,"Sarcoma, pleomorphic dermal (C44. _) [2021+]"
8802,3,0,"Sarcoma, pleomorphic, undifferentiated "
8802,3,0,Undifferentiated pleomorphic sarcoma 
8803,3,1,Small cell sarcoma
8803,3,0,Round cell sarcoma
8803,3,0,"Round cell sarcoma, undifferentiated"
8803,3,0,"Sarcoma, round cell"
8803,3,0,"Sarcoma, round cell, undifferentiated "
8803,3,0,"Sarcoma, small cell"
8803,3,0,Undifferentiated round cell sarcoma 
8804,3,1,Epithelioid sarcoma
8804,3,0,Classic epithelioid sarcoma [2022+]
8804,3,0,Epithelioid cell sarcoma
8804,3,0,"Epithelioid sarcoma, classic [2022+]"
8804,3,0,"Epithelioid sarcoma, proximal or large cell [2022+]"
8804,3,0,"Epithelioid sarcoma, undifferentiated "
8804,3,0,Large cell or proximal epithelioid sarcoma [2022+]
8804,3,0,Proximal or large cell epithelioid sarcoma [2022+]
8804,3,0,"Sarcoma, epithelioid"
8804,3,0,"Sarcoma, epithelioid cell"
8804,3,0,"Sarcoma, epithelioid, classic [2022+]"
8804,3,0,"Sarcoma, epithelioid, proximal or large cell [2022+]"
8804,3,0,"Sarcoma, epithelioid, undifferentiated"
8804,3,0,Undifferentiated epithelioid sarcoma 
8805,3,1,Undifferentiated sarcoma
8805,3,0,"Sarcoma, undifferentiated"
8805,3,0,"Sarcoma, uterine, undifferentiated (C54.0 – C54.3, C54.8, C54.9)"
8805,3,0,"Undifferentiated uterine sarcoma (C54.0 – C54.3, C54.8, C54.9)"
8805,3,0,"Uterine sarcoma, undifferentiated (C54.0 – C54.3, C54.8, C54.9)"
8806,3,1,Desmoplastic small round cell tumor
8806,3,0,"Round cell tumor, desmoplastic small"
8806,3,0,"Tumor, desmoplastic small round cell"
8806,3,0,"Tumor, round cell, desmoplastic small"
8806,3,0,"Tumor, small round cell, desmoplastic"
8810,0,1,"Fibroma, NOS"
8810,1,1,Cellular fibroma (C56.9)
8810,1,0,"Fibroma, cellular (C56.9)"
8810,3,1,"Fibrosarcoma, NOS"
8811,0,1,Fibromyxoma
8811,0,0,"Fibroma, myxoid"
8811,0,0,"Myxofibroma, NOS"
8811,0,0,Myxoid fibroma
8811,0,0,Plexiform fibromyxoma
8811,1,1,Myxoinflammatory fibroblastic sarcoma (MIFS) (C49._) [NOT REPORTABLE]
8811,1,0,"Fibroblastic sarcoma, myxoinflammatory (MIFS) (C49._) [NOT REPORTABLE]"
8811,1,0,"Sarcoma, myxoinflammatory fibroblastic (MIFS) (C49._) [NOT REPORTABLE]"
8811,3,1,Myxofibrosarcoma 
8811,3,0,Epithelioid fibromyxosarcoma [2022+]
8811,3,0,Epithelioid myxofibrosarcoma [2022+]
8811,3,0,Fibromyxosarcoma
8811,3,0,"Fibromyxosarcoma, epithelioid [2022+]"
8811,3,0,"Myxofibrosarcoma, epithelioid [2022+]"
8812,0,1,"Periosteal fibroma (C40._, C41._)"
8812,0,0,"Fibroma, periosteal (C40._, C41._)"
8812,3,1,"Periosteal fibrosarcoma (C40._, C41._)"
8812,3,0,"Fibrosarcoma, periosteal (C40._, C41._)"
8812,3,0,"Periosteal sarcoma, NOS (C40._, C41._)"
8812,3,0,"Sarcoma, periosteal, NOS (C40._, C41._)"
8813,0,1,Fascial fibroma
8813,0,0,"Fibroma, fascial"
8813,3,1,Fascial fibrosarcoma
8813,3,0,"Fibrosarcoma, fascial"
8814,3,1,Infantile fibrosarcoma
8814,3,0,Congenital fibrosarcoma
8814,3,0,"Fibrosarcoma, congenital"
8814,3,0,"Fibrosarcoma, infantile"
8815,0,1,Solitary fibrous tumor
8815,0,0,"Fibrous tumor, localized"
8815,0,0,"Fibrous tumor, solitary"
8815,0,0,"Fibrous tumor, solitary/hemangiopericytoma Grade 1 (CNS) (C71._) [2018+] [REPORTABLE FOR CNS]"
8815,0,0,Hemangiopericytoma/Solitary fibrous tumor Grade 1(CNS) (C71._) [2018+] [REPORTABLE FOR CNS]
8815,0,0,Localized fibrous tumor
8815,0,0,Solitary fibrous tumor/hemangiopericytoma Grade 1 (CNS) (C71._) [2018+] [REPORTABLE FOR CNS]
8815,0,0,"Tumor, fibrous, localized"
8815,0,0,"Tumor, fibrous, solitary"
8815,0,0,"Tumor, solitary fibrous/hemangiopericytoma Grade 1 (CNS) (C71._) [2018+] [REPORTABLE FOR CNS]"
8815,1,1,Solitary fibrous tumor/hemangiopericytoma Grade 2 (CNS) (C71._) [2018+] [REPORTABLE FOR CNS]
8815,1,0,"Fibrous tumor, solitary/hemangiopericytoma Grade 2 (CNS) (C71._) [2018+] [REPORTABLE FOR CNS]"
8815,1,0,Hemangiopericytoma/solitary fibrous tumor Grade 2 (CNS) (C71._) [2018+] [REPORTABLE FOR CNS]
8815,1,0,"Tumor, solitary fibrous/hemangiopericytoma Grade 2 (CNS) (C71._) [2018+]"
8815,3,1,"Solitary fibrous tumor, malignant"
8815,3,0,"Fibrous tumor, solitary, malignant"
8815,3,0,"Fibrous tumor, solitary/hemangiopericytoma Grade 3 (CNS) (C71._) [2018+]"
8815,3,0,"Hemangiopericytoma, malignant [2021+ ONLY. FOR PRE-2021, USE CODE 9150/3]"
8815,3,0,Hemangiopericytoma/solitary fibrous tumor Grade 3 (CNS) (C71._) [2018+]
8815,3,0,"Malignant hemangiopericytoma [2021+ ONLY. FOR PRE-2021, USE CODE 9150/3]"
8815,3,0,Solitary fibrous tumor/hemangiopericytoma Grade 3 (CNS) (C71._) [2018+]
8815,3,0,Solitary fibrous tumor/hemangiopericytoma Grade 3 (CNS) (C71._) [2018+]
8815,3,0,"Tumor, fibrous, solitary, malignant"
8815,3,0,"Tumor, solitary fibrous/hemangiopericytoma Grade 3 (CNS) (C71._) [2018+]"
8816,0,1,Calcifying aponeurotic fibroma [2021+]
8816,0,0,"Fibroma, calcifying aponeurotic [2021+]"
8817,0,1,Calcifying fibrous tumor [2021+]
8817,0,0,"Tumor, calcifying fibrous [2021+]"
8818,0,1,Fibrous dysplasia [2021+]
8818,0,0,"Dysplasia, fibrous [2021+]"
8820,0,1,Elastofibroma
8821,1,1,Aggressive fibromatosis
8821,1,0,"Desmoid, extra-abdominal"
8821,1,0,"Desmoid, NOS"
8821,1,0,Extra-abdominal desmoid
8821,1,0,"Fibroma, invasive"
8821,1,0,"Fibromatosis, aggressive"
8821,1,0,Invasive fibroma
8822,1,1,Abdominal fibromatosis
8822,1,0,Abdominal desmoid
8822,1,0,"Desmoid, abdominal"
8822,1,0,"Fibromatosis, abdominal"
8822,1,0,"Fibromatosis, mesenteric (C48.1)"
8822,1,0,"Fibromatosis, retroperitoneal (C48.0)"
8822,1,0,Mesenteric fibromatosis (C48.1)
8822,1,0,Retroperitoneal fibromatosis (C48.0)
8823,0,1,Desmoplastic fibroma
8823,0,0,"Fibroma, desmoplastic"
8824,0,1,Myofibroma
8824,1,1,Myofibromatosis
8824,1,0,"Congenital fibromatosis, generalized"
8824,1,0,Congenital generalized fibromatosis
8824,1,0,"Fibromatosis, congenital generalized"
8824,1,0,"Generalized fibromatosis, congenital"
8824,1,0,Infantile myofibromatosis
8824,1,0,"Myofibromatosis, infantile"
8825,0,1,Myofibroblastoma
8825,1,1,"Myofibroblastic tumor, NOS"
8825,1,0,Inflammatory myofibroblastic tumor
8825,1,0,"Myofibroblastic tumor, inflammatory"
8825,1,0,"Tumor, myofibroblastic, inflammatory"
8825,1,0,"Tumor, myofibroblastic, NOS"
8825,3,1,Myofibroblastic sarcoma 
8825,3,0,"Low-grade myofibroblastic sarcoma (C01.9, C02._, C06.9, C49._) "
8825,3,0,"Myofibroblastic sarcoma, low-grade (C01.9, C02._, C06.9, C49._) "
8825,3,0,"Sarcoma, myofibroblastic"
8825,3,0,"Sarcoma, myofibroblastic, low-grade (C01.9, C02._, C06.9, C49._) "
8826,0,1,Angiomyofibroblastoma
8827,1,1,"Myofibroblastic tumor, peribronchial (C34._)"
8827,1,0,"Congenital myofibroblastic tumor, peribronchial (C34._)"
8827,1,0,Congenital peribronchial myofibroblastic tumor (C34._)
8827,1,0,"Myofibroblastic tumor, peribronchial, congenital (C34._)"
8827,1,0,Peribronchial myofibroblastic tumor (C34._)
8827,1,0,"Peribronchial myofibroblastic tumor, congenital (C34._)"
8827,1,0,"Tumor, myofibroblastic, congenital peribronchial (C34._)"
8827,1,0,"Tumor, myofibroblastic, peribronchial (C34._)"
8828,0,1,Nodular fasciitis [2021+]
8828,0,0,"Fasciitis, nodular [2021+]"
8828,0,0,"Fasciitis, proliferative [2021+]"
8828,0,0,"Myositis, proliferative [2021+]"
8828,0,0,Proliferative fasciitis [2021+]
8828,0,0,Proliferative myositis [2021+]
8830,0,1,Benign fibrous histiocytoma
8830,0,0,"Fibrous histiocytoma, benign"
8830,0,0,"Fibrous histiocytoma, NOS"
8830,0,0,"Fibroxanthoma, NOS"
8830,0,0,"Histiocytoma, fibrous, benign"
8830,0,0,"Histiocytoma, fibrous, NOS"
8830,0,0,Xanthofibroma
8830,1,1,Atypical fibrous histiocytoma
8830,1,0,Atypical fibroxanthoma
8830,1,0,"Fibrous histiocytoma, atypical"
8830,1,0,"Fibroxanthoma, atypical"
8830,1,0,"Histiocytoma, fibrous, atypical"
8830,3,1,Malignant fibrous histiocytoma
8830,3,0,"Fibrous histiocytoma, malignant"
8830,3,0,"Fibrous histiocytoma, malignant (MFH) of bone"
8830,3,0,"Fibroxanthoma, malignant"
8830,3,0,"Histiocytoma, fibrous, malignant"
8830,3,0,"Histiocytoma, malignant fibrous (MFH) of bone"
8830,3,0,Malignant fibrous histiocytoma (MFH) of bone 
8830,3,0,"Pleomorphic sarcoma, undifferentiated high-grade"
8830,3,0,"Pleomorphic sarcoma, undifferentiated high-grade of bone (C40._)"
8830,3,0,"Sarcoma, pleomorphic, undifferentiated high-grade"
8830,3,0,"Sarcoma, pleomorphic, undifferentiated high-grade of bone (C40._)"
8830,3,0,Undifferentiated high-grade pleomorphic sarcoma
8830,3,0,Undifferentiated high-grade pleomorphic sarcoma of bone (C40._)
8831,0,1,"Histiocytoma, NOS"
8831,0,0,Deep histiocytoma
8831,0,0,"Histiocytoma, deep"
8831,0,0,"Histiocytoma, juvenile"
8831,0,0,Juvenile histiocytoma
8831,0,0,Reticulohistiocytoma
8832,0,1,"Dermatofibroma, NOS (C44._)"
8832,0,0,"Cutaneous histiocytoma, NOS (C44._)"
8832,0,0,Dermatofibroma lenticulare (C44._)
8832,0,0,"Fibrosis, subepidermal nodular (C44._)"
8832,0,0,"Hemangioma, sclerosing (C44._)"
8832,0,0,"Histiocytoma, cutaneous, NOS (C44._)"
8832,0,0,"Lenticulare, dermatofibroma (C44._)"
8832,0,0,Nodular subepidermal fibrosis (C44.)
8832,0,0,Sclerosing hemangioma (C44._)
8832,0,0,Subepidermal nodular fibrosis (C44._)
8832,1,1,"Dermatofibrosarcoma protuberans, NOS (C44._) [2021+, NOT REPORTABLE. FOR PRE-2021 USE CODE 8832/3.]"
8832,1,0,"Dermatofibrosarcoma, NOS (C44._) [2021+, NOT REPORTABLE. FOR PRE-2021 USE CODE 8832/3.]"
8832,1,0,"Protuberans, dermatofibrosarcoma, NOS (C44._) [2021+, NOT REPORTABLE. FOR PRE-2021 USE CODE 8832/3.]"
8832,3,1,"Dermatofibrosarcoma protuberans, fibrosarcomatous"
8832,3,0,Dermatofibrosarcoma protuberans with myoid differentiation [2022+]
8832,3,0,"Dermatofibrosarcoma protuberans, myxoid [2022+]"
8832,3,0,"Dermatofibrosarcoma protuberans, NOS (C44._) [REPORTABLE PRE-2021 ONLY. FOR 2021+ USE CODE 8832/1.]"
8832,3,0,"Dermatofibrosarcoma protuberans, plaque-like [2022+]"
8832,3,0,"Dermatofibrosarcoma, NOS (C44._) [REPORTABLE PRE-2021 ONLY. FOR 2021+ USE CODE 8832/1.]"
8832,3,0,"Dermatofibrosarcoma, sarcomatous (C44._)"
8832,3,0,Fibrosarcomatous dermatofibrosarcoma protuberans
8832,3,0,Myxoid dermatofibrosarcoma protuberans [2022+]
8832,3,0,Plaque-like dermatofibrosarcoma protuberans [2022+]
8832,3,0,"Protuberans, dermatofibrosarcoma, myxoid [2022+]"
8832,3,0,"Protuberans, dermatofibrosarcoma, NOS (C44._) [REPORTABLE PRE-2021 ONLY. FOR 2021+ USE CODE 8832/1.]"
8832,3,0,"Protuberans, dermatofibrosarcoma, plaque-like [2022+]"
8832,3,0,"Protuberans, dermatofibrosarcoma, with myoid differentiation [2022+]"
8832,3,0,Sarcomatous dermatofibrosarcoma (C44._)
8833,1,1,"Pigmented dermatofibrosarcoma protuberans (C44._) [2021+, NOT REPORTABLE. FOR PRE-2021 USE CODE 8833/3.]"
8833,1,0,"Bednar tumor (C44._) [2021+, NOT REPORTABLE. FOR PRE-2021 USE CODE 8833/3.]"
8833,1,0,"Dermatofibrosarcoma protuberans, pigmented (C44._) [2021+, NOT REPORTABLE. FOR PRE-2021 USE CODE 8833/3.]"
8833,1,0,"Protuberans, dermatofibrosarcoma, pigmented (C44._) [2021+, NOT REPORTABLE. FOR PRE-2021 USE CODE 8833/3.]"
8833,1,0,"Tumor, Bednar (C44._) [2021+, NOT REPORTABLE. FOR PRE-2021 USE CODE 8833/3.]"
8833,3,1,Pigmented dermatofibrosarcoma protuberans (C44._) [REPORTABLE PRE-2021 ONLY. FOR 2021+ USE CODE 8833/1.]
8833,3,0,Bednar tumor (C44._) [REPORTABLE PRE-2021 ONLY. FOR 2021+ USE CODE 8833/1.]
8833,3,0,"Dermatofibrosarcoma protuberans, pigmented (C44._) [REPORTABLE PRE-2021 ONLY. FOR 2021+ USE CODE 8833/1.]"
8833,3,0,"Protuberans, dermatofibrosarcoma, pigmented (C44._) [REPORTABLE PRE-2021 ONLY. FOR 2021+ USE CODE 8833/1.]"
8833,3,0,"Tumor, Bednar (C44._) [REPORTABLE PRE-2021 ONLY. FOR 2021+ USE CODE 8833/1.]"
8834,1,1,Giant cell fibroblastoma
8834,1,0,"Fibroblastoma, giant cell"
8835,1,1,Plexiform fibrohistiocytic tumor
8835,1,0,"Fibrohistiocytic tumor, plexiform"
8835,1,0,"Tumor, fibrohistiocytic, plexiform"
8835,1,0,"Tumor, plexiform fibrohistiocytic"
8836,1,1,Angiomatoid fibrous histiocytoma
8836,1,0,"Fibrosis histiocytoma, angiomatoid"
8836,1,0,"Histiocytoma, fibrous, angiomatoid"
8840,0,1,"Myxoma, NOS"
8840,3,1,Myxosarcoma
8840,3,0,"Epithelioid fibrosarcoma, sclerosing"
8840,3,0,"Fibromyxoid sarcoma, low-grade"
8840,3,0,"Fibrosarcoma, sclerosing epithelioid"
8840,3,0,Low-grade fibromyxoid sarcoma 
8840,3,0,"Sarcoma, fibromyxoid low-grade"
8840,3,0,Sclerosing epithelioid fibrosarcoma 
8841,1,1,Angiomyxoma
8841,1,0,Aggressive angiomyxoma
8841,1,0,"Angiomyxoma, aggressive"
8842,0,1,Ossifying fibromyxoid tumor
8842,0,0,"Fibromyxoid tumor, ossifying"
8842,0,0,"Tumor, fibromyxoid, ossifying"
8842,0,0,"Tumor, ossifying fibromyxoid"
8842,3,1,"Ossifying fibromyxoid tumor, malignant (C49._) "
8842,3,0,"Fibromyxoid tumor, ossifying, malignant (C49._) "
8842,3,0,"Myxoid sarcoma, pulmonary with EWSR1-CREB1 translocation (C34._) "
8842,3,0,Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation (C34._) 
8842,3,0,"Sarcoma, myxoid, pulmonary with EWSR1-CREB1 translocation (C34._) "
8842,3,0,"Tumor, fibromyxoid ossifying, malignant (C49._) "
8850,0,1,"Lipoma, NOS"
8850,1,1,Atypical lipoma
8850,1,0,"Lipoma, atypical"
8850,1,0,"Liposarcoma, superficial well differentiated"
8850,1,0,"Liposarcoma, well differentiated, superficial soft tissue"
8850,1,0,"Soft tissue, superficial, well differentiated liposarcoma"
8850,1,0,"Superficial soft tissue, well differentiated liposarcoma"
8850,1,0,Superficial well differentiated liposarcoma
8850,1,0,Well differentiated liposarcoma of superficial soft tissue
8850,1,0,"Well differentiated liposarcoma, superficial"
8850,3,1,"Liposarcoma, NOS"
8850,3,0,Fibroliposarcoma
8851,0,1,Fibrolipoma
8851,3,1,"Liposarcoma, well differentiated"
8851,3,0,Differentiated liposarcoma
8851,3,0,Inflammatory liposarcoma
8851,3,0,Lipoma-like liposarcoma
8851,3,0,"Liposarcoma, differentiated"
8851,3,0,"Liposarcoma, inflammatory"
8851,3,0,"Liposarcoma, lipoma-like"
8851,3,0,"Liposarcoma, sclerosing"
8851,3,0,Sclerosing liposarcoma
8851,3,0,"Well differentiated liposarcoma, NOS"
8852,0,1,Fibromyxolipoma
8852,0,0,Myxolipoma
8852,3,1,Myxoid liposarcoma
8852,3,0,"Liposarcoma, myxoid"
8852,3,0,Myxoliposarcoma
8853,3,1,Round cell liposarcoma
8853,3,0,"Liposarcoma, round cell"
8854,0,1,Pleomorphic lipoma
8854,0,0,"Lipoma, pleomorphic"
8854,3,1,Pleomorphic liposarcoma
8854,3,0,"Liposarcoma, pleomorphic"
8855,3,1,Mixed liposarcoma
8855,3,0,"Liposarcoma, mixed"
8856,0,1,Intramuscular lipoma
8856,0,0,"Angiolipoma, infiltrating"
8856,0,0,Infiltrating angiolipoma
8856,0,0,Infiltrating lipoma
8856,0,0,"Lipoma, infiltrating"
8856,0,0,"Lipoma, intramuscular"
8857,0,1,Spindle cell lipoma
8857,0,0,"Lipoma, spindle cell"
8857,3,1,Fibroblastic liposarcoma
8857,3,0,"Liposarcoma, fibroblastic"
8858,3,1,Dedifferentiated liposarcoma
8858,3,0,"Liposarcoma, dedifferentiated"
8859,3,1,Myxoid pleomorphic liposarcoma [2022+]
8859,3,0,"Liposarcoma, myxoid pleomorphic [2022+]"
8859,3,0,"Pleomorphic liposarcoma, myxoid [2022+]"
8860,0,1,Angiomyolipoma
8861,0,1,"Angiolipoma, NOS"
8862,0,1,Chondroid lipoma
8862,0,0,"Lipoma, chondroid"
8870,0,1,Myelolipoma
8880,0,1,Hibernoma
8880,0,0,Brown fat tumor
8880,0,0,"Fat cell lipoma, fetal"
8880,0,0,"Fat tumor, brown"
8880,0,0,Fetal fat cell lipoma
8880,0,0,"Lipoma, fetal fat cell"
8880,0,0,"Tumor, brown fat"
8881,0,1,Lipoblastomatosis
8881,0,0,"Fetal lipoma, NOS"
8881,0,0,Fetal lipomatosis
8881,0,0,Lipoblastoma
8881,0,0,"Lipoma, fetal, NOS"
8881,0,0,"Lipomatosis, fetal"
8890,0,1,"Leiomyoma, NOS"
8890,0,0,Fibroid uterus (C55.9)
8890,0,0,Fibromyoma
8890,0,0,Leiomyofibroma
8890,0,0,"Leiomyoma, plexiform"
8890,0,0,Lipoleiomyoma
8890,0,0,Plexiform leiomyoma
8890,0,0,"Uterus, fibroid (C55.9)"
8890,1,1,"Leiomyomatosis, NOS"
8890,1,0,Intravascular leiomyomatosis
8890,1,0,"Leiomyomatosis, intravascular"
8890,3,1,"Leiomyosarcoma, NOS"
8891,0,1,Epithelioid leiomyoma
8891,0,0,Leiomyoblastoma
8891,0,0,"Leiomyoma, epithelioid"
8891,3,1,Epithelioid leiomyosarcoma
8891,3,0,"Leiomyosarcoma, epithelioid"
8892,0,1,Cellular leiomyoma
8892,0,0,"Leiomyoma, cellular"
8893,0,1,Bizarre leiomyoma
8893,0,0,Atypical leiomyoma
8893,0,0,"Leiomyoma, atypical"
8893,0,0,"Leiomyoma, bizarre"
8893,0,0,"Leiomyoma, pleomorphic"
8893,0,0,"Leiomyoma, symplastic"
8893,0,0,Pleomorphic leiomyoma
8893,0,0,Symplastic leiomyoma
8894,0,1,Angiomyoma
8894,0,0,Angioleiomyoma
8894,0,0,"Leiomyoma, vascular"
8894,0,0,Vascular leiomyoma
8894,3,1,Angiomyosarcoma
8895,0,1,Myoma
8895,3,1,Myosarcoma
8896,3,1,Myxoid leiomyosarcoma
8896,3,0,"Leiomyosarcoma, myxoid"
8897,1,1,Smooth muscle tumor of uncertain malignant potential
8897,1,0,"Muscle tumor, smooth, NOS"
8897,1,0,"Muscle tumor, smooth, uncertain malignant potential"
8897,1,0,"Potential, uncertain malignant, smooth muscle tumor"
8897,1,0,"Smooth muscle tumor, NOS"
8897,1,0,"Tumor, smooth muscle, NOS"
8897,1,0,"Tumor, smooth muscle, uncertain malignant potential"
8897,1,0,"Uncertain malignant potential, tumor, smooth muscle"
8898,1,1,Metastasizing leiomyoma
8898,1,0,"Leiomyoma, metastasizing"
8900,0,1,"Rhabdomyoma, NOS"
8900,3,1,"Rhabdomyosarcoma, NOS"
8900,3,0,Rhabdosarcoma
8901,3,1,"Pleomorphic rhabdomyosarcoma, adult type"
8901,3,0,"Adult type, pleomorphic rhabdomyosarcoma"
8901,3,0,"Pleomorphic rhabdomyosarcoma, NOS"
8901,3,0,"Rhabdomyosarcoma, adult type"
8901,3,0,"Rhabdomyosarcoma, pleomorphic, adult type"
8901,3,0,"Rhabdomyosarcoma, pleomorphic, NOS"
8902,3,1,Mixed type rhabdomyosarcoma
8902,3,0,"Alveolar and embryonal rhabdomyosarcoma, mixed"
8902,3,0,"Alveolar rhabdomyosarcoma and embryonal rhabdomyosarcoma, mixed"
8902,3,0,"Embryonal and alveolar rhabdomyosarcoma, mixed"
8902,3,0,"Embryonal rhabdomyosarcoma and alveolar, mixed"
8902,3,0,Mixed alveolar rhabdomyosarcoma and embryonal rhabdomyosarcoma
8902,3,0,Mixed embryonal rhabdomyosarcoma and alveolar rhabdomyosarcoma
8902,3,0,"Mixed rhabdomyosarcoma, alveolar and embryonal"
8902,3,0,"Rhabdomyosarcoma, alveolar and embryonal, mixed"
8902,3,0,"Rhabdomyosarcoma, mixed embryonal and alveolar"
8902,3,0,"Rhabdomyosarcoma, mixed type"
8903,0,1,Fetal rhabdomyoma
8903,0,0,"Rhabdomyoma, fetal"
8904,0,1,Adult rhabdomyoma
8904,0,0,Glycogenic rhabdomyoma
8904,0,0,"Rhabdomyoma, adult"
8904,0,0,"Rhabdomyoma, glycogenic"
8905,0,1,"Genital rhabdomyoma (C51._, C52.9)"
8905,0,0,"Rhabdomyoma, genital (C51._, C52.9)"
8910,3,1,"Embryonal rhabdomyosarcoma, NOS"
8910,3,0,Botryoid sarcoma
8910,3,0,"Botryoides, sarcoma"
8910,3,0,"Embryonal rhabdomyosarcoma, pleomorphic"
8910,3,0,"Pleomorphic rhabdomyosarcoma, embryonal"
8910,3,0,"Rhabdomyosarcoma, embryonal, NOS"
8910,3,0,"Rhabdomyosarcoma, embryonal, pleomorphic"
8910,3,0,Sarcoma botryoides
8910,3,0,"Sarcoma, botryoid"
8912,3,1,Spindle cell rhabdomyosarcoma
8912,3,0,Congenital spindle cell rhabdomyosarcoma with VGLL2/NCOA2/CITED2 rearrangements [2022+]
8912,3,0,Intraosseous spindle cell rhabdomyosarcoma with TFCP2/NCOA2 rearrangements [2022+]
8912,3,0,MYOD1-mutant spindle cell/sclerosing rhabdomyosarcoma [2022+]
8912,3,0,"Rhabdomyosarcoma, congenital spindle cell with VGLL2/NCOA2/CITED2 rearrangements [2022+]"
8912,3,0,"Rhabdomyosarcoma, intraosseous spindle cell with TFCP2/NCOA2 rearrangements [2022+]"
8912,3,0,"Rhabdomyosarcoma, MYOD1-mutant spindle cell/sclerosing [2022+]"
8912,3,0,"Rhabdomyosarcoma, sclerosing"
8912,3,0,"Rhabdomyosarcoma, spindle cell"
8912,3,0,"Rhabdomyosarcoma, spindle cell, congenital with VGLL2/NCOA2/CITED2 rearrangements [2022+]"
8912,3,0,"Rhabdomyosarcoma, spindle-cell/sclerosing type"
8912,3,0,Sclerosing rhabdomyosarcoma 
8912,3,0,"Spindle cell rhabdomyosarcoma, congenital with VGLL2/NCOA2/CITED2 rearrangements [2022+]"
8912,3,0,"Spindle cell rhabdomyosarcoma, intraosseous with TFCP2/NCOA2 rearrangements [2022+]"
8912,3,0,Spindle-cell/sclerosing type rhabdomyosarcoma
8920,3,1,Alveolar rhabdomyosarcoma
8920,3,0,"Rhabdomyosarcoma, alveolar"
8921,3,1,Ectomesenchymoma
8921,3,0,"Differentiation, rhabdomyosarcoma with ganglionic"
8921,3,0,"Ganglionic differentiation, rhabdomyosarcoma with"
8921,3,0,Rhabdomyosarcoma with ganglionic differentiation
8930,0,1,Endometrial stromal nodule (C54.1)
8930,0,0,"Nodule, endometrial stromal (C54.1)"
8930,0,0,"Stromal nodule, endometrial (C54.1)"
8930,3,1,"Endometrial stromal sarcoma, NOS (C54.1)"
8930,3,0,"Endometrial sarcoma, NOS (C54.1)"
8930,3,0,"Endometrial stromal sarcoma, high grade (C54.1)"
8930,3,0,"Sarcoma, endometrial stromal, high grade (C54.1)"
8930,3,0,"Sarcoma, endometrial stromal, NOS (C54.1)"
8930,3,0,"Sarcoma, endometrial, NOS (C54.1)"
8930,3,0,"Sarcoma, stromal, endometrial, high grade (C54.1)"
8930,3,0,"Sarcoma, stromal, endometrial, NOS (C54.1)"
8930,3,0,"Stromal sarcoma, endometrial, high grade (C54.1)"
8930,3,0,"Stromal sarcoma, endometrial, NOS (C54.1)"
8931,3,1,"Endometrial stromal sarcoma, low grade (C54.1)"
8931,3,0,Endolymphatic stromal myosis (C54.1)
8931,3,0,Endometrial stromatosis (C54.1)
8931,3,0,"Endometriosis, stromal (C54.1)"
8931,3,0,Low grade endometrial stromal sarcoma (C54.1)
8931,3,0,"Myosis, stromal, endolymphatic (C54.1)"
8931,3,0,"Myosis, stromal, NOS (C54.1)"
8931,3,0,"Sarcoma, endometrial stromal, low grade (C54.1)"
8931,3,0,"Sarcoma, stromal, endometrial, low grade (C54.1)"
8931,3,0,Stromal endometriosis (C54.1)
8931,3,0,"Stromal myosis, endolymphatic (C54.1)"
8931,3,0,"Stromal myosis, NOS (C54.1)"
8931,3,0,"Stromal sarcoma, endometrial, low grade (C54.1)"
8931,3,0,"Stromatosis, endometrial (C54.1)"
8932,0,1,Adenomyoma
8932,0,0,"Adenomyoma, atypical polypoid"
8932,0,0,Atypical polypoid adenomyoma
8932,0,0,Polypoid atypical adenomyoma
8933,3,1,Adenosarcoma
8933,3,0,"Adenosarcoma, Mullerian (C54._, C55.9)"
8933,3,0,"Mullerian adenosarcoma (C54._, C55.9)"
8934,3,1,Carcinofibroma
8935,0,1,"Stromal tumor, benign"
8935,0,0,"Tumor, stromal, benign"
8935,1,1,"Stromal tumor, NOS"
8935,1,0,"Tumor, stromal, NOS"
8935,3,1,"Stromal sarcoma, NOS"
8935,3,0,"Sarcoma, stromal, NOS"
8936,0,1,"Gastrointestinal stromal tumor, benign"
8936,0,0,"GIST, benign"
8936,0,0,"Stromal tumor, gastrointestinal, benign"
8936,0,0,"Tumor, gastrointestinal stromal, benign"
8936,0,0,"Tumor, stromal, gastrointestinal, benign"
8936,1,1,"Gastrointestinal stromal tumor, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8936/3.]"
8936,1,0,"Autonomic nerve tumor, gastrointestinal [PRE-2021 ONLY. FOR 2021+ USE CODE 8936/3.]"
8936,1,0,GANT [PRE-2021 ONLY. FOR 2021+ USE CODE 8936/3.]
8936,1,0,Gastrointestinal autonomic nerve tumor [PRE-2021 ONLY. FOR 2021+ USE CODE 8936/3.]
8936,1,0,Gastrointestinal pacemaker cell tumor [PRE-2021 ONLY. FOR 2021+ USE CODE 8936/3.]
8936,1,0,"Gastrointestinal stromal tumor, uncertain malignant potential"
8936,1,0,"GIST, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8936/3.]"
8936,1,0,"Pacemaker cell tumor, gastrointestinal [PRE-2021 ONLY. FOR 2021+ USE CODE 8936/3.]"
8936,1,0,"Potential, uncertain malignant, gastrointestinal stromal tumor"
8936,1,0,"Stromal tumor, gastrointestinal, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8936/3.]"
8936,1,0,"Stromal tumor, gastrointestinal, uncertain malignant potential"
8936,1,0,"Tumor, autonomic nerve, gastrointestinal [PRE-2021 ONLY. FOR 2021+ USE CODE 8936/3.]"
8936,1,0,"Tumor, gastrointestinal stromal, NOS [PRE-2021 ONLY. FOR 2021+ USE CODE 8936/3.]"
8936,1,0,"Tumor, gastrointestinal stromal, uncertain malignant potential"
8936,1,0,"Tumor, gastrointestinal, autonomic nerve [PRE-2021 ONLY. FOR 2021+ USE CODE 8936/3.]"
8936,1,0,"Tumor, gastrointestinal, pacemaker cell [PRE-2021 ONLY. FOR 2021+ USE CODE 8936/3.]"
8936,1,0,"Tumor, pacemaker cell, gastrointestinal [PRE-2021 ONLY. FOR 2021+ USE CODE 8936/3.]"
8936,1,0,"Tumor, stromal, gastrointestinal, uncertain malignant potential"
8936,1,0,"Uncertain malignant potential, tumor, gastrointestinal stromal"
8936,3,1,"Gastrointestinal stromal tumor, NOS [REPORTABLE 2021+]"
8936,3,0,"Autonomic nerve tumor, gastrointestinal [REPORTABLE 2021+]"
8936,3,0,GANT [REPORTABLE 2021+]
8936,3,0,Gastrointestinal autonomic nerve tumor [REPORTABLE 2021+]
8936,3,0,Gastrointestinal pacemaker cell tumor [REPORTABLE 2021+]
8936,3,0,Gastrointestinal stromal sarcoma
8936,3,0,"Gastrointestinal stromal tumor, malignant"
8936,3,0,"GIST, malignant"
8936,3,0,"GIST, NOS [REPORTABLE 2021+]"
8936,3,0,"Pacemaker cell tumor, gastrointestinal [REPORTABLE 2021+]"
8936,3,0,"Sarcoma, gastrointestinal stromal"
8936,3,0,"Sarcoma, stromal, gastrointestinal"
8936,3,0,"Stromal sarcoma, gastrointestinal"
8936,3,0,"Stromal tumor, gastrointestinal, malignant"
8936,3,0,"Stromal tumor, gastrointestinal, NOS [REPORTABLE 2021+]"
8936,3,0,"Tumor, autonomic nerve, gastrointestinal [REPORTABLE 2021+]"
8936,3,0,"Tumor, gastrointestinal stromal, malignant"
8936,3,0,"Tumor, gastrointestinal stromal, NOS [REPORTABLE 2021+]"
8936,3,0,"Tumor, gastrointestinal, autonomic nerve [REPORTABLE 2021+]"
8936,3,0,"Tumor, gastrointestinal, pacemaker cell [REPORTABLE 2021+]"
8936,3,0,"Tumor, pacemaker cell, gastrointestinal [REPORTABLE 2021+]"
8936,3,0,"Tumor, stromal, gastrointestinal, malignant"
8940,0,1,Pleomorphic adenoma
8940,0,0,"Adenoma, pleomorphic"
8940,0,0,Chondroid syringoma (C44._)
8940,0,0,"Mixed tumor, NOS"
8940,0,0,"Mixed tumor, salivary gland type, NOS (C07._, C08._)"
8940,0,0,"Salivary gland type mixed tumor, NOS (C07._, C08._)"
8940,0,0,"Syringoma, chondroid (C44._)"
8940,0,0,"Tumor, mixed, NOS"
8940,0,0,"Tumor, mixed, salivary gland type, NOS (C07._,C08._)"
8940,3,1,"Mixed tumor, malignant, NOS"
8940,3,0,"Chondroid syringoma, malignant (C44._)"
8940,3,0,Malignant chondroid syringoma (C44._)
8940,3,0,"Mixed tumor, salivary gland type, malignant (C07._,C08._)"
8940,3,0,"Salivary gland type mixed tumor, malignant (C07._,C08._)"
8940,3,0,"Syringoma, chondroid, malignant (C44._)"
8940,3,0,"Tumor, malignant, mixed, NOS"
8940,3,0,"Tumor, malignant, mixed, salivary gland type (C07._,C08._)"
8940,3,0,"Tumor, mixed, malignant, NOS"
8940,3,0,"Tumor, mixed, salivary gland type, malignant (C07._,C08._)"
8941,3,1,"Carcinoma in pleomorphic adenoma (C07._, C08._)"
8941,3,0,"Adenoma, pleomorphic, carcinoma in (C07._, C08._)"
8941,3,0,"Pleomorphic adenoma, carcinoma in (C07._, C08._)"
8950,3,1,Mullerian mixed tumor (C54._)
8950,3,0,Mixed Mullerian tumor (C54._)
8950,3,0,"Mixed tumor, Mullerian (C54._)"
8950,3,0,"Tumor, Mullerian mixed (C54._)"
8951,3,1,Mesodermal mixed tumor
8951,3,0,Mixed mesodermal tumor
8951,3,0,"Mixed tumor, mesodermal"
8951,3,0,"Tumor, mesodermal, mixed"
8951,3,0,"Tumor, mixed mesodermal"
8959,0,1,Benign cystic nephroma (C64.9)
8959,0,0,"Cystic nephroma, benign (C64.9)"
8959,0,0,"Nephroma, cystic, benign (C64.9)"
8959,1,1,Cystic partially differentiated nephroblastoma (C64.9)
8959,1,0,"Cystic nephroblastoma, partially differentiated (C64.9)"
8959,1,0,"Nephroblastoma, cystic partially differentiated (C64.9)"
8959,1,0,"Partially differentiated nephroblastoma, cystic (C64.9)"
8959,3,1,Malignant cystic nephroma (C64.9)
8959,3,0,"Cystic nephroma, malignant (C64.9)"
8959,3,0,"Cystic nephroma, multilocular, malignant (C64.9)"
8959,3,0,Malignant multilocular cystic nephroma (C64.9)
8959,3,0,"Multilocular cystic nephroma, malignant (C64.9)"
8959,3,0,"Nephroma, cystic, malignant (C64.9)"
8959,3,0,"Nephroma, cystic, multilocular, malignant (C64.9)"
8960,1,1,Mesoblastic nephroma
8960,1,0,"Nephroma, mesoblastic"
8960,3,1,"Nephroblastoma, NOS (C64.9)"
8960,3,0,"Nephroma, NOS (C64.9)"
8960,3,0,"Tumor, Wilms (C64.9)"
8960,3,0,Wilms tumor (C64.9)
8963,3,1,"Rhabdoid tumor, NOS"
8963,3,0,Malignant rhabdoid tumor
8963,3,0,Rhabdoid sarcoma
8963,3,0,"Rhabdoid tumor, malignant"
8963,3,0,"Sarcoma, rhabdoid"
8963,3,0,"Tumor, rhabdoid, malignant"
8963,3,0,"Tumor, rhabdoid, NOS"
8964,3,1,Clear cell sarcoma of kidney (C64.9)
8964,3,0,"Sarcoma, clear cell of kidney (C64.9)"
8965,0,1,"Nephrogenic adenofibroma (C64.9) [obs] [PRE-2021 ONLY. FOR 2021+, USE CODE 9013/0.]"
8965,0,0,"Adenofibroma, nephrogenic (C64.9) [obs] [PRE-2021 ONLY. FOR 2021+, USE CODE 9013/0.]"
8966,0,1,Renomedullary interstitial cell tumor (C64.9)
8966,0,0,"Fibroma, renomedullary (C64.9)"
8966,0,0,"Interstitial cell tumor, renomedullary (C64.9)"
8966,0,0,Renomedullary fibroma (C64.9)
8966,0,0,"Tumor, renomedullary interstitial cell (C64.9)"
8967,0,1,Ossifying renal tumor (C64.9)
8967,0,0,"Renal tumor, ossifying (C64.9)"
8967,0,0,"Tumor, ossifying renal (C64.9)"
8967,0,0,"Tumor, renal, ossifying (C64.9)"
8970,3,1,Hepatoblastoma (C22.0)
8970,3,0,Embryonal hepatoma (C22.0)
8970,3,0,"Hepatoblastoma, epithelioid (C22.0)"
8970,3,0,"Hepatoblastoma, mixed epithelial-mesenchymal (C22.0)"
8970,3,0,"Hepatoma, embryonal (C22.0)"
8971,3,1,Pancreatoblastoma (C25._)
8972,3,1,Pulmonary blastoma (C34._)
8972,3,0,"Blastoma, pulmonary (C34._)"
8972,3,0,Pneumoblastoma (C34._)
8973,3,1,Pleuropulmonary blastoma
8973,3,0,"Blastoma, pleuropulmonary"
8974,1,1,Sialoblastoma
8975,1,1,Calcifying nested epithelial stromal tumor (C22.0)
8975,1,0,"Epithelial stromal tumor, calcifying nested (C22.0) "
8975,1,0,"Stromal tumor, epithelial, calcifying nested (C22.0) "
8975,1,0,"Tumor, epithelial stromal, calcifying nested (C22.0) "
8976,3,1,Gastroblastoma (C16._) [2022+)
8980,3,1,"Carcinosarcoma, NOS"
8981,3,1,"Carcinosarcoma, embryonal"
8981,3,0,Embryonal carcinosarcoma
8982,0,1,Myoepithelioma
8982,0,0,"Adenoma, myoepithelial"
8982,0,0,Myoepithelial adenoma
8982,0,0,Myoepithelial tumor
8982,0,0,"Tumor, myoepithelial"
8982,3,1,Myoepithelial carcinoma
8982,3,0,"Carcinoma, myoepithelial"
8982,3,0,Malignant myoepithelioma
8982,3,0,"Myoepithelioma, malignant"
8983,0,1,Adenomyoepithelioma (C50._)
8983,3,1,Adenomyoepithelioma with carcinoma (C50._) 
8983,3,0,Carcinoma with adenomyoepithelioma (C50._) 
8990,0,1,"Mesenchymoma, benign"
8990,1,1,"Mesenchymoma, NOS"
8990,1,0,"Mesenchymal tumor, mixed"
8990,1,0,Mixed mesenchymal tumor
8990,1,0,"Tumor, mesenchymal, mixed"
8990,1,0,"Tumor, mixed mesenchymal"
8990,3,1,"Mesenchymoma, malignant"
8990,3,0,"Mesenchymal sarcoma, mixed"
8990,3,0,"Mesenchymal tumor, phosphaturic, malignant"
8990,3,0,Mixed mesenchymal sarcoma
8990,3,0,"Neoplasm, NTRK-rearranged spindle cell (emerging) [2022+]"
8990,3,0,"Neoplasm, spindle cell, NTRK-rearranged (emerging) [2022+]"
8990,3,0,NTRK-rearranged spindle cell neoplasm (emerging) [2022+]
8990,3,0,"Phosphaturic mesenchymal tumor, malignant "
8990,3,0,"Sarcoma, mesenchymal, mixed"
8990,3,0,"Tumor, mesenchymal, phosphaturic, malignant"
8991,3,1,Embryonal sarcoma
8991,3,0,"Sarcoma, embryonal"
8992,0,1,Pulmonary hamartoma (C34._) [2021+]
8992,0,0,"Hamartoma, pulmonary (C34._) [2021+]"
9000,0,1,"Brenner tumor, NOS (C56.9)"
9000,0,0,"Tumor, Brenner, NOS (C56.9)"
9000,1,1,"Brenner tumor, borderline malignancy (C56.9)"
9000,1,0,"Brenner tumor, proliferating (C56.9)"
9000,1,0,Proliferating Brenner tumor (C56.9)
9000,1,0,"Tumor, Brenner, borderline malignancy (C56.9)"
9000,1,0,"Tumor, Brenner, proliferating (C56.9)"
9000,3,1,"Brenner tumor, malignant (C56.9)"
9000,3,0,"Tumor, Brenner, malignant (C56.9)"
9010,0,1,"Fibroadenoma, NOS (C50._)"
9011,0,1,Intracanalicular fibroadenoma (C50._)
9011,0,0,"Fibroadenoma, intracanalicular (C50._)"
9012,0,1,Pericanalicular fibroadenoma (C50._)
9012,0,0,"Fibroadenoma, pericanalicular (C50._)"
9013,0,1,"Adenofibroma, NOS"
9013,0,0,"Adenofibroma, metanephric (C64.9)"
9013,0,0,"Adenofibroma, nephrogenic (C64.9) [2021+ ONLY. FOR PRE-2021, USE CODE 8965/0.]"
9013,0,0,"Adenofibroma, papillary"
9013,0,0,"Cystadenofibroma, NOS"
9013,0,0,Metanephric adenofibroma (C64.9)
9013,0,0,"Nephrogenic adenofibroma (C64.9) [2021+ ONLY. FOR PRE-2021, USE CODE 8965/0.]"
9013,0,0,Papillary adenofibroma
9014,0,1,"Serous adenofibroma, NOS"
9014,0,0,"Adenofibroma, serous, NOS"
9014,0,0,"Cystadenofibroma, serous, NOS"
9014,0,0,"Serous cystadenofibroma, NOS"
9014,1,1,Serous adenofibroma of borderline malignancy
9014,1,0,"Adenofibroma, serous, borderline malignancy"
9014,1,0,"Cystadenofibroma, serous, borderline malignancy"
9014,1,0,Serous cystadenofibroma of borderline malignancy
9014,3,1,Serous adenocarcinofibroma
9014,3,0,"Adenocarcinofibroma, serous"
9014,3,0,"Adenofibroma, serous, malignant"
9014,3,0,"Cystadenocarcinofibroma, serous"
9014,3,0,"Cystadenofibroma, serous, malignant"
9014,3,0,Malignant serous adenofibroma
9014,3,0,Malignant serous cystadenofibroma
9014,3,0,"Serous adenofibroma, malignant"
9014,3,0,Serous cystadenocarcinofibroma
9015,0,1,"Mucinous adenofibroma, NOS"
9015,0,0,"Adenofibroma, mucinous"
9015,0,0,"Cystadenofibroma, mucinous, NOS"
9015,0,0,"Mucinous cystadenofibroma, NOS"
9015,1,1,Mucinous adenofibroma of borderline malignancy
9015,1,0,"Adenofibroma, mucinous, of borderline malignancy"
9015,1,0,"Cystadenofibroma, mucinous, borderline malignancy"
9015,1,0,Mucinous cystadenofibroma of borderline malignancy
9015,3,1,Mucinous adenocarcinofibroma
9015,3,0,"Adenocarcinofibroma, mucinous"
9015,3,0,"Cystadenocarcinofibroma, mucinous"
9015,3,0,"Cystadenofibroma, mucinous, malignant"
9015,3,0,Malignant mucinous adenofibroma
9015,3,0,Malignant mucinous cystadenofibroma
9015,3,0,Mucinous cystadenocarcinofibroma
9015,3,0,"Mucinous cystadenofibroma, malignant"
9015,3,0,"Mucinous, adenofibroma, malignant"
9016,0,1,Giant fibroadenoma (C50._)
9016,0,0,"Fibroadenoma, giant (C50._)"
9020,0,1,"Phyllodes tumor, benign (C50._)"
9020,0,0,"Cystosarcoma phyllodes, benign (C50._) [obs]"
9020,0,0,"Phyllodes, cystosarcoma, benign (C50._) [obs]"
9020,0,0,"Tumor, phyllodes, benign (C50._)"
9020,1,1,"Phyllodes tumor, borderline (C50._)"
9020,1,0,"Cystosarcoma phyllodes, NOS (C50._)"
9020,1,0,"Phyllodes tumor, NOS (C50._)"
9020,1,0,"Phyllodes, cystosarcoma, NOS (C50._)"
9020,1,0,"Tumor, phyllodes, borderline (C50._)"
9020,1,0,"Tumor, phyllodes, NOS (C50._)"
9020,3,1,"Phyllodes tumor, malignant (C50._)"
9020,3,0,"Cystosarcoma phyllodes, malignant (C50._)"
9020,3,0,"Periductal stromal tumor, low grade (C50._) "
9020,3,0,"Phyllodes, cystosarcoma, malignant (C50._)"
9020,3,0,"Stromal tumor, periductal, low grade (C50._) "
9020,3,0,"Tumor, periductal stromal, low grade (C50._)"
9020,3,0,"Tumor, phyllodes, malignant (C50._)"
9030,0,1,Juvenile fibroadenoma (C50._)
9030,0,0,"Fibroadenoma, juvenile (C50._)"
9040,0,1,"Synovioma, benign"
9040,3,1,"Synovial sarcoma, NOS"
9040,3,0,"Sarcoma, synovial, NOS"
9040,3,0,"Synovioma, malignant"
9040,3,0,"Synovioma, NOS"
9041,3,1,"Synovial sarcoma, spindle cell"
9041,3,0,"Fibrous synovial sarcoma, monophasic"
9041,3,0,Monophasic fibrous synovial sarcoma
9041,3,0,"Sarcoma, synovial, monophasic fibrous"
9041,3,0,"Sarcoma, synovial, spindle cell"
9041,3,0,Spindle cell synovial sarcoma
9041,3,0,"Synovial sarcoma, monophasic fibrous"
9042,3,1,"Synovial sarcoma, epithelioid cell"
9042,3,0,Epithelioid cell synovial sarcoma
9042,3,0,"Sarcoma, synovial, epithelioid cell"
9043,3,1,"Synovial sarcoma, biphasic"
9043,3,0,Biphasic synovial sarcoma
9043,3,0,"Sarcoma, synovial, biphasic"
9044,3,1,Clear cell sarcoma (except of kidney M-8964/3)
9044,3,0,"Aponeuroses and tendons, clear cell sarcoma (C49._)"
9044,3,0,Clear cell sarcoma of tendons and aponeuroses (C49._)
9044,3,0,"Melanoma, malignant, of soft parts (C49._)"
9044,3,0,"Sarcoma, clear cell of tendons and aponeuroses (C49._)"
9044,3,0,"Sarcoma, clear cell, NOS (except of kidney M-8964/3)"
9044,3,0,"Soft parts, melanoma, malignant (C49._)"
9045,3,1,"Biphenotypic sinonasal sarcoma (C30.0, C31.0-C31.3, C31.8, C31.9) [2018+]"
9045,3,0,"Sarcoma, sinonasal, biphenotypic (C30.0, C31.0-C31.3, C31.8, C31.9) [2018+]"
9045,3,0,"Sinonasal sarcoma, biphenotypic (C30.0, C31.0-C31.3, C31.8, C31.9) [2018+]"
9050,0,1,"Mesothelioma, benign"
9050,3,1,"Mesothelioma, malignant"
9050,3,0,"Mesothelioma, NOS"
9051,0,1,"Fibrous mesothelioma, benign"
9051,0,0,"Mesothelioma, fibrous, benign"
9051,3,1,"Fibrous mesothelioma, malignant"
9051,3,0,Desmoplastic mesothelioma
9051,3,0,"Fibrous mesothelioma, NOS"
9051,3,0,"Mesothelioma, desmoplastic"
9051,3,0,"Mesothelioma, fibrous, malignant"
9051,3,0,"Mesothelioma, fibrous, NOS"
9051,3,0,"Mesothelioma, sarcomatoid"
9051,3,0,"Mesothelioma, spindled"
9051,3,0,Sarcomatoid mesothelioma
9051,3,0,Spindled mesothelioma
9052,0,1,"Epithelioid mesothelioma, benign"
9052,0,0,Mesothelial papilloma
9052,0,0,"Mesothelioma, epithelioid, benign"
9052,0,0,"Mesothelioma, papillary, well differentiated, benign"
9052,0,0,"Papillary mesothelioma, well differentiated, benign"
9052,0,0,"Papilloma, mesothelial"
9052,0,0,"Well differentiated papillary mesothelioma, benign"
9052,3,1,"Epithelioid mesothelioma, malignant"
9052,3,0,"Epithelioid mesothelioma, NOS"
9052,3,0,"Mesothelioma, epithelioid, malignant"
9052,3,0,"Mesothelioma, epithelioid, NOS"
9053,3,1,"Mesothelioma, biphasic, malignant"
9053,3,0,"Biphasic mesothelioma, malignant"
9053,3,0,"Biphasic mesothelioma, NOS"
9053,3,0,"Mesothelioma, biphasic, NOS"
9054,0,1,"Adenomatoid tumor, NOS"
9054,0,0,"Tumor, adenomatoid, NOS"
9055,0,1,"Multicystic mesothelioma, benign"
9055,0,0,"Cystic mesothelioma, benign (C48._)"
9055,0,0,"Mesothelioma, cystic, benign (C48._)"
9055,0,0,"Mesothelioma, multicystic, benign"
9055,1,1,"Cystic mesothelioma, NOS (C48._)"
9055,1,0,"Mesothelioma, cystic, NOS (C48._)"
9060,3,1,Dysgerminoma
9061,3,1,"Seminoma, NOS (C62._)"
9062,3,1,"Seminoma, anaplastic (C62._)"
9062,3,0,Anaplastic seminoma (C62._)
9062,3,0,Seminoma with high mitotic index (C62._)
9063,3,1,Spermatocytic seminoma (C62._)
9063,3,0,"Seminoma, spermatocytic (C62._)"
9063,3,0,Spermatocytoma (C62._)
9064,2,1,Intratubular malignant germ cells (C62._)
9064,2,0,"Germ cell neoplasia, intratubular (C62._)"
9064,2,0,"Germ cells, intratubular malignant (C62._)"
9064,2,0,Intratubular germ cell neoplasia (C62._)
9064,2,0,"Neoplasia, intratubular germ cell (C62._)"
9064,3,1,Germinoma
9064,3,0,"Germ cell tumor, NOS"
9064,3,0,"Tumor, germ cell, NOS"
9065,3,1,"Germ cell tumor, nonseminomatous (C62._)"
9065,3,0,"Tumor, germ cell, nonseminomatous (C62._)"
9065,3,0,"Tumor, nonseminomatous germ cell (C62._)"
9070,3,1,"Embryonal carcinoma, NOS"
9070,3,0,"Adenocarcinoma, embryonal"
9070,3,0,"Carcinoma, embryonal, NOS"
9070,3,0,Embryonal adenocarcinoma
9071,3,1,Yolk sac tumor
9071,3,0,"Carcinoma, embryonal, infantile"
9071,3,0,"Carcinoma, infantile, embryonal"
9071,3,0,"Embryonal carcinoma, infantile"
9071,3,0,Endodermal sinus tumor
9071,3,0,Hepatoid yolk sac tumor
9071,3,0,Infantile embryonal carcinoma
9071,3,0,Orchioblastoma (C62._)
9071,3,0,Polyvesicular vitelline tumor
9071,3,0,"Sinus tumor, endodermal"
9071,3,0,"Tumor, endodermal sinus"
9071,3,0,"Tumor, polyvesicular vitelline"
9071,3,0,"Tumor, sinus, endodermal"
9071,3,0,"Tumor, vitelline, polyvesicular"
9071,3,0,"Tumor, yolk sac"
9071,3,0,"Tumor, yolk sac, hepatoid"
9071,3,0,"Vitelline tumor, polyvesicular"
9071,3,0,"Yolk sac tumor, hepatoid"
9072,3,1,Polyembryoma
9072,3,0,"Carcinoma, embryonal, polyembryonal type"
9072,3,0,"Embryonal carcinoma, polyembryonal type"
9072,3,0,Polyembryonal type embryonal carcinoma
9073,1,1,Gonadoblastoma
9073,1,0,Gonocytoma
9080,0,1,"Teratoma, benign"
9080,0,0,Adult cystic teratoma
9080,0,0,"Adult teratoma, cystic"
9080,0,0,"Adult teratoma, NOS"
9080,0,0,"Cystic teratoma, adult"
9080,0,0,"Cystic teratoma, NOS"
9080,0,0,Differentiated teratoma
9080,0,0,Mature teratoma
9080,0,0,"Teratoma, adult, cystic"
9080,0,0,"Teratoma, adult, NOS"
9080,0,0,"Teratoma, cystic, adult"
9080,0,0,"Teratoma, cystic, NOS"
9080,0,0,"Teratoma, differentiated"
9080,0,0,"Teratoma, mature"
9080,1,1,"Teratoma, NOS"
9080,1,0,"Immature teratoma of the lung (C34._) [2021+, NOT REPORTABLE]"
9080,1,0,"Immature teratoma of the thymus (C37.9) [2021+, NOT REPORTABLE]"
9080,1,0,"Immature teratoma of the thyroid (C73.9) [2021+, NOT REPORTABLE]"
9080,1,0,Solid teratoma
9080,1,0,"Teratoma, immature (C34._) [2021+, NOT REPORTABLE]"
9080,1,0,"Teratoma, immature (C37.9) [2021+, NOT REPORTABLE]"
9080,1,0,"Teratoma, immature (C73.9) [2021+, NOT REPORTABLE]"
9080,1,0,"Teratoma, solid"
9080,3,1,"Teratoma, malignant, NOS"
9080,3,0,Embryonal teratoma
9080,3,0,"Immature teratoma, malignant"
9080,3,0,"Immature teratoma, NOS [FOR 2021+, USE CODE 9080/1 FOR C34._, C37.9, C73.9]"
9080,3,0,"Teratoblastoma, malignant"
9080,3,0,"Teratoma, embryonal"
9080,3,0,"Teratoma, immature, malignant"
9080,3,0,"Teratoma, immature, NOS [FOR 2021+, USE CODE 9080/1 FOR C34._, C37.9, C73.9]"
9081,3,1,Teratocarcinoma
9081,3,0,"Carcinoma, embryonal and teratoma, mixed"
9081,3,0,"Embryonal carcinoma and teratoma, mixed"
9081,3,0,Mixed embryonal carcinoma and teratoma
9081,3,0,Mixed teratoma and embryonal carcinoma
9081,3,0,"Teratoma and embryonal carcinoma, mixed"
9082,3,1,"Malignant teratoma, undifferentiated"
9082,3,0,Anaplastic malignant teratoma
9082,3,0,"Anaplastic teratoma, malignant"
9082,3,0,"Malignant teratoma, anaplastic"
9082,3,0,"Teratoma, anaplastic, malignant"
9082,3,0,"Teratoma, malignant, anaplastic"
9082,3,0,"Teratoma, malignant, undifferentiated"
9082,3,0,"Teratoma, undifferentiated, malignant"
9082,3,0,"Undifferentiated teratoma, malignant"
9083,3,1,"Malignant teratoma, intermediate"
9083,3,0,Intermediate malignant teratoma
9083,3,0,"Teratoma, intermediate, malignant"
9083,3,0,"Teratoma, malignant, intermediate"
9084,0,1,"Dermoid cyst, NOS"
9084,0,0,"Cyst, dermoid, NOS"
9084,0,0,"Dermoid, NOS"
9084,3,1,Teratoma with malignant transformation
9084,3,0,"Cyst, dermoid, with malignant transformation (C56.9)"
9084,3,0,"Cyst, dermoid, with secondary tumor"
9084,3,0,Dermoid cyst with malignant transformation (C56.9)
9084,3,0,Dermoid cyst with secondary tumor
9084,3,0,"Secondary tumor, dermoid cyst with"
9084,3,0,"Transformation, malignant, dermoid cyst with (C56.9)"
9084,3,0,"Transformation, malignant, teratoma with"
9084,3,0,"Tumor, secondary, dermoid cyst with"
9085,3,1,Mixed germ cell tumor
9085,3,0,"Germ cell tumor, mixed"
9085,3,0,Mixed seminoma and teratoma
9085,3,0,Mixed teratoma and seminoma
9085,3,0,"Seminoma and teratoma, mixed"
9085,3,0,"Teratoma and seminoma, mixed"
9085,3,0,"Tumor, germ cell, mixed"
9085,3,0,"Tumor, mixed germ cell"
9086,3,1,Germ cell tumors with associated hematological malignancy (C37.9) [2018+]
9086,3,0,Hematological malignancy associated with germ cell tumors (C37.9) [2018+]
9086,3,0,"Malignancy, hematological, associated with germ cell tumors (C37.9) [2018+]"
9086,3,0,"Tumors, germ cell, with associated hematological malignancy (C37.9) (2018+)"
9090,0,1,"Struma ovarii, NOS (C56.9)"
9090,0,0,"Ovarii, struma (C56.9)"
9090,3,1,"Struma ovarii, malignant (C56.9)"
9090,3,0,"Ovarii, struma, malignant (C56.9)"
9091,1,1,Strumal carcinoid (C56.9)
9091,1,0,Carcinoid and struma ovarii (C56.9)
9091,1,0,"Carcinoid, struma ovarii and (C56.9)"
9091,1,0,"Carcinoid, strumal (C56.9)"
9091,1,0,Struma ovarii and carcinoid (C56.9)
9100,0,1,"Hydatidiform mole, NOS (C58.9)"
9100,0,0,Complete hydatidiform mole (C58.9)
9100,0,0,Hydatid mole (C58.9)
9100,0,0,"Hydatidiform mole, complete (C58.9)"
9100,0,0,"Mole, hydatid (C58.9)"
9100,0,0,"Mole, hydatidiform, complete (C58.9)"
9100,0,0,"Mole, hydatidiform, NOS (C58.9)"
9100,1,1,Invasive hydatidiform mole (C58.9)
9100,1,0,Chorioadenoma (C58.9)
9100,1,0,Chorioadenoma destruens (C58.9)
9100,1,0,"Destruens, chorioadenoma (C58.9)"
9100,1,0,"Hydatidiform mole, invasive (C58.9)"
9100,1,0,"Hydatidiform mole, malignant (C58.9)"
9100,1,0,"Invasive mole, NOS (C58.9)"
9100,1,0,Malignant hydatidiform mole (C58.9)
9100,1,0,"Mole, hydatidiform, invasive (C58.9)"
9100,1,0,"Mole, hydatidiform, malignant (C58.9)"
9100,1,0,"Mole, invasive, NOS (C58.9)"
9100,3,1,"Choriocarcinoma, NOS"
9100,3,0,Chorioepithelioma
9100,3,0,Chorionepithelioma
9101,3,1,Choriocarcinoma combined with other germ cell elements
9101,3,0,"Carcinoma, embryonal, combined with choriocarcinoma"
9101,3,0,Choriocarcinoma combined with embryonal carcinoma
9101,3,0,Choriocarcinoma combined with teratoma
9101,3,0,Combined choriocarcinoma with embryonal carcinoma
9101,3,0,Combined choriocarcinoma with other germ cell elements
9101,3,0,Combined choriocarcinoma with teratoma
9101,3,0,"Elements, choriocarcinoma combined with other germ cell"
9101,3,0,"Embryonal carcinoma, combined with choriocarcinoma"
9101,3,0,"Germ cell elements, choriocarcinoma combined with other"
9101,3,0,"Other germ cell elements, choriocarcinoma combined with"
9101,3,0,Teratoma combined with choriocarcinoma
9102,3,1,"Malignant teratoma, trophoblastic"
9102,3,0,"Teratoma, malignant, trophoblastic"
9102,3,0,"Teratoma, trophoblastic, malignant"
9102,3,0,Trophoblastic malignant teratoma
9103,0,1,Partial hydatidiform mole (C58.9)
9103,0,0,"Hydatidiform mole, partial (C58.9)"
9103,0,0,"Mole, hydatidiform, partial (C58.9)"
9104,1,1,Placental site trophoblastic tumor (C58.9)
9104,1,0,"Trophoblastic tumor, placental site (C58.9)"
9104,1,0,"Tumor, placental site trophoblastic (C58.9)"
9104,1,0,"Tumor, trophoblastic, placental site (C58.9)"
9105,3,1,"Trophoblastic tumor, epithelioid"
9105,3,0,Epithelioid trophoblastic tumor
9105,3,0,"Tumor, trophoblastic, epithelioid"
9110,0,1,"Mesonephroma, benign"
9110,0,0,"Adenoma, mesonephric"
9110,0,0,"Adenoma, Wolffian duct"
9110,0,0,"Duct, Wolffian, adenoma"
9110,0,0,Mesonephric adenoma
9110,0,0,Wolffian duct adenoma
9110,1,1,"Mesonephric tumor, NOS"
9110,1,0,"Duct, Wolffian, tumor"
9110,1,0,"Tumor, mesonephric, NOS"
9110,1,0,"Tumor, Wolffian duct"
9110,1,0,Wolffian duct tumor
9110,3,1,"Adenocarcinoma, HPV-independent, mesonephric type [2022+]"
9110,3,0,Adenocarcinoma of rete ovarii (C56.9) 
9110,3,0,"Adenocarcinoma, mesonephric"
9110,3,0,"Carcinoma, Wolffian duct"
9110,3,0,"Duct, Wolffian, carcinoma"
9110,3,0,HPV-independent mesonephric type adenocarcinoma [2022+]
9110,3,0,Mesonephric adenocarcinoma
9110,3,0,"Mesonephric type adenocarcinoma, HPV-independent [2022+]"
9110,3,0,"Mesonephroma, malignant"
9110,3,0,"Mesonephroma, NOS"
9110,3,0,Wolffian duct carcinoma
9111,3,1,"Mesonephric-like adenocarcinoma (C54._, C56.9) [2022+]"
9111,3,0,"Adenocarcinoma, mesonephric-like (C54._, C56.9) [2022+]"
9120,0,1,"Hemangioma, NOS"
9120,0,0,"Angioma, NOS"
9120,0,0,Chorioangioma (C58.9)
9120,3,1,Hemangiosarcoma
9120,3,0,Angiosarcoma
9120,3,0,"Angiosarcoma of the breast, post radiation (C50._) [2022+]"
9120,3,0,"Angiosarcoma, epithelioid [2022+]"
9120,3,0,Epithelioid angiosarcoma [2022+]
9120,3,0,Post radiation angiosarcoma of the breast (C50._) [2022+]
9121,0,1,Cavernous hemangioma
9121,0,0,"Hemangioma, cavernous"
9122,0,1,Venous hemangioma
9122,0,0,"Hemangioma, venous"
9123,0,1,Racemose hemangioma
9123,0,0,Arteriovenous hemangioma
9123,0,0,"Hemangioma, arteriovenous"
9123,0,0,"Hemangioma, racemose"
9124,3,1,Kupffer cell sarcoma (C22.0)
9124,3,0,"Sarcoma, Kupffer cell (C22.0)"
9125,0,1,Epithelioid hemangioma
9125,0,0,"Hemangioma, epithelioid"
9125,0,0,"Hemangioma, histiocytoid"
9125,0,0,Histiocytoid hemangioma
9126,0,1,Atypical vascular lesion [2021+]
9126,0,0,"Vascular lesion, atypical [2021+]"
9130,0,1,"Hemangioendothelioma, benign"
9130,1,1,"Hemangioendothelioma, NOS"
9130,1,0,"Angioendothelioma, NOS"
9130,1,0,"Hemangioendothelioma, Kaposi form"
9130,1,0,Kaposiform hemangioendothelioma
9130,3,1,"Hemangioendothelioma, malignant"
9130,3,0,Hemangioendothelial sarcoma
9130,3,0,"Sarcoma, hemangioendothelial"
9131,0,1,Capillary hemangioma
9131,0,0,Hemangioma simplex
9131,0,0,"Hemangioma, capillary"
9131,0,0,"Hemangioma, infantile"
9131,0,0,"Hemangioma, juvenile"
9131,0,0,"Hemangioma, plexiform"
9131,0,0,Infantile hemangioma
9131,0,0,Juvenile hemangioma
9131,0,0,Plexiform hemangioma
9131,0,0,"Simplex, hemangioma"
9132,0,1,Intramuscular hemangioma
9132,0,0,"Hemangioma, intramuscular"
9133,1,1,"Epithelioid hemangioendothelioma, NOS"
9133,1,0,"Hemangioendothelioma, epithelioid, NOS"
9133,3,1,Epithelioid hemangioendothelioma
9133,3,0,"Alveolar tumor, intravascular bronchial (C34._) [obs]"
9133,3,0,"Bronchial alveolar tumor, intravascular (C34._) [obs]"
9133,3,0,Epithelioid hemangioendothelioma with WWTR1-CAMTA1 fusion [2022+]
9133,3,0,Epithelioid hemangioendothelioma with YAP1-TFE3 fusion [2022+]
9133,3,0,"Epithelioid hemangioendothelioma, malignant"
9133,3,0,"Hemangioendothelioma, epithelioid"
9133,3,0,"Hemangioendothelioma, epithelioid, malignant"
9133,3,0,"Hemangioendothelioma, epithelioid, with WWTR1-CAMTA1 fusion [2022+]"
9133,3,0,"Hemangioendothelioma, epithelioid, with YAP1-TFE3 fusion [2022+]"
9133,3,0,Intravascular bronchial alveolar tumor (C34._) [obs]
9133,3,0,"Tumor, alveolar, intravascular bronchial (C34._) [obs]"
9133,3,0,"Tumor, bronchial alveolar, intravascular (C34._) [obs]"
9133,3,0,"Tumor, intravascular bronchial alveolar (C34._) [obs]"
9135,1,1,Endovascular papillary angioendothelioma
9135,1,0,"Angioendothelioma, endovascular papillary"
9135,1,0,Dabska tumor
9135,1,0,"Papillary endovascular, angioendothelioma"
9135,1,0,"Tumor, Dabska"
9136,1,1,Spindle cell hemangioendothelioma
9136,1,0,"Angioendothelioma, spindle cell"
9136,1,0,"Hemangioendothelioma, spindle cell"
9136,1,0,Spindle cell angioendothelioma
9137,3,1,Intimal sarcoma [2018+]
9137,3,0,Pulmonary artery intimal sarcoma [2018+]
9137,3,0,"Sarcoma, intimal [2018+]"
9137,3,0,"Sarcoma, pulmonary artery intimal [2018+]"
9138,1,1,Pseudomyogenic (epithelioid sarcoma-like) hemangioendothelioma [2021+]
9138,1,0,"Hemangioendothelioma, pseudomyogenic (epithelioid sarcoma-like) [2021+]"
9140,3,1,Kaposi sarcoma
9140,3,0,AIDS-associated Kaposi sarcoma [2022+]
9140,3,0,Classic indolent Kaposi sarcoma [2022+]
9140,3,0,Endemic African Kaposi sarcoma [2022+]
9140,3,0,"Hemorrhagic sarcoma, multiple"
9140,3,0,Iatrogenic Kaposi sarcoma [2022+]
9140,3,0,"Kaposi sarcoma, AIDS-associated [2022+]"
9140,3,0,"Kaposi sarcoma, classic indolent [2022+]"
9140,3,0,"Kaposi sarcoma, endemic African [2022+]"
9140,3,0,"Kaposi sarcoma, iatrogenic [2022+]"
9140,3,0,Multiple hemorrhagic sarcoma
9140,3,0,"Sarcoma, hemorrhagic, multiple"
9140,3,0,"Sarcoma, Kaposi"
9140,3,0,"Sarcoma, Kaposi, AIDS-associated [2022+]"
9140,3,0,"Sarcoma, Kaposi, classic indolent [2022+]"
9140,3,0,"Sarcoma, Kaposi, endemic African [2022+]"
9140,3,0,"Sarcoma, Kaposi, iatrogenic [2022+]"
9140,3,0,"Sarcoma, multiple hemorrhagic"
9141,0,1,Angiokeratoma
9142,0,1,Verrucous keratotic hemangioma
9142,0,0,"Hemangioma, verrucous keratotic"
9142,0,0,"Keratotic hemangioma, verrucous"
9142,0,0,Keratotic verrucous hemangioma
9150,0,1,"Hemangiopericytoma, benign"
9150,1,1,"Hemangiopericytoma, NOS"
9150,1,0,Hemangiopericytic meningioma (C70._) [obs]
9150,1,0,"Meningioma, hemangiopericytic (C70._) [obs]"
9150,3,1,"Hemangiopericytoma, malignant [PRE-2021 ONLY. FOR 2021+, USE CODE 8815/3]"
9160,0,1,"Angiofibroma, NOS"
9160,0,0,"Angiofibroma, cellular"
9160,0,0,"Angiofibroma, giant cell"
9160,0,0,"Angiofibroma, juvenile"
9160,0,0,Cellular angiofibroma
9160,0,0,Fibrous papule of nose (C44.3) [obs]
9160,0,0,"Fibrous papule, nose (C44.3) [obs]"
9160,0,0,Giant cell angiofibroma
9160,0,0,Involuting nevus (C44._) [obs]
9160,0,0,Juvenile angiofibroma
9160,0,0,"Nevus, involuting (C44._) [obs]"
9160,0,0,"Papule, fibrous, of nose (C44.3) [obs]"
9161,0,1,Acquired tufted hemangioma
9161,0,0,"Hemangioma, acquired tufted"
9161,0,0,"Tufted hemangioma, acquired"
9161,1,1,Hemangioblastoma
9161,1,0,Angioblastoma
9170,0,1,"Lymphangioma, NOS"
9170,0,0,"Lymphangioendothelioma, NOS"
9170,3,1,Lymphangiosarcoma
9170,3,0,Lymphangioendothelial sarcoma
9170,3,0,"Lymphangioendothelioma, malignant"
9170,3,0,"Sarcoma, lymphangioendothelial"
9171,0,1,Capillary lymphangioma
9171,0,0,"Lymphangioma, capillary"
9172,0,1,Cavernous lymphangioma
9172,0,0,"Lymphangioma, cavernous"
9173,0,1,Cystic lymphangioma
9173,0,0,Cystic hygroma
9173,0,0,"Hygroma, cystic"
9173,0,0,"Hygroma, NOS"
9173,0,0,"Lymphangioma, cystic"
9174,0,1,Lymphangiomyoma
9174,1,1,Lymphangiomyomatosis
9174,1,0,Lymphangioleiomyomatosis
9175,0,1,Hemolymphangioma
9180,0,1,"Osteoma, NOS (C40._, C41._)"
9180,3,1,"Osteosarcoma, NOS (C40._, C41._)"
9180,3,0,"Osteoblastic sarcoma (C40._, C41._)"
9180,3,0,"Osteochondrosarcoma (C40._, C41._)"
9180,3,0,"Osteogenic sarcoma, NOS (C40._, C41._)"
9180,3,0,"Sarcoma, osteoblastic (C40._, C41._)"
9180,3,0,"Sarcoma, osteogenic, NOS (C40._, C41._)"
9181,3,1,"Chondroblastic osteosarcoma (C40._, C41._)"
9181,3,0,"Osteosarcoma, chondroblastic (C40._, C41._)"
9182,3,1,"Fibroblastic osteosarcoma (C40._, C41._)"
9182,3,0,"Osteofibrosarcoma (C40._, C41._)"
9182,3,0,"Osteosarcoma, fibroblastic (C40._, C41._)"
9183,3,1,"Telangiectatic osteosarcoma (C40._, C41._)"
9183,3,0,"Osteosarcoma, telangiectatic (C40._, C41._)"
9184,3,1,"Osteosarcoma in Paget disease of bone (C40._, C41._)"
9184,3,0,"Paget disease, bone, osteosarcoma in (C40._, C41._)"
9185,3,1,"Small cell osteosarcoma (C40._, C41._)"
9185,3,0,"Osteosarcoma, round cell (C40._, C41._)"
9185,3,0,"Osteosarcoma, small cell (C40._, C41._)"
9185,3,0,"Round cell osteosarcoma (C40._, C41._)"
9186,3,1,"Central osteosarcoma (C40._, C41._)"
9186,3,0,"Central osteosarcoma, conventional (C40._, C41._)"
9186,3,0,"Conventional central osteosarcoma (C40._, C41._)"
9186,3,0,"Medullary osteosarcoma (C40._, C41._)"
9186,3,0,"Osteosarcoma, central (C40._, C41._)"
9186,3,0,"Osteosarcoma, central, conventional (C40._, C41._)"
9186,3,0,"Osteosarcoma, medullary (C40._, C41._)"
9187,3,1,"Intraosseous well differentiated osteosarcoma (C40._, C41._)"
9187,3,0,"Central osteosarcoma, low-grade (C40._, C41._)"
9187,3,0,"Intramedullary osteosarcoma, low-grade (C40._, C41._) "
9187,3,0,"Intraosseous low grade osteosarcoma (C40._, C41._)"
9187,3,0,"Intraosseous osteosarcoma, low grade (C40._, C41._)"
9187,3,0,"Intraosseous osteosarcoma, well differentiated (C40._, C41._)"
9187,3,0,"Low grade osteosarcoma, intraosseous (C40._, C41._)"
9187,3,0,"Low-grade central osteosarcoma (C40._, C41._)"
9187,3,0,"Low-grade intramedullary osteosarcoma (C40._, C41._) "
9187,3,0,"Osteosarcoma, central, low-grade (C40._, C41._)"
9187,3,0,"Osteosarcoma, intramedullary, low-grade (C40._, C41._)"
9187,3,0,"Osteosarcoma, intraosseous low grade (C40._, C41._)"
9187,3,0,"Osteosarcoma, intraosseous well differentiated (C40._, C41._)"
9187,3,0,"Well differentiated osteosarcoma, intraosseous (C40._, C41._)"
9191,0,1,"Osteoid osteoma, NOS (C40._, C41._)"
9191,0,0,"Osteoma, osteoid, NOS (C40._, C41._)"
9192,3,1,"Parosteal osteosarcoma (C40._, C41._)"
9192,3,0,"Juxtacortical osteosarcoma (C40._, C41._)"
9192,3,0,"Osteosarcoma, juxtacortical (C40._, C41._)"
9192,3,0,"Osteosarcoma, parosteal (C40., C41._)"
9193,3,1,"Periosteal osteosarcoma (C40._, C41._)"
9193,3,0,"Osteosarcoma, periosteal (C40._, C41._)"
9194,3,1,"High grade surface osteosarcoma (C40._, C41._)"
9194,3,0,"Osteosarcoma, surface, high grade (C40._, C41._)"
9194,3,0,"Surface osteosarcoma, high grade (C40._, C41._)"
9195,3,1,"Intracortical osteosarcoma (C40._, C41._)"
9195,3,0,"Osteosarcoma, intracortical (C40._, C41._)"
9200,0,1,"Osteoblastoma, NOS (C40._, C41._) [PRE-2022 ONLY. FOR 2022+ USE CODE 9200/1; NOT REPORTABLE]"
9200,0,0,"Giant osteoid osteoma(C40._, C41._)"
9200,0,0,"Osteoid osteoma, giant (C40._, C41._)"
9200,0,0,"Osteoma, osteoid, giant (C40._, C41._)"
9200,1,1,"Osteoblastoma, NOS (C40._, C41._) [2022+. FOR PRE-2022, USE CODE 9200/0; NOT REPORTABLE]"
9200,1,0,"Aggressive osteoblastoma (C40._, C41._)"
9200,1,0,"Osteoblastoma, aggressive (C40._, C41._)"
9210,0,1,"Osteochondroma (C40._, C41._)"
9210,0,0,"Cartilaginous exostosis (C40._, C41._)"
9210,0,0,"Ecchondroma (C40._, C41._)"
9210,0,0,"Exostosis, cartilaginous (C40._, C41._)"
9210,0,0,"Exostosis, osteocartilaginous (C40._, C41._)"
9210,0,0,"Osteocartilaginous exostosis (C40._, C41._)"
9210,1,1,"Osteochondromatosis, NOS (C40._, C41._)"
9210,1,0,"Ecchondrosis (C40._, C41._)"
9211,0,1,Osteochondromyxoma [2021+]
9212,0,1,Bizarre parosteal osteochondromatous proliferation [2021+]
9212,0,0,"Parosteal osteochondromatous proliferation, bizarre [2021+]"
9213,0,1,Subungual exostosis [2021+]
9213,0,0,"Exostosis, subungual [2021+]"
9220,0,1,"Chondroma, NOS (C40._, C41._)"
9220,0,0,"Enchondroma (C40._, C41._)"
9220,1,1,"Chondromatosis, NOS"
9220,3,1,"Chondrosarcoma, NOS (C40._, C41._)"
9220,3,0,Chondrosarcoma grade II/III (grade 2/3)
9220,3,0,"Fibrochondrosarcoma (C40._, C41._)"
9221,0,1,"Juxtacortical chondroma (C40._, C41._)"
9221,0,0,"Chondroma, juxtacortical (C40._, C41._)"
9221,0,0,"Chondroma, periosteal (C40._, C41._)"
9221,0,0,"Periosteal chondroma (C40._, C41._)"
9221,3,1,"Juxtacortical chondrosarcoma (C40._, C41._)"
9221,3,0,"Chondrosarcoma, juxtacortical (C40._, C41._)"
9221,3,0,"Chondrosarcoma, periosteal (C40._, C41._)"
9221,3,0,"Periosteal chondrosarcoma (C40._, C41._)"
9222,1,1,Atypical cartilaginous tumor [2021+]
9222,1,0,"Cartilaginous tumor, atypical [2021+]"
9222,1,0,"Chondrosarcoma, grade 1 (C40._, C41._) [2021 ONLY; NOT REPORTABLE]. FOR 2022+ USE CODE 9222/3]"
9222,3,1,"Chondrosarcoma, grade 1 (C40._, C41._) [REPORTABLE 2022+. FOR PRE-2022 USE CODE 9222/1]"
9230,0,1,"Chondroblastoma, NOS (C40._, C41._)"
9230,0,0,"Chondromatous giant cell tumor (C40._, C41._)"
9230,0,0,"Codman tumor (C40._, C41._)"
9230,0,0,"Giant cell tumor, chondromatous (C40.-, C41._)"
9230,0,0,"Tumor, chondromatous giant cell (C40._, C41._)"
9230,0,0,"Tumor, Codman (C40._, C41._)"
9230,0,0,"Tumor, giant cell, chondromatous (C40._, C41._)"
9230,3,1,"Chondroblastoma, malignant (C40._, C41._)"
9231,3,1,Myxoid chondrosarcoma
9231,3,0,"Chondrosarcoma, myxoid"
9240,3,1,Mesenchymal chondrosarcoma
9240,3,0,"Chondrosarcoma, mesenchymal"
9241,0,1,"Chondromyxoid fibroma (C40._, C41._)"
9241,0,0,"Fibroma, chondromyxoid (C40._, C41._)"
9242,3,1,"Clear cell chondrosarcoma (C40._, C41._)"
9242,3,0,"Chondrosarcoma, clear cell (C40._, C41._)"
9243,3,1,"Dedifferentiated chondrosarcoma (C40._, C41._)"
9243,3,0,"Chondrosarcoma, dedifferentiated (C40._, C41._)"
9250,1,1,"Giant cell tumor of bone, NOS (C40._, C41._)"
9250,1,0,"Giant cell tumor, bone, NOS (C40._, C41._)"
9250,1,0,"Osteoclastoma, NOS (C40._, C41._)"
9250,1,0,"Tumor, giant cell, bone, NOS (C40._, C41._)"
9250,3,1,"Giant cell tumor of bone, malignant (C40._, C41._)"
9250,3,0,"Giant cell sarcoma of bone (C40._, C41._)"
9250,3,0,"Giant cell sarcoma, bone (C40._, C41._)"
9250,3,0,"Giant cell tumor, bone, malignant (C40._, C41._)"
9250,3,0,"Osteoclastoma, malignant (C40._, C41._)"
9250,3,0,"Sarcoma, giant cell, bone (C40._, C41._)"
9250,3,0,"Tumor, giant cell, bone, malignant (C40._, C41._)"
9251,1,1,"Giant cell tumor of soft parts, NOS"
9251,1,0,"Giant cell tumor, soft parts, NOS"
9251,1,0,"Soft parts, giant cell tumor, NOS"
9251,1,0,"Tumor, giant cell, soft parts, NOS"
9251,3,1,Malignant giant cell tumor of soft parts
9251,3,0,"Giant cell tumor, soft parts, malignant"
9251,3,0,"Soft parts, giant cell tumor, malignant"
9251,3,0,"Tumor, giant cell, soft parts, malignant"
9252,0,1,Tenosynovial giant cell tumor (C49._)
9252,0,0,Fibrous histiocytoma of tendon sheath (C49._)
9252,0,0,Giant cell tumor of tendon sheath (C49._)
9252,0,0,"Giant cell tumor, tendon sheath (C49._)"
9252,0,0,"Giant cell tumor, tenosynovial (C49._)"
9252,0,0,"Histiocytoma, fibrous, tendon sheath (C49._)"
9252,0,0,"Tumor, giant cell, tendon sheath (C49._)"
9252,0,0,"Tumor, giant cell, tenosynovial (C49._)"
9252,0,0,"Tumor, tenosynovial giant cell (C49._)"
9252,3,1,Malignant tenosynovial giant cell tumor (C49._)
9252,3,0,"Giant cell tumor of tendon sheath, malignant (C49._)"
9252,3,0,"Giant cell tumor, tendon sheath, malignant (C49._)"
9252,3,0,"Giant cell tumor, tenosynovial, malignant (C49._)"
9252,3,0,"Tenosynovial giant cell tumor, malignant (C49._)"
9252,3,0,"Tumor, giant cell, tendon sheath, malignant (C49._)"
9252,3,0,"Tumor, giant cell, tenosynovial, malignant (C49._)"
9252,3,0,"Tumor, tenosynovial giant cell, malignant (C49._)"
9260,3,1,"Ewing sarcoma (C40._, C41._) [USE FOR PRE-2021. FOR 2021+ USE 9364/3]"
9260,3,0,"Ewing tumor (C40._, C41._) [USE FOR PRE-2021. FOR 2021+ USE 9364/3]"
9260,3,0,"Sarcoma, Ewing (C40._, C41._) [USE FOR PRE-2021. FOR 2021+ USE 9364/3]"
9260,3,0,"Tumor, Ewing (C40._, C41._) [USE FOR PRE-2021. FOR 2021+ USE 9364/3]"
9261,1,1,Osteofibrous dysplasia-like adamantinoma [2022+; NOT REPORTABLE]
9261,1,0,"Adamantinoma, osteofibrous dysplasia-like [2022+; NOT REPORTABLE]"
9261,3,1,Adamantinoma of long bones (C40._)
9261,3,0,"Adamantinoma, tibial (C40.2)"
9261,3,0,Tibial adamantinoma (C40.2)
9262,0,1,"Ossifying fibroma (C40._, C41._)"
9262,0,0,"Fibroma, ossifying (C40._, C41._)"
9262,0,0,"Fibro-osteoma (C40._, C41._)"
9262,0,0,"Osteofibroma (C40._, C41._)"
9270,0,1,"Odontogenic tumor, benign (C41._)"
9270,0,0,"Tumor, odontogenic, benign (C41._)"
9270,1,1,"Odontogenic tumor, NOS (C41._)"
9270,1,0,"Tumor, odontogenic, NOS (C41._)"
9270,3,1,"Odontogenic tumor, malignant (C41._)"
9270,3,0,Ameloblastic carcinoma (C41._)
9270,3,0,"Carcinoma, ameloblastic (C41._)"
9270,3,0,"Carcinoma, intraosseous, primary (C41.1)"
9270,3,0,"Carcinoma, odontogenic (C41._)"
9270,3,0,"Carcinoma, primary intraosseous (C41.1)"
9270,3,0,"Intraosseous carcinoma, primary (C41.1)"
9270,3,0,Odontogenic carcinoma (C41._)
9270,3,0,Odontogenic sarcoma (C41._)
9270,3,0,Primary intraosseous carcinoma (C41._)
9270,3,0,"Sarcoma, odontogenic (C41._)"
9270,3,0,"Tumor, odontogenic, malignant (C41._)"
9271,0,1,Ameloblastic fibrodentinoma (C41._)
9271,0,0,Dentinoma (C41._)
9271,0,0,"Fibrodentinoma, ameloblastic (C41._)"
9272,0,1,"Cementoma, NOS (C41._)"
9272,0,0,"Cemental dysplasia, periapical (C41._)"
9272,0,0,"Cemento-osseous dysplasia, periapical (C41._)"
9272,0,0,"Dysplasia, periapical cemental (C41._)"
9272,0,0,"Dysplasia, periapical cemento-osseous (C41._)"
9272,0,0,Periapical cemental dysplasia (C41._)
9272,0,0,Periapical cemento-osseous dysplasia (C41._)
9273,0,1,"Cementoblastoma, benign (C41._)"
9274,0,1,Cementifying fibroma (C41._)
9274,0,0,Cemento-ossifying fibroma (C41._)
9274,0,0,"Fibroma, cementifying (C41._)"
9274,0,0,"Fibroma, cemento-ossifying (C41._)"
9275,0,1,Gigantiform cementoma (C41._)
9275,0,0,"Cementoma, gigantiform (C41._)"
9275,0,0,"Dysplasia, florid osseous (C41._)"
9275,0,0,Florid osseous dysplasia (C41._)
9275,0,0,"Osseous dysplasia, florid (C41._)"
9280,0,1,"Odontoma, NOS (C41._)"
9281,0,1,Compound odontoma (C41._)
9281,0,0,"Odontoma, compound (C41._)"
9282,0,1,Complex odontoma (C41._)
9282,0,0,"Odontoma, complex (C41._)"
9290,0,1,Ameloblastic fibro-odontoma (C41._)
9290,0,0,Fibroameloblastic odontoma (C41._)
9290,0,0,"Fibro-odontoma, ameloblastic (C41._)"
9290,0,0,"Odontoma, fibroameloblastic (C41._)"
9290,3,1,Ameloblastic odontosarcoma (C41._)
9290,3,0,Ameloblastic fibrodentinosarcoma (C41._)
9290,3,0,Ameloblastic fibro-odontosarcoma (C41._)
9290,3,0,"Fibrodentinosarcoma, ameloblastic (C41._)"
9290,3,0,"Fibro-odontosarcoma, ameloblastic (C41._)"
9290,3,0,"Odontosarcoma, ameloblastic (C41._)"
9300,0,1,Adenomatoid odontogenic tumor (C41._)
9300,0,0,Adenoameloblastoma (C41._)
9300,0,0,"Adenomatoid tumor, odontogenic (C41._)"
9300,0,0,Odontogenic adenomatoid tumor (C41._)
9300,0,0,"Odontogenic tumor, adenomatoid (C41._)"
9300,0,0,"Tumor, adenomatoid, odontogenic (C41._)"
9300,0,0,"Tumor, odontogenic, adenomatoid (C41._)"
9301,0,1,Calcifying odontogenic cyst (C41._)
9301,0,0,"Cyst, calcifying odontogenic (C41._)"
9301,0,0,"Cyst, odontogenic, calcifying (C41._)"
9301,0,0,"Odontogenic cyst, calcifying (C41._)"
9302,0,1,Odontogenic ghost cell tumor (C41._)
9302,0,0,"Ghost cell tumor, odontogenic (C41._)"
9302,0,0,"Tumor, ghost cell, odontogenic (C41._)"
9302,0,0,"Tumor, odontogenic, ghost cell (C41._)"
9302,3,1,"Ghost cell odontogenic carcinoma (C41.0, C41.1) "
9302,3,0,"Carcinoma, odontogenic, ghost cell (C41.0, C41.1)"
9302,3,0,"Odontogenic carcinoma, ghost cell (C41.0, C41.1)"
9310,0,1,"Ameloblastoma, NOS (C41._)"
9310,0,0,"Adamantinoma, NOS (except of long bones M-9261/3) (C41._)"
9310,3,1,"Ameloblastoma, metastasizing [2021+]"
9310,3,0,"Adamantinoma, malignant (except of long bones M-9261/3) (C41._)"
9310,3,0,"Ameloblastoma, malignant (C41._)"
9311,0,1,Odontoameloblastoma (C41._)
9312,0,1,Squamous odontogenic tumor (C41._)
9312,0,0,"Odontogenic tumor, squamous (C41._)"
9312,0,0,"Tumor, odontogenic, squamous (C41._)"
9312,0,0,"Tumor, squamous odontogenic (C41._)"
9320,0,1,Odontogenic myxoma (C41._)
9320,0,0,"Myxofibroma, odontogenic (C41._)"
9320,0,0,"Myxoma, odontogenic (C41._)"
9320,0,0,Odontogenic myxofibroma (C41._)
9321,0,1,Central odontogenic fibroma (C41._)
9321,0,0,"Central fibroma, odontogenic (C41._)"
9321,0,0,"Fibroma, central odontogenic (C41._)"
9321,0,0,"Fibroma, odontogenic, central (C41._)"
9321,0,0,"Fibroma, odontogenic, NOS (C41._)"
9321,0,0,"Odontogenic fibroma, central (C41._)"
9321,0,0,"Odontogenic fibroma, NOS (C41._)"
9322,0,1,Peripheral odontogenic fibroma (C41._)
9322,0,0,"Fibroma, odontogenic, peripheral (C41._)"
9322,0,0,"Fibroma, peripheral odontogenic (C41._)"
9322,0,0,"Odontogenic fibroma, peripheral (C41._)"
9330,0,1,Ameloblastic fibroma (C41._)
9330,0,0,"Fibroma, ameloblastic (C41._)"
9330,3,1,Ameloblastic fibrosarcoma (C41._)
9330,3,0,Ameloblastic sarcoma (C41._)
9330,3,0,"Fibrosarcoma, ameloblastic (C41._)"
9330,3,0,"Fibrosarcoma, odontogenic (C41._)"
9330,3,0,Odontogenic fibrosarcoma (C41._)
9330,3,0,"Sarcoma, ameloblastic (C41._)"
9340,0,1,Calcifying epithelial odontogenic tumor (C41._)
9340,0,0,"Epithelial odontogenic tumor, calcifying (C41._)"
9340,0,0,"Epithelial tumor, odontogenic, calcifying (C41._)"
9340,0,0,"Odontogenic tumor, calcifying epithelial (C41._)"
9340,0,0,Pindborg tumor (C41._)
9340,0,0,"Tumor, odontogenic, calcifying epithelial (C41._)"
9340,0,0,"Tumor, Pindborg (C41._)"
9341,1,1,Clear cell odontogenic tumor (C41._)
9341,1,0,"Odontogenic tumor, clear cell (C44._)"
9341,3,1,"Clear cell odontogenic carcinoma (C41.0, C41.1) "
9341,3,0,"Carcinoma, odontogenic, clear cell (C41.0, C41.1) "
9341,3,0,"Odontogenic carcinoma, clear cell (C41.0, C41.1) "
9341,3,0,"Tumor, odontogenic, clear cell (C41._)"
9342,3,1,Odontogenic carcinosarcoma (C41._)
9342,3,0,"Carcinosarcoma, odontogenic (C41._)"
9350,1,1,Craniopharyngioma (C75.2)
9350,1,0,"Pouch, Rathke, tumor (C75.1)"
9350,1,0,Rathke pouch tumor (C75.1)
9350,1,0,"Tumor, Rathke pouch (C75.1)"
9351,1,1,"Craniopharyngioma, adamantinomatous (C75.2)"
9351,1,0,Adamantinomatous craniopharyngioma (C75.2)
9352,1,1,"Craniopharyngioma, papillary (C75.2)"
9352,1,0,Papillary craniopharyngioma (C75.2)
9360,1,1,"Pinealoma, NOS (C75.3)"
9361,1,1,Pineocytoma (C75.3)
9361,3,1,Papillary tumor of the pineal region [USE FOR 2015-2017. FOR 2018+ USE 9395/3]
9362,3,1,Pineoblastoma (C75.3)
9362,3,0,"Differentiation, pineal parenchymal tumor, intermediate (C75.3)"
9362,3,0,"Intermediate differentiation, pineal parenchymal tumor (C75.3)"
9362,3,0,Mixed pineal tumor (C75.3)
9362,3,0,Mixed pineocytoma-pineoblastoma (C75.3)
9362,3,0,"Mixed tumor, pineal (C75.3)"
9362,3,0,"Parenchymal tumor, pineal, intermediate differentiation (C75.3)"
9362,3,0,Pineal parenchymal tumor of intermediate differentiation (C75.3)
9362,3,0,"Pineal tumor, mixed (C75.3)"
9362,3,0,"Pineal tumor, parenchymal, intermediate differentiation (C75.3)"
9362,3,0,"Pineal tumor, transitional (C75.3)"
9362,3,0,"Pineoblastoma-pineocytoma, mixed (C75.3)"
9362,3,0,"Pineocytoma-pineoblastoma, mixed (C75.3)"
9362,3,0,Transitional pineal tumor (C75.3)
9362,3,0,"Tumor, parenchymal, pineal, intermediate differentiation (C75.3)"
9362,3,0,"Tumor, pineal, mixed (C75.3)"
9362,3,0,"Tumor, pineal, parenchymal, intermediate differentiation (C75.3)"
9362,3,0,"Tumor, pineal, transitional (C75.3)"
9362,3,0,"Tumor, transitional pineal (C75.3)"
9363,0,1,Melanotic neuroectodermal tumor
9363,0,0,"Anlage tumor, retinal"
9363,0,0,Melanoameloblastoma
9363,0,0,Melanotic progonoma
9363,0,0,"Neuroectodermal tumor, melanotic"
9363,0,0,"Progonoma, melanotic"
9363,0,0,Retinal anlage tumor
9363,0,0,"Tumor, melanotic neuroectodermal"
9363,0,0,"Tumor, neuroectodermal, melanotic"
9363,0,0,"Tumor, retinal angle"
9364,3,1,"Ewing sarcoma (C40._, C41._) [2021+. FOR PRE-2021 USE 9260/3]"
9364,3,0,"Ewing tumor (C40._, C41._) [2021+. FOR PRE-2021 USE 9260/3]"
9364,3,0,"Neuroectodermal tumor, NOS"
9364,3,0,"Neuroectodermal tumor, peripheral"
9364,3,0,"Neuroectodermal tumor, peripheral primitive, NOS"
9364,3,0,Peripheral neuroectodermal tumor
9364,3,0,"Peripheral primitive neuroectodermal tumor, NOS"
9364,3,0,PPNET
9364,3,0,"Primitive neuroectodermal tumor, peripheral, NOS"
9364,3,0,"Sarcoma, Ewing (C40._, C41._) [2021+. FOR PRE-2021 USE 9260/3]"
9364,3,0,"Tumor, Ewing (C40._, C41._) [2021+. FOR PRE-2021 USE 9260/3]"
9364,3,0,"Tumor, neuroectodermal, NOS"
9364,3,0,"Tumor, neuroectodermal, peripheral"
9364,3,0,"Tumor, peripheral neuroectodermal"
9364,3,0,"Tumor, peripheral, primitive neuroectodermal, NOS"
9364,3,0,"Tumor, primitive neuroectodermal, peripheral, NOS"
9365,3,1,Askin tumor
9365,3,0,"Tumor, Askin"
9366,3,1,Round cell sarcoma with EWSR1-non-ETS fusions [2022+]
9366,3,0,"Sarcoma, round cell with EWSR1-non-ETS fusions [2022+]"
9367,3,1,CIC-rearranged sarcoma [2022+]
9367,3,0,"Sarcoma, CIC-rearranged [2022+]"
9368,3,1,Sarcoma with BCOR genetic alterations [2022+]
9370,3,1,"Chordoma, NOS"
9371,3,1,Chondroid chordoma
9371,3,0,"Chordoma, chondroid"
9372,3,1,Dedifferentiated chordoma
9372,3,0,"Chordoma, dedifferentiated"
9373,0,1,Parachordoma
9380,1,1,Angiocentric glioma [USE FOR 2015-2017. FOR 2018+ USE 9431/1]
9380,1,0,Pituicytoma [USE FOR 2015-2017. FOR 2018+ USE 9432/1]
9380,3,1,"Glioma, malignant (C71._)"
9380,3,0,"Glioma, NOS (except nasal glioma, not neoplastic) (C71._)"
9381,3,1,Gliomatosis cerebri (C71._)
9381,3,0,"Cerebri, gliomatosis (C71._)"
9382,3,1,Mixed glioma (C71._)
9382,3,0,Anaplastic oligoastrocytoma (C71._)
9382,3,0,"Glioma, mixed (C71._)"
9382,3,0,Oligoastrocytoma (C71._)
9382,3,0,"Oligoastrocytoma, anaplastic (C71._)"
9382,3,0,"Oligoastrocytoma, NOS (C71._) "
9383,1,1,Subependymoma (C71._)
9383,1,0,"Astrocytoma, subependymal, NOS (C71._)"
9383,1,0,"Ependymoma-subependymoma, mixed (C71._)"
9383,1,0,"Glioma, subependymal (C71._)"
9383,1,0,Mixed ependymoma-subependymoma (C71._)
9383,1,0,Mixed subependymoma-ependymoma (C71._)
9383,1,0,"Subependymal astrocytoma, NOS (C71._)"
9383,1,0,Subependymal glioma (C71._)
9383,1,0,"Subependymoma-ependymoma, mixed (C71._)"
9384,1,1,Subependymal giant cell astrocytoma (C71._)
9384,1,0,"Astrocytoma, subependymal, giant cell (C71._)"
9384,1,0,"Giant cell astrocytoma, subependymal (C71._)"
9384,1,0,"Subependymal astrocytoma, giant cell (C71._)"
9385,3,1,"Diffuse midline glioma, H3 K27M-mutant (C71._) [2018+]"
9385,3,0,"Glioma, diffuse midline, H3 K27M-mutant (C71._) [2018+]"
9385,3,0,"Glioma, midline, diffuse, H3 K27M-mutant (C71._) [2018+]"
9385,3,0,"Midline glioma, diffuse, H3 K27M-mutant (C71._) [2018+]"
9390,0,1,"Choroid plexus papilloma, NOS (C71.5)"
9390,0,0,"Papilloma, choroid plexus, NOS (C71.5)"
9390,1,1,Atypical choroid plexus papilloma (C71.5)
9390,1,0,"Choroid plexus papilloma, atypical (C71.5)"
9390,1,0,"Papilloma, choroid plexus, atypical (C71.5)"
9390,3,1,Choroid plexus carcinoma (C71.5)
9390,3,0,Anaplastic choroid plexus papilloma (C71.5)
9390,3,0,"Carcinoma, choroid plexus (C71.5)"
9390,3,0,"Choroid plexus papilloma, anaplastic (C71.5)"
9390,3,0,"Choroid plexus papilloma, malignant (C71.5)"
9390,3,0,"Papilloma, choroid plexus, anaplastic (C71.5)"
9390,3,0,"Papilloma, choroid plexus, malignant (C71.5)"
9391,3,1,Sellar ependymoma (C75.1) [2021+]
9391,3,0,Cellular ependymoma (C71._)
9391,3,0,Clear cell ependymoma (C71._)
9391,3,0,"Ependymoma, cellular (C71._)"
9391,3,0,"Ependymoma, clear cell (C71._)"
9391,3,0,"Ependymoma, epithelial (C71._)"
9391,3,0,"Ependymoma, NOS (C71._)"
9391,3,0,"Ependymoma, sellar (C75.1) [2021+]"
9391,3,0,"Ependymoma, tanycytic (C71._)"
9391,3,0,Epithelial ependymoma (C71._)
9391,3,0,Tanycytic ependymoma (C71._)
9392,3,1,"Ependymoma, anaplastic (C71._)"
9392,3,0,Anaplastic ependymoma (C71._)
9392,3,0,Ependymoblastoma (C71._)
9393,3,1,Papillary ependymoma (C71._)
9393,3,0,"Ependymoma, papillary (C71._)"
9394,1,1,Myxopapillary ependymoma (C72.0)
9394,1,0,"Ependymoma, myxopapillary (C72.0)"
9395,3,1,Papillary tumor of pineal region (C75.3)  [2018 +. FOR PRE-2018 USE 9361/3]
9395,3,0,"Pineal region, papillary tumor of (C75.3) [2018 +. FOR PRE-2018 USE 9361/3]"
9395,3,0,"Tumor, papillary of pineal region (C75.3) [2018 +. FOR PRE-2018 USE 9361/3]"
9396,3,1,"Ependymoma, RELA fusion-positive (C71._) [2018+]"
9396,3,0,RELA fusion-positive ependymoma (C71._) [2018+]
9400,3,1,"Astrocytoma, NOS (C71._)"
9400,3,0,Astrocytic glioma (C71._)
9400,3,0,"Astrocytoma, cystic (C71._) [obs]"
9400,3,0,"Astrocytoma, diffuse (C71._)"
9400,3,0,"Astrocytoma, diffuse, IDH-mutant (C71._)"
9400,3,0,"Astrocytoma, diffuse, IDS-wildtype (C71._)"
9400,3,0,"Astrocytoma, diffuse, low grade (C71._)"
9400,3,0,"Astrocytoma, low grade (C71._)"
9400,3,0,"Astrocytoma, low grade diffuse (C71._)"
9400,3,0,Astroglioma (C71._) [obs]
9400,3,0,Cystic astrocytoma (C71._) [obs]
9400,3,0,Diffuse astrocytoma (C71._)
9400,3,0,"Diffuse astrocytoma, IDH-mutant (C71._) "
9400,3,0,"Diffuse astrocytoma, IDH-wildtype (C71._) "
9400,3,0,"Diffuse astrocytoma, low grade (C71._)"
9400,3,0,"Glioma, astrocytic (C71._)"
9400,3,0,Low grade astrocytoma (C71._)
9400,3,0,Low grade diffuse astrocytoma (C71._)
9401,3,1,"Astrocytoma, anaplastic (C71._)"
9401,3,0,Anaplastic astrocytoma (C71._)
9401,3,0,"Anaplastic astrocytoma, IDH-mutant (C71._) "
9401,3,0,"Anaplastic astrocytoma, IDH-wildtype (C71._) "
9401,3,0,"Astrocytoma, anaplastic, IDH-mutant (C71._) "
9401,3,0,"Astrocytoma, anaplastic, IDH-wildtype (C71._) "
9410,3,1,Protoplasmic astrocytoma (C71._)
9410,3,0,"Astrocytoma, protoplasmic (C71._)"
9411,3,1,Gemistocytic astrocytoma (C71._)
9411,3,0,"Astrocytoma, gemistocytic (C71._)"
9411,3,0,"Astrocytoma, gemistocytic, IDH mutant (C71. _) [2021+]"
9411,3,0,Gemistocytoma (C71._)
9411,3,0,Gemistrocytic astrocytoma IDH mutant (C71. _) [2021+]
9411,3,0,IDH mutant gemistrocytic astrocytoma (C71. _) [2021+]
9412,1,1,Desmoplastic infantile astrocytoma (C71._)
9412,1,0,"Astrocytoma, desmoplastic infantile (C71._)"
9412,1,0,"Desmoplastic astrocytoma, infantile (C71._)"
9412,1,0,"Desmoplastic ganglioglioma, infantile (C71._)"
9412,1,0,Desmoplastic infantile ganglioglioma (C71._)
9412,1,0,"Ganglioglioma, desmoplastic infantile (C71._)"
9412,1,0,"Infancy, desmoplastic astrocytoma of (C71._)"
9412,1,0,"Infantile astrocytoma, desmoplastic (C71._)"
9412,1,0,"Infantile ganglioglioma, desmoplastic (C71._)"
9413,0,1,Dysembryoplastic neuroepithelial tumor
9413,0,0,"Neuroepithelial tumor, dysembryoplastic"
9413,0,0,"Tumor, dysembryoplastic neuroepithelial"
9413,0,0,"Tumor, neuroepithelial, dysembryoplastic"
9420,3,1,Fibrillary astrocytoma (C71._)
9420,3,0,"Astrocytoma, fibrillary (C71._)"
9420,3,0,"Astrocytoma, fibrous (C71._)"
9420,3,0,Fibrous astrocytoma (C71._)
9421,1,1,Pilocytic astrocytoma (C71._) [WHO behavior]
9421,1,0,"Astrocytoma, juvenile (C71._) [WHO behavior]"
9421,1,0,"Astrocytoma, pilocytic (C71._) [WHO behavior]"
9421,1,0,"Astrocytoma, piloid (C71._) [WHO behavior]"
9421,1,0,Juvenile astrocytoma (C71._) [WHO behavior]
9421,1,0,Piloid astrocytoma (C71._) [WHO behavior]
9421,1,0,"Spongioblastoma, NOS (C71._) [obs] [WHO behavior]"
9421,3,1,Pilocytic astrocytoma (C71._) [N. America behavior]
9421,3,0,"Astrocytoma, juvenile (C71._) [N. America behavior]"
9421,3,0,"Astrocytoma, pilocytic (C71._) [N. America behavior]"
9421,3,0,"Astrocytoma, piloid (C71._) [N. America behavior]"
9421,3,0,"Astrocytoma, pilomyxoid (C71._) [FOR PRE-2018.  2018+ USE 9425/3]"
9421,3,0,Juvenile astrocytoma (C71._) [N. America behavior]
9421,3,0,Piloid astrocytoma (C71._) [N. America behavior]
9421,3,0,Pilomyxoid astrocytoma (C71._) [FOR PRE-2018.  2018+ USE 9425/3]
9421,3,0,"Spongioblastoma, NOS (C71._) [obs] [N. America behavior]"
9423,3,1,Polar spongioblastoma (C71._)
9423,3,0,"Polar spongioblastoma, primitive (C71._) [obs]"
9423,3,0,"Polare, spongioblastoma (C71._)"
9423,3,0,Primitive polar spongioblastoma (C71._) [obs]
9423,3,0,Spongioblastoma polare (C71._)
9423,3,0,"Spongioblastoma, polar (C71._)"
9423,3,0,"Spongioblastoma, primitive polar (C71._) [obs]"
9424,3,1,Pleomorphic xanthoastrocytoma (C71._)
9424,3,0,Anaplastic pleomorphic xanthoastrocytoma (C71._) 
9424,3,0,"Pleomorphic xanthoastrocytoma, anaplastic (C71._)"
9424,3,0,"Xanthoastrocytoma, pleomorphic (C71._)"
9424,3,0,"Xanthoastrocytoma, pleomorphic, anaplastic (C71._) "
9425,3,1,Pilomyxoid astrocytoma (C71._) [2018+. FOR PRE-2018 USE 9421/3]
9425,3,0,"Astrocytoma, pilomyxoid (C71._) [2018+. FOR PRE-2018 USE 9421/3]"
9430,3,1,Astroblastoma (C71._)
9431,1,1,Angiocentric glioma  [2018+. FOR PRE-2018 USE 9380/1]
9431,1,0,"Glioma, angiocentric (C71._) [2018+. FOR PRE-2018 USE 9380/1]"
9432,1,1,Pituicytoma (C75.1) [2018+. FOR PRE-2018 USE 9380/1]
9440,3,1,"Glioblastoma, NOS (C71._)"
9440,3,0,Epithelioid glioblastoma (C71._)
9440,3,0,Glioblastoma multiforme (C71._)
9440,3,0,"Glioblastoma, epithelioid (C71._)"
9440,3,0,"Glioblastoma, IDH-wildtype (C71._)"
9440,3,0,"Multiforme, glioblastoma (C71._)"
9440,3,0,"Multiforme, spongioblastoma (C71._)"
9440,3,0,Spongioblastoma multiforme (C71._)
9441,3,1,Giant cell glioblastoma (C71._)
9441,3,0,"Glioblastoma, giant cell (C71._)"
9441,3,0,Monstrocellular sarcoma (C71._) [obs]
9441,3,0,"Sarcoma, monstrocellular (C71._) [obs]"
9442,1,1,Gliofibroma (C71._)
9442,3,1,Gliosarcoma (C71._)
9442,3,0,"Component, glioblastoma with sarcomatous (C71._)"
9442,3,0,Glioblastoma with sarcomatous component (C71._)
9442,3,0,"Sarcomatous component, glioblastoma with (C71._)"
9444,1,1,Chordoid glioma (C71._)
9444,1,0,Chordoid glioma of third ventricle (C71.5)
9444,1,0,"Glioma, chordoid (C71._)"
9444,1,0,"Glioma, chordoid, third ventricle (C71.5)"
9445,3,1,"Glioblastoma, IDH-mutant (C71._) [2018+]"
9450,3,1,"Oligodendroglioma, NOS (C71._)"
9450,3,0,"Oligodendroglioma, IDH-mutant and 1p/19q-codeleted (C71._)"
9451,3,1,"Oligodendroglioma, anaplastic (C71._)"
9451,3,0,Anaplastic oligodendroglioma (C71._)
9451,3,0,"Anaplastic oligodendroglioma, IDH-mutant and 1p/19q codeleted (C71._)"
9451,3,0,"Oligodendroglioma, anaplastic, IDH-mutant and 1p/19q codeleted (C71._)"
9460,3,1,Oligodendroblastoma (C71._) [obs]
9470,3,1,"Medulloblastoma, NOS (C71.6)"
9470,3,0,"Medulloblastoma, classic (C71._)"
9470,3,0,"Medulloblastoma, melanotic (C71.6)"
9470,3,0,Melanotic medulloblastoma (C71.6)
9471,3,1,Desmoplastic nodular medulloblastoma (C71.6)
9471,3,0,"Arachnoidal cerebellar sarcoma, circumscribed (C71.6)"
9471,3,0,"Cerebellar sarcoma, arachnoidal, circumscribed (C71.6) [obs]"
9471,3,0,Circumscribed arachnoidal cerebellar sarcoma (C71.6) [obs]
9471,3,0,Desmoplastic medulloblastoma (C71.6)
9471,3,0,"Desmoplastic medulloblastoma, nodular (C71.6)"
9471,3,0,Medulloblastoma with extensive nodularity
9471,3,0,"Medulloblastoma, desmoplastic (C71.6)"
9471,3,0,"Medulloblastoma, desmoplastic nodular (C71.6)"
9471,3,0,"Medulloblastoma, SHH-activated and TP53-wildtype (C71._)"
9471,3,0,"Nodular medulloblastoma, desmoplastic (C71.6)"
9471,3,0,"Sarcoma, arachnoidal cerebellar, circumscribed (C71.6) [obs]"
9471,3,0,"Sarcoma, circumscribed arachnoidal cerebellar (C71.6) [obs]"
9472,3,1,Medullomyoblastoma (C71.6)
9473,3,0,"Central primitive neuroectodermal tumor, NOS (C71._)"
9473,3,0,"CNS embryonal tumor, NOS"
9473,3,0,CPNET (C71._)
9473,3,0,"Embryonal tumor, CNS, NOS"
9473,3,0,"Neuroectodermal tumor, central primitive, NOS (C71._)"
9473,3,0,"Neuroectodermal tumor, primitive, central, NOS (C71._)"
9473,3,0,"Neuroectodermal tumor, primitive, NOS (C71._)"
9473,3,0,"PNET, NOS"
9473,3,0,"PNET, supratentorial (C71._)"
9473,3,0,"Primitive neuroectodermal tumor, central, NOS (C71._)"
9473,3,0,"Primitive neuroectodermal tumor, NOS (C71._)"
9473,3,0,Supratentorial PNET (C71._)
9473,3,0,"Tumor, central primitive neuroectodermal, NOS (C71._)"
9473,3,0,"Tumor, neuroectodermal, central primitive, NOS (C71._)"
9473,3,0,"Tumor, neuroectodermal, primitive, NOS (C71._)"
9473,3,0,"Tumor, primitive neuroectodermal, central, NOS (C71._)"
9473,3,0,"Tumor, primitive neuroectodermal, NOS (C71._)"
9474,3,1,Large cell medulloblastoma (C71.6)
9474,3,0,Anaplastic medulloblastoma
9474,3,0,"Medulloblastoma, large cell (C71.6)"
9475,3,1,"Medulloblastoma, WNT-activated (C71._) [2018+]"
9475,3,0,"Medulloblastoma, WNT-activated, anaplastic type (C71._) [2021+]"
9475,3,0,"Medulloblastoma, WNT-activated, classic (C71._) [2021+]"
9475,3,0,"Medulloblastoma, WNT-activated, large cell type (C71._) [2021+]"
9476,3,1,"Medulloblastoma, SHH-activated and TP53 mutant (C71._) [2018+]"
9477,3,1,"Medulloblastoma, non-WNT/non-SHH (C71._) [2018+]"
9477,3,0,"Medulloblastoma, group 3 (C71.6) [2018+]"
9477,3,0,"Medulloblastoma, group 4 (C71.6) [2018+]"
9478,3,1,"Embryonal tumor with multilayered rosettes, NOS (C71._) [2018+]"
9478,3,0,Embryonal tumor with multilayered rosettes C19MC-altered (C71._) [2018+]
9478,3,0,"Tumor, embryonal, with multilayered rosettes C19MC-altered (C71._) [2018+]"
9478,3,0,"Tumor, embryonal, with multilayered rosettes, NOS (C71._) [2018+]"
9480,3,1,"Cerebellar sarcoma, NOS (C71.6) [obs]"
9480,3,0,"Sarcoma, cerebellar, NOS (C71.6) [obs]"
9490,0,1,Ganglioneuroma
9490,3,1,Ganglioneuroblastoma
9491,0,1,Ganglioneuromatosis
9492,0,1,Gangliocytoma
9493,0,1,Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos) (C71.6)
9493,0,0,"Gangliocytoma of cerebellum, dysplastic (Lhermitte-Duclos) (C71.6)"
9493,0,0,Lhermitte-Duclos dysplastic gangliocytoma of cerebellum (C71.6)
9500,3,1,"Neuroblastoma, NOS"
9500,3,0,Central neuroblastoma (C71._)
9500,3,0,"Neuroblastoma, central (C71._)"
9500,3,0,Sympathicoblastoma
9501,0,1,"Medulloepithelioma, benign (C69.4)"
9501,0,0,"Diktyoma, benign (C69._)"
9501,3,1,"Medulloepithelioma, NOS"
9501,3,0,"Diktyoma, malignant (C69._)"
9502,0,1,"Teratoid medulloepithelioma, benign (C69.4)"
9502,0,0,"Medulloepithelioma, teratoid, benign (C69.4)"
9502,3,1,Teratoid medulloepithelioma (C69.4)
9502,3,0,"Medulloepithelioma, teratoid (C69.4)"
9503,3,1,"Neuroepithelioma, NOS"
9504,3,1,Spongioneuroblastoma
9505,0,1,Multinodular and vascolating neuronal tumor (MVNT) (C71.2) [2021+]
9505,0,0,MVNT (C71.2) [2021+]
9505,0,0,"Neuronal tumor, multinodular and vascolating(MVNT) (C71.2) [2021+]"
9505,1,1,"Ganglioglioma, NOS"
9505,1,0,Glioneuroma [obs]
9505,1,0,"Glioneuronal tumor, papillary [FOR USE 2015-2017. FOR 2018+ USE 9509/1]"
9505,1,0,"Glioneuronal tumor, rosette-forming [FOR USE 2015-2017. FOR 2018+ USE 9509/1.]"
9505,1,0,Neuroastrocytoma [obs]
9505,1,0,Papillary glioneuronal tumor [FOR USE 2015-2017. FOR 2018+ USE 9509/1]
9505,1,0,Rosette-forming glioneuronal tumor [FOR USE 2015-2017. FOR 2018+ USE 9509/1.]
9505,3,1,"Ganglioglioma, anaplastic"
9505,3,0,Anaplastic ganglioglioma
9506,1,1,Central neurocytoma
9506,1,0,Cerebellar liponeurocytoma (C71.6)
9506,1,0,Extraventricular neurocytoma
9506,1,0,Lipomatous medulloblastoma (C71.6)
9506,1,0,"Liponeurocytoma, cerebellar (C71.6)"
9506,1,0,"Medulloblastoma, lipomatous (C71.6)"
9506,1,0,Medullocytoma (C71.6)
9506,1,0,"Neurocytoma, central"
9506,1,0,"Neurocytoma, NOS"
9506,1,0,Neurolipocytoma (C71.6)
9507,0,1,Pacinian tumor
9507,0,0,"Tumor, Pacinian"
9508,3,1,Embryonal tumor with rhabdoid features (C71._) 
9508,3,0,Atypical teratoid/rhabdoid tumor (C71._)
9508,3,0,CNS Embryonal tumor with rhabdoid features (C71._)
9508,3,0,"Rhabdoid/teratoid tumor, atypical (C71._)"
9508,3,0,"Teratoid/rhabdoid tumor, atypical (C71._)"
9508,3,0,"Tumor, atypical teratoid/rhabdoid (C71._)"
9508,3,0,"Tumor, rhabdoid/teratoid, atypical (C71._)"
9508,3,0,"Tumor, teratoid/rhabdoid, atypical (C71._)"
9509,1,1,Papillary glioneuronal tumor (C71._) [2018+. FOR PRE-2018 USE 9505/1]
9509,1,0,Diffuse leptomeningeal glioneuronal tumor (C71._)
9509,1,0,"Glioneuronal tumor, leptomeningeal diffuse (C71._)"
9509,1,0,"Glioneuronal tumor, papillary (C71._) [2018+. FOR PRE-2018 USE 9505/1]"
9509,1,0,"Glioneuronal tumor, rosette-forming (C71._) [2018+. FOR PRE-2018 USE 9505/1]"
9509,1,0,"Leptomeningeal glioneuronal tumor, diffuse (C71._)"
9509,1,0,Rosette-forming glioneuronal tumor [2018+. FOR PRE-2018 USE 9505/1]
9509,1,0,"Tumor, glioneuronal papillary [2018+. FOR PRE-2018 USE 9505/1]"
9509,1,0,"Tumor, glioneuronal, leptomeningeal, diffuse (C71._)"
9509,1,0,"Tumor, glioneuronal, rosette-forming (C71._) [2018+. FOR PRE-2018 USE 9505/1]"
9510,0,1,Retinocytoma (C69.2)
9510,3,1,"Retinoblastoma, NOS (C69.2)"
9511,3,1,"Retinoblastoma, differentiated (C69.2)"
9511,3,0,Differentiated retinoblastoma (C69.2)
9512,3,1,"Retinoblastoma, undifferentiated (C69.2)"
9512,3,0,Undifferentiated retinoblastoma (C69.2)
9513,3,1,"Retinoblastoma, diffuse (C69.2)"
9513,3,0,Diffuse retinoblastoma (C69.2)
9514,1,1,"Retinoblastoma, spontaneously regressed (C69.2)"
9514,1,0,"Regressed, spontaneously, retinoblastoma (C69.2)"
9514,1,0,Spontaneously regressed retinoblastoma (C69.2)
9520,3,1,Olfactory neurogenic tumor
9520,3,0,"Neurogenic tumor, olfactory"
9520,3,0,"Tumor, neurogenic, olfactory"
9520,3,0,"Tumor, olfactory neurogenic"
9521,3,1,Olfactory neurocytoma (C30.0)
9521,3,0,Esthesioneurocytoma (C30.0)
9521,3,0,"Neurocytoma, olfactory (C30.0)"
9522,3,1,Olfactory neuroblastoma (C30.0)
9522,3,0,Esthesioneuroblastoma (C30.0)
9522,3,0,"Neuroblastoma, olfactory (C30.0)"
9523,3,1,Olfactory neuroepithelioma (C30.0)
9523,3,0,Esthesioneuroepithelioma (C30.0)
9523,3,0,"Neuroepithelioma, olfactory (C30.0)"
9530,0,1,"Meningioma, NOS (C70._)"
9530,0,0,Lymphoplasmacyte-rich meningioma (C70._)
9530,0,0,"Meningioma, lymphoplasmacyte-rich (C70._)"
9530,0,0,"Meningioma, metaplastic (C70._)"
9530,0,0,"Meningioma, microcytic (C70._)"
9530,0,0,"Meningioma, secretory (C70._)"
9530,0,0,Metaplastic meningioma (C70._)
9530,0,0,Microcystic meningioma (C70._)
9530,0,0,Secretory meningioma (C70._)
9530,1,1,"Meningiomatosis, NOS (C70._)"
9530,1,0,Diffuse meningiomatosis (C70._)
9530,1,0,"Meningiomas, multiple (C70._)"
9530,1,0,"Meningiomatosis, diffuse (C70._)"
9530,1,0,Multiple meningiomas (C70._)
9530,3,1,"Meningioma, malignant (C70._)"
9530,3,0,Anaplastic meningioma (C70._)
9530,3,0,Leptomeningeal sarcoma (C70._)
9530,3,0,Meningeal sarcoma (C70._)
9530,3,0,"Meningioma, anaplastic (C70._)"
9530,3,0,Meningothelial sarcoma (C70._)
9530,3,0,"Sarcoma, leptomeningeal (C70._)"
9530,3,0,"Sarcoma, meningeal (C70._)"
9530,3,0,"Sarcoma, meningothelial (C70._)"
9531,0,1,Meningothelial meningioma (C70._)
9531,0,0,Endotheliomatous meningioma (C70._)
9531,0,0,"Meningioma, endotheliomatous (C70._)"
9531,0,0,"Meningioma, meningothelial (C70._)"
9531,0,0,"Meningioma, syncytial (C70._)"
9531,0,0,Syncytial meningioma (C70._)
9532,0,1,Fibrous meningioma (C70._)
9532,0,0,Fibroblastic meningioma (C70._)
9532,0,0,"Meningioma, fibroblastic (C70._)"
9532,0,0,"Meningioma, fibrous (C70._)"
9533,0,1,Psammomatous meningioma (C70._)
9533,0,0,"Meningioma, psammomatous (C70._)"
9534,0,1,Angiomatous meningioma (C70._)
9534,0,0,"Meningioma, angiomatous (C70._)"
9535,0,1,Hemangioblastic meningioma (C70._) [obs]
9535,0,0,Angioblastic meningioma (C70._) [obs]
9535,0,0,"Meningioma, angioblastic (C70._) [obs]"
9535,0,0,"Meningioma, hemangioblastic (C70._) [obs]"
9537,0,1,Transitional meningioma (C70._)
9537,0,0,"Meningioma, mixed (C70._)"
9537,0,0,"Meningioma, transitional (C70._)"
9537,0,0,Mixed meningioma (C70._)
9538,1,1,Clear cell meningioma (C70._)
9538,1,0,Chordoid meningioma (C70._)
9538,1,0,"Meningioma, chordoid (C70._)"
9538,1,0,"Meningioma, clear cell (C70._)"
9538,3,1,Papillary meningioma (C70._)
9538,3,0,"Meningioma, papillary (C70._)"
9538,3,0,"Meningioma, rhabdoid (C70._)"
9538,3,0,Rhabdoid meningioma (C70._)
9539,1,1,Atypical meningioma (C70._)
9539,1,0,"Meningioma, atypical (C70._)"
9539,3,1,Meningeal sarcomatosis (C70._)
9539,3,0,"Sarcomatosis, meningeal (C70._)"
9540,0,1,"Neurofibroma, NOS"
9540,1,1,"Neurofibromatosis, NOS [REMOVED FROM ICD-O-3.2; NOT REPORTABLE 2018+]"
9540,1,0,"Disease, Recklinghausen (except of bone) [REMOVED FROM ICD-O-3.2; NOT REPORTABLE 2018+]"
9540,1,0,"Disease, von Recklinghausen (except of bone) [REMOVED FROM ICD-O-3.2; NOT REPORTABLE 2018+]"
9540,1,0,Multiple neurofibromatosis [REMOVED FROM ICD-O-3.2; NOT REPORTABLE 2018+]
9540,1,0,"Neurofibromatosis, multiple [REMOVED FROM ICD-O-3.2; NOT REPORTABLE 2018+]"
9540,1,0,Recklinghausen disease (except of bone) [REMOVED FROM ICD-O-3.2; NOT REPORTABLE 2018+]
9540,1,0,von Recklinghausen disease (except of bone) [REMOVED FROM ICD-O-3.2; NOT REPORTABLE 2018+]
9540,3,1,Malignant peripheral nerve sheath tumor
9540,3,0,Epithelioid MPNST
9540,3,0,"Glandular differentiation, MPNST with"
9540,3,0,Melanotic MPNST
9540,3,0,"Melanotic MPNST, psammomatous"
9540,3,0,Melanotic psammomatous MPNST
9540,3,0,"Mesenchymal differentiation, MPNST with"
9540,3,0,MPNST with glandular differentiation
9540,3,0,MPNST with mesenchymal differentiation
9540,3,0,"MPNST, epithelioid"
9540,3,0,"MPNST, melanotic"
9540,3,0,"MPNST, melanotic psammomatous"
9540,3,0,"MPNST, NOS"
9540,3,0,"Nerve sheath tumor, malignant peripheral"
9540,3,0,Neurofibrosarcoma [obs]
9540,3,0,Neurogenic sarcoma [obs]
9540,3,0,Neurosarcoma [obs]
9540,3,0,"Peripheral nerve sheath tumor, malignant"
9540,3,0,"Psammomatous MPNST, melanotic"
9540,3,0,"Sarcoma, neurogenic [obs]"
9540,3,0,"Tumor, malignant, peripheral nerve sheath"
9540,3,0,"Tumor, nerve sheath, malignant peripheral"
9540,3,0,"Tumor, peripheral nerve sheath, malignant"
9541,0,1,Melanotic neurofibroma
9541,0,0,"Neurofibroma, melanotic"
9542,3,1,"Epithelioid malignant peripheral nerve sheath tumor  (C47.0-C47.6, C47.8, C47.9) [2018+]"
9542,3,0,"Nerve sheath tumor, peripheral epithelioid malignant (C47.0-C47.6, C47.8, C47.9) [2018+]"
9542,3,0,"Peripheral nerve sheath tumor, epithelioid malignant   (C47.0-C47.6, C47.8, C47.9) [2018+]"
9542,3,0,"Tumor, nerve sheath, peripheral epithelioid malignant (C47.0-C47.6, C47.8, C47.9) [2018+]"
9550,0,1,Plexiform neurofibroma
9550,0,0,"Neurofibroma, plexiform"
9550,0,0,"Neuroma, plexiform"
9550,0,0,Plexiform neuroma
9560,0,1,"Neurilemoma, NOS"
9560,0,0,Acoustic neuroma (C72.4)
9560,0,0,Ancient schwannoma
9560,0,0,Cellular schwannoma
9560,0,0,Degenerated schwannoma
9560,0,0,Melanotic schwannoma [PRE-2018 ONLY. FOR 2018+ USE CODE 9560/1.]
9560,0,0,Neurinoma
9560,0,0,"Neuroma, acoustic (C72.4)"
9560,0,0,Pigmented schwannoma
9560,0,0,Plexiform schwannoma
9560,0,0,Psammomatous schwannoma
9560,0,0,"Schwannoma, cellular"
9560,0,0,"Schwannoma, degenerated"
9560,0,0,"Schwannoma, melanotic [PRE-2018 ONLY. FOR 2018+ USE CODE 9560/1.]"
9560,0,0,"Schwannoma, NOS"
9560,0,0,"Schwannoma, pigmented"
9560,0,0,"Schwannoma, plexiform"
9560,0,0,"Schwannoma, psammomatous"
9560,1,1,Neurinomatosis
9560,1,0,Melanotic schwannoma [2018+ ONLY. FOR PRE-2018 USE CODE 9560/0.]
9560,1,0,"Schwannoma, melanotic [2018+ ONLY. FOR PRE-2018 USE CODE 9560/0.]"
9560,3,1,"Neurilemoma, malignant [obs]"
9560,3,0,"Malignant schwannoma, NOS [obs]"
9560,3,0,Neurilemosarcoma [obs]
9560,3,0,"Schwannoma, malignant, NOS [obs]"
9561,3,1,Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation
9561,3,0,"Differentiation, malignant peripheral nerve sheath tumor with rhabdomyoblastic"
9561,3,0,"Differentiation, malignant schwannoma with rhabdomyoblastic"
9561,3,0,"Differentiation, MPNST with rhabdomyoblastic"
9561,3,0,Malignant Schwannoma with rhabdomyoblastic differentiation
9561,3,0,MPNST with rhabdomyoblastic differentiation
9561,3,0,"Nerve sheath tumor, malignant peripheral with rhabdomyoblastic differentiation"
9561,3,0,"Peripheral nerve sheath tumor with rhabdomyoblastic differentiation, malignant"
9561,3,0,"Rhabdomyoblastic differentiation, malignant peripheral nerve sheath tumor with"
9561,3,0,"Rhabdomyoblastic differentiation, malignant schwannoma with"
9561,3,0,"Rhabdomyoblastic differentiation, MPNST with"
9561,3,0,"Schwannoma with rhabdomyoblastic differentiation, malignant"
9561,3,0,"Schwannoma, malignant, with rhabdomyoblastic differentiation"
9561,3,0,"Triton tumor, malignant"
9561,3,0,"Tumor, nerve sheath, malignant peripheral, with rhabdomyoblastic differentiation"
9561,3,0,"Tumor, nerve sheath, malignant, with rhabdomyoblastic differentiation"
9561,3,0,"Tumor, Triton, malignant"
9562,0,1,Neurothekeoma
9562,0,0,"Myxoma, nerve sheath"
9562,0,0,Nerve sheath myxoma
9563,0,1,"Nerve sheath tumor, NOS [2021+]"
9563,0,0,Hybrid nerve sheath tumor [2021+]
9563,0,0,"Nerve sheath tumor, hybrid [2021+]"
9570,0,1,"Neuroma, NOS"
9571,0,1,"Perineurioma, NOS"
9571,0,0,Intraneural perineurioma
9571,0,0,"Perineuroma, intraneural"
9571,0,0,"Perineuroma, soft tissue"
9571,0,0,Soft tissue perineurioma
9571,3,1,"Perineurioma, malignant"
9571,3,0,"MPNST, perineural"
9571,3,0,Perineural MPNST
9580,0,1,"Granular cell tumor, NOS"
9580,0,0,"Granular cell myoblastoma, NOS"
9580,0,0,"Myoblastoma, granular cell, NOS"
9580,0,0,"Tumor, granular cell, NOS"
9580,3,1,"Granular cell tumor, malignant"
9580,3,0,"Granular cell myoblastoma, malignant"
9580,3,0,"Myoblastoma, granular cell, malignant"
9580,3,0,"Tumor, granular cell, malignant"
9581,3,1,Alveolar soft part sarcoma
9581,3,0,"Sarcoma, alveolar soft part"
9581,3,0,"Soft part sarcoma, alveolar "
9582,0,1,Granular cell tumor of the sellar region (C75.1) 
9582,0,0,Sellar region granular cell tumor (C75.1) 
9582,0,0,"Tumor, granular cell, sellar region (C75.1) "
9590,3,1,"Malignant lymphoma, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9590,3,0,"Lymphoma (malignant), NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9590,3,0,"Lymphoma, NOS {see Lymphoma (malignant)} [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9590,3,0,Microglioma (C71._) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9591,1,1,"Monoclonal B-cell lymphocytosis, NOS [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,1,0,"Lymphocytosis, monoclonal B-cell, non-CLL type [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,1,0,"Lymphocytosis, monoclonal B-cell, NOS [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,1,0,"Monoclonal B-cell lymphocytosis, non-CLL type [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,1,"Malignant lymphoma, non-Hodgkin, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"B cell lymphoma, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,Diffuse lymphosarcoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9591,3,0,"Lymphoma (malignant), B-cell, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), cleaved cell, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), cleaved cell, small, diffuse [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), cleaved cell, small, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), diffuse, lymphocytic, poorly differentiated [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), diffuse, noncleaved, small cell [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), diffuse, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), diffuse, small cell, noncleaved [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), diffuse, small cleaved cell [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), intermediate differentiation, lymphocytic, nodular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), lymphocytic, diffuse, poorly differentiated [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), lymphocytic, nodular, intermediate differentiation [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), lymphocytic, poorly differentiated, diffuse [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), nodular, lymphocytic, intermediate differentiation [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), non-Burkitt undifferentiated cell [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), noncleaved cell, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), noncleaved, small cell, diffuse [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), non-Hodgkin, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), poorly differentiated, lymphocytic, diffuse [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), small cell, cleaved, diffuse [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), small cell, noncleaved, diffuse [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), small cleaved cell, diffuse [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), small cleaved cell, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), undifferentiated cell type, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphoma (malignant), undifferentiated cell, non-Burkitt [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphosarcoma, diffuse [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Lymphosarcoma, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Malignant lymphoma, cleaved cell, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Malignant lymphoma, diffuse, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Malignant lymphoma, lymphocytic, intermediate differentiation, nodular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Malignant lymphoma, lymphocytic, poorly differentiated, diffuse [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Malignant lymphoma, noncleaved cell, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Malignant lymphoma, small cell, noncleaved, diffuse [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Malignant lymphoma, small cleaved cell, diffuse [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Malignant lymphoma, small cleaved cell, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Malignant lymphoma, undifferentiated cell type, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Malignant lymphoma, undifferentiated cell, non-Burkitt [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Non-Hodgkin lymphoma, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Reticulosarcoma, diffuse [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Reticulosarcoma, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Reticulum cell sarcoma, diffuse [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Reticulum cell sarcoma, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Sarcoma, reticulum cell, diffuse [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9591,3,0,"Sarcoma, reticulum cell, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9596,3,1,Composite Hodgkin and non-Hodgkin lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9596,3,0,"Hodgkin lymphoma and non-Hodgkin lymphoma, composite [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9596,3,0,"Lymphoma (malignant), composite Hodgkin and non-Hodgkin [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9596,3,0,"Lymphoma (malignant), Hodgkin and non-Hodgkin, composite [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9596,3,0,"Lymphoma (malignant), non-Hodgkin and Hodgkin, composite [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9597,3,1,Primary cutaneous follicle centre lymphoma [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9650,3,1,Classical Hodgkin lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9650,3,0,"Hodgkin disease, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9650,3,0,"Hodgkin lymphoma, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9650,3,0,Hodgkin malignant lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9650,3,0,"Lymphoma (malignant), Hodgkin [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9650,3,0,"Malignant lymphoma, Hodgkin [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9651,3,1,"Hodgkin lymphoma, lymphocyte-rich [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9651,3,0,"Classical Hodgkin lymphoma, lymphocyte-rich [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9651,3,0,"Hodgkin disease, lymphocyte predominance, diffuse [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9651,3,0,"Hodgkin disease, lymphocyte predominance, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9651,3,0,"Hodgkin disease, lymphocytic-histiocytic predominance [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9651,3,0,"Hodgkin lymphoma, classical, lymphocyte-rich [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9652,3,1,"Hodgkin lymphoma, mixed cellularity, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9652,3,0,"Classical Hodgkin lymphoma, mixed cellularity, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9652,3,0,"Hodgkin lymphoma, classical, mixed cellularity, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9652,3,0,"Hodgkin lymphoma, mixed cellularity, classical, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9653,3,1,"Hodgkin lymphoma, lymphocyte depletion, NOS  [2010+. FOR PRE-2010 USE CODE 9654/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9653,3,0,"Classical Hodgkin lymphoma, lymphocyte depletion, NOS [2010+. FOR PRE-2010 USE CODE 9654/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9653,3,0,"Hodgkin lymphoma, classical, lymphocyte depletion, NOS [2010+. FOR PRE-2010 USE CODE 9654/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9654,3,1,"Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis [obs] [PRE-2010 ONLY. FOR 2010+ USE CODE 9653/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9654,3,0,"Classical Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis [obs] [PRE-2010 ONLY. FOR 2010+ USE CODE 9653/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9654,3,0,"Hodgkin lymphoma, classical, lymphocyte depletion, diffuse fibrosis [obs] [PRE-2010 ONLY. FOR 2010+ USE CODE 9653/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9655,3,1,"Hodgkin lymphoma, lymphocyte depletion, reticular [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9655,3,0,"Classical Hodgkin lymphoma, lymphocyte depletion, reticular [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9655,3,0,"Hodgkin lymphoma, classical, lymphocyte depletion, reticular [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9659,3,1,"Hodgkin lymphoma, nodular lymphocyte predominance [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9659,3,0,"Hodgkin lymphoma, lymphocyte predominance, nodular [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9659,3,0,"Hodgkin paragranuloma, nodular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9659,3,0,"Hodgkin paragranuloma, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9659,3,0,"Paragranuloma, Hodgkin, nodular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9659,3,0,"Paragranuloma, Hodgkin, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9661,3,1,Hodgkin granuloma [obs] [PRE-2010 ONLY. FOR 2010+ USE CODE 9650/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9661,3,0,"Granuloma, Hodgkin [obs] [PRE-2010 ONLY. FOR 2010+ USE CODE 9650/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9662,3,1,Hodgkin sarcoma [obs] [PRE-2010 ONLY. FOR 2010+ USE CODE 9650/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9662,3,0,"Sarcoma, Hodgkin [obs] [PRE-2010 ONLY. FOR 2010+ USE CODE 9650/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9663,3,1,Nodular sclerosis classical Hodgkin lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9663,3,0,"Classical Hodgkin lymphoma, nodular sclerosis, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9663,3,0,"Hodgkin disease, nodular sclerosis, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9663,3,0,"Hodgkin lymphoma, classical, nodular sclerosis, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9663,3,0,"Hodgkin lymphoma, nodular sclerosis, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9664,3,1,"Hodgkin lymphoma, nodular sclerosis, cellular phase [PRE-2010 ONLY. FOR 2010+ USE CODE 9663/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9664,3,0,"Classical Hodgkin lymphoma, nodular sclerosis, cellular phase [PRE-2010 ONLY. FOR 2010+ USE CODE 9663/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9664,3,0,"Hodgkin lymphoma, classical, nodular sclerosis, cellular phase [PRE-2010 ONLY. FOR 2010+ USE CODE 9663/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9664,3,0,"Hodgkin lymphoma, nodular sclerosis, cellular phase, classical [PRE-2010 ONLY. FOR 2010+ USE CODE 9663/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9665,3,1,"Hodgkin lymphoma, nodular sclerosis, grade 1 [PRE-2010 ONLY. FOR 2010+ USE CODE 9663/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9665,3,0,"Classical Hodgkin lymphoma, nodular sclerosis, grade1 D5142 [PRE-2010 ONLY. FOR 2010+ USE CODE 9663/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9665,3,0,"Hodgkin disease, nodular sclerosis, lymphocyte predominance [PRE-2010 ONLY. FOR 2010+ USE CODE 9663/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9665,3,0,"Hodgkin disease, nodular sclerosis, mixed cellularity [PRE-2010 ONLY. FOR 2010+ USE CODE 9663/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9665,3,0,"Hodgkin lymphoma, classical, nodular sclerosis, grade 1 [PRE-2010 ONLY. FOR 2010+ USE CODE 9663/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9667,3,1,"Hodgkin lymphoma, nodular sclerosis, grade 2 [PRE-2010 ONLY. FOR 2010+ USE CODE 9663/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9667,3,0,"Classical Hodgkin lymphoma, nodular sclerosis, grade2 [PRE-2010 ONLY. FOR 2010+ USE CODE 9663/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9667,3,0,"Hodgkin disease, nodular sclerosis, lymphocyte depletion [PRE-2010 ONLY. FOR 2010+ USE CODE 9663/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9667,3,0,"Hodgkin disease, nodular sclerosis, syncytial variant [PRE-2010 ONLY. FOR 2010+ USE CODE 9663/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9667,3,0,"Hodgkin lymphoma, classical, nodular sclerosis, grade 2 [PRE-2010 ONLY. FOR 2010+ USE CODE 9663/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,1,"Malignant lymphoma, small B lymphocytic, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), B lymphocytic, small, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), B-cell, small lymphocytic/chronic lymphocytic leukemia  [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), diffuse, lymphocytic, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), diffuse, lymphocytic, small [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), diffuse, lymphocytic, well differentiated [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), diffuse, small cell [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), diffuse, small lymphocytic [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), lymphocytic, B, small, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), lymphocytic, diffuse, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), lymphocytic, diffuse, small [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), lymphocytic, diffuse, well differentiated [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), lymphocytic, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), lymphocytic, small, B, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), lymphocytic, small, diffuse [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), lymphocytic, small, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), lymphocytic, small/B-cell chronic lymphocytic leukemia [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), lymphocytic, well differentiated, diffuse [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), small B lymphocytic, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), small cell, diffuse [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), small cell, lymphocytic, diffuse [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), small cell, lymphocytic, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), small cell, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), small lymphocytic, B, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), small lymphocytic, diffuse, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), small lymphocytic, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), small lymphocytic/B-cell chronic lymphocytic leukemia [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Lymphoma (malignant), well-differentiated, lymphocytic, diffuse [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Malignant lymphoma, lymphocytic, diffuse, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Malignant lymphoma, lymphocytic, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Malignant lymphoma, lymphocytic, well differentiated, diffuse [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Malignant lymphoma, small cell diffuse [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Malignant lymphoma, small cell, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Malignant lymphoma, small lymphocytic, diffuse [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9670,3,0,"Malignant lymphoma, small lymphocytic, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9823/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9671,3,1,"Malignant lymphoma, lymphoplasmacytic (see also M-9761/3) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9671,3,0,Immunocytoma [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9671,3,0,"Lymphoma (malignant), lymphoplasmacytic [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9671,3,0,"Lymphoma (malignant), lymphoplasmacytoid [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9671,3,0,"Lymphoma (malignant), plasmacytic [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9671,3,0,"Lymphoma (malignant), plasmacytoid [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9671,3,0,"Malignant lymphoma, lymphoplasmacytoid [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9671,3,0,"Malignant lymphoma, plasmacytoid [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9671,3,0,Plasmacytic lymphoma [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9673,1,1,In situ mantle cell neoplasia [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9673,1,0,In situ mantle cell lymphoma [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9673,1,0,"Lymphoma, in situ mantle cell [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9673,1,0,"Neoplasia, in situ mantle cell [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9673,3,1,"Mantle cell lymphoma (includes all variants: blastic, pleomorphic, small cell) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9673,3,0,"Lymphoma (malignant), centrocytic (includes all variants: blastic, pleomorphic, small cell) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9673,3,0,"Lymphoma (malignant), diffuse, lymphocytic, intermediate differentiation (includes all variants: blastic, pleomorphic, small cell) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9673,3,0,"Lymphoma (malignant), intermediate differentiation, lymphocytic, diffuse (includes all variants: blastic, pleomorphic, small cell) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9673,3,0,"Lymphoma (malignant), lymphocytic, diffuse, intermediate differentiation (includes all variants: blastic, pleomorphic, small cell) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9673,3,0,"Lymphoma (malignant), lymphocytic, intermediate differentiation, diffuse (includes all variants: blastic, pleomorphic, small cell) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9673,3,0,"Lymphoma (malignant), mantle cell (includes all variants: blastic, pleomorphic, small cell) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9673,3,0,"Lymphoma (malignant), mantle zone (includes all variants: blastic, pleomorphic, small cell) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9673,3,0,"Lymphomatous polyposis, malignant [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9673,3,0,"Malignant lymphoma, centrocytic [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9673,3,0,"Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9673,3,0,Malignant lymphomatous polyposis [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9673,3,0,Mantle zone lymphoma [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9673,3,0,"Polyposis, lymphomatous, malignant [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9673,3,0,"Polyposis, malignant lymphomatous [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9675,3,1,"Malignant lymphoma, mixed small and large cell, diffuse [PRE-2010 ONLY. FOR 2010+ USE CODE 9690/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9675,3,0,"Lymphoma (malignant), centroblastic-centrocytic, diffuse [PRE-2010 ONLY. FOR 2010+ USE CODE 9690/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9675,3,0,"Lymphoma (malignant), centroblastic-centrocytic, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9690/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9675,3,0,"Lymphoma (malignant), diffuse, centroblastic-centrocytic [PRE-2010 ONLY. FOR 2010+ USE CODE 9690/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9675,3,0,"Lymphoma (malignant), diffuse, mixed cell type [PRE-2010 ONLY. FOR 2010+ USE CODE 9690/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9675,3,0,"Lymphoma (malignant), diffuse, mixed lymphocytic-histiocytic [PRE-2010 ONLY. FOR 2010+ USE CODE 9690/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9675,3,0,"Lymphoma (malignant), diffuse, mixed small and large cell [PRE-2010 ONLY. FOR 2010+ USE CODE 9690/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9675,3,0,"Lymphoma (malignant), large cell and small cell, mixed, diffuse [PRE-2010 ONLY. FOR 2010+ USE CODE 9690/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9675,3,0,"Lymphoma (malignant), lymphocytic-histiocytic, mixed, diffuse [PRE-2010 ONLY. FOR 2010+ USE CODE 9690/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9675,3,0,"Lymphoma (malignant), mixed cell type, diffuse [PRE-2010 ONLY. FOR 2010+ USE CODE 9690/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9675,3,0,"Lymphoma (malignant), mixed lymphocytic-histiocytic, diffuse [PRE-2010 ONLY. FOR 2010+ USE CODE 9690/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9675,3,0,"Lymphoma (malignant), mixed small and large cell, diffuse [PRE-2010 ONLY. FOR 2010+ USE CODE 9690/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9675,3,0,"Lymphoma (malignant), small and large cell, mixed, diffuse [PRE-2010 ONLY. FOR 2010+ USE CODE 9690/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9675,3,0,"Lymphoma (malignant), small cell and large cell, mixed, diffuse[PRE-2010 ONLY. FOR 2010+ USE CODE 9690/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9675,3,0,"Malignant lymphoma, centroblastic-centrocytic, diffuse [PRE-2010 ONLY. FOR 2010+ USE CODE 9690/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9675,3,0,"Malignant lymphoma, centroblastic-centrocytic, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9690/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9675,3,0,"Malignant lymphoma, mixed cell type, diffuse [PRE-2010 ONLY. FOR 2010+ USE CODE 9690/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9675,3,0,"Malignant lymphoma, mixed lymphocytic-histiocytic, diffuse [PRE-2010 ONLY. FOR 2010+ USE CODE 9690/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9678,3,1,Primary effusion lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9678,3,0,"Lymphoma (malignant), primary effusion [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9679,3,1,Mediastinal large B-cell lymphoma (C38.3) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9679,3,0,"Lymphoma (malignant), B-cell, mediastinal large (C38.3) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9679,3,0,"Lymphoma (malignant), large B-cell, mediastinal (C38.3) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9679,3,0,"Lymphoma (malignant), large B-cell, thymic (C37.9) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9679,3,0,"Lymphoma (malignant), mediastinal large B-cell (C38.3) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9679,3,0,"Lymphoma (malignant), thymic large B-cell (C37.9) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9679,3,0,Thymic large B-cell lymphoma (C37.9) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9680,1,1,EBV positive mucocutaneous ulcer [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9680,1,0,"Mucocutaneous ulcer, EBV positive [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,1,0,"Ulcer, mucocutaneous, EBV positive [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,1,"Diffuse large B-cell lymphoma, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,Anaplastic large B-cell lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9680,3,0,Angioendotheliomatosis [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9680,3,0,Angiotropic lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9680,3,0,"Diffuse large B-cell lymphoma, activated B-cell subtype [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Diffuse large B-cell lymphoma, germinal center B-cell subtype [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,DLBCL [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9680,3,0,"Granulomatosis, lymphomatoid, grade 3 [PRE-2021; FOR 2021+ USE CODE 9766/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,Histiocyte-rich large B-cell lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9680,3,0,Intravascular B-cell lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9680,3,0,Intravascular large B-cell lymphoma (C49.9) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9680,3,0,"Lymphoma (malignant), activated B-cell subtype, diffuse large B-cell [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), angiotropic [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), B-cell, anaplastic large [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), B-cell, diffuse large, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), B-cell, histiocyte-rich large [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), B-cell, intravascular [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), B-cell, intravascular large (C49.9) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), B-cell, large, diffuse, centroblastic, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), B-cell, large, diffuse, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), B-cell, large, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), B-cell, T-cell rich large [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), B-cell, T-cell rich/histiocyte-rich large [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), centroblastic, diffuse [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), centroblastic, large B-cell, diffuse, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), centroblastic, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), cleaved and noncleaved, large cell [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), cleaved cell and noncleaved, large cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), cleaved cell, large cell, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), cleaved cell, large, diffuse [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), cleaved cell, large, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), diffuse, centroblastic [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), diffuse, histiocytic [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), diffuse, large B-cell, activated B-cell subtype [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), diffuse, large B-cell, centroblastic, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), diffuse, large B-cell, germinal center B-cell subtype [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), diffuse, large B-cell, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), diffuse, large cell, cleaved [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), diffuse, large cell, noncleaved [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), diffuse, large cell, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), diffuse, noncleaved, large cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), diffuse, noncleaved, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), germinal center B-cell subtype, diffuse, large B-cell [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), histiocyte-rich large B-cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), histiocyte-rich/T-cell rich large B-cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), histiocytic, diffuse [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), histiocytic, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), intravascular B-cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), intravascular large B-cell (C49.9) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), large B-cell, anaplastic [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), large B-cell, diffuse, activated B-cell subtype [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), large B-cell, diffuse, centroblastic, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), large B-cell, diffuse, germinal center B-cell subtype [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), large B-cell, diffuse, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), large B-cell, histiocyte-rich [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), large B-cell, intravascular (C49.9) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), large B-cell, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), large B-cell, T-cell rich [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), large B-cell, T-cell rich/histiocyte-rich [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), large cell anaplastic, B-cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), large cell, cleaved and noncleaved [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), large cell, cleaved, diffuse [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), large cell, cleaved, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), large cell, diffuse, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), large cell, noncleaved and cleaved [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), large cell, noncleaved, diffuse [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), large cell, noncleaved, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), large cell, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), large cell, primary cutaneous anaplastic (C44._) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), noncleaved and cleaved large cell [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), noncleaved, diffuse, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), noncleaved, large cell, diffuse [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), noncleaved, large cell, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), noncleaved,  NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), T-cell rich large B-cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), T-cell rich/histiocyte-rich large B-cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphoma (malignant), vitreoretinal (C69. _) [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphomatoid granulomatosis, grade 3 [PRE-2021; FOR 2021+ USE CODE 9766/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Lymphomatoid Papulosis, Grade 3 [PRE-2021; FOR 2021+ USE CODE 9766/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Malignant lymphoma, centroblastic, diffuse [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Malignant lymphoma, centroblastic, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Malignant lymphoma, histiocytic, diffuse [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Malignant lymphoma, histiocytic, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Malignant lymphoma, large B-cell, diffuse, activated B-cell subtype [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Malignant lymphoma, large B-cell, diffuse, centroblastic, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Malignant lymphoma, large B-cell, diffuse, germinal center B-cell subtype [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Malignant lymphoma, large B-cell, diffuse, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Malignant lymphoma, large B-cell, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Malignant lymphoma, large cell, cleaved and noncleaved [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Malignant lymphoma, large cell, cleaved, diffuse [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Malignant lymphoma, large cell, cleaved, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Malignant lymphoma, large cell, diffuse, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Malignant lymphoma, large cell, noncleaved, diffuse [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Malignant lymphoma, large cell, noncleaved, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Malignant lymphoma, large cell, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Malignant lymphoma, large cleaved cell, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Malignant lymphoma, noncleaved, diffuse, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Malignant lymphoma, noncleaved, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Malignant lymphoma, vitreoretinal (C69. _) [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,"Papulosis lymphomatoid, Grade 3 [PRE-2021; FOR 2021+ USE CODE 9766/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9680,3,0,T-cell rich large B-cell lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9680,3,0,T-cell rich/histiocyte-rich large B-cell lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9680,3,0,Vitreoretinal lymphoma (C69. _) [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9684,3,1,"Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS D5425 [PRE-2010 ONLY. FOR 2010+ USE CODE 9680/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9684,3,0,Immunoblastic sarcoma [obs] [PRE-2010 ONLY. FOR 2010+ USE CODE 9680/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9684,3,0,"Lymphoma (malignant), B-cell, large, diffuse, immunoblastic, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9680/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9684,3,0,"Lymphoma (malignant), diffuse, large B-cell, immunoblastic, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9680/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9684,3,0,"Lymphoma (malignant), immunoblastic, large B-cell diffuse, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9680/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9684,3,0,"Lymphoma (malignant), immunoblastic, large cell [PRE-2010 ONLY. FOR 2010+ USE CODE 9680/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9684,3,0,"Lymphoma (malignant), immunoblastic, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9680/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9684,3,0,"Lymphoma (malignant), large B-cell, diffuse, immunoblastic, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9680/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9684,3,0,"Lymphoma (malignant), large cell, immunoblastic [PRE-2010 ONLY. FOR 2010+ USE CODE 9680/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9684,3,0,"Lymphoma (malignant), plasmablastic [PRE-2010 ONLY. FOR 2010+ USE CODE 9735/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9684,3,0,"Malignant lymphoma, immunoblastic, NOS [PRE-2010 ONLY. FOR 2010+ USE CODE 9680/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9684,3,0,"Malignant lymphoma, large cell, immunoblastic [PRE-2010 ONLY. FOR 2010+ USE CODE 9680/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9684,3,0,Plasmablastic lymphoma [FOR 2010 AND LATER USE CODE 9735/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9684,3,0,"Sarcoma, immunoblastic [obs] [PRE-2010 ONLY. FOR 2010+ USE CODE 9680/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,1,"Burkitt lymphoma, NOS (includes all variants) (see also M-9826/3) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Acute leukemia, Burkitt type (C42.1) [obs] [FOR PRE-2021, USE CODE 9826/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Acute lymphoblastic leukemia, mature B-cell type (C42.1) [2021+. FOR PRE-2021, USE CODE 9826/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"ALL, B (C42.1) [2021+. FOR PRE-2021, USE CODE 9826/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"B-ALL (C42.1)  [obs] [FOR PRE-2021, USE CODE 9826/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Burkitt cell leukemia (C42.1) [2021+. FOR PRE-2021, USE CODE 9826/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Burkitt lymphoma, endemic [2022+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Burkitt lymphoma, immunodeficiency-associated [2022+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Burkitt lymphoma, sporadic [2022+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,Burkitt tumor (includes all variants) (see also M-9826/3) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9687,3,0,"Burkitt type, acute leukemia (C42.1) [obs] [FOR PRE-2021, USE CODE 9826/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Burkitt type, malignant lymphoma, small noncleaved (includes all variants) (see also M-9826/3) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Burkitt type, malignant lymphoma, undifferentiated (includes all variants) (see also M-9826/3) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,Burkitt-like lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9687,3,0,Endemic Burkitt lymphoma [2022+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9687,3,0,"FAB L3 (C42.1) [obs] [FOR PRE-2021, USE CODE 9826/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,Immunodeficiency-associated Burkitt lymphoma [2022+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9687,3,0,"Leukemia, acute, B-ALL (C42.1) [2021+. FOR PRE-2021, USE CODE 9826/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Leukemia, acute, Burkitt type (C42.1) [obs] [FOR PRE-2021, USE CODE 9826/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Leukemia, acute, lymphoblastic, mature B-cell type (C42.1) [2021+. FOR PRE-2021, USE CODE 9826/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Leukemia, B-ALL (C42.1) [2021+. FOR PRE-2021, USE CODE 9826/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Leukemia, B-cell type, mature, acute lymphoblastic (C42.1) [2021+. FOR PRE-2021, USE CODE 9826/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Leukemia, Burkitt cell (C42.1) [2021+. FOR PRE-2021, USE CODE 9826/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Leukemia, Burkitt type, acute (C42.1) [obs] [FOR PRE-2021, USE CODE 9826/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Leukemia, FAB L3 (C42.1) [obs] [FOR PRE-2021, USE CODE 9826/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Leukemia, lymphoblastic, acute, mature B-cell type (C42.1) [2021+. FOR PRE-2021, USE CODE 9826/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Leukemia, lymphocytic, B-ALL (C42.1) [2021+. FOR PRE-2021, USE CODE 9826/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Leukemia, mature B-cell type, lymphoblastic, acute (C42.1) [2021+. FOR PRE-2021, USE CODE 9826/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Lymphoma (malignant), Burkitt type, endemic [2022+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Lymphoma (malignant), Burkitt type, immunodeficiency-associated [2022+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Lymphoma (malignant), Burkitt type, small noncleaved (includes all variants) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Lymphoma (malignant), Burkitt type, sporadic [2022+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Lymphoma (malignant), Burkitt type, undifferentiated (includes all variants) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Lymphoma (malignant), Burkitt, NOS (includes all variants) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Lymphoma (malignant), Burkitt-like [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Lymphoma (malignant), diffuse, small noncleaved, Burkitt type [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Lymphoma (malignant), noncleaved, small, Burkitt type (includes all variants) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Lymphoma (malignant), small noncleaved, Burkitt type (includes all variants) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Lymphoma (malignant), undifferentiated Burkitt type (includes all variants) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Lymphoma (malignant), undifferentiated cell, Burkitt type [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Malignant lymphoma, endemic Burkitt [2022+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Malignant lymphoma, immunodeficiency-associated Burkitt [2022+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Malignant lymphoma, small noncleaved, Burkitt type [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Malignant lymphoma, sporadic Burkitt [2022+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,"Malignant lymphoma, undifferentiated, Burkitt type [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9687,3,0,Sporadic Burkitt lymphoma [2022+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9687,3,0,"Tumor, Burkitt (includes all variants) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9688,3,1,T cell/histiocyte rich large B-cell lymphoma [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9689,3,1,Splenic marginal zone B-cell lymphoma (C42.2) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9689,3,0,"Lymphoma (malignant), B-cell, splenic marginal zone (C42.2) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9689,3,0,"Lymphoma (malignant), marginal zone, B-cell, splenic (C42.2) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9689,3,0,"Lymphoma (malignant), marginal zone, splenic, B-cell (C42.2) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9689,3,0,"Lymphoma (malignant), marginal zone, splenic, NOS (C42.2) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9689,3,0,"Lymphoma (malignant), splenic, marginal zone B-cell (C42.2) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9689,3,0,"Lymphoma (malignant), splenic, marginal zone, NOS (C42.2) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9689,3,0,"Lymphoma (malignant), splenic, with villous lymphocytes (C42.2) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9689,3,0,Splenic lymphoma with villous lymphocytes (C42.2) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9689,3,0,"Splenic marginal zone lymphoma, NOS (C42.2) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9690,3,1,"Follicular lymphoma, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9690,3,0,"Follicular lymphoma, pediatric type [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9690,3,0,"Lymphoma (malignant), centroblastic-centrocytic, follicular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9690,3,0,"Lymphoma (malignant), follicle center, follicular [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9690,3,0,"Lymphoma (malignant), follicle center, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9690,3,0,"Lymphoma (malignant), follicular, centroblastic-centrocytic [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9690,3,0,"Lymphoma (malignant), follicular, follicle center [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9690,3,0,"Lymphoma (malignant), follicular, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9690,3,0,"Lymphoma (malignant), lymphocytic, nodular, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9690,3,0,"Lymphoma (malignant), nodular, lymphocytic, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9690,3,0,"Lymphoma (malignant), nodular, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9690,3,0,"Lymphoma (malignant), pediatric type [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9690,3,0,"Malignant lymphoma, centroblastic-centrocytic, follicular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9690,3,0,"Malignant lymphoma, follicle center, follicular [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9690,3,0,"Malignant lymphoma, follicle center, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9690,3,0,"Malignant lymphoma, follicular, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9690,3,0,"Malignant lymphoma, lymphocytic, nodular, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9690,3,0,"Malignant lymphoma, nodular, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9690,3,0,"Malignant lymphoma, pediatric type [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9691,3,1,"Follicular lymphoma, grade 2 [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9691,3,0,"Lymphoma (malignant), cleaved cell, mixed small and large cell, follicular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9691,3,0,"Lymphoma (malignant), follicular, grade 2 [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9691,3,0,"Lymphoma (malignant), follicular, mixed cell type [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9691,3,0,"Lymphoma (malignant), follicular, mixed small cleaved and large cell [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9691,3,0,"Lymphoma (malignant), large cell and small cleaved, mixed, follicular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9691,3,0,"Lymphoma (malignant), lymphocytic-histiocytic, mixed, nodular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9691,3,0,"Lymphoma (malignant), mixed cell type, follicular[obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9691,3,0,"Lymphoma (malignant), mixed cell type, nodular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9691,3,0,"Lymphoma (malignant), mixed lymphocytic-histiocytic, nodular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9691,3,0,"Lymphoma (malignant), mixed small cleaved and large cell, follicular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9691,3,0,"Lymphoma (malignant), nodular, mixed cell type [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9691,3,0,"Lymphoma (malignant), nodular, mixed lymphocytic-histiocytic [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9691,3,0,"Lymphoma (malignant), small cell, cleaved, and large cell, mixed, follicular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9691,3,0,"Lymphoma (malignant), small cleaved and large cell, mixed, follicular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9691,3,0,"Malignant lymphoma, mixed cell type, follicular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9691,3,0,"Malignant lymphoma, mixed cell type, nodular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9691,3,0,"Malignant lymphoma, mixed lymphocytic-histiocytic, nodular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9691,3,0,"Malignant lymphoma, mixed small cleaved and large cell, follicular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9695,1,1,In situ follicular neoplasia [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9695,1,0,In situ follicular lymphoma [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9695,1,0,"Lymphoma, in situ follicular [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9695,1,0,"Neoplasia, in situ follicular [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9695,3,1,"Follicular lymphoma, grade 1 [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9695,3,0,"Follicular lymphoma, duodenal type (C17.0) [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9695,3,0,"Follicular lymphoma, small cleaved cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9695,3,0,"Lymphoma (malignant), cleaved cell, follicular small [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9695,3,0,"Lymphoma (malignant), cleaved cell, small, follicular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9695,3,0,"Lymphoma (malignant), duodenal type (C17.0) [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9695,3,0,"Lymphoma (malignant), follicular, grade 1 [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9695,3,0,"Lymphoma (malignant), follicular, small cleaved cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9695,3,0,"Lymphoma (malignant), lymphocytic, nodular, poorly differentiated [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9695,3,0,"Lymphoma (malignant), lymphocytic, poorly differentiated, nodular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9695,3,0,"Lymphoma (malignant), nodular, lymphocytic, poorly differentiated [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9695,3,0,"Lymphoma (malignant), poorly differentiated, lymphocytic, nodular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9695,3,0,"Lymphoma (malignant), small cell, cleaved, follicular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9695,3,0,"Lymphoma (malignant), small cleaved cell, follicular[obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9695,3,0,"Malignant lymphoma, lymphocytic, poorly differentiated, nodular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9695,3,0,"Malignant lymphoma, small cleaved cell, follicular[obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,1,"Follicular lymphoma, grade 3 [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,Large B-cell lymphoma with IRF4 rearrangement [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9698,3,0,"Lymphoma (malignant), centroblastic, follicular [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Lymphoma (malignant), cleaved cell, large, follicular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Lymphoma (malignant), follicular, centroblastic [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Lymphoma (malignant), follicular, grade 3 [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Lymphoma (malignant), follicular, large cell, noncleaved [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Lymphoma (malignant), follicular, large cell, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Lymphoma (malignant), follicular, large cleaved cell [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Lymphoma (malignant), follicular, noncleaved cell, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Lymphoma (malignant), follicular, noncleaved, large cell [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Lymphoma (malignant), histiocytic, nodular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Lymphoma (malignant), large B-cell with IRF4 rearrangement [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Lymphoma (malignant), large cell, cleaved, follicular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Lymphoma (malignant), large cell, follicular, noncleaved [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Lymphoma (malignant), large cell, follicular, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Lymphoma (malignant), large cell, noncleaved, follicular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Lymphoma (malignant), lymphocytic, nodular, well differentiated [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Lymphoma (malignant), lymphocytic, well differentiated, nodular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Lymphoma (malignant), nodular, histiocytic [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Lymphoma (malignant), nodular, lymphocytic, well differentiated [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Lymphoma (malignant), noncleaved cell, follicular, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Lymphoma (malignant), noncleaved, large cell, follicular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Lymphoma (malignant), well-differentiated, lymphocytic, nodular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Malignant lymphoma, centroblastic, follicular [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Malignant lymphoma, histiocytic, nodular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Malignant lymphoma, large B-cell with IRF4 rearrangement [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Malignant lymphoma, large cell, follicular, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Malignant lymphoma, large cell, noncleaved, follicular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Malignant lymphoma, large cleaved cell, follicular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Malignant lymphoma, lymphocytic, well differentiated, nodular [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9698,3,0,"Malignant lymphoma, noncleaved cell, follicular, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9699,3,1,"Marginal zone B-cell lymphoma, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9699,3,0,BALT lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9699,3,0,Bronchus associated lymphoid tissue lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9699,3,0,"Lymphoma (malignant), BALT [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9699,3,0,"Lymphoma (malignant), B-cell, marginal zone, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9699,3,0,"Lymphoma (malignant), B-cell, monocytoid [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9699,3,0,"Lymphoma (malignant), bronchus associated lymphoid tissue [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9699,3,0,"Lymphoma (malignant), lymphoid tissue, bronchus associated [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9699,3,0,"Lymphoma (malignant), lymphoid tissue, mucosa associated [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9699,3,0,"Lymphoma (malignant), lymphoid tissue, skin-associated [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9699,3,0,"Lymphoma (malignant), MALT [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9699,3,0,"Lymphoma (malignant), marginal zone, B-cell, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9699,3,0,"Lymphoma (malignant), marginal zone, nodal [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9699,3,0,"Lymphoma (malignant), marginal zone, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9699,3,0,"Lymphoma (malignant), monocytoid B-cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9699,3,0,"Lymphoma (malignant), mucosa associated lymphoid tissue [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9699,3,0,"Lymphoma (malignant), nodal marginal zone [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9699,3,0,"Lymphoma (malignant), primary choroidal (C69.3) [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9699,3,0,"Lymphoma (malignant), SALT [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9699,3,0,"Lymphoma (malignant), skin associated lymphoid tissue [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9699,3,0,MALT lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9699,3,0,"Marginal zone lymphoma, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9699,3,0,Monocytoid B-cell lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9699,3,0,Mucosa associated lymphoid tissue lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9699,3,0,Nodal marginal zone lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9699,3,0,Primary choroidal lymphoma (C69.3) [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9699,3,0,SALT lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9699,3,0,Skin-associated lymphoid tissue lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9700,3,1,Mycosis fungoides (C44._) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9700,3,0,"Fungoides, mycosis (C44._) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9700,3,0,Pagetoid reticulosis [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9700,3,0,"Reticulosis, Pagetoid [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9701,3,1,Sezary syndrome [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9701,3,0,"Disease, Sezary [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9701,3,0,Sezary disease [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9701,3,0,"Syndrome, Sezary [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,1,1,Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9702,1,0,"Disorder, lymphoproliferative, Indolent T-cell of the gastrointestinal tract [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,1,0,"Lymphoproliferative disorder of the gastrointestinal tract, indolent T-cell [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,1,"Mature T-cell lymphoma, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,Lennert lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9702,3,0,Lymphoepithelioid lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9702,3,0,"Lymphoma (malignant), large cell, peripheral T-cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Lymphoma (malignant), Lennert [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Lymphoma (malignant), lymphoepithelioid [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Lymphoma (malignant), mature T-cell, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Lymphoma (malignant), medium and large cell, peripheral T-cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Lymphoma (malignant), peripheral T-cell, large cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Lymphoma (malignant), peripheral T-cell, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Lymphoma (malignant), peripheral T-cell, pleomorphic medium and large cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Lymphoma (malignant), peripheral T-cell, pleomorphic small cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Lymphoma (malignant), pleomorphic medium and large cell, peripheral T-cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Lymphoma (malignant), pleomorphic small cell, peripheral T-cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Lymphoma (malignant), small cell, pleomorphic, peripheral T-cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Lymphoma (malignant), T-cell, large cell, peripheral [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Lymphoma (malignant), T-cell, mature, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Lymphoma (malignant), T-cell, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Lymphoma (malignant), T-cell, peripheral, large cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Lymphoma (malignant), T-cell, peripheral, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Lymphoma (malignant), T-cell, peripheral, pleomorphic medium and large cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Lymphoma (malignant), T-cell, peripheral, pleomorphic small cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Lymphoma (malignant), T-zone [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Peripheral T-cell lymphoma, large cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Peripheral T-cell lymphoma, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Peripheral T-cell lymphoma, pleomorphic medium and large cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"Peripheral T-cell lymphoma, pleomorphic small cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,"T-cell lymphoma, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9702,3,0,T-zone lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9705,3,1,Angioimmunoblastic T-cell lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9705,3,0,"AILD, peripheral T-cell lymphoma (Angioimmunoblastic Lymphadenopathy with Dysproteinemia) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9705,3,0,"Angioimmunoblastic Lymphadenopathy with dysproteinemia (AILD), peripheral T-cell lymphoma [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9705,3,0,Angioimmunoblastic lymphoma [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9705,3,0,"Dysproteinemia, peripheral T-cell lymphoma, Angioimmunoblastic Lymphadenopathy with (AILD) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9705,3,0,"Lymphadenopathy, angioimmunoblastic, with dysproteinemia (AILD), peripheral T-cell lymphoma [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9705,3,0,"Lymphoma (malignant), AILD (Angioimmunoblastic Lymphadenopathy with Dysproteinemia), peripheral T-cell [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9705,3,0,"Lymphoma (malignant), angioimmunoblastic [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9705,3,0,"Lymphoma (malignant), angioimmunoblastic T-cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9705,3,0,"Lymphoma (malignant), peripheral T-cell, AILD (Angioimmunoblastic Lymphadenopathy with Dysproteinemia) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9705,3,0,"Lymphoma (malignant), T-cell, angioimmunoblastic [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9705,3,0,"Lymphoma (malignant), T-cell, peripheral, AILD (Angioimmunoblastic Lymphadenopathy with Dysproteinemia) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9705,3,0,"Peripheral T-cell lymphoma, AILD (Angioimmunoblastic Lymphadenopathy with Dysproteinemia) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9708,3,1,Subcutaneous panniculitis-like T-cell lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9708,3,0,"Lymphoma (malignant), panniculitis-like T-cell, subcutaneous [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9708,3,0,"Lymphoma (malignant), subcutaneous panniculitis-like T-cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9708,3,0,"Lymphoma (malignant), T-cell, subcutaneous panniculitis-like [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9709,1,1,Primary cutaneous CD4-positive small/medium T-cell lymphoproliferative disorder (C44._) [2021+ NOT REPORTABLE; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9709,1,0,"Lymphoproliferative disorder, primary cutaneous CD4-positive small/medium T-cell (C44._) [2021+ NOT REPORTABLE; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9709,1,0,Primary cutaneous CD4-positive small/medium T-cell lymphoma (C44._) [obs] [2021+ NOT REPORTABLE; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9709,3,1,"Cutaneous T-cell lymphoma, NOS (C44._) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9709,3,0,"Cutaneous lymphoma, NOS (C44._) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9709,3,0,"Lymphoma (malignant), cutaneous, NOS (C44._) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9709,3,0,"Lymphoma (malignant), cutaneous, T-cell, NOS (C44._) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9709,3,0,"Lymphoma (malignant), T-cell, cutaneous, NOS (C44._) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9709,3,0,"Lymphoma (malignant), T-cell, NOS, cutaneous (C44._) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9709,3,0,Primary cutaneous acral CD8-positive T-cell lymphoma (C44._) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9709,3,0,"Primary cutaneous CD4-positive small/medium T-cell lymphoma (C44._) [obs] [REPORTABLE PRE-2021; FOR 2021+, USE 9709/1; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9712,3,1,Intravascular large B-cell lymphoma [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9714,3,1,"Anaplastic large cell lymphoma, T-cell and Null cell type [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9714,3,0,"Anaplastic large cell lymphoma, CD30+ [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9714,3,0,"Anaplastic large cell lymphoma, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9714,3,0,Large cell (Ki-1+) lymphoma [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9714,3,0,"Lymphoma (malignant), anaplastic large cell, CD30+ [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9714,3,0,"Lymphoma (malignant), anaplastic large cell, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9714,3,0,"Lymphoma (malignant), anaplastic large cell, T-cell and Null cell type [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9714,3,0,"Lymphoma (malignant), CD30+ anaplastic large cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9714,3,0,"Lymphoma (malignant), Ki-1+ large cell [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9714,3,0,"Lymphoma (malignant), large cell (Ki-1+) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9714,3,0,"Lymphoma (malignant), large cell anaplastic, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9714,3,0,"Lymphoma (malignant), large cell anaplastic, T-cell and Null cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9714,3,0,"Lymphoma (malignant), large cell CD30+ anaplastic [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9714,3,0,"Lymphoma (malignant), large cell, anaplastic, CD 30+ [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9714,3,0,"Lymphoma (malignant), null cell and T-cell type anaplastic large cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9714,3,0,"Lymphoma (malignant), T-cell, anaplastic large cell, T-cell and Null cell type [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9715,3,1,"Anaplastic large cell lymphoma, ALK negative [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9715,3,0,"Anaplastic large cell lymphoma, Breast implant-associated (C50._) [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9715,3,0,Breast implant-associated anaplastic large cell lymphoma (C50._) [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9715,3,0,"Lymphoma (malignant), ALK negative, anaplastic large cell [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9715,3,0,"Lymphoma (malignant), ALK negative, large cell, anaplastic [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9715,3,0,"Lymphoma (malignant), anaplastic large cell, ALK negative [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9715,3,0,"Lymphoma (malignant), anaplastic large cell, Breast implant-associated (C50._) [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9715,3,0,"Lymphoma (malignant), Breast implant-associated, anaplastic large cell (C50._) [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9715,3,0,"Lymphoma (malignant), Breast implant-associated, large cell, anaplastic (C50._) [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9715,3,0,"Lymphoma (malignant), large cell, anaplastic, ALK negative [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9715,3,0,"Lymphoma (malignant), large cell, anaplastic, Breast implant-associated (C50._) [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9715,3,0,"Lymphoma, ALK negative, anaplastic large cell [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9715,3,0,"Lymphoma, ALK negative, large cell, anaplastic [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9715,3,0,"Lymphoma, anaplastic large cell, ALK negative [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9715,3,0,"Lymphoma, anaplastic large cell, Breast implant-associated (C50._) [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9715,3,0,"Lymphoma, Breast implant-associated, anaplastic large cell (C50._) [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9715,3,0,"Lymphoma, Breast implant-associated, large cell, anaplastic (C50._) [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9715,3,0,"Lymphoma, large cell, anaplastic, ALK negative [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9715,3,0,"Lymphoma, large cell, anaplastic, Breast implant-associated (C50._) [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9716,3,1,Hepatosplenic gamma-delta cell lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9716,3,0,"Lymphoma (malignant), hepatosplenic gamma-delta cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9717,3,1,Intestinal T-cell lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9717,3,0,Enteropathy associated T-cell lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9717,3,0,Enteropathy type intestinal T-cell lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9717,3,0,"Lymphoma (malignant), enteropathy associated T-cell lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9717,3,0,"Lymphoma (malignant), enteropathy type intestinal T-cell lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9717,3,0,"Lymphoma (malignant), intestinal T-cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9717,3,0,"Lymphoma (malignant), intestinal T-cell, enteropathy type [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9717,3,0,"Lymphoma (malignant), T-cell, enteropathy associated [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9717,3,0,"Lymphoma (malignant), T-cell, enteropathy type, intestinal [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9717,3,0,"Lymphoma (malignant), T-cell, intestinal [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9718,1,1,Primary cutaneous CD30+ T-cell lymphoproliferative disorder (C44._) [2021+ NOT REPORTABLE; FOR PRE-2021 USE CODE 9718/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9718,1,0,"CD30+ T-cell lymphoproliferative disorder, primary cutaneous (C44._) [2021+ NOT REPORTABLE; FOR PRE-2021 USE CODE 9718/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9718,1,0,"Cutaneous CD30+ T-cell lymphoproliferative disorder, primary (C44._) [2021+ NOT REPORTABLE; FOR PRE-2021 USE CODE 9718/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9718,1,0,Lymphomatoid papulosis (C44._) [2010-2020 NOT REPORTABLE; FOR PRE-2010 USE CODE 9718/3; FOR 2021+ USE CODE 9766/1; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9718,1,0,"Lymphoproliferative disorder, primary cutaneous CD30+ T-cell (C44._) [2021+ NOT REPORTABLE; FOR PRE-2021 USE CODE 9718/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9718,1,0,"Lymphoproliferative disorder, primary cutaneous CD30+ T-cell (C44._) [2021+ NOT REPORTABLE; FOR PRE-2021 USE CODE 9718/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9718,1,0,"Papulosis, lymphomatoid (C44._)  [2010-2020 NOT REPORTABLE; FOR PRE-2010 USE CODE 9718/3; FOR 2021+ USE CODE 9766/1; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9718,1,0,"T-cell lymphoproliferative disorder, primary cutaneous CD30+ (C44._) [2021+ NOT REPORTABLE; FOR PRE-2021 USE CODE 9718/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9718,3,1,Primary cutaneous anaplastic large cell lymphoma (C44._) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9718,3,0,"CD30+ large T-cell lymphoma, primary cutaneous(C44._) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9718,3,0,"CD30+ T-cell lymphoproliferative disorder, primary cutaneous (C44._) [PRE-2021 REPORTABLE. FOR 2021+ USE CODE 9718/1; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9718,3,0,"Cutaneous CD30+ T-cell lymphoproliferative disorder, primary (C44._) [PRE-2021 REPORTABLE. FOR 2021+ USE CODE 9718/1; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9718,3,0,"Lymphoma (malignant), anaplastic large cell, primary cutaneous (C44._) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9718,3,0,"Lymphoma (malignant), CD30+ large T-cell, primary cutaneous (C44._) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9718,3,0,"Lymphoma (malignant), cutaneous, CD30+ large T-cell, primary (C44._) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9718,3,0,"Lymphoma (malignant), cutaneous, primary, anaplastic large-cell (C44._) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9718,3,0,"Lymphoma (malignant), primary cutaneous anaplastic large-cell (C44._) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9718,3,0,"Lymphoma (malignant), primary cutaneous CD30+ large T-cell (C44._) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9718,3,0,"Lymphoma (malignant), T-cell, primary cutaneous CD30+ large (C44._) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9718,3,0,Lymphomatoid papulosis (C44._) [PRE-2010 REPORTABLE. FOR 2010-2020 USE CODE 9718/1; FOR 2021+ USE CODE 9766/1; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9718,3,0,"Lymphoproliferative disorder, primary cutaneous CD30+ T-cell (C44._) [PRE-2021 REPORTABLE. FOR 2021+ USE CODE 9718/1; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9718,3,0,"Lymphoproliferative disorder, primary cutaneous CD30+ T-cell (C44._) [PRE-2021 REPORTABLE. FOR 2021+ USE CODE 9718/1; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9718,3,0,"Papulosis, lymphomatoid (C44._) [PRE-2010 REPORTABLE. FOR 2010-2020 USE CODE 9718/1; FOR 2021+ USE CODE 9766/1; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9718,3,0,Primary cutaneous CD30+ large T-cell lymphoma (C44._) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9718,3,0,Primary cutaneous CD30+ T-cell lymphoproliferative disorder (C44._) [PRE-2021 REPORTABLE. FOR 2021+ USE CODE 9718/1; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9718,3,0,"T-cell lymphoproliferative disorder, primary cutaneous CD30+ (C44._) [PRE-2021 REPORTABLE. FOR 2021+ USE CODE 9718/1; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9719,3,1,"NK/T-cell lymphoma, nasal and nasal-type [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9719,3,0,Angiocentric T-cell lymphoma [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9719,3,0,"Lymphoma (malignant), angiocentric T-cell [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9719,3,0,"Lymphoma (malignant), NK/T-cell lymphoma, nasal and nasal-type [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9719,3,0,"Lymphoma (malignant), T/NK-cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9719,3,0,"Lymphoma (malignant), T-cell, angiocentric [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9719,3,0,Malignant midline reticulosis [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9719,3,0,"Malignant reticulosis, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9719,3,0,"Midline reticulosis, malignant [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9719,3,0,Polymorphic reticulosis [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9719,3,0,"Reticulosis, malignant midline [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9719,3,0,"Reticulosis, malignant, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9719,3,0,"Reticulosis, polymorphic [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9719,3,0,T/NK-cell lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9724,3,1,Systemic EBV-positive T-cell lymphoproliferative disease of childhood [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9725,1,1,Hydroa vacciniforme-like lymphoproliferative disorder [2021 AND LATER NOT REPORTABLE. FOR PRE-2010 USE CODE 9725/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9725,1,0,Hydroa vacciniforme-like lymphoma [2021 AND LATER NOT REPORTABLE. FOR PRE-2010 USE CODE 9725/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9725,3,1,Hydroa vacciniforme-like lymphoproliferative disorder [REPORTABLE 2010 - 2020 ONLY. FOR 2021+ USE CODE 9725/1; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9725,3,0,Hydroa vacciniforme-like lymphoma [REPORTABLE 2010 - 2020 ONLY. FOR 2021+ USE CODE 9725/1; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9726,3,1,Primary cutaneous gamma delta T-cell lymphoma [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9727,3,1,"Precursor cell lymphoblastic lymphoma, NOS (see also M-9835/3) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9727,3,0,Lymphoblastoma [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9727,3,0,"Lymphoma (malignant), convoluted cell [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9727,3,0,"Lymphoma (malignant), lymphoblastic, NOS (see also M-9835/3) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9727,3,0,"Lymphoma (malignant), lymphoblastic, precursor cell, NOS (see also M-9835/3) [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9727,3,0,"Lymphoma (malignant), precursor cell lymphoblastic, NOS (see also M-9835/3) [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9727,3,0,"Malignant lymphoma, convoluted cell [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9727,3,0,"Malignant lymphoma, lymphoblastic, NOS (see also M-9835/3) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9728,3,1,Precursor B-cell lymphoblastic lymphoma [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9728,3,0,"Lymphoma (malignant), B-cell, lymphoblastic, precursor [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9728,3,0,"Lymphoma (malignant), B-cell, precursor, lymphoblastic [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9728,3,0,"Lymphoma (malignant), lymphoblastic, precursor B-cell [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9728,3,0,"Lymphoma (malignant), precursor B-cell lymphoblastic [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9729,3,1,"Precursor T-cell lymphoblastic lymphoma, NOS B lymphoblastic  [PRE-2010 ONLY. FOR 2010+ USE CODE 9837/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9729,3,0,"Lymphoma (malignant), lymphoblastic, precursor T-cell [PRE-2010 ONLY. FOR 2010+ USE CODE 9837/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9729,3,0,"Lymphoma (malignant), precursor T-cell lymphoblastic [PRE-2010 ONLY. FOR 2010+ USE CODE 9837/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9729,3,0,"Lymphoma (malignant), T-cell, lymphoblastic, precursor [PRE-2010 ONLY. FOR 2010+ USE CODE 9837/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9729,3,0,"Lymphoma (malignant), T-cell, precursor, lymphoblastic [PRE-2010 ONLY. FOR 2010+ USE CODE 9837/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9731,3,1,"Plasmacytoma, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9731,3,0,"Myeloma, solitary [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9731,3,0,Plasma cell tumor [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9731,3,0,"Plasmacytoma of bone (C40._, C41._) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9731,3,0,"Plasmacytoma, solitary [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9731,3,0,Solitary myeloma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9731,3,0,Solitary plasmacytoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9731,3,0,"Tumor, plasma cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9732,3,1,Plasma cell myeloma [2010+. FOR PRE-2010 USE CODE 9733/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9732,3,0,Multiple myeloma [2010+. FOR PRE-2010 USE CODE 9733/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9732,3,0,"Myeloma, multiple [2010+. FOR PRE-2010 USE CODE 9733/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9732,3,0,"Myeloma, NOS [2010+. FOR PRE-2010 USE CODE 9733/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9732,3,0,"Myeloma, plasma cell [2010+. FOR PRE-2010 USE CODE 9733/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9732,3,0,Myelomatosis [2010+. FOR PRE-2010 USE CODE 9733/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9733,3,1,Plasma cell leukemia [PRE-2010 ONLY. FOR 2010+ USE CODE 9832/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9733,3,0,"Leukemia, plasma cell [PRE-2010 ONLY. FOR 2010+ USE CODE 9832/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9733,3,0,"Leukemia, plasmacytic [PRE-2010 ONLY. FOR 2010+ USE CODE 9832/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9733,3,0,Plasmacytic leukemia [PRE-2010 ONLY. FOR 2010+ USE CODE 9832/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9734,3,1,"Plasmacytoma, extramedullary (not occurring in bone) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9734,3,0,Extramedullary plasmacytoma (not occurring in bone) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9735,3,1,Plasmablastic lymphoma [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9737,3,1,ALK-positive large B-cell lymphoma [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9738,1,1,HHV8-positive germinotrophic-lymphoproliferative disorder [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9738,3,1,HHV8-positive diffuse large B-cell lymphoma [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9738,3,0,Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9740,1,1,"Mastocytoma, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9740,1,0,"Mast cell tumor, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9740,1,0,"Tumor, mast cell, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9740,3,1,Mast cell sarcoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9740,3,0,Malignant mast cell tumor [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9740,3,0,Malignant mastocytoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9740,3,0,"Mast cell tumor, malignant [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9740,3,0,"Mastocytoma, malignant [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9740,3,0,"Sarcoma, mast cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9740,3,0,"Tumor, mast cell, malignant [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9741,1,1,Indolent systemic mastocytosis [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9741,1,0,"Mastocytosis, indolent systemic [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9741,1,0,"Systemic mastocytosis, indolent [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9741,3,1,Malignant mastocytosis [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9741,3,0,"Disease, mast cell, systemic tissue [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9741,3,0,"Disease, systemic tissue mast cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9741,3,0,"Mast cell disease, systemic tissue [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9741,3,0,"Mastocytosis, malignant [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9741,3,0,Systemic tissue mast cell disease [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9742,3,1,Mast cell leukemia (C42.1; SEE HEMATOPOIETIC DATABASE FOR REPORTING)
9742,3,0,"Leukemia, mast cell (C42.1; SEE HEMATOPOIETIC DATABASE FOR REPORTING)"
9749,3,1,Erdheim-Chester disease [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9749,3,0,"Disease, Erdheim-Chester [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9750,3,1,Malignant histiocytosis [PRE-2010 ONLY. FOR 2010+ USE CODE 9651/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9750,3,0,Histiocytic medullary reticulosis [PRE-2010 ONLY. FOR 2010+ USE CODE 9651/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9750,3,0,"Histiocytosis, malignant [PRE-2010 ONLY. FOR 2010+ USE CODE 9651/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9750,3,0,Medullary histiocytic reticulosis [PRE-2010 ONLY. FOR 2010+ USE CODE 9651/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9750,3,0,"Medullary reticulosis, histiocytic [PRE-2010 ONLY. FOR 2010+ USE CODE 9651/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9750,3,0,"Reticulosis, histiocytic medullary [PRE-2010 ONLY. FOR 2010+ USE CODE 9651/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,1,1,"Langerhans cell histiocytosis, NOS [NOT REPORTABLE 2021+. FOR 2010 - 2020 USE CODE 9751/3. FOR PRE-2010 USE CODE 9750/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,1,0,"Histiocytosis, Langerhans cell [NOT REPORTABLE 2021+. FOR 2010 - 2020 USE CODE 9751/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,1,0,"Histiocytosis, Langerhans cell, mono-ostotic [NOT REPORTABLE 2021+. FOR 2010 - 2020 USE CODE 9751/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,1,0,"Histiocytosis, Langerhans cell, poly-ostotic [NOT REPORTABLE 2021+. FOR 2010 - 2020 USE CODE 9751/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,1,0,"Langerhans cell histiocytosis, mono-ostotic [NOT REPORTABLE 2021+. FOR 2010 - 2020 USE CODE 9751/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,1,0,"Langerhans cell histiocytosis, poly-ostotic [NOT REPORTABLE 2021+. FOR 2010 - 2020 USE CODE 9751/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,1,0,Mono-ostotic Langerhans cell histiocytosis [NOT REPORTABLE 2021+. FOR 2010 - 2020 USE CODE 9751/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9751,1,0,Poly-ostotic Langerhans cell histiocytosis [NOT REPORTABLE 2021+. FOR 2010 - 2020 USE CODE 9751/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9751,3,1,"Langerhans cell histiocytosis, disseminated [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,Acute progressive histiocytosis X [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9751,3,0,"Disease, Hand-Schuller-Christian (if multiple lesions or visceral involvement) [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,"Disease, Letterer-Siwe [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,Disseminated Langerhans cell histiocytosis [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9751,3,0,Eosinophilic granuloma [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9751,3,0,Generalized Langerhans cell histiocytosis [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9751,3,0,"Granuloma, eosinophilic [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,"Granulomatosis, Langerhans cell [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,"Granulomatosis, Langerhans cell, unifocal [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,Hand-Schuller-Christian disease [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9751,3,0,"Histiocytosis X, acute progressive [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,"Histiocytosis X, NOS [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,"Histiocytosis, Langerhans cell [REPORTABLE 2010 - 2020 ONLY. FOR 2021+ USE CODE 9751/1; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,"Histiocytosis, Langerhans cell, disseminated [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,"Histiocytosis, Langerhans cell, generalized [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,"Histiocytosis, Langerhans cell, mono-ostotic [REPORTABLE 2010 - 2020 ONLY. FOR 2021+ USE CODE 9751/1; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,"Histiocytosis, Langerhans cell, multifocal [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,"Histiocytosis, Langerhans cell, poly-ostotic [REPORTABLE 2010 - 2020 ONLY. FOR 2021+ USE CODE 9751/1; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,"Histiocytosis, Langerhans cell, unifocal [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,Langerhans cell granulomatosis [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9751,3,0,"Langerhans cell granulomatosis, unifocal [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,"Langerhans cell histiocytosis, generalized [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,"Langerhans cell histiocytosis, mono-ostotic [REPORTABLE 2010 - 2020 ONLY. FOR 2021+ USE CODE 9751/1; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,"Langerhans cell histiocytosis, multifocal [REPORTABLE 2010+;  SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,"Langerhans cell histiocytosis, NOS [FOR 2010-2020 ONLY. FOR 2021+ USE CODE 9751/1. FOR PRE-2010 USE CODE 9750/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,"Langerhans cell histiocytosis, poly-ostotic [REPORTABLE 2010 - 2020 ONLY. FOR 2021+ USE CODE 9751/1; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,"Langerhans cell histiocytosis, unifocal [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,Letterer-Siwe disease (if disseminated or visceral involvement) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9751,3,0,Mono-ostotic Langerhans cell histiocytosis [REPORTABLE 2010 - 2020 ONLY. FOR 2021+ USE CODE 9751/1; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9751,3,0,Multifocal Langerhans cell histiocytosis [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9751,3,0,Nonlipid reticuloendotheliosis [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9751,3,0,Poly-ostotic Langerhans cell histiocytosis [REPORTABLE 2010 - 2020 ONLY. FOR 2021+ USE CODE 9751/1; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9751,3,0,"Progressive histiocytosis X, acute [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,"Reticuloendotheliosis, nonlipid [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9751,3,0,Unifocal Langerhans cell granulomatosis [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9751,3,0,Unifocal Langerhans cell histiocytosis [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9752,1,1,"Langerhans cell histiocytosis, unifocal [obs] [PRE-2010 NOT REPORTABLE. FOR 2010+ USE CODE 9751/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9752,1,0,Unifocal Langerhans cell histiocytosis [obs] [PRE-2010 NOT REPORTABLE. FOR 2010+ USE CODE 9751/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9753,1,1,"Langerhans cell histiocytosis, multifocal [obs] [PRE-2010 NOT REPORTABLE. FOR 2010+ USE CODE 9751/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9753,1,0,Multifocal Langerhans cell histiocytosis [obs] [PRE-2010 NOT REPORTABLE. FOR 2010+ USE CODE 9751/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9754,3,1,"Langerhans cell histiocytosis, disseminated [obs] [FOR 1978-2009 ONLY. FOR 2010+ USE CODE 9751/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9754,3,0,Disseminated Langerhans cell histiocytosis [obs] [FOR 1978-2009 ONLY. FOR 2010+ USE CODE 9751/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9755,3,1,Histiocytic sarcoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9755,3,0,"Histiocytic lymphoma, true [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9755,3,0,"Lymphoma (malignant), histiocytic, true [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9755,3,0,"Lymphoma (malignant), true histiocytic [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9755,3,0,"Sarcoma, histiocytic [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9755,3,0,True histiocytic lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9756,3,1,Langerhans cell sarcoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9756,3,0,"Sarcoma, Langerhans cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9757,3,1,Interdigitating dendritic cell sarcoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9757,3,0,"Dendritic cell sarcoma, interdigitating [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9757,3,0,"Dendritic cell sarcoma, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9757,3,0,Interdigitating cell sarcoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9757,3,0,"Sarcoma, dendritic cell, interdigitating [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9757,3,0,"Sarcoma, dendritic cell, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9757,3,0,"Sarcoma, interdigitating cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9757,3,0,"Sarcoma, interdigitating dendritic cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9758,3,1,Follicular dendritic cell sarcoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9758,3,0,"Dendritic cell sarcoma, follicular [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9758,3,0,"Dendritic cell tumor, follicular [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9758,3,0,Follicular dendritic cell tumor [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9758,3,0,"Sarcoma, dendritic cell, follicular [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9758,3,0,"Sarcoma, follicular dendritic cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9758,3,0,"Tumor, dendritic cell, follicular [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9758,3,0,"Tumor, follicular dendritic cell [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9759,3,1,Fibroblastic reticular cell tumor [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9760,3,1,"Immunoproliferative disease, NOS [PRE-2010 ONLY. FOR 2010+ SEE CODES 9761/3 AND 9762/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9760,3,0,"Disease, immunoproliferative, NOS [PRE-2010 ONLY. FOR 2010+ SEE CODES 9761/3 AND 9762/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9761,1,1,IgM monoclonal gammopathy of undetermined significance [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9761,1,0,"Gammopathy, IgM monoclonal of undetermined significance [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9761,3,1,Waldenstrom macroglobulinemia [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9761,3,0,"Macroglobulinemia, Waldenstrom [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9762,3,1,Heavy chain disease [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9762,3,0,Alpha heavy chain disease [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9762,3,0,"Chain disease, alpha heavy [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9762,3,0,"Chain disease, gamma heavy [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9762,3,0,"Chain disease, mu heavy [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9762,3,0,"Chain disease, NOS, heavy [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9762,3,0,"Disease, alpha heavy chain [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9762,3,0,"Disease, Franklin [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9762,3,0,"Disease, gamma heavy chain [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9762,3,0,"Disease, heavy chain, alpha [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9762,3,0,"Disease, heavy chain, gamma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9762,3,0,"Disease, heavy chain, mu [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9762,3,0,"Disease, heavy chain, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9762,3,0,"Disease, mu heavy chain [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9762,3,0,Franklin disease [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9762,3,0,Gamma heavy chain disease [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9762,3,0,"Heavy chain disease, alpha [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9762,3,0,"Heavy chain disease, gamma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9762,3,0,"Heavy chain disease, mu [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9762,3,0,"Lymphoma (malignant), Mediterranean [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9762,3,0,Mediterranean lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9762,3,0,Mu heavy chain disease [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9764,3,1,Immunoproliferative small intestinal disease (C17._) [PRE-2010 ONLY. FOR 2010+ USE CODE 9762/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9764,3,0,"Disease, immunoproliferative small intestinal (C17._) [PRE-2010 ONLY. FOR 2010+ USE CODE 9762/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9764,3,0,"Disease, small intestinal, immunoproliferative (C17._) [PRE-2010 ONLY. FOR 2010+ USE CODE 9762/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9764,3,0,"Intestinal, small, immunoproliferative disease (C17._) [PRE-2010 ONLY. FOR 2010+ USE CODE 9762/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9764,3,0,"Lymphoma (malignant), Mediterranean [PRE-2010 ONLY. FOR 2010+ USE CODE 9762/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9764,3,0,Mediterranean lymphoma [PRE-2010 ONLY. FOR 2010+ USE CODE 9762/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9764,3,0,Small intestinal immunoproliferative disease (C17._) [PRE-2010 ONLY. FOR 2010+ USE CODE 9762/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9765,1,1,Monoclonal gammopathy of undetermined significance [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9765,1,0,"Gammopathy, monoclonal, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9765,1,0,"Gammopathy, monoclonal, of undetermined significance [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9765,1,0,MGUS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9765,1,0,"Monoclonal gammopathy, NOS [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9765,1,0,"Undetermined significance, monoclonal gammopathy of [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9766,1,1,Angiocentric immunoproliferative lesion [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9766,1,0,"Granulomatosis, lymphomatoid [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9766,1,0,"Granulomatosis, lymphomatoid, grade 1 [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9766,1,0,"Granulomatosis, lymphomatoid, grade 2 [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9766,1,0,Immunoproliferative angiocentric lesion [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9766,1,0,"Immunoproliferative lesion, angiocentric [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9766,1,0,"Lesion, angiocentric immunoproliferative [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9766,1,0,Lymphomatoid granulomatosis [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9766,1,0,"Lymphomatoid granulomatosis, grade 1 [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9766,1,0,"Lymphomatoid granulomatosis, grade 2 [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9766,1,0,Lymphomatoid papulosis (C44._) [FOR 2021+ NOT REPORTABLE; USE CODE 9718/1 FOR 2010-2020; USE CODE 9718/3 FOR PRE-2010. SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9766,1,0,"Papulosis, lymphomatoid (C44._) [FOR 2021+ NOT REPORTABLE; USE CODE 9718/1 FOR 2010-2020; USE CODE 9718/3 FOR PRE-2010. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9766,3,1,"Lymphomatoid granulomatosis, grade 3 [2021+; FOR PRE-2021 USE CODE 9680/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9766,3,0,"Granulomatosis, lymphomatoid, grade 3 [2021+; FOR PRE-2021 USE CODE 9680/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9766,3,0,"Lymphomatoid Papulosis, Grade 3 [2021+; FOR PRE 2021 USE CODE 9680/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9766,3,0,"Papulosis Lymphomatoid, Grade 3 [2021+; FOR PRE 2021 USE CODE 9680/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9767,1,1,Angioimmunoblastic lymphadenopathy (AIL) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9767,1,0,AIL (Angioimmunoblastic lymphadenopathy) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9767,1,0,IBL (Immunoblastic lymphadenopathy) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9767,1,0,Immunoblastic lymphadenopathy (IBL) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9767,1,0,"Lymphadenopathy, angioimmunoblastic (AIL) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9767,1,0,"Lymphadenopathy, immunoblastic (IBL) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9768,1,1,T-gamma lymphoproliferative disease [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9768,1,0,"Disease, lymphoproliferative, T-gamma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9768,1,0,"Disease, T-gamma lymphoproliferative [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9768,1,0,"Lymphoproliferative disease, T-gamma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9769,1,1,Immunoglobulin deposition disease [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9769,1,0,"Amyloidosis, primary [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9769,1,0,"Deposition disease, immunoglobulin [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9769,1,0,"Disease, deposition, immunoglobulin [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9769,1,0,"Disease, immunoglobulin deposition [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9769,1,0,"Disease, systemic light chain [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9769,1,0,"Light chain disease, systemic [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9769,1,0,Primary amyloidosis [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9769,1,0,Systemic light chain disease [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9800,3,1,"Leukemia, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9800,3,0,"Aleukemic leukemia, NOS (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9800,3,0,"Chronic leukemia, NOS (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9800,3,0,"Leukemia, aleukemic, NOS (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9800,3,0,"Leukemia, chronic, NOS (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9800,3,0,"Leukemia, subacute, NOS (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9800,3,0,"Subacute leukemia, NOS (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9801,3,1,"Acute leukemia, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9801,3,0,Blast cell leukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9801,3,0,"Leukemia, acute, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9801,3,0,"Leukemia, blast cell (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9801,3,0,"Leukemia, stem cell (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9801,3,0,"Leukemia, undifferentiated (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9801,3,0,Stem cell leukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9801,3,0,Undifferentiated leukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9805,3,1,Acute biphenotypic leukemia (C42.1) [PRE 2010 ONLY. FOR 2010+ USE CODES 9806 - 9809; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9805,3,0,Acute bilineal leukemia (C42.1) [PRE 2010 ONLY. FOR 2010+ USE CODES 9806 - 9809; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9805,3,0,Acute mixed lineage leukemia (C42.1) [PRE 2010 ONLY. FOR 2010+ USE CODES 9806 - 9809; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9805,3,0,"Leukemia, acute, bilineal (C42.1) [PRE 2010 ONLY. FOR 2010+ USE CODES 9806 - 9809; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9805,3,0,"Leukemia, acute, biphenotypic (C42.1) [PRE 2010 ONLY. FOR 2010+ USE CODES 9806 - 9809; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9805,3,0,"Leukemia, acute, mixed lineage (C42.1) [PRE 2010 ONLY. FOR 2010+ USE CODES 9806 - 9809; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9805,3,0,"Leukemia, bilineal, acute (C42.1) [PRE 2010 ONLY. FOR 2010+ USE CODES 9806 - 9809; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9805,3,0,"Leukemia, biphenotypic, acute (C42.1) [PRE 2010 ONLY. FOR 2010+ USE CODES 9806 - 9809; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9805,3,0,"Leukemia, mixed lineage, acute (C42.1) [PRE 2010 ONLY. FOR 2010+ USE CODES 9806 - 9809; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9806,3,1,Mixed phenotype acute leukemia with t(9;22)(q34;q11.2); BCR-ABL1 [2010 AND LATER ONL. FOR PRE 2010 USE CODE 9805/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9806,3,0,"Acute leukemia, mixed phenotype with t(9;22)(q34;q11.2); BCR-ABL1 [2010+. FOR PRE 2010 USE CODE 9805/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9806,3,0,"Leukemia, acute, mixed phenotype with t(9;22)(q34;q11.2); BCR-ABL1 [2010+. FOR PRE 2010 USE CODE 9805/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9807,3,1,Mixed phenotype acute leukemia with t(v;11q23); MLL rearranged [2010+. FOR PRE 2010 USE CODE 9805/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9807,3,0,"Acute leukemia, mixed phenotype with t(v;11q23); MLL rearranged [2010+. FOR PRE 2010 USE CODE 9805/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9807,3,0,"Leukemia, acute, mixed phenotype with t(v;11q23); MLL rearranged [2010+. FOR PRE 2010 USE CODE 9805/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9808,3,1,"Mixed phenotype acute leukemia, B/myeloid, NOS [2010+. FOR PRE 2010 USE CODE 9805/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9808,3,0,"Acute leukemia, mixed phenotype, B/myeloid, NOS [2010+.FOR PRE 2010 USE CODE 9805/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9808,3,0,"Leukemia, acute, mixed phenotype, B/myeloid, NOS [2010+. FOR PRE 2010 USE CODE 9805/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9809,3,1,"Mixed phenotype acute leukemia, T/myeloid, NOS [2010+. FOR PRE 2010 USE CODE 9805/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9809,3,0,"Acute biphenic leukemia, NOS [2010+. FOR PRE 2010 USE CODE 9805/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9809,3,0,"Acute leukemia, mixed phenotype, T/myeloid, NOS [2010+. FOR PRE 2010 USE CODE 9805/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9809,3,0,"Leukemia, acute biphenic, NOS [2010+. FOR PRE 2010 USE CODE 9805/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9809,3,0,"Leukemia, acute, mixed phenotype, T/myeloid, NOS [2010+. FOR PRE 2010 USE CODE 9805/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9810,3,1,Compound leukemia [obs] [FOR 1978-1991 ONLY. FOR 1992+ USE CODE 9800/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9811,3,1,"B lymphoblastic leukemia/lymphoma, NOS [2010+. FOR PRE 2010 USE CODE 9728/3, 9835/3, OR 9836/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"ALL, c (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"ALL, common precursor B (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"ALL, pre-B (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"ALL, pre-pre-B (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"ALL, pro-B (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"B-ALL, common precursor (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,c-ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9811,3,0,Common ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9811,3,0,Common precursor B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9811,3,0,"Leukemia, acute, pre-B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"Leukemia, acute, pre-pre-B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"Leukemia, acute, pro-B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"Leukemia, B-cell, lymphoblastic, precursor (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"Leukemia, C-ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"Leukemia, common ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"Leukemia, common precursor ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"Leukemia, lymphoblastic, precursor, B-cell (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"Leukemia, lymphocytic, pre-B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"Leukemia, lymphocytic, pre-pre-B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"Leukemia, lymphocytic, pro-B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"Leukemia, pre-B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"Leukemia, precursor, B-cell lymphoblastic (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"Leukemia, pre-pre-B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"Leukemia, pro-B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"Leukemia/lymphoma, B lymphoblastic, NOS  [2010+. FOR PRE 2010 USE CODE 9728/3, 9835/3, OR 9836/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"Leukemia/lymphoma, B-lymphoblastic, not otherwise specified (NOS) [2010+. FOR PRE-2010 USE CODE 9728/3, 9835, OR 9836/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"Lymphoblastic leukemia/lymphoma, B, NOS [2010+. FOR PRE 2010 USE CODE 9728/3, 9835/3, OR 9836/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,"Lymphoma/leukemia, B lymphoblastic, NOS [2010+. FOR PRE 2010 USE CODE 9728/3, 9835/3, OR 9836/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9811,3,0,Pre-B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9811,3,0,Precursor B-cell lymphoblastic leukemia (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9811,3,0,Pre-pre-B ALL [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9811,3,0,Pro-B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9812,3,1,B lymphoblastic leukemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1 [2010+. FOR PRE 2010 USE CODE 9835/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9812,3,0,"Leukemia/lymphoma, B lymphoblastic, with t(9;22)(q34;q11.2); BCR-ABL1 [2010+; FOR PRE 2010 USE CODE 9835/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9813,3,1,B lymphoblastic leukemia/lymphoma with t(v;11q23); MLL rearranged [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9813,3,0,"Leukemia/lymphoma, B lymphoblastic, with t(v;11q23); MLL rearranged [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9814,3,1,B lymphoblastic  leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1 (ETV6-RUNX1) [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9814,3,0,"Leukemia/lymphoma, B lymphoblastic, with t(12;21)(p13;q22);TEL-AML1 (ETV6-RUNX1) [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9815,3,1,B lymphoblastic leukemia/lymphoma with hyperdiploidy [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9815,3,0,"Leukemia/lymphoma, B lymphoblastic, with hyperdiploidy [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9816,3,1,B lymphoblastic leukemia/lymphoma with hypodiploidy (hypodiploid ALL) [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9816,3,0,"Leukemia/lymphoma, B lymphoblastic, with hypodiploidy (hypodiploid ALL) [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9817,3,1,B lymphoblastic leukemia/lymphoma with t(5;14)(q31;q32); IL3-IGH [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9817,3,0,"Leukemia/lymphoma, B lymphoblastic, with t(5;14)(q31;q32); IL3-IGH [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9818,3,1,B lymphoblastic leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1) [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9818,3,0,"Leukemia/lymphoma, B lymphoblastic, with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1) [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9819,3,1,"B lymphoblastic leukemia/lymphoma, BCR-ABL1–like [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9819,3,0,"Leukemia/lymphoma, B lymphoblastic, BCR-ABL1–like [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9820,3,1,"Lymphoid leukemia, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9820,3,0,Aleukemic lymphatic leukemia (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9820,3,0,Aleukemic lymphocytic leukemia (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9820,3,0,Aleukemic lymphoid leukemia (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9820,3,0,"Leukemia, aleukemic, lymphatic (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9820,3,0,"Leukemia, aleukemic, lymphocytic (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9820,3,0,"Leukemia, aleukemic, lymphoid (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9820,3,0,"Leukemia, lymphatic, aleukemic (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9820,3,0,"Leukemia, lymphatic, NOS (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9820,3,0,"Leukemia, lymphatic, subacute (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9820,3,0,"Leukemia, lymphocytic, aleukemic (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9820,3,0,"Leukemia, lymphocytic, NOS (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9820,3,0,"Leukemia, lymphocytic, subacute (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9820,3,0,"Leukemia, lymphoid, aleukemic (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9820,3,0,"Leukemia, lymphoid, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9820,3,0,"Leukemia, lymphoid, subacute (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9820,3,0,"Leukemia, lymphosarcoma cell (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9820,3,0,"Leukemia, subacute, lymphatic (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9820,3,0,"Leukemia, subacute, lymphocytic (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9820,3,0,"Leukemia, subacute, lymphoid (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9820,3,0,"Lymphatic leukemia, NOS (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9820,3,0,"Lymphocytic leukemia, NOS (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9820,3,0,Lymphosarcoma cell leukemia (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9820,3,0,Subacute lymphatic leukemia (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9820,3,0,Subacute lymphocytic leukemia (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9820,3,0,Subacute lymphoid leukemia (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9823,1,1,"Monoclonal B-cell lymphocytosis, CLL-type [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9823,1,0,"B-cell lymphocytosis, monoclonal, CLL-type [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9823,1,0,"Lymphocytosis, Monoclonal B-cell, CLL-type [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9823,3,1,Chronic lymphocytic leukemia/small lymphocytic lymphoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9823,3,0,B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9823,3,0,Chronic lymphatic leukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9823,3,0,Chronic lymphocytic leukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9823,3,0,"Chronic lymphocytic leukemia, B-cell type (includes all variants of BCLL) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9823,3,0,Chronic lymphoid leukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9823,3,0,"Leukemia, B-cell type, chronic lymphocytic (include all variants of BCLL) (see also M-9670/3) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9823,3,0,"Leukemia, B-cell, chronic lymphocytic leukemia/small lymphocytic lymphoma (see also M-9670/3) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9823,3,0,"Leukemia, chronic, B-cell, lymphocytic leukemia/small lymphocytic lymphoma (see also M-9670/3) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9823,3,0,"Leukemia, chronic, lymphatic (see also M-9670/3) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9823,3,0,"Leukemia, chronic, lymphocytic, B-cell type (include all variants of BCLL) (see also M-9670/3) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9823,3,0,"Leukemia, chronic, lymphocytic, leukemia/small lymphocytic lymphoma, B-cell (see also M-9670/3) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9823,3,0,"Leukemia, chronic, lymphocytic, NOS (see alsoM-9670/3) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9823,3,0,"Leukemia, chronic, lymphoid (see also M-9670/3) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9823,3,0,"Leukemia, lymphatic, chronic (see also M-9670/3) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9823,3,0,"Leukemia, lymphocytic, B-cell chronic, leukemia/small lymphocytic lymphoma (see also M-9670/3) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9823,3,0,"Leukemia, lymphocytic, chronic (see also M-9670/3) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9823,3,0,"Leukemia, lymphocytic, chronic, B-cell type (includes all variants of BCLL) (see also M-9670/3) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9823,3,0,"Leukemia, lymphoid, chronic (see also M-9670/3) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9823,3,0,"Leukemia-lymphoma, B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma (see also M-9670/3) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9826,3,1,"Burkitt cell leukemia (C42.1) [PRE-2021 ONLY. 2021+, USE CODE 9687/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9826,3,0,"Acute leukemia, Burkitt type (C42.1) [obs] [PRE-2021 ONLY. 2021+, USE CODE 9687/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9826,3,0,"Acute lymphoblastic leukemia, mature B-cell type (C42.1) [PRE-2021 ONLY. 2021+, USE CODE 9687/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9826,3,0,"ALL, B (C42.1) [PRE-2021 ONLY. 2021+, USE CODE 9687/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9826,3,0,"B-ALL (C42.1) [obs] [PRE-2021 ONLY. 2021+, USE CODE 9687/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9826,3,0,"Burkitt type, acute leukemia (C42.1) [obs] [PRE-2021 ONLY. 2021+, USE CODE 9687/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9826,3,0,"FAB L3 (C42.1) [obs] [PRE-2021 ONLY. 2021+, USE CODE 9687/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9826,3,0,"Leukemia, acute, B-ALL (C42.1) [PRE-2021 ONLY. 2021+, USE CODE 9687/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9826,3,0,"Leukemia, acute, Burkitt type (C42.1) [obs] [PRE-2021 ONLY. 2021+, USE CODE 9687/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9826,3,0,"Leukemia, acute, lymphoblastic, mature B-cell type (C42.1) [PRE-2021 ONLY. 2021+, USE CODE 9687/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9826,3,0,"Leukemia, B-ALL (C42.1) [PRE-2021 ONLY. 2021+, USE CODE 9687/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9826,3,0,"Leukemia, B-cell type, mature, acute lymphoblastic (C42.1) [PRE-2021 ONLY. 2021+, USE CODE 9687/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9826,3,0,"Leukemia, Burkitt cell (C42.1) [PRE-2021 ONLY. 2021+, USE CODE 9687/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9826,3,0,"Leukemia, Burkitt type, acute (C42.1) [obs] [PRE-2021 ONLY. 2021+, USE CODE 9687/3] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9826,3,0,"Leukemia, FAB L3 (C42.1) [obs] [PRE-2021 ONLY. 2021+, USE CODE 9687/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9826,3,0,"Leukemia, lymphoblastic, acute, mature B-cell type (C42.1) [PRE-2021 ONLY. 2021+, USE CODE 9687/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9826,3,0,"Leukemia, lymphocytic, B-ALL (C42.1) [PRE-2021 ONLY. 2021+, USE CODE 9687/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9826,3,0,"Leukemia, mature B-cell type, lymphoblastic, acute (C42.1) [PRE-2021 ONLY. 2021+, USE CODE 9687/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9827,3,1,Adult T-cell leukemia/lymphoma (HTLV-1 positive) (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9827,3,0,Adult T-cell leukemia (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9827,3,0,Adult T-cell lymphoma (includes all variants) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9827,3,0,Adult T-cell lymphoma/leukemia (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9827,3,0,"HTLV-1 positive, adult T-cell leukemia/lymphoma (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9827,3,0,"Leukemia, adult T-cell (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9827,3,0,"Leukemia, adult T-cell leukemia/lymphoma (HTLV-1 positive) (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9827,3,0,"Leukemia, adult T-cell lymphoma/leukemia (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9827,3,0,"Leukemia, lymphoma, adult T-cell (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9827,3,0,"Leukemia, T-cell, adult (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9827,3,0,"Leukemia, T-cell, leukemia/lymphoma (HTLV-1 positive), adult (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9827,3,0,"Leukemia, T-cell, lymphoma/leukemia, adult (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9827,3,0,"Leukemia-lymphoma, adult T-cell (HTLV-1 positive) (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9827,3,0,"Leukemia-lymphoma, adult T-cell (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9827,3,0,"Lymphoma (malignant), adult T-cell (includes all variants) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9827,3,0,"Lymphoma (malignant), adult T-cell leukemia/lymphoma (HTLV-1 positive) (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9827,3,0,"Lymphoma (malignant), adult T-cell lymphoma/leukemia (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9827,3,0,"Lymphoma (malignant), leukemia, adult T-cell (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9827,3,0,"Lymphoma (malignant), T-cell, adult (includes all variants) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9827,3,0,"Lymphoma (malignant), T-cell, adult T-cell leukemia/lymphoma (HTLV-1 positive) (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9827,3,0,"Lymphoma (malignant), T-cell, adult T-cell lymphoma/leukemia (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9827,3,0,"Lymphoma/leukemia, adult T-cell (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9831,3,1,T-cell large granular lymphocytic leukemia (C42.1) [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9831,3,0,Chronic lymphoproliferative disorder of NK -cells [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9831,3,0,"Granular lymphocytosis, T-cell large (C42.1) [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9831,3,0,"Large granular lymphocytic leukemia, NK-cell (C42.1) [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9831,3,0,"Large granular lymphocytosis, NOS (C42.1) [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9831,3,0,"Large granular lymphocytosis, T-cell (C42.1) [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9831,3,0,"Leukemia, granular lymphocytic, NK-cell large(C42.1) [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9831,3,0,"Leukemia, granular lymphocytic, T-cell large (C42.1) [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9831,3,0,"Leukemia, large granular lymphocytic, NK-cell(C42.1) [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9831,3,0,"Leukemia, large granular lymphocytic, T-cell (C42.1) [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9831,3,0,"Leukemia, lymphocytic, NK-cell large granular(C42.1) [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9831,3,0,"Leukemia, lymphocytic, T-cell large granular (C42.1) [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9831,3,0,"Leukemia, NK-cell large granular lymphocytic (C42.1) [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9831,3,0,"Leukemia, T-cell, large granular lymphocytic (C42.1) [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9831,3,0,"Lymphocytosis, T-cell large granular (C42.1) [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9831,3,0,"Lymphoproliferative disorder of NK-cells, chronic [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9831,3,0,NK-cell large granular lymphocytic leukemia (C42.1) [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9831,3,0,T-cell large granular lymphocytosis (C42.1) [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9832,3,1,"Prolymphocytic leukemia, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9832,3,0,"Leukemia, prolymphocytic, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9833,3,1,"Prolymphocytic leukemia, B-cell type (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9833,3,0,"Leukemia, B-cell type, prolymphocytic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9833,3,0,"Leukemia, prolymphocytic, B-cell type (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9834,3,1,"Prolymphocytic leukemia, T-cell type (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9834,3,0,"Leukemia, prolymphocytic, T-cell type (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9834,3,0,"Leukemia, T-cell type, prolymphocytic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,1,"Precursor cell lymphoblastic leukemia, NOS (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,Acute lymphatic leukemia (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9835,3,0,"Acute lymphoblastic leukemia, L2 type, NOS (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Acute lymphoblastic leukemia, NOS (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Acute lymphoblastic leukemia, precursor-cell type (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Acute lymphoblastic leukemia-lymphoma, NOS (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,Acute lymphocytic leukemia (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9835,3,0,Acute lymphoid leukemia (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9835,3,0,FAB L1 (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9835,3,0,FAB L2 (C42.1) [obs] [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9835,3,0,"Leukemia, acute, L2 type lymphoblastic, NOS (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Leukemia, acute, lymphatic (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Leukemia, acute, lymphoblastic, NOS (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Leukemia, acute, lymphoblastic, NOS, L2 type (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Leukemia, acute, lymphoblastic, precursor-cell type (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Leukemia, acute, lymphocytic (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Leukemia, acute, lymphoid (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Leukemia, FAB L1 (C42.1) [obs] [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Leukemia, FAB L2 (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Leukemia, L2 type acute lymphoblastic, NOS (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Leukemia, lymphatic, acute (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Leukemia, lymphoblastic, acute, L2 type, NOS (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Leukemia, lymphoblastic, acute, NOS (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Leukemia, lymphoblastic, acute, NOS, L2 type (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Leukemia, lymphoblastic, acute, precursor-cell type (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Leukemia, lymphoblastic, NOS (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Leukemia, lymphoblastic, precursor cell, not phenotyped (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Leukemia, lymphocytic, acute (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Leukemia, lymphoid, acute (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Leukemia, precursor cell type, acute lymphoblastic (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Leukemia, precursor cell, acute lymphoblastic, not phenotyped (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Leukemia-lymphoma, acute lymphoblastic, NOS (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Lymphoblastic leukemia, NOS (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Lymphoblastic leukemia-lymphoma, acute, NOS (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9835,3,0,"Precursor cell lymphoblastic leukemia, not phenotyped (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836,3,1,Precursor B-cell lymphoblastic leukemia (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9836,3,0,"ALL, c (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836,3,0,"ALL, common precursor B (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836,3,0,"ALL, pre-B (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836,3,0,"ALL, pre-pre-B (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836,3,0,"ALL, pro-B (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836,3,0,"B-ALL, common precursor (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836,3,0,c-ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9836,3,0,Common ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9836,3,0,Common precursor B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9836,3,0,"Leukemia, acute, pre-B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836,3,0,"Leukemia, acute, pre-pre-B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836,3,0,"Leukemia, acute, pro-B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836,3,0,"Leukemia, B-cell, lymphoblastic, precursor (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836,3,0,"Leukemia, C-ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836,3,0,"Leukemia, common ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836,3,0,"Leukemia, common precursor ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836,3,0,"Leukemia, lymphoblastic, precursor, B-cell (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836,3,0,"Leukemia, lymphocytic, pre-B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836,3,0,"Leukemia, lymphocytic, pre-pre-B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836,3,0,"Leukemia, lymphocytic, pro-B ALL (C42.1) PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836,3,0,"Leukemia, pre-B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836,3,0,"Leukemia, precursor, B-cell lymphoblastic (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836,3,0,"Leukemia, pre-pre-B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836,3,0,"Leukemia, pro-B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9836,3,0,Pre-B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9836,3,0,Pre-pre-B ALL [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9836,3,0,Pro-B ALL (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9811/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9837,3,1,T lymphoblastic leukemia/lymphoma  [2010+. FOR PRE 2010 USE CODE 9729/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9837,3,0,"ALL, cortical T [2010+. FOR PRE 2010 USE CODE 9729/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9837,3,0,"ALL, mature T  [2010+. FOR PRE 2010 USE CODE 9729/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9837,3,0,"ALL, pre-T [2010+. FOR PRE 2010 USE CODE 9729/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9837,3,0,"ALL, pro-T [2010+. FOR PRE 2010 USE CODE 9729/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9837,3,0,Cortical T ALL [2010+. FOR PRE 2010 USE CODE 9729/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9837,3,0,"Leukemia, acute, cortical T ALL [2010+. FOR PRE 2010 USE CODE 9729/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9837,3,0,"Leukemia, acute, mature T ALL [2010+. FOR PRE 2010 USE CODE 9729/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9837,3,0,"Leukemia, acute, pre-T ALL [2010+. FOR PRE 2010 USE CODE 9729/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9837,3,0,"Leukemia, acute, pro-T ALL [2010+. FOR PRE 2010 USE CODE 9729/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9837,3,0,"Leukemia, cortical T ALL [2010+. FOR PRE 2010 USE CODE 9729/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9837,3,0,"Leukemia, lymphoblastic, precursor, T-cell  [2010+. FOR PRE 2010 USE CODE 9729/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9837,3,0,"Leukemia, pre-T ALL  [2010+. FOR PRE 2010 USE CODE 9729/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9837,3,0,"Leukemia, pro-T ALL  [2010+. FOR PRE 2010 USE CODE 9729/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9837,3,0,"Leukemia, T-cell, lymphoblastic, precursor  [2010+. FOR PRE 2010 USE CODE 9729/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9837,3,0,Mature T ALL  [2010+. FOR PRE 2010 USE CODE 9729/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9837,3,0,Precursor T-cell lymphoblastic leukemia [2010+. FOR PRE 2010 USE CODE 9729/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9837,3,0,Pre-T ALL  [2010+. FOR PRE 2010 USE CODE 9729/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9837,3,0,Pro-T ALL  [2010+. FOR PRE 2010 USE CODE 9729/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9837,3,0,"T ALL, cortical  [2010+. FOR PRE 2010 USE CODE 9729/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9837,3,0,"T ALL, mature  [2010+. FOR PRE 2010 USE CODE 9729/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9840,3,1,Acute erythroid leukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9840,3,0,Acute erythremia (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9840,3,0,Acute erythremic myelosis (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9840,3,0,"Acute myeloid leukemia, M6 type (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9840,3,0,AML M6 (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9840,3,0,Di Guglielmo disease (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9840,3,0,"Disease, Di Guglielmo (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9840,3,0,"Erythremia, acute (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]  "
9840,3,0,"Erythremic myelosis, acute (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9840,3,0,"Erythremic myelosis, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9840,3,0,Erythroleukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9840,3,0,FAB M6 (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9840,3,0,"Leukemia, acute, erythroid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9840,3,0,"Leukemia, acute, myeloid, M6 type (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9840,3,0,"Leukemia, AML M6 (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9840,3,0,"Leukemia, erythroid, acute (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9840,3,0,"Leukemia, FAB M6 (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9840,3,0,"Leukemia, M6 type acute myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9840,3,0,"Leukemia, M6A (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9840,3,0,"Leukemia, M6B (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9840,3,0,"Leukemia, myeloid, acute, M6 type (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9840,3,0,M6A (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9840,3,0,M6B (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9840,3,0,"Myelosis, acute erythremic (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9840,3,0,"Myelosis, erythremic, acute (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9840,3,0,"Myelosis, erythremic, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9860,3,1,"Myeloid leukemia, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9860,3,0,Aleukemic granulocytic leukemia (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9860,3,0,Aleukemic monocytic leukemia (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9860,3,0,Aleukemic myelogenous leukemia (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9860,3,0,Aleukemic myeloid leukemia (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9860,3,0,Chronic monocytic leukemia (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9860,3,0,Eosinophilic leukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9860,3,0,"Granulocytic leukemia, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9860,3,0,"Leukemia, aleukemic, granulocytic (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9860,3,0,"Leukemia, aleukemic, monocytic (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9860,3,0,"Leukemia, aleukemic, myelogenous (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9860,3,0,"Leukemia, aleukemic, myeloid (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9860,3,0,"Leukemia, chronic, monocytic (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9860,3,0,"Leukemia, eosinophilic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9860,3,0,"Leukemia, granulocytic, aleukemic (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9860,3,0,"Leukemia, granulocytic, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9860,3,0,"Leukemia, granulocytic, subacute (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]  "
9860,3,0,"Leukemia, monocytic, aleukemic (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9860,3,0,"Leukemia, monocytic, chronic (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9860,3,0,"Leukemia, monocytic, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9860,3,0,"Leukemia, monocytic, subacute (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9860,3,0,"Leukemia, myelocytic, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9860,3,0,"Leukemia, myelogenous, aleukemic (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9860,3,0,"Leukemia, myelogenous, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9860,3,0,"Leukemia, myelogenous, subacute (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9860,3,0,"Leukemia, myeloid, aleukemic (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9860,3,0,"Leukemia, myeloid, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9860,3,0,"Leukemia, myeloid, subacute (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9860,3,0,"Leukemia, myelomonocytic, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9860,3,0,"Leukemia, non-lymphocytic, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9860,3,0,"Leukemia, subacute, granulocytic (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9860,3,0,"Leukemia, subacute, monocytic (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9860,3,0,"Leukemia, subacute, myelogenous (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9860,3,0,"Leukemia, subacute, myeloid (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9860,3,0,"Monocytic leukemia, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9860,3,0,"Myelocytic leukemia, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9860,3,0,"Myelogenous leukemia, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9860,3,0,"Myelomonocytic leukemia, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9860,3,0,"Non-lymphocytic leukemia, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9860,3,0,Subacute granulocytic leukemia (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9860,3,0,Subacute monocytic leukemia (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9860,3,0,Subacute myelogenous leukemia (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9860,3,0,Subacute myeloid leukemia (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9861,3,1,"Acute myeloid leukemia, NOS (FAB or WHO type not specified) (see also M-9930/3) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9861,3,0,"Acute granulocytic leukemia, NOS (FAB or WHO type not specified) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9861,3,0,"Acute myelocytic leukemia, NOS (FAB or WHO type not specified) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9861,3,0,"Acute myelogenous leukemia, NOS (FAB or WHO type not specified) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9861,3,0,Acute non-lymphocytic leukemia (FAB or WHO type not specified) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9861,3,0,"Leukemia, acute, granulocytic (FAB or WHO type not specified) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9861,3,0,"Leukemia, acute, myelocytic (FAB or WHO type not specified) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9861,3,0,"Leukemia, acute, myelogenous (FAB or WHO type not specified) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9861,3,0,"Leukemia, acute, myeloid, NOS (FAB or WHO type not specified) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9861,3,0,"Leukemia, acute, non-lymphocytic (FAB or WHO type not specified) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9861,3,0,"Leukemia, granulocytic, acute (FAB or WHO type not specified) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9861,3,0,"Leukemia, myelocytic, acute (FAB or WHO type not specified) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9861,3,0,"Leukemia, myelogenous, acute (FAB or WHO type not specified) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9861,3,0,"Leukemia, myeloid, acute, NOS (FAB or WHO type not specified) (see also M-9930/3) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9861,3,0,"Leukemia, non-lymphocytic, acute (FAB or WHO type not specified) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9863,3,1,"Chronic myeloid leukemia, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9863,3,0,"Chronic granulocytic leukemia, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9863,3,0,"Chronic myelocytic leukemia, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9863,3,0,"Chronic myelogenous leukemia, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9863,3,0,"Leukemia, chronic, granulocytic, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9863,3,0,"Leukemia, chronic, myelocytic, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9863,3,0,"Leukemia, chronic, myelogenous, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9863,3,0,"Leukemia, chronic, myeloid, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9863,3,0,"Leukemia, granulocytic, chronic, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9863,3,0,"Leukemia, myelocytic, chronic, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9863,3,0,"Leukemia, myelogenous, chronic, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9863,3,0,"Leukemia, myeloid, chronic, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9865,3,1,Acute myeloid leukemia with t(6;9)(p23;q34); DEK-NUP214 [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9866,3,1,"Acute promyelocytic leukemia, t(15;17)(q22;q11-12) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9866,3,0,"Acute myeloid leukemia, PML/RAR-alpha (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9866,3,0,"Acute myeloid leukemia, t(15;17)(q22;q11-12) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9866,3,0,"Acute promyelocytic leukemia, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9866,3,0,"Acute promyelocytic leukemia, PML/RAR-alpha (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9866,3,0,FAB M3 (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9866,3,0,FAB M3 (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9866,3,0,"Leukemia, acute, myeloid, PML/RAR-alpha (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9866,3,0,"Leukemia, acute, myeloid, t(15;17)(q22;q11-12) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9866,3,0,"Leukemia, acute, promyelocytic, NOS (includes variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9866,3,0,"Leukemia, acute, promyelocytic, PML/RAR-alpha (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9866,3,0,"Leukemia, acute, promyelocytic, t(15;17)(q22;q11-12) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9866,3,0,"Leukemia, FAB M3 (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9866,3,0,"Leukemia, myeloid, acute, PML/RAR-alpha (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9866,3,0,"Leukemia, myeloid, acute, t(15;17)(q22;q11-12) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9866,3,0,"Leukemia, promyelocytic, acute, NOS (includes variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9866,3,0,"Leukemia, promyelocytic, acute, PML/RAR-alpha (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9866,3,0,"Leukemia, promyelocytic, acute, t(15;17)(q22;q11-12) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9866,3,0,"Leukemia, t(15;17)(q22;q11-12), acute myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9866,3,0,"Leukemia, t(15;17)(q22;q11-12), acute promyelocytic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9867,3,1,Acute myelomonocytic leukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9867,3,0,FAB M4 (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9867,3,0,"Leukemia, acute, myelomonocytic, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9867,3,0,"Leukemia, FAB M4 (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9867,3,0,"Leukemia, myelomonocytic, acute (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9869,3,1,Acute myeloid leukemia with inv(3)(q21;q26.2) or t(3;3)(q21p26.2); RPN1-EVI1 [2010+. SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9870,3,1,Acute basophilic leukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9870,3,0,"Leukemia, acute, basophilic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9870,3,0,"Leukemia, basophilic, acute (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,1,Acute myeloid leukemia with abnormal marrow eosinophils (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9871,3,0,"Abnormal marrow eosinophils, acute myeloid leukemia with (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Abnormal marrow eosinophils, acute myelomonocytic leukemia with (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Acute myeloid leukemia, CBF-beta/MYH11 (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Acute myeloid leukemia, inv(16)(p13;q22) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Acute myeloid leukemia, t(16;16)(p13;q11) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,Acute myelomonocytic leukemia with abnormal eosinophils (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9871,3,0,FAB M4Eo (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9871,3,0,"Leukemia, acute, myeloid, CBF-beta/MYH11 (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Leukemia, acute, myeloid, inv(16)(p13;q22) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Leukemia, acute, myeloid, t(16;16)(p13;q11) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Leukemia, acute, myeloid, with abnormal marrow eosinophils (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Leukemia, acute, myelomonocytic with abnormal eosinophils (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Leukemia, acute, with abnormal marrow eosinophils, myeloid (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Leukemia, CBF-beta/MYH11, acute myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Leukemia, FAB M4Eo (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Leukemia, inv(16)(p13;q22), acute myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Leukemia, myeloid, acute, CBF-beta/MYH11 (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Leukemia, myeloid, acute, inv(16)(p13;q22) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Leukemia, myeloid, acute, t(16;16)(p13;q11) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Leukemia, myeloid, acute, with abnormal marrow eosinophils (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Leukemia, myeloid, inv(16)(p13;q22), acute (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Leukemia, myeloid, with abnormal marrow eosinophils, acute (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Leukemia, myelomonocytic, acute, with abnormal eosinophils (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Leukemia, myelomonocytic, with abnormal eosinophils, acute (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Leukemia, t(16;16)(p13;q11), acute myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Leukemia, with abnormal marrow eosinophils, acute myeloid (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9871,3,0,"Leukemia, with abnormal marrow eosinophils, acute myelomonocytic (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9872,3,1,"Acute myeloid leukemia, minimal differentiation (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9872,3,0,Acute myeloblastic leukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9872,3,0,FAB M0 (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9872,3,0,"Leukemia, acute, myeloblastic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9872,3,0,"Leukemia, acute, myeloid, minimal differentiation (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9872,3,0,"Leukemia, FAB M0 (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9872,3,0,"Leukemia, minimal differentiation, acute myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9872,3,0,"Leukemia, myeloblastic, acute (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9872,3,0,"Leukemia, myeloid, acute, minimal differentiation (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9873,3,1,Acute myeloid leukemia without maturation (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9873,3,0,FAB M1 (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9873,3,0,"Leukemia, acute, myeloid, without maturation (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9873,3,0,"Leukemia, acute, without maturation, myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9873,3,0,"Leukemia, FAB M1 (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9873,3,0,"Leukemia, myeloid, acute, without maturation (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9873,3,0,"Leukemia, myeloid, without maturation, acute (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9873,3,0,"Leukemia, without maturation, acute myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9874,3,1,Acute myeloid leukemia with maturation (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9874,3,0,"FAB M2, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9874,3,0,"Leukemia, acute, myelocytic, with maturation (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9874,3,0,"Leukemia, acute, myeloid, with maturation (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9874,3,0,"Leukemia, FAB M2, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9874,3,0,"Leukemia, myelocytic, acute with maturation (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9874,3,0,"Leukemia, myeloid, acute, with maturation (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9874,3,0,"Leukemia, myeloid, with maturation, acute (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9874,3,0,"Leukemia, with maturation, acute myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,1,"Chronic myelogenous leukemia, BCR/ABL positive (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Chronic granulocytic leukemia, BCR/ABL (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Chronic granulocytic leukemia, Philadelphia chromosome (Ph1) positive (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Chronic granulocytic leukemia, t(9;22)(q34;q11) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Chronic myelogenous leukemia, Philadelphia chromosome (Ph1) positive (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Chronic myelogenous leukemia, t(9;22)(q34;q11) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Leukemia, BCR/ABL positive, chronic myelogenous (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Leukemia, BCR/ABL, chronic granulocytic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Leukemia, chronic, granulocytic, BCR/ABL (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Leukemia, chronic, granulocytic, Philadelphia chromosome Ph 1 positive (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Leukemia, chronic, granulocytic, t(9;22)(q34;q11) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Leukemia, chronic, myelogenous, BCR/ABL (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Leukemia, chronic, myelogenous, Philadelphia chromosome Ph 1 positive (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Leukemia, chronic, myelogenous, t(9;22)(q34;q11) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Leukemia, granulocytic, chronic, BCR/ABL (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Leukemia, granulocytic, chronic, Philadelphia chromosome (Ph 1) positive (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Leukemia, granulocytic, chronic, t(9;22)(q34;q11) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Leukemia, myelogenous, chronic, BCR/ABL (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Leukemia, myelogenous, chronic, Philadelphia chromosome Ph 1 positive (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Leukemia, myelogenous, chronic, t(9;22)(q34;q11) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Leukemia, Philadelphia chromosome Ph 1 positive, chronic granulocytic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Leukemia, Philadelphia chromosome Ph 1 positive, chronic myelogenous (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Leukemia, t(9;22)(q34;q11), chronic granulocytic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9875,3,0,"Leukemia, t(9;22)(q34;q11), chronic myelogenous (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9876,3,1,"Atypical chronic myeloid leukemia, BCR/ABL negative (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9876,3,0,"Atypical chronic myeloid leukemia, Philadelphia chromosome (Ph1) negative (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9876,3,0,"Leukemia, atypical chronic myeloid, BCR/ABL negative (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9876,3,0,"Leukemia, atypical chronic myeloid, Philadelphia chromosome Ph 1 negative (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9876,3,0,"Leukemia, BCR/ABL negative, atypical chronic myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9876,3,0,"Leukemia, chronic, atypical myeloid, BCR/ABL negative (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9876,3,0,"Leukemia, chronic, atypical myeloid, Philadelphia chromosome Ph 1 negative (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9876,3,0,"Leukemia, chronic, myeloid, BCR/ABL negative, atypical (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9876,3,0,"Leukemia, chronic, myeloid, Philadelphia chromosome Ph 1 negative, atypical (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9876,3,0,"Leukemia, myeloid, atypical chronic, BCR/ABL negative (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9876,3,0,"Leukemia, myeloid, atypical chronic, Philadelphia chromosome Ph 1 negative (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9876,3,0,"Leukemia, myeloid, chronic, BCR/ABL negative, atypical (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9876,3,0,"Leukemia, myeloid, chronic, Philadelphia chromosome Ph 1 negative, atypical (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9876,3,0,"Leukemia, Philadelphia chromosome Ph 1 negative, atypical chronic myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9877,3,1,Acute myeloid leukemia with mutated NPM1 [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9877,3,0,"Leukemia, acute, myeloid, with mutated NPM1 [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9877,3,0,"Leukemia, myeloid, acute, with mutated NPM1 [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9877,3,0,"Leukemia, myeloid, with mutated NPM1, acute [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9877,3,0,"Leukemia, with mutated NPM1, acute myeloid [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9878,3,1,Acute myeloid leukemia with biallelic mutation of CEBPA [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9878,3,0,"Leukemia, acute, myeloid, with biallelic mutation of CEBPA [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9878,3,0,"Leukemia, myeloid, acute, with biallelic mutation of CEBPA [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9878,3,0,"Leukemia, myeloid, with biallelic mutation of CEBPA, acute [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9878,3,0,"Leukemia, with biallelic mutation of CEBPA, acute myeloid [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9879,3,1,Acute myeloid leukemia with mutated RUNX1 [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9879,3,0,"Leukemia, acute, myeloid, with mutated RUNX1 [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9879,3,0,"Leukemia, myeloid, acute, with mutated RUNX1 [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9879,3,0,"Leukemia, myeloid, with mutated RUNX1, acute [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9879,3,0,"Leukemia, with mutated RUNX1, acute myeloid [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9891,3,1,Acute monocytic leukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9891,3,0,Acute monoblastic leukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9891,3,0,FAB M5 (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9891,3,0,"Leukemia, acute, monoblastic (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9891,3,0,"Leukemia, acute, monocytic (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9891,3,0,"Leukemia, FAB M5 (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9891,3,0,"Leukemia, monoblastic, acute (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9891,3,0,"Leukemia, monoblastic, NOS (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9891,3,0,"Leukemia, monocytic, acute (includes all variants) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9891,3,0,"Monoblastic leukemia, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9895,3,1,Acute myeloid leukemia with multilineage dysplasia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9895,3,0,Acute myeloid leukemia with prior myelodysplastic syndrome (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9895,3,0,Acute myeloid leukemia without prior myelodysplastic syndrome (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9895,3,0,"Dysplasia, multilineage, acute myeloid leukemia with (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9895,3,0,"Leukemia, acute, myeloid, with multilineage dysplasia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9895,3,0,"Leukemia, acute, myeloid, with prior myelodysplastic syndrome (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9895,3,0,"Leukemia, acute, myeloid, without prior myelodysplastic syndrome (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9895,3,0,"Leukemia, acute, with multilineage dysplasia, myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9895,3,0,"Leukemia, acute, with prior myelodysplastic syndrome, myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9895,3,0,"Leukemia, acute, without prior myelodysplastic syndrome, myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9895,3,0,"Leukemia, multilineage dysplasia, acute myeloid with (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9895,3,0,"Leukemia, myeloid, acute, with multilineage dysplasia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9895,3,0,"Leukemia, myeloid, acute, with prior myelodysplastic syndrome (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9895,3,0,"Leukemia, myeloid, acute, without prior myelodysplastic syndrome (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9895,3,0,"Leukemia, myeloid, with multilineage dysplasia, acute (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9895,3,0,"Leukemia, myeloid, with prior myelodysplastic syndrome, acute (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9895,3,0,"Leukemia, myeloid, without prior myelodysplastic syndrome, acute (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9895,3,0,"Leukemia, prior myelodysplastic syndrome, acute myeloid with (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9895,3,0,"Leukemia, prior myelodysplastic syndrome, acute myeloid without (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9895,3,0,"Leukemia, with multilineage dysplasia, acute myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9895,3,0,"Leukemia, without prior myelodysplastic syndrome, acute myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9895,3,0,"Myelodysplastic syndrome, prior, acute myeloid leukemia with (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9895,3,0,"Myelodysplastic syndrome, prior, acute myeloid leukemia without (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9895,3,0,"Syndrome, myelodysplastic, prior, acute myeloid leukemia with (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9895,3,0,"Syndrome, myelodysplastic, prior, acute myeloid leukemia without (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9896,3,1,"Acute myeloid leukemia, t(8;21)(q22;q22) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9896,3,0,"Acute myeloid leukemia, AML1(CBF-alpha)/ETO (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9896,3,0,"FAB M2, AML1(CBF-alpha)/ETO (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9896,3,0,"FAB M2, t(8;21)(q22;q22) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9896,3,0,"Leukemia, acute, myeloid, AML1(CBF-alpha)/ETO (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9896,3,0,"Leukemia, acute, myeloid, t(8;21)(q22;q22) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9896,3,0,"Leukemia, AML1(CBF-alpha)/ETO, acute myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9896,3,0,"Leukemia, AML1(CBF-alpha)/ETO, FAB M2 (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9896,3,0,"Leukemia, FAB M2, AML1(CBF-alpha)/ETO (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9896,3,0,"Leukemia, FAB M2, t(8;21)(q22;q22) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9896,3,0,"Leukemia, myeloid, acute, AML1(CBF-alpha)/ETO (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9896,3,0,"Leukemia, myeloid, acute, t(8;21)(q22;q22) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9896,3,0,"Leukemia, t(8;21)(q22;q22), acute myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9896,3,0,"Leukemia, t(8;21)(q22;q22), FAB M2 (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9897,3,1,"Acute myeloid leukemia, 11q23 abnormalities (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9897,3,0,"Acute myeloid leukemia, MLL (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9897,3,0,"Leukemia, 11q23 abnormalities, acute myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9897,3,0,"Leukemia, acute, myeloid, 11q23 abnormalities (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9897,3,0,"Leukemia, acute, myeloid, MLL (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9897,3,0,"Leukemia, MLL, acute myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9897,3,0,"Leukemia, myeloid, 11q23 abnormalities, acute (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9897,3,0,"Leukemia, myeloid, acute, MLL (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9898,3,1,Myeloid leukemia associated with Down Syndrome [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9910,3,1,Acute megakaryoblastic leukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9910,3,0,FAB M7 (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9910,3,0,"Leukemia, acute, megakaryoblastic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9910,3,0,"Leukemia, FAB M7 (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9910,3,0,"Leukemia, megakaryoblastic, acute (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9910,3,0,"Leukemia, megakaryocytic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9910,3,0,"Megakaryoblastic leukemia, acute (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9910,3,0,Megakaryocytic leukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9910,3,0,"Megakaryocytic leukemia, acute (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9911,3,1,Acute myeloid leukemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1 [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9911,3,0,"Leukemia, acute myeloid (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1 [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9912,3,1,Acute myeloid leukemia with BCR-ABL1 [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9912,3,0,"Leukemia, acute, myeloid, with BCR-ABL1 [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9912,3,0,"Leukemia, myeloid, acute, with BCR-ABL1 [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9912,3,0,"Leukemia, myeloid, with BCR-ABL1, acute [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9912,3,0,"Leukemia, with BCR-ABL1, acute myeloid [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9920,3,1,Therapy-related myeloid neoplasm (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9920,3,0,"Leukemia, acute, myeloid, therapy-related, alkylating agent related (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9920,3,0,"Leukemia, acute, myeloid, therapy-related, epipodophyllotoxin-related (C42.1)  [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9920,3,0,"Leukemia, acute, myeloid, therapy-related, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9920,3,0,"Leukemia, alkylating agent related, therapy-related, acute myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9920,3,0,"Leukemia, epipodophyllotoxin related, therapy related, acute myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9920,3,0,"Leukemia, myeloid, acute, therapy-related, alkylating agent related (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9920,3,0,"Leukemia, myeloid, acute, therapy-related, epipodophyllotoxin-related (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9920,3,0,"Leukemia, myeloid, acute, therapy-related, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9920,3,0,"Leukemia, therapy-related acute myeloid, alkylating agent related (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9920,3,0,"Leukemia, therapy-related acute myeloid, epipodophyllotoxin-related (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9920,3,0,"Leukemia, therapy-related acute myeloid, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9920,3,0,"Therapy-related acute myeloid leukemia, alkylating agent related (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9920,3,0,"Therapy-related acute myeloid leukemia, epipodophyllotoxin-related (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9920,3,0,"Therapy-related acute myeloid leukemia, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9930,3,1,Myeloid sarcoma (see also M-9861/3) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9930,3,0,Chloroma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9930,3,0,Granulocytic sarcoma [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9930,3,0,"Sarcoma, granulocytic [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9930,3,0,"Sarcoma, myeloid (see also M-9861/3) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9931,3,1,Acute panmyelosis with myelofibrosis (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9931,3,0,Acute myelofibrosis (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9931,3,0,"Acute myelosclerosis, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9931,3,0,"Acute panmyelosis, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9931,3,0,Malignant myelosclerosis (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9931,3,0,Myelofibrosis with panmyelosis (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9931,3,0,"Myelofibrosis, acute (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9931,3,0,"Myelosclerosis, acute, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9931,3,0,"Myelosclerosis, malignant (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9931,3,0,Panmyelosis with myelofibrosis (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9931,3,0,"Panmyelosis, acute, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9940,3,1,Hairy cell leukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9940,3,0,Hairy cell leukemia variant (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9940,3,0,"Leukemia, hairy cell (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9940,3,0,"Leukemia, hairy cell, variant (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9940,3,0,Leukemic reticuloendotheliosis (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9940,3,0,"Reticuloendotheliosis, leukemic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9945,3,1,"Chronic myelomonocytic leukemia, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9945,3,0,Chronic myelomonocytic leukemia in transformation (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9945,3,0,"Chronic myelomonocytic leukemia, Type I (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9945,3,0,"Chronic myelomonocytic leukemia, Type II (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9945,3,0,"Leukemia, chronic, myelomonocytic, in transformation (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9945,3,0,"Leukemia, chronic, myelomonocytic, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9945,3,0,"Leukemia, chronic, myelomonocytic, Type I (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9945,3,0,"Leukemia, chronic, myelomonocytic, Type II (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9945,3,0,"Leukemia, myelomonocytic, chronic, in transformation (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9945,3,0,"Leukemia, myelomonocytic, chronic, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9945,3,0,"Leukemia, myelomonocytic, chronic, Type I (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9945,3,0,"Leukemia, myelomonocytic, chronic, Type II (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9945,3,0,"Leukemia, myelomonocytic, in transformation, chronic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9946,3,1,Juvenile myelomonocytic leukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9946,3,0,Juvenile chronic myelomonocytic leukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9946,3,0,"Leukemia, chronic, juvenile myelomonocytic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9946,3,0,"Leukemia, chronic, myelomonocytic, juvenile (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9946,3,0,"Leukemia, juvenile myelomonocytic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9946,3,0,"Leukemia, myelomonocytic, chronic, juvenile (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9946,3,0,"Leukemia, myelomonocytic, juvenile (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9946,3,0,"Leukemia, myelomonocytic, juvenile, chronic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9948,3,1,Aggressive NK-cell leukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9948,3,0,"Leukemia, aggressive NK-cell (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9948,3,0,"Leukemia, NK-cell, aggressive (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9950,3,1,Polycythemia vera (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9950,3,0,Chronic erythremia (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9950,3,0,"Erythremia, chronic (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9950,3,0,Polycythemia rubra vera (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9950,3,0,"Polycythemia, proliferative (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9950,3,0,Proliferative polycythemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9950,3,0,"Rubra vera, polycythemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9960,3,1,"Chronic myeloproliferative disease, NOS (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9975/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9960,3,0,Chronic myeloproliferative disorder (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9975/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9960,3,0,"Disease, chronic myeloproliferative, NOS (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9975/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9960,3,0,"Disease, myeloproliferative, chronic, NOS (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9975/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9960,3,0,"Disorder, chronic myeloproliferative (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9975/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9960,3,0,"Myeloproliferative disease, chronic, NOS (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9975/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9960,3,0,"Myeloproliferative disorder, chronic (C42.1) [PRE-2010 ONLY. FOR 2010+ USE CODE 9975/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9961,3,1,Myelosclerosis with myeloid metaplasia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9961,3,0,Agnogenic myeloid metaplasia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9961,3,0,Chronic idiopathic myelofibrosis (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9961,3,0,"Idiopathic myelofibrosis, chronic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9961,3,0,Megakaryocytic myelosclerosis (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9961,3,0,"Metaplasia, agnogenic myeloid (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9961,3,0,"Metaplasia, myeloid, with myelofibrosis (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9961,3,0,"Metaplasia, myeloid, with myelosclerosis (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9961,3,0,Myelofibrosis as a result of myeloproliferative disease (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9961,3,0,Myelofibrosis with myeloid metaplasia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9961,3,0,"Myelofibrosis, chronic idiopathic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9961,3,0,"Myeloproliferative disease, myelofibrosis as a result of (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9961,3,0,"Myelosclerosis, megakaryocytic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9962,3,1,Essential thrombocythemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9962,3,0,Essential hemorrhagic thrombocythemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9962,3,0,"Essential thrombocythemia, hemorrhagic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9962,3,0,"Hemorrhagic thrombocythemia, essential (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9962,3,0,"Hemorrhagic thrombocythemia, idiopathic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9962,3,0,Idiopathic hemorrhagic thrombocythemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9962,3,0,Idiopathic thrombocythemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9962,3,0,"Idiopathic thrombocythemia, hemorrhagic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9962,3,0,"Thrombocythemia, essential (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9962,3,0,"Thrombocythemia, essential hemorrhagic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9962,3,0,"Thrombocythemia, hemorrhagic, essential (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9962,3,0,"Thrombocythemia, hemorrhagic, idiopathic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9962,3,0,"Thrombocythemia, idiopathic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9962,3,0,"Thrombocythemia, idiopathic hemorrhagic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9963,3,1,Chronic neutrophilic leukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9963,3,0,"Leukemia, chronic, neutrophilic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9963,3,0,"Leukemia, neutrophilic, chronic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9964,3,1,Hypereosinophilic syndrome (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9964,3,0,Chronic eosinophilic leukemia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9964,3,0,"Leukemia, chronic, eosinophilic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9964,3,0,"Leukemia, eosinophilic, chronic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9964,3,0,"Syndrome, hypereosinophilic (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9965,3,1,Myeloid and lymphoid neoplasms with PDGFRA rearrangement [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9966,3,1,Myeloid neoplasms with PDGFRB rearrangement [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9967,3,1,Myeloid and lymphoid neoplasm with FGFR1 abnormalities [2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9968,3,1,Myeloid or lymphoid neoplasm with PCM1-JAK2 [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9968,3,0,Lymphoid or Myeloid neoplasm with PCM1-JAK2 [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9968,3,0,"Neoplasm with PCM1-JAK2, lymphoid or myeloid [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9968,3,0,"Neoplasm with PCM1-JAK2, myeloid or lymphoid [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9968,3,0,"Neoplasm, lymphoid or myeloid with PCM1-JAK2 [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9968,3,0,"Neoplasm, myeloid or lymphoid with PCM1-JAK2 [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9970,1,1,"Lymphoproliferative disorder, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9970,1,0,"Disease, lymphoproliferative, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9970,1,0,"Disorder, lymphoproliferative, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9970,1,0,"Lymphoproliferative disease, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9971,1,1,"Post Transplant Lymphoproliferative Disorder, NOS (PTLD) [2021+ NOT REPORTABLE. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9971,1,0,Polymorphic Post Transplant Lymphoproliferative Disorder (PTLD) [2021+ NOT REPORTABLE. SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9971,3,1,Polymorphic Post Transplant Lymphoproliferative Disorder (PTLD) [REPORTABLE 2010 - 2020 ONLY. SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9975,3,1,"Myelodysplastic/Myeloproliferative neoplasm, unclassifiable [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9975,3,0,"Disease, myeloproliferative, NOS (C42.1) [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9975,3,0,"Myeloproliferative disease, NOS (C42.1) [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9975,3,0,"Myeloproliferative neoplasm, unclassifiable [REPORTABLE 2010+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9980,3,1,Myelodysplastic syndrome with single lineage dysplasia [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9980,3,0,"Anemia, refractory, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9980,3,0,"Anemia, refractory, without sideroblasts (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9980,3,0,Refractory anemia without sideroblasts (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9980,3,0,"Refractory anemia, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9980,3,0,"Refractory neutropenia [2021+. FOR 2010 - 2020, USE CODE 9991/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9980,3,0,"Refractory thrombocytopenia [2021+. FOR 2010 - 2020, USE CODE 9992/3; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9980,3,0,"Sideroblasts, refractory anemia without (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9980,3,0,"Syndrome, myelodysplastic with single lineage dysplasia [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9982,3,1,Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9982,3,0,"Anemia, refractory, with ringed sideroblasts (RARS) (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9982,3,0,"Anemia, refractory, with sideroblasts (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9982,3,0,RARS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9982,3,0,Refractory anemia with ringed sideroblasts (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9982,3,0,Refractory anemia with sideroblasts (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9982,3,0,"Sideroblasts, refractory anemia with (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9982,3,0,"Sideroblasts, refractory anemia with ringed (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9982,3,0,"Syndrome, myelodysplastic with ring sideroblasts and single lineage dysplasia [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9983,3,1,Myelodysplastic syndrome with excess blasts [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9983,3,0,"Anemia, refractory, with excess blasts, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9983,3,0,"Excess blasts, refractory anemia NOS with (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9983,3,0,RAEB (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9983,3,0,RAEB I (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9983,3,0,RAEB II (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9983,3,0,Refractory anemia with excess blasts (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9983,3,0,"Syndrome, myelodysplastic with excess blasts [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9984,3,1,Refractory anemia with excess blasts in transformation (C42.1) [obs] [FOR PRE-2010 ONLY. FOR 2010+ USE CODE 9983/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9984,3,0,"Anemia, refractory, with excess blasts in transformation (C42.1) [obs] [FOR PRE-2010 ONLY. FOR 2010+ USE CODE 9983/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9984,3,0,"Excess blasts in transformation, refractory anemia with (C42.1) [obs] [FOR PRE-2010 ONLY. FOR 2010+ USE CODE 9983/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9984,3,0,RAEB-T (C42.1)  [FOR PRE-2010 ONLY. FOR 2010+ USE CODE 9983/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9985,3,1,Myelodysplastic syndrome with multilineage dysplasia [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9985,3,0,"Cytopenia with multilineage dysplasia, refractory (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9985,3,0,"Dysplasia, multilineage, refractory cytopenia with (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9985,3,0,"Multilineage dysplasia, refractory cytopenia with (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9985,3,0,Refractory cytopenia of childhood [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9985,3,0,Refractory cytopenia with multilineage dysplasia (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9985,3,0,"Syndrome, myelodysplastic with multilineage dysplasia [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9986,3,1,Myelodysplastic syndrome with isolated del (5q) [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9986,3,0,Myelodysplastic syndrome with 5q deletion (5q-) syndrome (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9986,3,0,"Syndrome, 5q deletion (5q-), with myelodysplastic syndrome (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9986,3,0,"Syndrome, myelodysplastic with isolated del (5q) [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9986,3,0,"Syndrome, myelodysplastic, with 5q deletion (5q-) syndrome (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9987,3,1,"Therapy-related myelodysplastic syndrome, NOS (C42.1) [FOR PRE-2010 ONLY. FOR 2010+ USE CODE 9920/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9987,3,0,"Myelodysplastic syndrome, alkylating agent related, therapy-related (C42.1) [FOR PRE-2010 ONLY. FOR 2010+ USE CODE 9920/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9987,3,0,"Myelodysplastic syndrome, epipodophyllotoxin-related, therapy-related (C42.1) [FOR PRE-2010 ONLY. FOR 2010+ USE CODE 9920/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9987,3,0,"Myelodysplastic syndrome, therapy-related, alkylating agent related (C42.1) [FOR PRE-2010 ONLY. FOR 2010+ USE CODE 9920/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9987,3,0,"Myelodysplastic syndrome, therapy-related, epipodophyllotoxin-related (C42.1) [FOR PRE-2010 ONLY. FOR 2010+ USE CODE 9920/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9987,3,0,"Myelodysplastic syndrome, therapy-related, NOS(C42.1) [FOR PRE-2010 ONLY. FOR 2010+ USE CODE 9920/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9987,3,0,"Therapy-related myelodysplastic syndrome, alkylating agent related (C42.1) [FOR PRE-2010 ONLY. FOR 2010+ USE CODE 9920/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9987,3,0,"Therapy-related myelodysplastic syndrome, epipodophyllotoxin-related (C42.1) [FOR PRE-2010 ONLY. FOR 2010+ USE CODE 9920/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9989,3,1,"Myelodysplastic syndrome, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9989,3,0,Preleukemia (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9989,3,0,Preleukemic syndrome (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] 
9989,3,0,"Syndrome, myelodysplastic, NOS (C42.1) [SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9989,3,0,"Syndrome, preleukemic (C42.1) [obs] [SEE HEMATOPOIETIC DATABASE FOR REPORTING] "
9991,3,1,"Refractory neutropenia [FOR 2010 - 2020 ONLY. 2021+, USE CODE 9980/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9992,3,1,"Refractory thrombocytopenia [FOR 2010 - 2020 ONLY. 2021+, USE CODE 9980/3. SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9993,3,1,Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]
9993,3,0,"Syndrome, myelodysplastic, with ring sideroblasts and multilineage dysplasia [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
9993,3,0,"Syndrome, with ring sideroblasts and multilineage dysplasia, myelodysplastic [2021+; SEE HEMATOPOIETIC DATABASE FOR REPORTING]"
